final programme
TRANSCRIPT
Friday 17 84
Saturday 18 91
Sunday 19 231
Monday 21 361
scientifi c programme
European Society of Hypertension
Friday
17
Friday
17
84Friday 1784 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 201185
Friday 1715.00 - 16.45Red Hall
Satellite Symposium
Sponsored by Daiichi-Sankyo / The Menarini Group
EXCELLENCE IN THERAPY. HYPERTENSION CARE: A NEW WAY TO SUCCESS
Chairpersons: S. Laurent (Paris-FRANCE) J. Redon (Valencia-SPAIN)
IntroductionS. Laurent (Paris-FRANCE)
SESSION 1 - Clinical Hot Topics Microalbuminuria: A simple test can make all the differenceJ. Redon (Valencia-SPAIN) Olmesartan - based triple therapyM. Volpe (Rome-ITALY) Getting to goal and staying there: Simplify and comply!K. Narkiewicz (Gdansk-POLAND) Questions & Answers
SESSION 2 - We Need to Talk! Real-life issues in the management of hypertensionFacilitator: A. Maryon-Davis (London-UK)
Panel and audience discussionModerator: A. Maryon-Davis (London-UK)
SESSION 3 - Hypertension Care: Raising expectations! Olmesartan-based therapy: A complete range of optionsL.M. Ruilope (Madrid-SPAIN)
Solutions for improving hypertension careR.E. Schmieder (Erlangen-GERMANY) Questions & Answers Summary and Meeting CloseJ. Redon (Valencia-SPAIN)
Friday
17
86Friday 1786 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 201187
Friday 1717.30 - 19.00 Auditorium
Opening Ceremony and Concert
19.00 - 20.00Ground Floor
Welcome Cocktail
15.00 - 17.00Blue Hall
Satellite Symposium
Sponsored by Recordati
ROLE OF ANTIHYPERTENSIVE AND LIPID LOWERING TREATMENT IN CARDIOVASCULAR RISK REDUCTION
Chairpersons: G. Mancia (Milan-ITALY) P. Monteiro (Coimbra-PORTUGAL)
Opening remarksP. Monteiro (Coimbra-PORTUGAL) Early vascular damage as a target for treatment in hypertensionE. Agabiti Rosei (Brescia-ITALY) Blood pressure variability: mechanism, clinical relevance and impact of treatmentG. Parati (Milan-ITALY) What is the best therapeutic strategy to protect vascular function and structure? Results from S.E.L.E.N.E. studyS. Taddei (Pisa-ITALY) Endothelium damage and pleiotropic effects of pitavastatinP. Monteiro (Coimbra-PORTUGAL) The advantages of a new statin in polimedicated patientsM. Farnier (Dijion-FRANCE) Discussion Closing remarksG. Mancia (Milan-ITALY)
Friday
17
88Friday 1788 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 201189
Friday 1719.30 - 20.30 Orange Hall 2
ESH Working Group ON BLOOD PRESSURE IN CHILDREN AND ADOLESCENTS
Chairpersons: S. Erdine (Istanbul-TURKEY) M. Litwin (Warsaw-POLAND) Hypertension in pregnancy: the impact on the newbornR. Cifková (Prague-CZECH REPUBLIC) Mother antihypertensive drugs and adverse effects on the newbornE. Lurbe (Valencia-SPAIN) Effects of early growth on blood pressureJ.K. Cruickshank (Manchester-UK) Prevalence of hypertension in children and adolescents in EuropeD. Pall (Debrecen-HUNGARY) Panel discussants:D. Drozdz (Krakow-POLAND)N. Martell-Claros (Madrid-SPAIN)S. Stambouli (Thessaloniki-GREECE)M. Strambi (Siena-ITALY)
18.30 - 20.30 Orange Hall 3
ESH Working Group ON BLOOD PRESSURE MONITORING
I - Scientific Session
Chairpersons: E. O’Brien (Dublin-IRELAND) R. Asmar (Paris-FRANCE)
Oscillometric BP measurement in atrial fi brillationG. Stergiou (Athens-GREECE) Morning surge in blood pressure - Evidence and PerspectivesK. Kario (Tochigi-JAPAN) Clinical signifi cance of short and long-term BP variabilityG. Parati (Milan-ITALY) Validation of estimated Central Blood PressuresT. Mengden (Bonn-GERMANY) Validation of professional devices. Comments on IP 2010J. Topouchian (Paris-FRANCE) Discussion
II - Business Meeting (19.30 -20.30) 1. Minutes WGBPM Oslo 20102. Update on database: ABPM and HBPM3. The ARTEMIS project4. Publication of new guidelines on BP measurements5. Software for statistical analysis and report of the validation studies6. Space and links to the ESH website7. Submission of members8. The proposal of a merge with the WG on BP and HR variability9. Other issues
Saturday
18
90Friday 1790 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 201191
Saturday 1819.30 - 21.30Green Hall 1
ESH Working Group ON ENDOCRINE HYPERTENSION
Chairpersons: J.W.M. Lenders (Nijmegen-THE NETHERLANDS) F. Mantero (Padua-ITALY) Genetic approach to the Pheochromocytoma/Paraganglioma SyndromeM. Castellano (Brescia-ITALY) Introduction to FIRSTMAPP (a trial for treatment of malignant pheochromocytoma)P.F. Plouin (Paris-FRANCE) Advances in primary aldosteronism (a report of PIPA 2 Symposium)M. Reincke (Munchen-GERMANY) The PAPPHY study (Prospective Appraisal of Prevalence of Primary Aldosteronism in Hypertensives with Atrial Fibrillation and Flutter)G.P. Rossi (Padua-ITALY)
07.45 - 08.45 Orange Hall 1
Breakfast Workshop
ASSESSING TOTAL CARDIOVASCULAR RISK. WHICH METHODS?
Chairpersons: R. Cifková (Prague-CZECH REPUBLIC) M. Viigimaa (Tallinn-ESTONIA) Risk stratifi cation in hypertension. IntroductionR. Cifková (Prague-CZECH REPUBLIC) How does target organ damage change the risk in hypertension?M.H. Olsen (Glostrup-DENMARK) Microalbuminuria in risk stratifi cation in hypertensionJ. Redon (Valencia-SPAIN)
Saturday
18
92Saturday 1892 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 201193
Saturday 1807.45 - 08.45 Orange Hall 3
Breakfast Workshop
RARE CASES OF SECONDARY HYPERTENSION
Chairperson: P.F. Plouin (Paris-FRANCE)
A patient with hypertension and Liddle syndrome J. Deinum (Nijmegen-THE NETHERLANDS) Macroaneurysms in a patient with fribromuscular dysplasiaM. Frank (Paris-FRANCE)
07.45 - 08.45 Orange Hall 2
Breakfast Workshop
PITFALLS IN THE ASSESSMENT OF BP AND THE DIAGNOSIS OF HYPERTENSION IN CHILDREN
Chairperson: G.S. Stergiou (Athens-GREECE)
Pitfalls in the assessment of BP and the diagnosis of hypertension in the offi ce/clinicG.S. Stergiou (Athens-GREECE) Pitfalls in the assessment of BP and the diagnosis of hypertension at homeG.S. Stergiou (Athens-GREECE) Pitfalls in the assessment of BP and the diagnosis of hypertension with ambulatory monitoringE. Lurbe (Valencia-SPAIN)
Pitfalls in the interpretation of all BP measurement methods and the diagnosis of hypertensionE. Lurbe (Valencia-SPAIN)
Saturday
18
94Saturday 1894 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 201195
Saturday 189.50AUTOMATED OSCILLOMETRIC DETERMINATION OF THE ANKLE BRACHIAL INDEX: A META-ANALYSISW. Verberk (1), A. Kollias (2), G. Stergiou (2)(1) Taipei-TAIWAN; (2) Athens-GREECE 10.00A FEW MINUTES REST BEFORE HOME BLOOD PRESSURE MEASUREMENT IS NOT RELEVANTJ.M Boivin, E. Boutte, R. Fay, P. Rossignol, F. ZannadVandoeuvre les Nancy-FRANCE
10.10REDUCED NOCTURNAL PULSE PRESSURE DIPPING IN SALT-SENSITIVE MILD HYPERTENSIVE SUBJECTS ALSO DURING HABITUAL DIET. A SCREENING TOOL FOR SODIUM SENSITIVITY?P. Castiglioni (1), G. Parati (1), L. Brambilla (2), V. Brambilla (2), M. Gualerzi (2), M. Di Rienzo (1), P. Coruzzi (2)(1) Milan, (2) Parma-ITALY 10.20PROGNOSIS OF ISOLATED SYSTOLIC AND DIASTOLIC HYPERTENSION DETERMINED WITH HOME BLOOD PRESSURE MEASUREMENTS: THE FINN-HOME STUDYT. Niiranen, A. Jula, J. Johansson, A. ReunanenTurku-FINLAND
10.30BLOOD FLOW IN THE MIDDLE CEREBRAL ARTERY IN RELATION TO THE STEADY AND PULSATILE COMPONENTS OF BLOOD PRESSURE IN THE SYSTEMIC CIRCULATIONT. Xu (1), W. Fan (1), J.A. Staessen (2), J. Xu (1), F. Li (1), P. Gao (1), J. Wang (1), Y. Li (1)(1) Shanghai-CHINA; (2) Leuven-BELGIUM 10.40SUMMER DOES NOT ALWAYS MEAN LOWER: SEASONALITY OF 24 H, DAYTIME AND NIGHT-TIME BLOOD PRESSUREM. Fedecostante, F. Guerra, P. Barbatelli, L. Lancioni, E. Giannini, E. Espinosa, R. Sarzani, P. Dessì-FulgheriAncona-ITALY
09.00 - 11.00 Auditorium
Parallel Oral Session 1A
BLOOD PRESSURE MEASUREMENT
Chairpersons: T. Kahan (Stockholm-SWEDEN) A. de la Sierra (Barcelona-SPAIN) 9.00CARDIOVASCULAR EVENTS IN THE SPANISH ABPM REGISTRYA. De La Sierra (1), J. Segura (2), J.R. Banegas (2), M. Gorostidi (3), L.M. Ruilope (2) on behalf of THE CARDIORISC EVENT INVESTIGATORS(1) Terrassa, (2) Madrid, (3) Oviedo-SPAIN
9.10IS BLUNTED HEART RATE DECREASE AT NIGHT ASSOCIATED TO PREVALENT ORGAN DAMAGE IN ESSENTIAL HYPERTENSION?S. Meani (1), C. Cuspidi (2), F. Negri (2), C. Valerio (2), C. Sala (2), G. Mancia (2)(1) Rho, (2) Milan-ITALY
9.20OSCILLOMETRIC ESTIMATION OF CENTRAL BLOOD PRESSURE: VALIDATION OF THE MOBIL-O-GRAPH® IN COMPARISON TO THE SPHYGMOCOR® DEVICEW. Weiss, C. Gohlisch, W. Zidek, M. van der GietBerlin-GERMANY
9.30ACCURACY OF AUTOMATED OSCILLOMETRIC BLOOD PRESSURE MEASUREMENT IN PATIENTS WITH ATRIAL FIBRILLATIONG.S. Stergiou, A. Destounis, A. Kollias, D. Tzamouranis, N. Karpettas, P. Kalogeropoulos, E. AndreadisAthens-GREECE
9.40AMBULATORY BLOOD PRESSURE MONITORING IN AUSTRALIA: 2011 DRAFT POSITION STATEMENTG. Head (1), B. McGrath (1), A. Mihailidou (2), M. Nelson (3), M. Schlaich (1), M. Stowasser (4), D. Cowley (4), A. Mangoni (5), J. Harman (2), L. Ruta (1),J. Wilson (1), A. Boyden (1)(1) Melbourne, (2) Sydney, (3) Hobart, (4) Brisbane-AUSTRALIA; (5) Aberdeen-UK
Saturday
18
96Saturday 1896 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 201197
Saturday 1809.00 - 10.30 Red Hall
Topical Workshop
ANTIHYPERTENSIVE DRUGS OF THE FUTURE
Chairpersons: M. Burnier (Lausanne-SWITZERLAND) H.A.J. Struijker-Boudier (Maastricht-THE NETHERLANDS) Endothelin receptor antagonists: what place in hypertension managementM. Burnier (Lausanne-SWITZERLAND) Drugs infl uencing arterial stiffnessS. Laurent (Paris-FRANCE) Aldosterone synthesis inhibitors and antagonistsH.A.J. Struijker-Boudier (Maastricht-THE NETHERLANDS)
10.50ON-TREATMENT AMBULATORY BLOOD PRESSURE IS A POTENT PREDICTOR OF FUTURE CARDIOVASCULAR RISK IN THE DUBLIN OUTCOME STUDYE. Dolan, E O’BrienDublin-IRELAND
Saturday
18
98Saturday 1898 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 201199
Saturday 1809.00 - 11.00 Orange Hall 1
Parallel Oral Session 1B
EPIDEMIOLOGY
Chairpersons: N.R. Poulter (London-UK) A. Rappelli (Ancona-ITALY) 9.00IMPACT OF NADIR CD4 CELL COUNT AND ANTIRETROVIRAL THERAPY ON HYPERTENSION IN A LONGITUDINAL STUDY OF HIV-INFECTED INDIVIDUALSI.W. Manner, M. Baekken, O. Oektedalen, I. OsOslo-NORWAY 9.10BIOCHEMICAL PREDICTORS OF PREGNANCY-INDUCED HYPERTENSIONN. Martell-Claros, M. Abad-Cardiel, F. Blanco-Kelly, M.A. Herráiz, M.E. Fuentes, M.J. Torrejon, A. Fernandez-CruzMadrid-SPAIN
9.20METABOLIC PROFILE, PATTERNS OF METABOLIC CONTROL BY TREATMENT AND RELATIONSHIPS WITH BLOOD PRESSURE VALUES IN PATIENTS FROM CENTRAL AND EASTERN EUROPEAN COUNTRIES: THE BP-CARE METABOLIC STUDYG. Brambilla (1), G. Seravalle (2), R. Cifková (3), S. Laurent (4), K. Narkiewicz (5),J. Redon (6), C. Farsang (7), M. Bombelli (1), C. Giannattasio (1), G. Mancia (2), G. Grassi (1)(1) Monza, (2) Milan-ITALY; (3) Prague-CZECH REPUBLIC; (4) Paris-FRANCE; (5) Gdansk-POLAND; (6) Valencia-SPAIN; (7) Budapest-HUNGARY
9.30IMPACT OF DIFFERENT ADIPOSITY MEASURES ON THE RELATION BETWEEN SERUM URIC ACID AND BLOOD PRESSURE IN YOUTHT. Lyngdoh (1), B. Viswanathan (2), G. Myers (3), M. Bochud (1), P. Bovet (1)(1) Lausanne-SWITZERLAND; (2) Seychelles-SEYCHELLES; (3) Rochester, NY-USA
09.00 - 10.30Blue Hall
Educational Session
Supported by an unrestricted educational grant by Daiichi-Sankyo
THE ROLE OF MICROALBUMINURIA (MAU) DETECTION FOR RISK PREVENTION IN CLINICAL PRACTICE
Chairpersons: G. Mancia (Milan-ITALY) J. Redon (Valencia-SPAIN)
IntroductionG. Mancia (Milan-ITALY) The pathophysiology of MAU: From risk factor to organ damageH. Haller (Hannover-GERMANY) Understanding MAU and its clinical implicationsR.E. Schmieder (Erlangen-GERMANY) MAU in untreated and treated hypertensive patients: European guidelinesG. Mancia (Milan-ITALY) MAU: Prevention and intervention, what can be achieved?J. Redon (Valencia-SPAIN) MAU in daily clinical practice: From guidelines to practical interventionPanel discussion Closing remarksJ. Redon (Valencia-SPAIN)
Saturday
18
100Saturday 18100 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011101
Saturday 1810.40LECTURELONG-TERM PROGNOSTIC IMPACT OF SYSTOLIC BLOOD PRESSURE MEASURED DURING PHYSICAL EXERCISES.E. KjeldsenOslo-NORWAY
9.40IMPAIRED FASTING GLUCOSE MARKEDLY INCREASES CARDIOVASCULAR RISK IN TREATED AND CONTROLLED HYPERTENSIVE PATIENTSP. Aranda (1), M.D. Martinez-Esteban (1), M. Gorostidi (2), J.J. De La Cruz (3), J. Segura (3), A. De La Sierra (4), J.R. Banegas (3), L.M. Ruilope (3), on behalf of the Spanish Society of Hypertension ABPM Registry investigators(1) Malaga, (2) Oviedo, (3) Madrid, (4) Barcelona-SPAIN 9.50OBESITY IS ASSOCIATED WITH INCREASED DAYTIME AND NIGHT-TIME PROXIMAL TUBULAR SODIUM REABSORPTION IN THE GENERAL ADULT POPULATIONM. Bochud, G. Wuerzner, M. Maillard, P. Vollenweider, F. Paccaud, M. BurnierLausanne-SWITZERLAND 10.00INCREASED DAYTIME PROXIMAL SODIUM REABSORPTION IS ASSOCIATED WITH REDUCED NOCTURNAL BLOOD PRESSURE DIPPING IN THE GENERAL POPULATIONM. Bochud, G. Wuerzner, M. Maillard, A. Beggah, P. Vollenweider, F. Paccaud, M. BurnierLausanne-SWITZERLAND
10.10HIGH PLASMA LEPTIN LEVELS PREDICT THE DEVELOPMENT OF INSULIN RESISTANCE IN AN INSELECTED SAMPLE OF ADULT MALE POPULATION. RESULTS OF THE OLIVETTI HEART STUDY (OHS)F. Galletti, L. D’Elia, G. Rossi, D. De Palma, R. Ippolito, A. Barbato, P. StrazzulloNaples-ITALY
10.20INCREASES IN CENTRAL FAT AND DECREASES IN PERIPHERAL FAT MASSES ARE ASSOCIATED WITH ACCELERATED ARTERIAL STIFFENING IN HEALTHY ADULTS. THE AMSTERDAM GROWTH AND HEALTH LONGITUDINAL STUDYF. Schouten (1), J.W. Twisk (1), M. De Boer (1), E.H. Serne (1), C.D. Stehouwer (2), Y.M. Smulders (1), I. Ferreira (2)(1) Amsterdam, (2) Maastricht-THE NETHERLANDS
10.30HYPERTENSION AND OSTEOPOROSIS IN POSTMENOPAUSAL WOMENM. Rasic Popovic (1), A. Dimic (2), I. Tasic (2)(1) Vranje, (2) Niska Banja-SERBIA
Saturday
18
102Saturday 18102 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011103
Saturday 189.40SIMVASTATIN TREATMENT IMPROVES AUTONOMIC CONTROL OF CIRCULATION AND REDUCES NORADRENALINE-INDUCED CONTRACTION IN RESISTANCE VESSEL FROM HYPERCHOLESTEROLEMIC MICEI.C. Moraes-Silva, L.E. Souza, L.V. Rossoni, K. De Angelis, M.C. IrigoyenSão Paulo-BRAZIL 9.50ALTERATION IN BETA-ADRENERGIC RELAXATION IS ASSOCIATED WITH MYOCARDIAL INFARCTION ADJUSTMENTS IN CORONARY ARTERIES FROM NORMOTENSIVE AND HYPERTENSIVE RATSG.K. Couto, L.V. RossoniSão Paulo-BRAZIL
10.00LECTURENEW LIFE TO AN OLD EXAMINATION. RETINAL CHANGES IN HYPERTENSIONG. MichelsonErlangen-GERMANY
10.20RECOMBINANT HUMAN ERYTHROPOIETIN ALTERS SUBCUTANEOUS RESISTANCE ARTERY ENDOTHELIAL FUNCTION THROUGH A MECHANISM INVOLVING OXIDATIVE STRESS AND ENDOTHELIN-1 IN PATIENTS WITH STAGE 4 CHRONIC KIDNEY DISEASEM. Briet, T. Barhoumi, M. Davidman, D. Bercovitch, G. Frisch, S.J. Nessim, M.L. Lipman, E.L. SchiffrinMontreal-CANADA 10.30CLOSE RELATIONSHIP BETWEEN MEDIA TO LUMEN RATIO OF SUBCUTANEOUS SMALL ARTERIES AND WALL TO LUMEN RATIO OF RETINAL ARTERIOLES EVALUATED NON INVASIVELY BY SCANNING LASER DOPPLER FLOWMETRYD. Rizzoni (1), C. De Ciuceis (1), E. Porteri (1), E. La Boria (1), S. Duse (1),F. Semeraro (1), C. Costagliola (2), A. Sebastiani (3), P. Danzi (1), G.A.M. Tiberio (1), S.M. Giulini (1), C. Agabiti Rosei (1), A. Sarkar (1), D. Avanzi (1), E. Agabiti Rosei (1)(1) Brescia, (2) Campobasso, (3) Ferrara-ITALY
09.00 - 11.00 Orange Hall 2
Parallel Oral Session 1C
SMALL VESSELS
Chairpersons: A. Benetos (Nancy-FRANCE) A. Pittaras (Athens-GREECE) 9.00ENHANCEMENT OF ANGIOTENSIN II INDUCED CONTRACTION BY OXIDATIVE STRESS INVOLVES ACTIVATION OF P38 MAPK IN MESENTERIC ARTERIES OF MICEA. Patzak (1), S. Schmidt (1), M. Faehling (1), M. Gaestel (2), J. Rettig-Zimmermann (1), A. Perlewitz (1), P. Martinka (1)(1) Berlin, (2) Hannover-GERMANY
9.10RETINAL PULSE WAVE VELOCITY IN MALE SUBJECTS WITH OPTIMAL TO MILD BLOOD PRESSURE VALUESK. Kotliar (1), H. Hanssen (2), K. Eberhardt (1), W. Vilser (3), M. Halle (1), U. Heemann (1), M. Baumann (1)(1) Munich-GERMANY; (2) Basel-SWITZERLAND; (3) Jena-GERMANY
9.20THE PATTERNS OF THE RETINAL MICROVASCULAR NETWORK ARE NOT RELATED TO THE OVERWEIGHT OR THE OBESE STATES. Buzzi (1), R. Dell’Oro (1), C. Mineo (1), G. Seravalle (2), L. Lonati (2), G. Brambilla (1), C. Giannattasio (1), G. Mancia (1), G. Grassi (1)(1) Monza, (2) Milan-ITALY
9.30PERIVASCULAR ADIPOSE TISSUE RELAXING FACTOR AND THE BKCA CHANNEL IN MOUSE MESENTERIC SMALL ARTERIESF. Lynch, S. Withers, A. HeagertyManchester-UK
Saturday
18
104Saturday 18104 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011105
Saturday 1809.00 - 11.00 Orange Hall 3
Parallel Oral Session 1D
OBESITY
Chairpersons: N. Martell-Claros (Madrid-SPAIN) I. Wilkinson (Cambridge-UK) 9.00OVERWEIGHT OR OBESITY ARE STRONG PREDICTORS OF HYPERTENSIVE COMPLICATIONS IN YOUNG SUBJECTS WITH STAGE 1 HYPERTENSIONP. Palatini (1), F. Saladini (1), L. Mos (2), M. Santonastaso (3), G. Maraglino (1), A. Mazzer (3), F. Pegoraro (4), L. Milani (5), D. D’este (6), P. Mormino (1), E. Casiglia (1)(1) Padua, (2) San Daniele del Friuli, (3) Vittorio Veneto, (4) Dolo, (5) San Donà, (6) Mirano-ITALY 9.10EXPRESSION OF THE CARDIOVASCULAR SUSCEPTIBILITY GENE CDKN2B IS UP REGULATED IN OBESITY AND ASSOCIATES WITH FACTORS OF THE METABOLIC SYNDROMEB. Wahlstrand (1), D. Kellis (1), O. Melander (2), P-A. Svensson (1), A. Walley (3), P. Froguel (3), L. Carlsson (1), T. Hedner (1), P Jacobson (1)(1) Gothenburg, (2) Malmö-SWEDEN; (3) London-UK
9.20EFFECT OF INSULIN RESISTANCE IN DETERMINING PRE-HYPERTENSION AND HYPERTENSION RISK AND BLOOD PRESSURE VALUES IN PAEDIATRIC AGEF. Pieruzzi, P. Brambilla, L. Antolini, M. Giussani, S. Galbiati, S. Mastriani, A. Stella, S. GenovesiMilan-ITALY
9.30EFFECTS OF BARIATRIC SURGERY ON INSULIN SENSITIVITY AND SYMPATHETIC NERVE TRAFFIC IN OBESE SUBJECTS. A LONGITUDINAL STUDYF. Quarti (1), G. Seravalle (2), M. Colombo (1), P. Perego (1), V. Giardini (1), M. Volpe (1), V. Vella (1), S. Muraro (2), R. Dell’oro (1), G. Mancia (1), G. Grassi (1)(1) Monza, (2) Milan-ITALY
10.40THE ANTICONTRACTILE CAPACITY OF PERIVASCULAR ADIPOSE TISSUE LOST FOLLOWING EXPERIMENTAL HYPOXIA CAN BE RESCUED BY ANP VIA A PKG MEDIATED PATHWAYS. Withers, L. Simpson, N. Jakka, M. Werner, A. HeagertyManchester-UK
10.50VASOCONSTRICTOR EFFECTS OF INSULIN IN THE MICROCIRCULATION OF DIABETIC PATIENTS ARE MEDIATED VIA BOTH ENDOTHELIN-1 TYPE A- AND B-RECEPTORSU. Rushentsova, A. Kribben, Th. Philipp, A. MitchellEssen-GERMANY
Saturday
18
106Saturday 18106 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011107
Saturday 1810.40SUBCUTANEOUS SMALL RESISTANCE ARTERY MORPHOLOGY AND CIRCULATING INDICES OF INFLAMMATION/OXIDATIVE STRESS IN OBESE PATIENTS BEFORE AND AFTER BARIATRIC SURGERY AND CONSISTENT WEIGHT LOSSC. De Ciuceis, E. Porteri, E. La Boria, G.E.M. Boari, F. Mittempergher, C. Casella, C. Agabiti Rosei, G. Ruggeri, D. RizzoniBrescia-ITALY
10.50IMPLICATION OF THE ADIPOSE TISSUE (PRO)RENIN RECEPTOR IN THE REGULATION OF BODY WEIGHT AND ADIPOSITYB. Ahmed, C. Michel, O. Seda, J. LavoieMontreal-CANADA
9.40ANGIOTENSIN AT2R STIMULATION IMPROVES GLUCOSE TOLERANCE AND INSULIN SENSITIVITY IN OBESE MICES. Wardat (1), M. Iwai (2), M. Horiuchi (2), B. Dahlöf (3), A. Hallberg (4), T. Unger (1), U. Kintscher (1), U.M. Steckelings (1), A. Foryst-Ludwig (1)(1) Berlin-GERMANY; (2) Ehime-JAPAN; (3) Gothenburg, (4) Uppsala-SWEDEN 9.50URINARY ALBUMIN EXCRETION IN OBESE CHILDREN IS DEPENDENT ON METABOLIC FACTORSE. Lurbe (1), I. Torro (1), J. Alvarez (2), F. Aguilar (2), G. Marcaida (2), J. Redon (1)(1) Madrid, (2) Valencia-SPAIN
10.00FREE RADICAL SCAVENGERS RESCUE OBESITY-INDUCED DAMAGE TO THE ANTICONTRACTILE PROPERTY OF PERIVASCULAR ADIPOSE TISSUE IN RAT AND HUMAN SMALL ARTERIESR. Aghamohammadzadeh, A.S Greenstein, A.M. HeagertyManchester-UK
10.10CONTRIBUTION OF ABDOMINAL OBESITY AND AMBULATORY BLOOD PRESSURE TO LEFT ATRIUM SIZE: A 10-YEAR FOLLOW-UP OF YOUNG NORMOTENSIVE SUBJECTSA. Rojek, M. Chrostowska, M. Dudziak, B. Krupa-Wojciechowska, K. NarkiewiczGdansk-POLAND
10.20HIGH LEVELS OF E-SELECTIN ARE ASSOCIATED WITH A REDUCTION OF SIRT1 EXPRESSION IN LYMPHOMONOCYTES FROM SUBJECTS WITH METABOLIC SYNDROMEA. Cattelan (1), G. Ceolotto (1), A. Bortoluzzi (1), A. Fabricio (2), E. Squarcina (2), M. Gion (2), S. Vigili De Kreutzenberg (1), A. Avogaro (1), A. Semplicini (1)(1) Padua, (2) Venice-ITALY
10.30THE EFFECT OF ACCELERATED WEIGHT GAIN ON BLOOD PRESSURE, INTRINSIC HEART RATE AND THE FUNCTION OF THE CARDIAC CONDUCTION SYSTEMO. Monfredi, A. Mastan, R. Aghamohammadzadeh, I. Egner, M. Boyett, A. HeagertyManchester-UK
Saturday
18
108Saturday 18108 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011109
Saturday 1809.30 - 10.30Green Hall 1
Minisymposium for Interventional Doctors
Supported by Medtronic Ardian
NUOVE MISURE TERAPEUTICHE NELL’IPERTENSIONE RESISTENTE. LA DENERVAZIONE RENALE
Moderatore: A. Salvetti (Pisa)
Basi fi siopatologicheA. Stella (Monza) Dati cliniciG. Grassi (Monza)
09.30 - 10.30Yellow Hall
Minisymposium
Supported by an unrestricted educational grant by Omron Healthcare
HOME BP MONITORING IN THE MANAGEMENT OF HYPERTENSIVE PATIENTS: FROM GUIDELINES TO DAILY CLINICAL PRACTICE
Chairpersons: R. Asmar (Paris-FRANCE) B. Waeber (Lausanne-SWITZERLAND)
The 2010 ESH HBPM Practice GuidelinesG. Stergiou (Athens-GREECE) HBPM implementation in clinical practice: which solutions for optimal use?G. Parati (Milan-ITALY)
Saturday
18
110Saturday 18110 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011111
Saturday 1812.00NEW ONSET LEFT ATRIAL ENLARGEMENT IN A GENERAL POPULATION. DATA FROM THE PAMELA STUDYM. Bombelli (1), C. Cuspidi (1), D. Fodri (1), M. Peronio (1), E. Toso (1), H. Polo Friz (2), G. Brambilla (1), L. Primitz (2), I. Ronchi (1), F. Ganz (1), R. Facchetti (1), G. Grassi (1), R. Sega (2), G. Mancia (1)(1) Monza, (2) Vimercate-ITALY 12.15BLOOD PRESSURE TREATMENT WITH CANDESARTAN IN ACUTE STROKE: THE SCANDINAVIAN CANDESARTAN ACUTE STROKE TRIALE.C. Sandset (1), P.M.W. Bath (2), G. Boysen (3), D. Jatuzis (4), J. Kõrv (5), S. Lüders (6), G.D. Murray (7), P.S. Richter (8), R.O. Roine (9), A. Terent (10),V. Thijs (11), E. Berge (1), on behalf of the SCAST study group(1) Oslo-NORWAY; (2) Nottingham-UK; (3) Copenhagen-DENMARK;(4) Vilnius-LITHUANIA; (5) Tartu-ESTONIA; (6) Cloppenburg-GERMANY;(7) Edinburgh-UK; (8) Warsaw-POLAND; (9) Turku-FINLAND;(10) Uppsala-SWEDEN; (11) Leuven-BELGIUM
11.00 - 12.30Auditorium
Late-Breaker Session 1
Chairpersons: G. Bakris (Chicago, IL-USA) P.S. Sever (London-UK)
11.00LONG-TERM ASSOCIATIONS OF PLASMA RENIN ACTIVITY WITH ALL-CAUSE AND CARDIOVASCULAR MORTALITYM. Gonzalez (1), M. Alderman (1), H. Cohen (1), J. Sealey (2), J. Laragh (2)(1) Bronx, (2) New York-USA 11.15HERITABILITY OF BLOOD PRESSURE PHENOTYPES IN EXTENDED PEDIGREES FROM THE GUBBIO POPULATION STUDY: PRELIMINARY RESULTSM.T. Bonati (1), M.C. Monti (2), C. Crocamo (2), C. Montomoli (2), O. Terradura-Vagnarelli (3) M. Mancini (3) M. Laurenzi (3) A. Zanchetti (1), on behalf of the Gubbio Study Group(1) Milan, (2) Pavia, (3) on behalf of the Gubbio Study Group, Gubbio-ITALY 11.30THE ANGLO-SCANDINAVIAN CARDIAC OUTCOMES TRIAL (ASCOT) BIOMARKER PROGRAMMEC. Chan (1), N. Poulter (1), M. Scanlon (1), A. Whitehouse (1), P. Welsh (2), N. Sattar (2), P. Sever (1), on behalf of The ASCOT Investigators(1) London, (2) Glasgow-UK 11.45BLOOD PRESSURE AND OTHER DETERMINANTS OF NEW-ONSET ATRIAL FIBRILLATION IN PATIENTS AT HIGH CARDIOVASCULAR RISK: THE ONTARGET/TRANSCEND STUDYP. Verdecchia, on behalf of The ONTARGET/TRANSCEND Investigators Assisi-ITALY
Saturday
18
112Saturday 18112 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011113
Saturday 1811.00 - 12.30Yellow Hall
Educational Session
Supported by an unrestricted educational grant by Bayer Healthcare Pharmaceuticals
NOVEL PERSPECTIVES AND PRACTICAL INSIGHTS INTO HYPERTENSION TREATMENT
Chairpersons: R. Asmar (Paris-FRANCE) K. Narkiewicz (Gdansk-POLAND)
Welcome & IntroductionR. Asmar (Paris-France) Hypertension and Beyond - How to Optimise Patients’ Care?M. Volpe (Rome-ITALY) Focus on a Morbid Alliance - Diabetes and HypertensionH. Haller (Hannover-GERMANY) Patient Profi ling - an Individual ApproachS. Jarvis (London-UK) Novel Perspectives in the Hypertension SkylineK. Narkiewicz (Gdansk-POLAND) Summary & ClosingK. Narkiewicz (Gdansk-POLAND)
11.00 - 12.30Blue Hall
Topical Workshop
ASH/ESH JOINT SESSION: BLOOD PRESSURE VARIABILITY AND TREATMENT GOALS
Chairpersons: G.L. Bakris (Chicago, IL-USA) J. Redon (Valencia-SPAIN)
Short and long-term blood pressure variabilityG. Mancia (Milan-ITALY)
J-curve revisitedA.J. Manolis (Athens-GREECE) Target blood pressure in nephropatic patientsG.L. Bakris (Chicago, IL-USA) Ambulatory and home blood pressure targetsM.A. Weber (New York, NY-USA)
Saturday
18
114Saturday 18114 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011115
Saturday 1811.40HIGH OSTEOPONTIN (OPN) N-TERMINAL/C-TERMINAL RATIO IS ASSOCIATED WITH CAROTID PLAQUE INFLAMMATIONT. Wolak, N. Sion-Vardy, G. Greenberg, G. Szendro, A. Rudich, N. Nov, V. Novack, E. ParanBear Sheva-ISRAEL 11.50EVIDENCE THAT EDHF DEFICIENCY CONTRIBUTES TO ENDOTHELIAL DYSFUNCTION IN HUMAN ATHEROSCLEROSISW.G. Haynes, A.V. Agapitov, R.D. Smetanka, C.A. SinkeyIowa City-USA 12.00EXAGGERATED EXERCISE BLOOD PRESSURE RESPONSE IS ASSOCIATED WITH ARTERIAL STIFFNESS, ASYMMETRIC DIMETHYLARGININE AND OSTEOPROTEGERIN IN ESSENTIAL HYPERTENSIONK. Dimitriadis, C. Tsioufi s, I. Andrikou, K. Kintis, M. Almyroudi, I. Bafakis, M. Giakoumis, M. Poulakis, C. StefanadisAthens-GREECE 12.10LECTUREINFLAMMATION, URIC ACID AND HYPERTENSIONA. SoLausanne-SWITZERLAND
11.00 - 12.30 Orange Hall 1
Parallel Oral Session 2A
ATHEROSCLEROSIS
Chairpersons: M. Dorobantu (Bucharest-ROMANIA) K. Kawecka-Jaszcz (Cracow-POLAND) 11.00THE ANTI-INFLAMMATORY CAPACITY OF HDL IS LOST BY ACCUMULATION OF THE PRO-INFLAMMATORY ACUTE PHASE PROTEIN SERUM AMYLOID A IN THE HDL PARTICLE OF PATIENTS WITH END-STAGE RENAL DISEASEM. Tölle, M. Schuchardt, T. Huang, J. Prüfer, W. Zidek, M. van der GietBerlin-GERMANY
11.10A MYOCARDIAL INFARCTION GENETIC RISK SCORE ASSOCIATES WITH CAROTID ATHEROSCLEROSISV. Hamrefors, B. Hedblad, G. Engström, P. Almgren, M. Sjögren, O. MelanderMalmö-SWEDEN
11.20THE INFLUENCE OF GENETIC VARIANTS ON BIGLYCAN GENE EXPRESSIONB. Schmitz (1), A. Rötrige (1), R. Telgmann (1), E. Brand (1), J. Fischer (2), M. Paul (3), S.M. Brand (1)(1) Münster, (2) Essen-GERMANY; (3) Maastricht-THE NETHERLANDS
11.30DECREASED LEVELS OF SOLUBLE RECEPTOR FOR ADVANCED GLYCATION END-PRODUCTS ARE ACCOMPANIED BY PRONOUNCED ARTERIAL STIFFENING, ALBUMINURIA AND ATTENUATED GLOMERULAR FILTRATION RATE IN HYPERTENSIONK. Dimitriadis, C. Tsioufi s, M. Poulakis, I. Bafakis, K. Kintis, M. Almyroudi, D. Flessas, C. StefanadisAthens-GREECE
Saturday
18
116Saturday 18116 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011117
Saturday 1811.50IMPACT OF RENAL NERVE ABLATION ON RENAL PERFUSION AND COMPONENTS OF THE RAAS IN TREATMENT RESISTANT HYPERTENSIONC. Ott , A. Schmid, S. Titze, T. Ditting, U. Raff, R. Janka, K. Hilgers, R. Veelken, M. Uder, R. SchmiederErlangen-GERMANY 12.00URINARY CALCIUM EXCRETION IS RELATED TO PLASMA ALDOSTERONE LEVELS IN HYPERTENSIVE PATIENTSL. Marzano, C. Catena, G.L. Colussi, L.A. SechiUdine-ITALY 12.10AMINO TERMINAL NATRIURETIC PEPTIDES AND ASSOCIATION TO GLOBAL CARDIOVASCULAR RISK IN A MALE ADULT POPULATION FROM SOUTHERN ITALYA. Barbato (1), S. Sciarretta (2), S. Marchitti (3), R. Iacone (1), A. Battistoni (2), M. De Giusti (2), E. Dito (3), A. Marra (2), M. Schiano di Cola (1), R. Ippolito (1), C. Calvieri (2), M. Volpe (2), P. Strazzullo (1), S. Rubattu (3)(1) Frattamaggiore, (2) Rome, (3) Pozzilli-ITALY 12.20ASSOCIATION OF SERUM FETUIN-A WITH CARDIOVASCULAR DISEASE: A SYSTEMATIC META-ANALYSISH. Khan, D.F. Freitag, D. SaleheenCambridge-UK
11.00 - 12.30 Orange Hall 2
Parallel Oral Session 2B
RENIN ANGIOTENSIN SYSTEM AND VASOACTIVE SUBSTANCES
Chairpersons: J. Nussberger (Lausanne-SWITZERLAND) B. Schmidt (Hannover-GERMANY) 11.00FIBRIN CLOT PROPERTIES IN ARTERIAL HYPERTENSION AND THEIR MODIFICATION BY ANTIHYPERTENSIVE TREATMENTM. Rajzer, A. Undas, W. Wojciechowska, T. Kameczura, K. Kawecka-JaszczCracow-POLAND
11.10OXYTOCIN ROLE IN THE EMBRYONAL DEVELOPMENT OF THE HEARTM. Jankowski, B.A. Danalache, J. GutkowskaMontreal-CANADA
11.20BLOCKADE OF INTERLEUKIN-1 BETA ATTENUATES RENOVASCULAR HYPERTENSION IN MICEQ. Wang, A. So, J. Nussberger, M. BurnierLausanne-SWITZERLAND 11.30PROBNP GENE DELIVERY PREVENTS HYPERTENSIVE HEART DISEASE IN SPONTANEOUSLY HYPERTENSIVE RATSA. Cataliotti, D. Bellavia, F.L. Martin, S. Mangiafi co, L.S. Malatino, J.C. Burnett, Y. IkedaRochester-USA 11.40AT1A RECEPTORS TRANSFECTED INTO THE CAUDAL MEDULLA OF AT1A-/- MICE INHIBIT THE CARDIOVASCULAR RESPONSE TO STRESSG. Head, K. Palma-Rigo, T. Nguyen-Huu, D. Chen, A. AllenMelbourne-AUSTRALIA
Saturday
18
118Saturday 18118 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011119
Saturday 1811.30ANTIHYPERTENSIVE EFFECT OF LACTOTRIPEPTIDES IN A LARGE COHORT OF NORMOTENSIVE AND MILDLY-TO-MODERATELY HYPERTENSIVE SUBJETS: A DOUBLE-BLIND, RANDOMIZED, CLINICAL TRIALA. Cicero, M. Rosticci, B. Gerocarni, M. Veronesi, E. Strocchi, M. Giovannini,E. Grandi, C. BorghiBologna-ITALY
11.40COCOA CONSUMPTION EFFECTS ON BLOOD PRESSURE, OXIDATIVE STRESS, METABOLIC PROFILE AND BIOMARKERS OF INFLAMMATION AND ENDOTHELIAL FUNCTION IN INDIVIDUALS WITH STAGE 1 HYPERTENSIONL. Nogueira, M. Knibel, D. Valença, M. Rodrigues, J. Nogueira Neto, S. Argolo, M. Torres, M. Guedes, C. Lima, A. SanjulianiRio de Janeiro-BRAZIL 11.50EFFECT OF HABITUAL PHYSICAL ACTIVITY MEASURED BY ACCELEROMETER ON CAROTID AND CARDIAC STRUCTURE AND FUNCTIONM. Kozakova (1), C. Palombo (1), C. Morizzo (1), E. Muscelli (1), B. Balkau (2)(1) Pisa-ITALY; (2) Villejuif-FRANCE 12.00ACUTE AND MID-TERM EFFECTS OF TOMATO PASTE DIET SUPPLEMENTATION ON ENDOTHELIAL FUNCTION AND BLOOD PRESSURE: A RANDOMISED, CROSS-OVER STUDYP. Xaplanteris, C. Vlachopoulos, D. Terentes-Printzios, P. Pietri, N. Alexopoulos, N. Ioakeimidis, C. StefanadisAthens-GREECE 12.10COFFEE CONSUMPTION HAS A LESS POTENT ACUTE-ON-CHRONIC EFFECT ON AORTIC STIFFNESS AND WAVE REFLECTIONS THAN CAFFEINEN. Ioakeimidis, C. Vlachopoulos, N. Alexopoulos, I. Dima, P. Xaplanteris, A. Ioakeimidis, A. Gravos, K. Tentolouris, C. Pitsavos, C. StefanadisAthens-GREECE 12.20LONG TERM SMOKE EXPOSURE INDUCES ALBUMINURIA BUT ONLY MILD HISTOLOGICAL CHANGESJ. Menne (1), K. Krüger (2), F.K. Mooren (2), N. Weissmann (2), M. Seimetz (2), H. Haller (1)(1) Hannover, (2) Giessen-GERMANY
11.00 - 12.30 Orange Hall 3
Parallel Oral Session 2C
LIFESTYLE CHANGES
Chairpersons: Z. Gaciong (Warsaw-POLAND) S. Torbova (Sofia-BULGARIA) 11.00FATAL AND NONFATAL OUTCOMES, INCIDENCE OF HYPERTENSION, AND BLOOD PRESSURE CHANGES IN RELATION TO URINARY SODIUM EXCRETION IN WHITE EUROPEANSK. Stolarz-Skrzypek (1), T. Kuznetsova (2), L. Thijs (2), V. Tikhonoff (3), J. Seidlerova (4), T. Richart (5), Y. Jin (2), A. Olszanecka (1), S. Malyutina (6), E. Casiglia (3), J. Filipovsky (4) K. Kawecka-Jaszcz (1), Y. Nikitin (6), J. Staessen (2), on behalf of the European Project on Genes in Hypertension (EPOGH) Investigators(1) Cracow-POLAND; (2) Leuven-BELGIUM; (3) Padua-ITALY; (4) Pilsen-CZECH REPUBLIC; (5) Maastricht-THE NETHERLANDS; (6) Novosibirsk-RUSSIA
11.10BLOOD PRESSURE LOWERING EFFECT OF DIETARY INTEGRATION WITH GRANA PADANO CHEESE IN HYPERTENSIVE PATIENTSG. Crippa, M. Bosi, A. Cassi, L. Fiorentini, F. RossiPiacenza-ITALY 11.20CAN OMEGA 3 POLYUNSATURATED FATTY ACIDS SUPPLEMENTATION ACT BLOOD PRESSURE LEVELS IN HYPERTRIGLYCERIDEMIC PATIENTS, WITH OR WITHOUT METABOLIC SYNDROME AND WITH UNTREATED NORMAL-HIGH BLOOD PRESSURE?M.L. De RosaNaples-ITALY
Saturday
18
120Saturday 18120 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011121
Saturday 1812.00OBSTRUCTIVE SLEEP APNOEA IS MAINLY DETERMINED BY GLUCOSE ABNORMALITIES IN OBESE WOMENL. Gilardini, C. Lombardi, G. Redaelli, L. Vallone, G.F. Parati, C. InvittiMilan-ITALY
12.10ENDOTHELIAL FUNCTION AND RENAL VASODILATION, BUT NOT ARTERIAL STIFFNESS, ARE IMPAIRED IN LEAN, NORMOTENSIVE PATIENTS WITH SLEEP-APNEA SYNDROMER.M. Bruno, L. Ghiadoni, M. Fabbrini, L. Rossi, A. Lena, M. Maestri, E. Bonanni, S. TaddeiPisa-ITALY 12.20PREVALENCE OF OBSTRUCTIVE SLEEP APNEA SYNDROME IN HYPERTENSIVE PATIENTS REFERRED TO A SPECIALIZED OUTPATIENT CLINIC AND ASSOCIATION WITH PRIMARY ALDOSTERONISMG.P. Rossi, G. Pitter, V. Gallina, G. Rossitto, A.C. PessinaPadua-ITALY
11.00 - 12.30 Green Hall 1
Parallel Oral Session 2D
SLEEP APNOEA
Chairpersons: D.V. Vlachakos (Athens-GREECE) K. Widecka (Szczecin-POLAND) 11.00LECTURELEPTIN AND ANGIOTENSIN MEET IN THE BRAIN: IMPLICATIONS FOR HYPERTENSIONA.L. MarkIowa City, IA-USA 11.20INHALATION OF HYDROGEN GAS REDUCES OXIDATIVE STRESS AND ATTENUATES CARDIAC REMODELING INDUCED BY INTERMITTENT HYPOXIA IN MICET. Hayashi, M. Miyamura, T. Mori, A. Ukimura, Y. Okada, N. Ishizaka, T. Yoshioka, K. Hasegawa, Y. MatsumuraTakatsuki-JAPAN 11.30ARTERIAL HYPERTENSION AND SLEEP QUALITY IN THE FRENCH POPULATION IN 2010: THE FLAHS 2010 SURVEYJ. Mourad, N. Postel-Vinay, B. Pannier, O. Hanon, X. GirerdParis-FRANCE 11.40NOCTURNAL HOME BLOOD PRESSURE AND OBSTRUCTIVE SLEEP APNEAA. Destounis, K. Cholidou, A. Kollias, N. Karpettas, E. Markozannes, E. Alchanatis, G.S. StergiouAthens-GREECE 11.50BEHAVIOUR OF REGIONAL SYMPATHETIC DRIVE IN OBSTRUCTIVE SLEEP APNEA SYNDROMEC. Mineo (1), V. Vella (1), L. Magni (1), M. Volpe (1), G. Seravalle (2), C. Giannattasio (1), G. Mancia (1), G. Grassi (1)(1) Monza, (2) Milan-ITALY
Saturday
18
122Saturday 18122 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011123
Saturday 1811.30 - 12.30Red Hall
Minisymposium
Supported by an unrestricted educational grant by Sanofi -Aventis
NEW TRENDS IN ANTIARRHYTHMIC DRUG THERAPY. AN INTEGRATED APPROACH
Chairpersons: E. Agabiti Rosei (Brescia-ITALY) R. Cifková (Prague-CZECH REPUBLIC)
Upstream therapy of atrial fi brillation with ARBs: how to take on this opportunityA. Coca (Barcelona-SPAIN) From rhythm or rate control strategies to clinical endpoints management. Dronedarone: A new frontierA. Capucci (Ancona-ITALY) Stroke, ischemia and blood pressure: let’s raise new challenges to antiarrhythmic therapy!C. Rapezzi (Bologna-ITALY)
11.00 - 12.00Green Hall 2
Meet-The-Expert Session
THE WORKUP OF A HYPERTENSIVE PATIENT
Chairperson: M. Viigimaa (Tallin-ESTONIA)
Saturday
18
124Saturday 18124 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011125
Saturday 1812.45 - 14.15Red Hall
Satellite Symposium
Sponsored by Novartis
TREATING PATIENTS WITH HYPERTENSION AND DIABETES - A CLINICAL BALANCING ACT?
Chairpersons: G.T. McInnes (Glasgow-UK) H.H. Parving (Copenhagen-DENMARK)
Welcome and introductionG.T. McInnes (Glasgow-UK) The current landscape in the treatment of hypertension and diabetes: is there room for improvement?J. Sowers (Columbia-MO, USA) Enhancing early and optimal glycemic control: what can DPP-4 inhibition offer?S. Del Prato (Pisa-ITALY) Direct renin inhibition: an opportunity for improved treatment of hypertensive patients with diabetesT. Unger (Berlin-GERMANY) Exploring the potential cardiorenal effects of direct renin inhibition in hypertensive patients with diabetesH.H. Parving (Copenhagen-DENMARK) Summary and closeH.H. Parving (Copenhagen-DENMARK)
12.45 - 14.15Auditorium
Teaching Session
SESSION 1 - RISK FACTOR CONTROL
Chairpersons: A. Dominiczak (Glasgow-UK) D.L.Clement (Gent-BELGIUM)
DiabetesP.M. Nilsson (Malmö-SWEDEN) Obesity and other metabolic factorsM.H. Olsen (Glostrup-DENMARK) Stress: a risk factor for cardiovascular diseases?P. van de Borne (Bruxelles-BELGIUM) Home Blood Pressure. New ESH guidelinesG. Parati (Milan-ITALY)
Saturday
18
126Saturday 18126 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011127
Saturday 1814.00 - 15.30Ground FloorATTENDED POSTER SESSIONS
Chairperson: S. Padmanabhan (Glasgow-UK)
PS 01. EPIDEMIOLOGY ROOM 1 / POSTERS FROM 1 TO 38
PS 13. CLINICAL ASPECTS ROOM 13 / POSTERS FROM 328 TO 372
PS 14. CLINICAL TRIALS ROOM 14 / POSTERS FROM 373 TO 391
Chairperson: D. Rizzoni (Brescia-ITALY)
PS 02. LIFESTYLE CHANGES ROOM 2 / POSTERS FROM 39 TO 62
PS 03. RISK FACTORS ROOM 3 / POSTERS FROM 63 TO 84
Chairperson: G. Bilo (Milan-ITALY)
PS 04. BLOOD PRESSURE MEASUREMENT ROOM 4 / POSTERS FROM 85 TO 121
PS 06. ENDOTHELIUM ROOM 6 / POSTERS FROM 143 TO 164
Chairperson: P. Pauletto (Treviso-ITALY)
PS 05. ATHEROSCLEROSIS ROOM 5 / POSTERS FROM 122 TO 142
PS 09. OBESITY ROOM 9 / POSTERS FROM 221 TO 257
PS 10. SLEEP APNOEA ROOM 10 / POSTERS FROM 258 TO 280
Chairperson: M.P. Schlaich (Melbourne-AUSTRALIA)
PS 07. SMALL VESSELS ROOM 7 / POSTERS FROM 165 TO 183
PS 08. RENAL ASPECTS ROOM 8 / POSTERS FROM 184 TO 220
PS 11. DIABETES ROOM 11 / POSTERS FROM 281 TO 312
Chairperson: C. Borghi (Bologna-ITALY)
PS 12. ATRIAL FIBRILLATION ROOM 12 / POSTERS FROM 313 TO 327
PS 15. THERAPEUTIC ASPECTS ROOMS 15-16 / POSTERS FROM 392 TO 440
LATE-BREAKER POSTER SESSION 1 ROOM 17 / POSTERS FROM 441 TO 453
Saturday
18
128Saturday 18128 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011129
Saturday 18 1 6 / THE INFLUENCE OF STRESS AT WORK ON THE RISK OF DEVELOPING OF ARTERIAL HYPERTENSION IN GENERAL POPULATION 25-64 YEARS OLD IN RUSSIA DURING 14-YEARS (PROGRAM WHO MONICA-PSYCHOSOCIAL)V. Gafarov, E. Gromova, A. Gafarova, I. GagulinNovosibirsk-RUSSIA
1 7 / PREVALENCE OF MASKED HYPERTENSION IN RELATIVES OF HYPERTENSIVE PATIENTSM. Domenech, J. Sobrino, M. Camafort, E. Vinyoles, I. Martinez, J.M. Graña, V. Estopiñan, F. Alonso, J.C. Rodriguez, J.L. Griera, A. Hermida, J. Calls, J.E. Castillo, V. Castellanos, A. Coca, on behalf of the ESTHEN Study Group-SPAIN
1 8 / VITAMIN D DEFICIENCY AND INSULIN RESISTANCE IN PATIENTS WITH ESSENTIAL HYPERTENSIONL. Vigil, M. Lopez, R. García-Carretero, M. Varela, D. Ferrero, C. Rodriguez, J. RuizMadrid-SPAIN
1 9 / ARTERIAL HYPERTENSION AS THE DEFINING FACTOR OF THE HIGH LEVEL OF MEN MORTALITY IN UKRAINEO. KvashaKyiv-UKRAINE
1 10 / HIGH LEVEL OF THE SERUM HEPATOCYTE GROWTH FACTOR PREDICTS THE DEVELOPMENT OF METABOLIC SYNDROME;THE TANUSHIMARU COHORT STUDYE. Tsukagawa, H. Adachi, Y. Hirai, M. Enomoto, A. Fukami, M. Otsuka, T. Miyamoto, Y. Nanjo, K. Yoshikawa, E. Kumagai, E. Esaki, K. Ogata, K. Yokoi, K. Murayama, T. ImaizumiKurume-JAPAN
1 11 / DIFFERENCES BETWEEN HYPERTENSIVE AND NORMOTENSIVE WOMEN ATTENDED IN PRIMARY CARE. BASELINE DATA OF THE EVA STUDYF. Fernandez-Vega (1), F.J. Garcia-Norro Herreros (2), N. Suliman Jabary (3), S. Suarez Garcia (1), A. Diaz Rodriguez (4), J.J. Garcia Fernandez (5), P. Redondo Oliver (6), J. Cachon Fernandez (7), J.L. Martin Carbayo (8), J.M. Fernandez Rodriguez-Lacin (9), J.A. Tarrazo Suarez (5), L. Bousquets Toral (10), R. Villa Estebanez (11), P. Sanz Gallego (12), M.A. Prieto Diaz (1), on behalf of THE EVA STUDY INVESTIGATORS(1) Oviedo, (2) Leon, (3) Valladolid, (4) Bembibre, (5) Pola De Siero, (6) Carrion De Los Condes, (7) Aviles, (8) Palencia, (9) Gijon, (10) Tineo, (11) Grado, (12) Riosa-SPAIN
14.00 - 15.30Ground Floor
Poster Session 01
EPIDEMIOLOGY
ROOM 1 / POSTERS FROM 1 TO 38
Chairperson: S. Padmanabhan (Glasgow-UK)
1 1 / INFLAMMATORY MARKERS AND BLOOD PRESSURE: SEX DIFFERENCES AND THE CONFOUNDING EFFECT OF FAT MASS IN THE COLAUS STUDYM. Pruijm (1), P. Vollenweider (2), F. Paccaud (1), M. Preisig (1), G. Waeber (1), P. Marques-Vidal (1), M. Burnier (1), M. Bochud (1)(1) Lausanne-SWITZERLAND; (2) Philadelphia-USA
1 2 / HEART SCORE IN RURAL PREHYPERTENSIVESS. Karanovic (1), D. Juric (2), I. Vukovic Lela (1), M. Fistrek (1), V. Premuzic (1), A. Cvitkovic (2), Z. Dika (1), J. Kos (1), V. Capkun (3), M. Laganovic (1), L.J. Fodor (1), M. Bitunjac (2), N. Leko (2), I. Pecin (1), B. Jelakovic (1)(1) Zagreb, (2) Slavonski Brod, (3) Split-CROATIA
1 3 / CARDIAC STRUCTURE AND FUNCTION IN RELATION TO CENTRAL BLOOD PRESSURE COMPONENTS IN CHINESEY. Zhang, Y. Li, F.H. Ding, C.S. Sheng, Q.F. Huang, J.G. WangShanghai-CHINA
1 4 / ASSOCIATION OF INSULIN RESISTANCE WITH BEAT-TO-BEAT CARDIOVASCULAR DYNAMICS IN NON-OBESE, NON-DIABETIC INDIVIDUALS FROM LATIN-AMERICAN ORIGINJ.E. Ochoa (1), M.M. Correa (2), J.A. Gallo (2), J.G. McEwen (2), G. Bilo (1), D. Aristizabal (2), G. Parati (1)(1) Milan-ITALY; (2) Medellin-COLOMBIA
1 5 / PREVALENCE AND CHARACTERISTICS OF NOCTURNAL HYPERTENSION IN RELATIVES OF HYPERTENSIVE PATIENTSJ. Sobrino, M. Domenech, M. Camafort, E. Vinyoles, M.L. Mendez, S. Suarez, C. Escobar, J. Rueda, A. Vazquez, A. Batalla, F.J. Fernandez, M.F. Davila, F.J. Fuentes, R.E. Alvarez, A. Coca, on behalf of the ESTHEN Study Group-SPAIN
Saturday
18
130Saturday 18130 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011131
Saturday 18 1 19 / EVOLUTION OF THE CARDIOVASCULAR RISK IN IMMIGRANTS LATINAMERICAN RESIDENTS IN SPAIN. INMIRISK STUDY. PRELIMINARY RESULTSM.L Lozano, M. Leal, G. Ruiz, M. Tomás, F. Lafuente, E. García, M.A. Franco, M.D. Abellan, J. AbellanMurcia-SPAIN
1 20 / BLOOD PRESSURE CONTROL IN SPANISH HYPERTENSIVE PATIENTS ATTENDED IN PRIMARY CARE SETTINGS (THE PRESCAP 2010 STUDY)J.L. Llisterri Caro (1), G.C. Rodríguez Roca (2), F.J. Alonso Moreno (2), V. Barrios Alonso (3), J.L. Gorriz Teruel (1), R. Dura Belinchon (1), F. Valls Roca (1), V. Pallarés Carratalá (4), T. Sánchez Ruiz (1), D. González-Segura Alsina (5), on behalf of the Working Group of Arterial Hypertension of the Spanish Society of Primary Care physicians (Group HTA/SEMERGEN) and the PRESCAP 2010 investigators(1) Valencia, (2) Toledo, (3) Madrid, (4) Castellón, (5) Barcelona-SPAIN
1 21 / INTERRELATION OF ARTERIAL HYPERTENSION WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN POPULATION OF THE INTERNALLY DISPLACED PEOPLE OF 20-59 YEARS, LIVING IN SUMGAYIT CITYN.N. Huseynova, A.F. Zeynalov, F.N. GasimovaBaku-AZERBAIJAN
1 22 / PREVALENCE OF ARTERIAL HYPERTENSION IN WOMEN WITH VIOLATION OF CARBOHYDRATE EXCHANGES.S. Sultanova, F.N. GasimovaBaku-AZERBAIJAN
1 23 / CHARACTERISTICS OF EPIDEMIOLOGICAL SITUATION CONCERNING ARTERIAL HYPERTENSION AMONG THE MASCULINE POPULATION OF ZAQATALA REGION OF AZERBAIJANN.R. Ismayilova, A.F. Zeynalov, F.N. GasimovaBaku-AZERBAIJAN
1 24 / BLOOD PRESSURE CONTROL IN UNCOMPLICATED AND COMPLICATED HYPERTENSION IN SWITZERLANDR. Brenner (1), B. Waeber (2), Y. Allemann (1)(1) Bern, (2) Lausanne-SWITZERLAND
1 25 / CURRENT ANTIHYPERTENSIVE THERAPY IN SWITZERLANDR. Brenner (1), B. Waeber (2), Y. Allemann (1)(1) Bern, (2) Lausanne-SWITZERLAND
1 12 / DIFFERENCES BETWEEN PREHYPERTENSIVE AND HYPERTENSIVE SUBJECTS IN THE FIRST YEAR OF FOLLOW-UP. THE PREVASTURIAS STUDYA De La Escosura Garcia (1), C. Rubiera Alvarez (2), C. Varela Suarez (3), L. Bousquets Toral (4), J. Alonso Arguelles (5), S. Suarez Garcia (1), C. Martin Lopez (1), M.T. Arias Garcia (1), M. Pizarro Lopez (1), I. Perez Fernandez (6), J. Florez Garcia (6), I. Pastrana Pastrana (2), J.R. Crespo Garcia (2), R. Marin Iranzo (1), M.A. Prieto Diaz (1), on behalf of THE PREVASTURIAS STUDY(1) Oviedo, (2) Gijon, (3) Lugones, (4) Tineo, (5) Cangas Del Narcea, (6) Aviles-SPAIN
1 13 / EPIDEMIOLOGY OF ARTERIAL HYPERTENSION IN UKRAINE: RESULTS OF THE 30-YEAR OBSERVATIONI. Gorbas, on behalf of I. GorbasKyiv-UKRAINE
1 14 / BLOOD PRESSURE CONTROL IN HYPERTENSIVE PATIENTS ATTENDED IN REFERRAL UNITSV. Barrios (1), A. de la Sierra (2), D. González-Segura (3), G. Traveria (3)(1) Madrid, (2) Terrassa, (3) Barcelona-SPAIN
1 15 / BLOOD PRESSURE CONTROL IN PATIENTS WITH HIGH CARDIOVASCULAR RISK ATTENDED IN HYPERTENSION REFERRAL UNITSA. de la Sierra (1), V. Barrios (2), D. Asensio (3), G. Traveria (3)(1) Terrassa, (2) Madrid, (3) Barcelona-SPAIN
1 16 / HYPERTENSION IS RISING IN NEPALESE COMMUNITY: EVIDENCE FROM A REPEAT CROSS-SECTIONAL STUDY IN RURAL KATHMANDU AFTER TWENTY-FIVE YEARSA. Vaidya, R. Prasad Pathak, M. Raj PandeyKathmandu-NEPAL
1 17 / SALT INTAKE ADJUSTED FOR BODY WEIGHT AS WELL AS TOTAL SALT INTAKE IS ASSOCIATED WITH CARDIOVASCULAR DAMAGE IN THE GENERAL POPULATIONH. Takase (1), Y. Dohi (2), T. Toriyama (1), T. Okado (1), H. Sonoda (2), A. Hagikura (1), T. Hashimoto (1), G. Kimura (2)(1) Hamamatsu, (2) Nagoya-JAPAN
1 18 / STRATEGY OF HYPOTENSIVE THERAPY OF AN OUT-PATIENTS DEPARTMENTY. Poponina, M. Komarova, T. PoponinaTomsk-RUSSIA
Saturday
18
132Saturday 18132 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011133
Saturday 18 1 34 / ALCOHOL CONSUMPTION AND DEPENDENCE IN RUSSIAN MEN WITH ARTERIAL HYPERTENSIONV. Pyankov, Y. Chuyasova, E. PoyarkovaKirov-RUSSIA
1 35 / SOCIO ECONOMIC, LIFESTYLE AND ANTHROPOMETRIC RISK FACTORS INCREASE ODDS OF DEVELOPING HYPERTENSION MAIN CULPRIT BEHIND CORONARY ARTERY DISEASE IN A DEVELOPING EASTERN EUROPEAN ECONOMYU. Mallick (1), M. Flather (1), M. Dorobantu (3), W. Zou (1), A. Fruntelata (3), T. Gabriel (3), A. Scafa (3), A. Vasile (3), O. Roxana (3), T. Spircu (3)(1) London-UK; (3) Bucharest-ROMANIA
1 36 / RESULTS OF POLISH NATIONAL HEALTH TEST SHOW HIGH PREVALENCE OF CORRECTABLE CARDIOVASCULAR RISK FACTORS AMONG “NETIZENS”J. Tyszkiewicz (1), B. Symonides (1), Z. Gaciong (1), E. Figurny-Puchalska (2), P. Kołodziajak (2), M. Niemczyk (2)(1) Warsaw, (2) Cracow-POLAND
1 37 / EPIDEMIOLOGICAL STUDY IN PATIENTS WITH HYPERTENSION SECONDARY TO RENAL ARTERY STENOSIS IN A GENERAL HOSPITALM.I. Poveda-García, M.A. Esteban-Moreno, M.D. Del Pino Y Pino, M.C. Prados SolerAlmería-SPAIN
1 38 / SYSTEMIC METABOLIC DISTURBANCES AS A NATURAL COMPONENT OF ESSENTIAL HYPERTENSION; THEIR ORIGIN AND PROATHEROGENIC SIGNIFICANCET. Talaieva, V. BratusKiev-UKRAINE
1 26 / PREVALENCE OF ARTERIAL HYPERTENSION AND OTHER CARDIOVASCULAR RISK FACTORS IN AN ADULT GIPSY POPULATION FROM ROMANIAD. Bartos, E. Badila, G. Oprea, S. Ghiorghe, R. Lungu, M. Hostiuc, A. NastacBucharest-ROMANIA
1 27 / THE PREVALENCE AND CAUSES OF RESISTANT HYPERTENSION IN PATIENTS OF DIFFERENT MEDICAL UNITSI. Emelyanov, N. Avdonina, V. Ivanenko, A. Konrady, E. ShlyakhtoSt. Petersburg-RUSSIA
1 28 / FACTORS ASSOCIATED WITH “IN-STUDY” BLOOD PRESSURE CONTROL: FINDINGS FROM THE 2ND AUSTRALIAN NATIONAL BLOOD PRESSURE STUDYE.K. Chowdhury (1), A. Owen (1), H. Krum (1), L.M.H. Wing (2), P. Ryan (2), C.M. Ried (1), on behalf of the Second Australian National Blood Pressure Study Group(1) Melbourne, (2) Adelaide-AUSTRALIA
1 29 / BLOOD PRESSURE CONTROL DEPENDS ON ENVIRONMENTAL FACTORSB. Pannier, F. Thomas, A. Benlmauden, K. Bean, N. DanchinParis-FRANCE
1 30 / PREVALENCE OF METABOLIC SYNDROME IN CITIES OF RUSSIAN FEDERATIONA. Erina (1), R. Libis (2), E. Isaeva (2), D. Savshin (1), O. Rotar (1), V. Solntsev (1), S. Zagranichnaya (1), A. Konradi (1), E. Shlyakhto (1)(1) St. Petersburg, (2) Orenburg-RUSSIA
1 31 / ANALYSIS OF POSITIVE SCREENING IN CARDIOVASCULAR PREVENTION PROGRAMV. Pallares-Carratala (1), V. Gil-Guillen (2), D. Orozco-Beltran (2), F. Valls-Roca (3), J. Redon (4), J.L. Martinez (2), C. De La Sen (5), J. Navarro-Perez (4), C. Fluixa (4), C. Carratala (2), A. Fernandez (2), J.C. Andres (2)(1) Burriana, (2) San Juan, (3) Beniganim, (4) Valencia, (5) Alicante-SPAIN
1 32 / ARTERIAL HYPERTENSION AND DIABETES MELLITUS IN LIVER CIRRHOSIS: THE EXPERIENCE OF A SINGLE CENTRES. Leoni, S. Flori, B. Stagni, I. Serio, L. BolondiBologna-ITALY
1 33 / TRENDS AND AGE PECULIARITIES OF MORTALITY FROM CARDIOVASCULAR DISEASES AND CORRELATION WITH ARTERIAL HYPERTENSIONE. Efi mova, I. Konobeevskaya, R. KarpovTomsk-RUSSIA
Saturday
18
134Saturday 18134 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011135
Saturday 18 2 44 / INFLUENCE OF ANXIOUS-DEPRESSIVE SYNDROME ON PRIMARY PREVENTION OF CARDIOVASCULAR DISEASEM. Colotto, A. D’Angelo, F. Vinci, A. Renzi, E. D’Erasmo, A. Castello, G. Barbarossa, S. Da Ros, P. ColettaRome-ITALY
2 45 / EFFECTIVENESS OF MAIN ISCHEMIC HEART DISEASE RISK FACTOR CONTROL IN PATIENTS AFTER ACUTE CORONARY SYNDROME, THEIR COMPLIANCE TO THERAPY. PROSPECTIVE SURVEYA.Y. Efanov, S.V. Shalaev Tuymen-RUSSIA
2 46 / SMOKING ASSOCIATED WITH LOWER LEVELS OF HDL-C MAY INCREASE THE RISK OF EARLY ONSET OF CORONARY ARTERY DISEASE AS ASSESSED BY MULTI-DETECTOR ROW COMPUTED TOMOGRAPHYR. Mitsutake, S. Miura, Y. Shiga, K. SakuFukuoka-JAPAN
2 47 / LONG-TERM EFFICACY AND SAFETY OF A COMBINED NUTRACEUTICAL ADDED TO THERAPEUTIC LIFE-STYLE IN OVERWEIGHT AND NORMOWEIGHT DYSLIPIDAEMIC SUBJECTS: A CONTROLLED TRIALA. Cicero (1), G. Derosa (2), P. Maffi oli (2), B. Gerocarni (1), E. Grandi (1), C. Borghi (1)(1) Bologna, (2) Pavia-ITALY
2 48 / EFFECT OF A COMBINED NUTRACEUTICAL ADDED TO THERAPEUTIC LIFE-STYLE ON BIOMARKERS OF VASCULAR REMODELLING IN OVERWEIGHT AND NORMOWEIGHT DYSLIPIDAEMIC SUBJECTS: A CONTROLLED TRIALA. Cicero (1), G. Derosa (2), P. Maffi oli (2), B. Gerocarni (1), E. Grandi (1), C. Borghi (1)(1) Bologna, (2) Pavia-ITALY
2 49 / APPROACH TO HIGH RISK PATIENTSS. Iurciuc, A. Avram, M. Iurciuc, L. Craciun, C. Avram, S. Ursoniu, D. Gaita, S. MancasTimisoara-ROMANIA
2 50 / THE IMPACT OF FRUIT AND VEGETABLE INTAKE ON BLOOD PRESSURE IN PATIENTS WITH CORONARY HEART DISEASEV. Heazlewood (1), K. Kotseva (2), El. Turner (2), D. Wood (2)(1) Caboolture-AUSTRALIA; (2) London-UK
14.00 - 15.30Ground Floor
Poster Session 02
LIFESTYLE CHANGES
ROOM 2 / POSTERS FROM 39 TO 62
Chairperson: D. Rizzoni (Brescia-ITALY)
2 39 / SUPERVISED EXERCISE TRAINING IN HYPERTENSIVE PATIENTS, BEYOND BLOOD PRESSURE CONTROLM. Iurciuc, S. Ursoniu, S. Iurciuc, A. Avram, C. Marin, D. Duda-Seiman, S. Mancas Timisoara-ROMANIA
2 40 / THE STUDY ON LIFESTYLE-INTERVENTION IN SUBJECTS WITH IMPAIRED FASTING GLUCOSE AND PRE-HYPERTENSION A 5 YEARS RANDOMISED CLINICAL TRIAL (2 YEARS PRELIMINARY RESULTS)Z. GasimovBaku-AZERBAIJAN
2 41 / FROM CHANGING NUTRITION HABITS TOWARDS NEW STRATEGIES OF AN ACTIVE LIFESTYLE - A EUROPEAN STUDY ON OVERWEIGHT AMONG CHILDREN AND ADOLESCENTSB. Schau (1), M. Bielfeldt (2)(1) Mannheim-GERMANY; (2) Barcelona-SPAIN
2 42 / THE EFFECT OF SOME EATING HABITS ON BLOOD PRESSURE OF SCHOOL CHILDRENK. Paunovic, G. Belojevic, B. Jakovljevic, V. StojanovBelgrade-SERBIA
2 43 / LONG-TERM EFFECTS OF A BERBERINE BASED NUTRACEUTICAL ON BODY WEIGHT AND INSULIN-SENSITIVITY IN NON DIABETIC HYPERLIPIDAEMIC PATIENTSA. Cicero (1), G. Derosa (2), P. Maffi oli (2), B. Gerocarni (1), E. Grandi (1), C. Borghi (1)(1) Bologna, (2) Pavia-ITALY
Saturday
18
136Saturday 18136 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011137
Saturday 18 2 59 / DYSLIPIDEMIA AGGRAVATES QUALITY OF LIFE OF HYPERTENSIVESV. Katsi, G. Souretis, D. Tousoulis, C. Vlachopoulos, C. Stefanadis, I. KallikazarosAthens-GREECE
2 60 / THE INFLUENCE OF PHYSICAL ACTIVITIES IN BLOOD PRESSURE IN ADOLESCENTSV.C. Romero Martinez, E.R Silva, J.J Villasmil, G.A. Bermudez, F. MadueñoMaracaibo-VENEZUELA
2 61 / EFFECT OF PROTEIN DIET IN BLOOD PRESSURE AND HEALTH RISKN. Escribano, P. Zafrilla, J.A. Gomez, J. Abellan, J. MuleroMurcia-SPAIN
2 62 / ADAPTED PHYSICAL ACTIVITY AND PULSE PRESSURE IN ELDERLY PEOPLE WITH CHRONIC OBSTRUCTIVE BRONCHOPNEUMOPATHYF. D’Amico, R. Grasso, L. BittoMessina-ITALY
2 51 / CONCORDANCE OF HEALTHY EATING BEHAVIOURS AND LIFESTYLE IN PATIENTS WITH CORONARY HEART DISEASE UNDER MULTIDISCIPLINARY CAREV. Heazlewood (1), K. Kotseva (2), E.L. Turner (2), D. Wood (2)(1) Caboolture-AUSTRALIA, (2) London-UK
2 52 / EFFECT OF A HIGH-CALCIUM ENERGY-REDUCED DIET ON INFLAMMATORY STRESS AND ENDOTHELIAL FUNCTION IN BRAZILIAN OBESE SUBJECTSM. Torres, M. Rodrigues, D. Valença, L. Nogueira, J. Nogueira Neto, M. Guedes, C. Lima, A. SanjulianiRio de Janeiro-BRAZIL
2 53 / THE EFFECT OF DIETARY COUNSELING ON LONG-TERM WEIGHT LOSS IN HYPERTENSIVE PATIENTS WITH EXCESS BODY WEIGHTM. Torres, T. Ferreira, D. Carvalho, L. Nogueira, D. Valença, M. Rodrigues, L. Araujo, M. Guedes, C. Lima, A. SanjulianiRio de Janeiro-BRAZIL
2 54 / PREVALENCE OF ALCOHOL CONSUMPTION AND CARDIOVASCULAR RISK FACTORS IN AN EXTREMADURA’S HEALTH AREA. HERMEX STUDYF. Felix-Redondo, D. Fernandez-Berges, F. Buitrago, L. Palomo, J. Perez-Castan, L. Lozano, V. Tejero, P. Alvarez-Palacios, A. Hidalgo, Y. MorcilloVillanueva De La Serena-SPAIN
2 55 / EFFECT OF LIFE STYLE MODIFICATION IN MENOPAUSAL WOMEN WITH OBESITY, HYPERTENSION, AUTONOMIC AND ENDOTHELIAL DYSFUNCTIONR. Santos, J. Freitas, E. Tejera, A. Monteiro, J. Lima, I. RebeloPorto-PORTUGAL
2 56 / FOOD INFLUENCE ON BLOOD PRESSURE: OBSERVATION FROM THE SIXTH WORLD HYPERTENSION DAYR. Meazza, A. Villarini, D. Ruggiero, C. Vecchiato, M.M. Ciulla, F. MagriniMilan-ITALY
2 57 / QUALITY OF LIFE AND HYPERTENSION IN THE ELDERLYC. Maridaki, C. Basagiannis, I. Anyfantis, I. Papargyriou, D. PapadogiannisAthens-GREECE
2 58 / RELATIONSHIP BETWEEN BLOOD PRESSURE CONTROL STATUS AND LIFESTYLE IN HYPERTENSIVE OUTPATIENTSY. Ohta, T. Tsuchihashi, K. KiyoharaFukuoka-JAPAN
Saturday
18
138Saturday 18138 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011139
Saturday 18 3 69 / THE INFLUENCE OF PROFESSIONAL STRESS LEVEL ON BEHAVIOURAL RISK FACTORS IN MEN OF STRESSFUL PROFESSIONI. Osipova, O. Antropova, A. Zalzman, N. Pyrikova, I. Komissarova, I. KurbatovaBarnaul-RUSSIA
3 70 / KNOWLEDGE ON THE CAUSES AND COMPLICATIONS OF ARTERIAL HYPERTENSION IN RANDOMLY SELECTED STUDENTS FROM POLISH CITIESP. Gac, R. Poreba, M. Poreba, M. Lemanski, K. Lewczuk, M. Zawadzki, K. PawlasWroclaw-POLAND
3 71 / AGE AND GENDER EFFECT ON GEOGRAPHICAL VARIATION OF HYPERTENSION IN CANADA: GEOGRAPHICAL KNOWLEDGE FOR PUBLIC HEALTH DECISIONS MAKERSD. Leroux, L. Cloutier, C. Drouin, G. Tassitano Dit SpainTrois-Rivières-CANADA
3 72 / PREDICTIVE ROLE OF ARTERIAL HYPERTENSION AND OTHER RISK FACTORS AFTER MYOCARDIAL INFARCTION: A PROSPECTIVE STUDYI. Sichkaruk, A. Yagensky, N. Sydor, L. DukhnevychLutsk-UKRAINE
3 73 / EFFECT OF SEASONAL TEMPERATURE CHANGE FOR PATIENTS WITH FIXED DOSE COMBINATION TREATMENTC. Grassos, D. Gourlis, A. PittarasAthens-GREECE
3 74 / EFFECT OF HIGH BLOOD PRESSURE AND OVERWEIGHT ON PLASMA LIPID LEVELS IN SEVEN YEARS OLD CHILDREN IN EASTERN SLAVONIJA AND BARANJA, CROATIAM. Katic, V. Tomac, N. AberleOsijek-CROATIA
3 75 / THE HISTORY OF HYPERTENSION AS AN IMPORTANT DETERMINANT OF AN IMPAIRED QUALITY OF LIFE 5 YEARS AFTER CABG IN LOW-RISK PATIENTSM. Zdravkovic, M. Krotin, M. Ristic, J. Perunicic, N. Milic, I. Soldatovic, S. Radovanovic, J. Saric, D. Lisulov, B. TodicBelgrade-JUGOSLAVIA
3 76 / A STUDY OF VITAMIN D LEVELS AND CIRCULATORY RISK FACTORS IN PRIMARY CAREA. Mastan, A. Bokhari, R. Aghamohammadzadeh, A.M. HeagertyManchester-UK
14.00 - 15.30Ground Floor
Poster Session 03
RISK FACTORS
ROOM 3 / POSTERS FROM 63 TO 84
Chairperson: D. Rizzoni (Brescia-ITALY)
3 63 / THE RELATIONSHIP BETWEEN HYPERURICEMIA AND GLUCOSE METABOLISM VALUES IN PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSIONV. Bozhko, S. Koval, L. Reznik, M. PenkovaKharkov-UKRAINE
3 64 / ARTERIAL BLOOD PRESSURE AND HEART RATE VARIABILITY IN PERSONS AFTER SMOKING CESSATIONM. Poreba, R. Poreba, P. Gac, W. Pilecki, M. Sobieszczanska Wroclaw-POLAND
3 65 /ANALYSIS OF CARDIOVASCULAR RISK IN FIRST-DEGREE RELATIVES OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION (FAMIAM STUDY). PRELIMINARY RESULTSM.D. Blanco (1), I. Chuecos (1), S. del Pozo (1), J. Ferrer (1), M.A. Franco (1), S. Balanza (2), I. Tovar (2), P. Martinez (2), M. Leal (2), J. Abellan (2)(1) Lorca, (2) Murcia-SPAIN
3 66 / ECONOMIC BURDEN OF HYPERTENSION IN RUSSIAN FEDERATIONA. Kontsevaya, A. KalininaMoscow-RUSSIA
3 67 / PREVENTION OF CARDIOVASCULAR DISEASE: WHAT PHYSICIANS, WHO TREAT HYPERTENSIVE PATIENTS, KNOW ABOUT THEIR HEALTHG. Radchenko (1), I. Marzovenko (2), Yu. Sirenko (1)(1) Kiev, (2) Summy-UKRAINE
3 68 / ARTERIAL HYPERTENSION, RISK FACTORS AND INTEGRAL CARDIOVASCULAR RISK IN UNORGANIZED POPULATION OF MEN AGED 35-55 YEARS IN TYUMEN REGIONS. Shalaev, V. Berezina, I. Shutova, S. Yartzev, Z. Safi ullinaTyumen-RUSSIA
Saturday
18
140Saturday 18140 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011141
Saturday 18 3 83 / INCIDENCE OF CARDIOVASCULAR RISK FACTORS ON LIPID METABOLISM IN A MOROCCAN POPULATIONF. Essiarab, H. Taki, N. Ghalim, R. SaileCasablanca-MOROCCO
3 84 / NON HIGH DENSITY LIPOPROTEIN CHOLESTEROL IS MORE STRONGLY ASSOCIATED TO CAROTID PLAQUES THAN LDL CHOLESTEROL IN AN ITALIAN HYPERTENSIVE POPULATIONV. Spagnuolo, F. Cetraro, N. Greco, T. Bartolillo, M. Sprovieri, M. FerraroCosenza-ITALY
3 77 / ORGANIC POLYPHOSPHATES AS PROGNOSTIC FACTORS OF HYPERTENSION PROGRESS IN WOMENA. Sadykova, R. Baykeev, A. Shamkina, R. GizyatullovaKazan-RUSSIA
3 78 / PREVALENCE AND TRENDS IN CARDIOVASCULAR RISK FACTORS IN ELDERLY PATIENTS FROM GENERAL PRACTICE SETTING IN POLAND. THE RESULTS OF LIPIDOGRAM2004 AND LIPIDOGRAM2006 SURVEYSJ. Gasowski (1), J. Jozwiak (2), M. Klonowski (3), A. Winak (1), M. Mastej (3), T. Grodzicki (1), T. Tomasik (1), A. Tykarski (4), M. Tomaszewski (5), B.M. Kaess (5), J. Kramer (6), A. Manasar (3), A. Slezak (2), W. Lukas (3)(1) Krakow, (2) Czestochowa, (3) Katowice, (4) Poznan-POLAND; (5) Leicester-UK; (6) Geesthacht-GERMANY
3 79 / PATIENT COMPLIANCE ON HYPERTENSIVE MANAGEMENT AND ITS RELATED FACTORS IN DEVELOPING COUNTRY: A STUDY OF COMMUNITY DIAGNOSIS IN PONDOK KELAPA, EAST JAKARTA, INDONESIAF. Ahsan (1) D. Notosusanto (2) M. Fitra Purnama (2) E. Renjana (2) D. Utama (2) J. Prihartono (2), on behalf of FACULTY OF MEDICINE, UNIVERSITY OF INDONESIA(1) Rotterdam-THE NETHERLANDS, (2) Jakarta-INDONESIA
3 80 / PREVALENCE OF OBESITY AND SMOKING IN STUDENTS OF GREECE: TWO IMPORTANT CARDIOVASCULAR RISK FACTORSS. Patiakas, K. RousosThessaloniki-GREECE
3 81 / LP(A) LEVELS ARE ASSOCIATED WITH INSULIN RESISTANCE AND HYPERINSULINEMIA IN HYPERTENSIVE PATIENTSL. Marzano, C. Catena, G.L. Colussi, L.A. SechiUdine-ITALY
3 82 / LIPID PROFILE OF PATIENTS ADMITTED WITH ACUTE CORONARY SYNDROME TO THE TOLEDO HEALTH CARE AREA BETWEEN 2005 AND 2008G.C. Rodriguez-Roca (1), L. Rodriguez-Padial (1), F.J. Alonso-Moreno (1), A. Romero-Gutierrez (1), F. Akerström (1), A. Segura-Fragoso (1), A. Villarin-Castro (1), J. Hernandez-Moreno (1), A. Menchen-Herreros (1), E. Fernandez-Rodriguez (1), L.M. Artigao-Rodenas (2), on behalf of RICARTO Working Group(1) Toledo, (2) Albacete-SPAIN
Saturday
18
142Saturday 18142 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011143
Saturday 18 4 90 / SEVEN-DAY AMBULATORY BLOOD PRESSURE MONITORING AND DAY AND NIGHT BLOOD PRESSURE VARIABILITYJ. Siegelova (1), A. Havelkova (1), B. Fiser (1), J. Dusek (1), M. Pohanka (1), L. Dunklerova (1), G. Cornelissen (2), F. Halberg (2)(1) Brno-CZECH REPUBLIC; (2) Minnesota-USA
4 91 / ALTERATION OF THE CIRCADIAN BLOOD PRESSURE PATTERN IN SUBJECTS WITH CHRONIC KIDNEY DISEASE: THE HYGIA PROJECTA. Otero (1), M. Dominguez-Sardiña (2), M.C. Castiñeira (3), J.J. Crespo (2), A. Ferreras (2), A. Mojon (2), D.E. Ayala (2), J.R. Fernandez (2), R.C. Hermida (2), on behalf of Hygia Project Investigators(1) Orense, (2) Vigo, (3) Lugo-SPAIN
4 92 / INFLUENCE OF DIPPING CLASSIFICATION ON FASTING GLUCOSE IN SUBJECTS WITH OR WITHOUT ELEVATED AMBULATORY BLOOD PRESSURE: THE HYGIA PROJECTM. Dominguez-Sardiña (1), P.A. Callejas (1), P. Eiroa (1), J.J. Crespo (1), J.L. Salgado (1), A. Otero (2), M.J. Fontao (1), S. Lorenzo (1), R.C. Hermida (1), on behalf of Hygia Project Investigators(1) Vigo, (2) Orense-SPAIN
4 93 / DISCORDANT ESTIMATION OF THE PREVALENCE OF MASKED HYPERTENSION ACCORDING TO DAYTIME OR NIGHTTIME BLOOD PRESSURE IN SUBJECTS WITH CHRONIC KIDNEY DISEASE: THE HYGIA PROJECTR.C. Hermida (1), A. Otero (2), L. Piñeiro (3), D.E. Ayala (1), A. Moya (3), E. Sineiro (3), M.J. Fontao (1), A. Mojon (1), J.R. Fernandez (1), on behalf of Hygia Project Investigators(1) Vigo, (2) Orense, (3) Pontevedra-SPAIN
4 94 / AUTOMATED OFFICE BLOOD PRESSURE MEASUREMENTS VERSUS MORNING HOME BLOOD PRESSURE MONITORING IN THE ASSESSMENT OF HYPERTENSIONE. Andreadis, E. Angelopoulos, A. Tsakanikas, G. Agaliotis, G. MousoulisAthens-GREECE
4 95 / AUTOMATED OFFICE BLOOD PRESSURE MEASUREMENT BY USING THE BPTRU DEVICE FOR THE DIAGNOSIS OF RESISTANT HYPERTENSIONG. Crippa, A. Cassi, M. Bosi, M.L. FaresPiacenza-ITALY
14.00 - 15.30Ground Floor
Poster Session 04
BLOOD PRESSURE MEASUREMENT
ROOM 4 / POSTERS FROM 85 TO 121
Chairperson: G. Bilo (Milan-ITALY)
4 85 / THE SUSPPUP RATIO IN PATIENTS WITH ESSENTIAL HYPERTENSION AND DIPPING AND NON-DIPPING PATTERN OF NOCTURNAL BLOOD PRESSUREJ. Porzezinska-Furtak, A. Brzeska, T. Miazgowski, K. WideckaSzczecin-POLAND
4 86 / USEFULNESS OF AMBULATORY BLOOD PRESSURE MEASUREMENT IN EVALUATION OF CARDIOVASCULAR COMPLICATIONS IN THE GROUP OF HYPERTENSIVE PATIENTSL. Woznicka-Leskiewicz, I. Klorek, A. Posadzy-MalaczynskaPoznan-POLAND
4 87 / IMPACT OF DAYTIME AMBULATORY BLOOD PRESSURE ON CAROTID ARTERY INTIMA-MEDIA THICKNESS IN PREHYPERTENSIVE PATIENTSE. Manios, F. Michas, E. Koroboki, K. Stamatelopoulos, V. Chouzouri, A. Dimitriou, C. Papamichael, N. ZakopoulosAthens-GREECE
4 88 / LONG-TERM EFFECTS OF TELEMETRIC BLOOD PRESSURE MONITORING IN ADEQUATELY TREATED PATIENTS WITH ARTERIAL HYPERTENSIONC.L. Neumann, E.M. Rieken, J.M. Schmidt Thrun, E.G. SchulzGöttingen-GERMANY
4 89 / THE INFLUENCE OF DEPRESSION IN BLOOD PRESSURE AND PULSE IN ADOLESCENTSV.C. Romero Martinez, E.R. Silva, J.J. Villasmil, G.A. Bermudez, F. MadueñoMaracaibo-VENEZUELA
Saturday
18
144Saturday 18144 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011145
Saturday 18 4 102 / AMBULATORY ARTERIAL STIFFNESS INDEX FOR THE PREDICTION OF ANTIHYPERTENSIVE TREATMENT RESPONSEG. Marakomichelakis, V. Sevastianos, N. Skliros, A. Missiakouli, D. Pavlopoulou, E.J. DiamantopoulosAthens-GREECE
4 103 / HEALTH CARE PROFESSIONALS’ KNOWLEDGE AND ATTITUDES TOWARDS HOME BLOOD PRESSURE MEASUREMENTL. Cloutier, M.E. LeblancTrois-Rivières-CANADA
4 104 / BLOOD PRESSURE AND HEART RATE RESPONSE TO EXERCISE IN PATIENTS WITH ISOLATED NOCTURNAL HYPERTENSIONC.H. Lee (1), M.S. Cho (1), J.Y. Lee (1), E. Hwang (2), C. Park (1)(1) Seoul, (2) Goyang-SOUTH KOREA
4 105 / PREVALENCE AND PREDICTIVE FACTORS FOR MASKED INEFFICACY OF ANTIHYPERTENSIVE TREATMENTA. Klimenko, S. Villevalde, E. Pavlova, Z. KobalavaMoscow-RUSSIA
4 106 / ANALYSIS OF TWENTY-FOUR-HOUR CENTRAL BLOOD PRESSURE PROFILE – A FEASIBILITY STUDYP. Jankowski, A. Bednarek, A. Olszanecka, A. Windak, D. Czarnecka, K. Kawecka-JaszczCracow-POLAND
4 107 / IS ANTIHYPERTENSIVE TREATMENT ADAPTATION FROM HOME BLOOD PRESSURE MEASUREMENT OPTIMAL? A PILOT STUDY IN GENERAL PRACTICEJ.M. Boivin, E. Boutte, R. Fay, P. Rossignol, F. ZannadVandoeuvre Les Nancy-FRANCE
4 108 / SHISHA (NARGHILE, WATERPIPE) SMOKING AND ITS EFFECT ON THE ARTERIAL STIFFNESS, PULSE WAVE VELOCITY AND OTHER HEMODYNAMIC PARAMETERSM. Al-Kubati (1), A.S. Al-Kubati (2), A.A. Gunaid (3)(1) Brno-CZECH REPUBLIC; (2) Taiz, (3) Sana’a-YEMEN
4 96 / PROGNOSTIC VALUE OF AMBULATORY BLOOD PRESSURE MONITORINGS. Cinza Sanjurgo (1), A. Hermida Ameijeiras (2), J.E. López Paz (2), M. Pena Seijo (2), G. Calvo González (2), A. Pascual Montes (2), V. Martinez Durán (2), M.L. Romero Miguez (2), J.M. Paz Fernández (2), C. Calvo Gómez (2)(1) Malpica, (2) Santiago De Compostela-SPAIN
4 97 / FEASIBILITY OF HOME BLOOD PRESSURE MEASUREMENT IN THE ELDERLYC. Cacciolati, O. Hanon, A. Alperovitch, C. Dufouil, C. TzourioParis-FRANCE
4 98 / A PERFECT REPLACEMENT FOR THE MERCURY SPHYGMOMANOMETER: THE CASE OF THE HYBRID BLOOD PRESSURE MONITORG. Stergiou, N. Karpettas, A. Kollias, A. Destounis, D. TzamouranisAthens-GREECE
4 99 / MAY WE INCREASE AMBULATORY BLOOD PRESSURE REPRODUCIBILITY?M. Pena Seijo, A. Hermida Ameijeiras, J.E. López Paz, G. Calvo Gonzalez, M.L. Romero Míguez, A. Pascual Montes, V. Martinez Durán, A. Pose Reino, C. Calvo GómezSantiago De Compostela-SPAIN
4 100 /AGE DEPENDENCY OF CENTRAL AND PERIPHERAL SYSTOLIC BLOOD PRESSURES: CROSS-SECTIONAL AND LONGITUDINAL OBSERVATIONS IN EUROPEAN POPULATIONSW. Wojciechowska (1), K. Stolarz-Skrzypek (1), V. Tikhonoff (2), T. Richart (3), J. Seidlerová (4), M. Cwynar (1), L. Thijs (3), Y. Li (5), T. Kuznetsova (3), J. Filipovský (4), E. Casiglia (2), T. Grodzicki (1), K. Kawecka-Jaszcz (1), M. O’Rourke (6), J. Staessen (3), on behalf of the European Project on Genes in Hypertension (EPOGH) Investigators(1) Krakow-POLAND; (2) Padua-ITALY, (3) Leuven-BELGIUM; (4) Pilsen-CZECH REPUBLIC; (5) Shanghai-CHINA; (6) Sidney-AUSTRALIA
4 101 / TELECARE IS A VALUABLE TOOL FOR HYPERTENSION MANAGEMENT, A META-ANALYSISW. Verberk (1), F. Kessels (2), T. Thien (3)(1) Taipei-TAIWAN; (2) Maastricht, (3) Nijmegen-THE NETHERLANDS
Saturday
18
146Saturday 18146 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011147
Saturday 18 4 116 / OFFICE BLOOD PRESSURE MONITORING: A POSSIBLE NEW TOOL FOR EVALUATING BLOOD PRESSURE IN CHILDREN AND ADOLESCENTSP. Salice (1), G.B. Danzi (1), F. Magrini (1), F. De Luca (2), S. Ghiglia (1), A.M. Colli (1), M.A. Galli (1), L. Manuri (2), P.P. Bassareo (3), L. Baca’ (1), D. Li Vecchi (1), G. Ardissino (1)(1) Milan, (2) Messina, (3) Cagliari-ITALY
4 117 / REPEATABILITY OF THE MORNING BLOOD PRESSURE SURGE IN NEVER TREATED HYPERTENSIVE PATIENTSA. Prejbisz, G. Kowalewski, K. Paschalis-Purtak, B. Puciłowska-Jankowska, M. Makowiecka-Ciesla, M. Kluk, E. Florczak, M. Kabat, A. JanuszewiczWarsaw-POLAND
4 118 / EMOTIONAL INTELLIGENCE, PSYCHOLOGICAL FACTORS MAY INFLUENCE THE DIFFERENCE BETWEEN CLINICAL AND AMBULATORY BLOOD PRESSURE LEVELS IN PATIENTS WITH HYPERTENSIONG. Andreeva, O. Lerman, D. Lyusin, A. Deev, V. GorbunovMoscow-RUSSIA
4 119 / EFFECTS OF EXERCISE PRESCRIPTION AND REMOTE BLOOD PRESSURE MONITORING ON HEART RATE VARIABILITY IN A RURAL POPULATION WITH METABOLIC SYNDROMEM.I. Stuckey (1), K.J. Sabourin (1), S. Shapiro (1), C. Munoz (2), R.J. Petrella (1)(1) London, (2) Seaforth-CANADA
4 120 / AMBULATORY BLOOD PRESSURE MONITORING IN DIABETIC PATIENTS ADMITTED IN GENERAL HOSPITALM.A. Esteban-Moreno, M.I. Poveda-García, F.J. González-Martínez, M.D. Del Pino y PinoAlmería-SPAIN
4 121 / AMBULATORY BLOOD PRESSURE MONITORING USEFULNESS IN HYPERTENSION DIAGNOSTIC AND HYPERTENSION TREATMENT CONTROL (2000-2011)P. Cortes Hausmann, J. Bisbe Company, V. Bisbe Company, H. Briceño Garcia, S. Soler Simon, J.C. Trullas VilaOlot-SPAIN
4 109 / AMBULATORY BLOOD PRESSURE MONITORING AFFECTS SLEEP QUALITY AND BLOOD PRESSUREV. Katsi, G. Souretis, N. Kalovidouris, I. Vlasseros, A.N. Koumoulidis, S. Christakopoulos, D. Tsiachris, C. Masoura, D. Papoutsis, M. Divani, N. Alexopoulos, C.H. Vlachopoulos, C.H. Stefanadis, I. KallikazarosAthens-GREECE
4 110 / PREVALENCE OF HIGH BLOOD PRESSURE DURING SCHEDULED VISITS IN FAMILY PRACTITIONERB. Symonides, M. Cieplak, E. Kudraszew, C. Ducki, Z. GaciongWarsaw-POLAND
4 111 / THE EFFECT OF CUFF SIZE ON AUTOMATED BLOOD PRESSURE MEASUREMENT IN PREGNANT AND NON-PREGNANT INDIVIDUALSG.J. Mangos, J.L. Ram, M.A. BrownKogarah-AUSTRALIA
4 112 / LEFT VENTRICULAR GEOMETRIC PATTERN AND ABPM PROFILE IN THE ELDERLYA. Esposito (1), D. Solari (1), S. Carugo (1), A. Pernigotti (1), C. Redaelli (1), M. Maisaidi (1), F. Magrini (1), G. Mancia (2)(1) Milan, (2) Monza-ITALY
4 113 / EFFECT OF CHRONOTHERAPY WITH BETA-BLOCKER (BISOPROLOL) ON CHRONOBIOLOGICAL PARAMETERS OF CIRCADIAN BLOOD PRESSURE PATTERN IN PATIENTS WITH ARTERIAL HYPERTENSION UNDER CONDITIONS OF CIRCUMPOLAR SHIFT WORKA. Vetoshkin (1), N. Shurkevitch (2), L. Gapon (2), D. Gubin (2), N. Belozerova (2), F. Poshinov (1)(1) Yamburg, (2) Tyumen-RUSSIA
4 114 / HOME ARTERIAL STIFFNESS INDEX AND HOME PULSE PRESSURE IN SUBJECTS OLDER THAN 55 FROM FREE-LIVING POPULATIONE. Platonova, A. Deev, V. Gorbunov, V. Konstantinov, S. ShalnovaMoscow-RUSSIA
4 115 / ASSESSMENT OF SINGLE INTRAVENOUS INFUSION OF COENZYME Q10 EFFECT ON POST-INFARCTED MYOCARDIUM FUNCTION WITH CONDUCTANCE CATHETER TECHNIQUEA. Ivanov, E. Kalenikova, E. Gorodetskaya, O. MedvedevMoscow-RUSSIA
Saturday
18
148Saturday 18148 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011149
Saturday 18 5 127 / FOOD PEPTIDES REDUCE ANGIOTENSIN II- OR INTERLEUKIN 1β-INDUCED CYCLOOXIGENASE-2 EXPRESSION IN VASCULAR FIBROBLASTSM. Garcés, M. Quiñones, M. Galán, R. López-Fandiño, M. Salaices, M. MiguelMadrid-SPAIN
5 128 / PREDICTORS OF SUBCLINICAL ATHEROSCLEROSIS AND INCIPIENT MYOCARDIAL DYSFUNCTION IN ASYMPTOMATIC YOUNG HYPERTENSIVE SUBJECTSRagab Mahfouz, ELSayed FaragZagazig-EGYPT
5 129 / DETAILED ANALYSIS OF PARAMETERS DERIVED FROM PERIPHERAL ARTERIAL TONOMETRY IN CORONARY ARTERY DISEASEU. Neisius, S. Rossi, A. Dominiczak, C. DellesGlasgow-UK
5 130 / EFFECT OF HYPERTENSION ON CORONARY ATHEROSCLEROSIS IN PATIENTS WITH STABLE CORONARY HEART DISEASEO. LomakovskyiKiev-UKRAINE
5 131 / ESTIMATION OF ANTI-OXLDL AUTOANTIBODIES IN PATIENTS WITH ACUTE CORONARY SYNDROME IN ASSOCIATION WITH PREVIOUS STATIN THERAPYR. Laczik (1), P. Szodoray (2), K. Veres (1), I. Csipö (1), S. Sipka (1), Z. Szekanecz (1), P. Soltész (1)(1) Debrecen-HUNGARY; (2) Oslo-NORWAY
5 132 / ALUMINIUM PHTALOCYANINE ACCUMULATION IN ENDARTERECTOMY CAROTID PLAQUES IN PATIENTS WITH ARTERIAL HYPERTENSION AND ATHEROSCLEROSIS: STUDY IN VITROY. Efremova, G. Soboleva, E. Andreeva, N. Radukhina, E. Tararak, Y. Karpov, on behalf of Russian Cardiology Research and Production CenterMoscow-RUSSIA
5 133 / CHRONIC PERIODONTITIS AND ALBUMIN EXCRETION IN HYPERTENSIVE PATIENTS: A POSITIVE ASSOCIATION BEYOND SYSTEMIC INFLAMMATIONA. Kasiakogias, C. Tsioufi s, C. Thomopoulos, N. Soldatos, K. Kintis, I. Andrikou, C. StefanadisAthens-GREECE
14.00 - 15.30Ground Floor
Poster Session 05
ATHEROSCLEROSIS
ROOM 5 / POSTERS FROM 122 TO 142
Chairperson: P. Pauletto (Treviso-ITALY)
5 122 / AGE RELATED INTIMA–MEDIA THICKNESS DYNAMICS IN ELDERLY PATIENTS WITH ARTERIAL HYPERTENSIONL. Malinova, L. Sadgaya, L. TikhonovaSaratov-RUSSIA
5 123 / RELATIONSHIP BETWEEN VITAMIN D STATUS AND EARLY ARTERIAL CHANGES IN PRIMARY HYPERTENSION. PRELIMARY DATAF. Tornese, C. Scazzone, R. Arsena, L. Guarino, A.C. Fornaci, E. Ajello, G. Mule’, G. Cerasola, S. CottonePalermo-ITALY
5 124 / ORTHOSTATIC HYPOTENSION AND INTIMA MEDIA THICKNESS: IS THERE ANY ASSOCIATION?A. Fedorowski, P. Nilsson, G. Engström, B. Hedblad, O. MelanderMalmö-SWEDEN
5 125 / A DEVELOPING STORY: TWINS AND EARLY ATHEROSCLEROSIS PREVENTIOND.L. Tarnoki (1), A.D. Tarnoki (1), R. Cotichini (2), C. Fagnani (2), F. Fanelli (2), C. Baracchini (3), G. Meneghetti (3), G. Schillaci (4), R.G. Kiss (1), A. Lannert (1), L. Littvay (1), A.A. Molnar (1), V. Nambi (5), Z. Garami (5), V. Berczi (1)(1) Budapest-HUNGARY; (2) Rome, (3) Padua, (4) Perugia-ITALY; (5) Houston-USA
5 126 / HDL DIMINISHES MMP-9 PRODUCTION IN A S1P3/TGF-ß DEPENDENT MANNERM. Schuchardt, M. Tölle, T. Huang, W. Zidek, M. van der GietBerlin-GERMANY
Saturday
18
150Saturday 18150 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011151
Saturday 18 5 141 / STRUCTURAL AND FUNCTIONAL ARTERIAL PARAMETERS USED IN CARDIOVASCULAR RISK ASSESSMENT AND SUBCLINICAL ATHEROSCLEROSIS DIAGNOSIS: REFERENCE VALUES FOR A YOUNG URUGUAYAN POPULATIOND. Bia, Y. Zocalo, I. Farro, J. Torrado, F. Farro, L. Florio, M. Molinari, A. Olascoaga, W. Alallón, R. Lluberas, R. ArmentanoMontevideo-URUGUAY
5 142 / HDL-CHOLESTEROL, OBESITY AND EARLY ATHEROSCLEROSIS IN YOUNG PEOPLEA. Starodubova, G. Storozhakov, O. Kisliak, V. Govorun, V. Sergienko, L. Djedjeva, A. Kopelev, S. KosyuraMoscow-RUSSIA
5 134 / AORTIC STIFFNESS AND WAVE REFLECTIONS IN RELATION TO ADVANCED GLYCATION END PRODUCTS IN CHINESEQ. Huang, F. Li, C. Sheng, J. Zou, B. Hu, Y. Li, J. WangShanghai-CHINA
5 135 / MICROALBUMINURIA AND ITS CORRELATION WITH ATHEROSCLEROSIS IN ESSENTIAL HYPERTENSIONM. Gjata, V. Duraj, E. Nelaj, L. Collaku, J. Klosi, M. TaseTirana-ALBANIA
5 136 / GENDER DIFFERENCES IN THE MANAGEMENT OF ARTERIAL HYPERTENSION IN PATIENTS WITH CORONARY ARTERY DISEASE. PILOT STUDYA. Vachulova, B. Vohnout, B. Liska, S. FilipovaBratislava-SLOVAK REPUBLIC
5 137 / HYPERTENSION IS A DETERMINANT OF ABCA1 EXPRESSION IN ATHEROSCLEROTIC PLAQUES FROM HYPERCHOLESTEROLEMIC PATIENTSD. Santovito, C. Mandolini, F. Buttitta, V. De Nardis, M. Bucci, A. Marchetti, S. Ucchino, A. Mezzetti, F. CipolloneChieti-ITALY
5 138 / A STUDY OF LONG-TERM PROGNOSIS IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE VERIFIED BY CORONARY ANGIOGRAPHY: RESULTS OF OBSERVATION FOR PATIENTS INCLUDED IN THE REGISTER OF NATIONAL RESEARCH CENTER FOR PREVENTIVE MEDICINEA. Malysheva, S. Martsevich, S. Tolpygina, Yu. Polyanskaya, E. Gofman, A. Deev, V. MazaevMoscow-RUSSIA
5 139 / PRECLINICAL ATHEROSCLEROSIS IN DIABETIC HYPERTENSIVE PATIENTSC. Serban, S. Dragan, I. Mozos, L. Susan, R. Christodorescu, A. Pacurari, L. Noveanu, M. Craina, A. Caraba, I. RomosanTimisoara-ROMANIA
5 140 / CAROTID PLAQUE ECHOLUCENCY IS ASSOCIATED WITH WORSE COGNITIVE PERFORMANCE IN ELDERLY PATIENTS WITH ATHEROSCLEROTIC DISEASEG. Desideri (1), D. Mastroiacovo (1), M. Pinelli (2), G. De Blasis (2), M. Andriulli (1), I. Petrella (1), L. Semeraro (1), A. Raffaele (2), R. Bocale (1), D. Grassi (1), C. Marini (1), C. Ferri (1)(1) L’Aquila, (2) Avezzano-ITALY
Saturday
18
152Saturday 18152 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011153
Saturday 18 6 148 / RECOVERY TIME POST NYTROGLYCERIN IN FOLLOWING UP ENDOTHELIAL DYSFUNCTION IN ESSENTIAL ARTERIAL HYPERTENSIONV. Aursulesei, M.D. DatcuIasi-ROMANIA
6 149 / ALDOSTERONE DOES NOT MODIFY GENE EXPRESSION IN HUMAN ENDOTHELIAL CELLSA. Verhovez (1), T.A. Williams (1), V. Crudo (1), J. Burrello (1), M. Covella (1), D. Leone (1), E. Berra (1), F. Fallo (2), B. Fabris (3), F. Amenta (4), C.E. Gomez-Sanchez (5), F. Veglio (1), P. Mulatero (1)(1) Turin, (2) Padua, (3) Trieste, (4) Camerino-ITALY; (5) Jackson-USA
6 150 / COCOA IMPROVES ENDOTHELIUM-DEPENDENT VASODILATATION BUT NOT ALTERS BLOOD PRESSURE AND PULSE WAVE VELOCITY IN HYPERTENSIVESM. Knibel, L. Nogueira, M. Rodrigues, D. Valença, J. Nogueira Neto, A. Cunha, M. Torres, M. Guedes, C. Lima, A. SanjulianiRio de Janeiro-BRAZIL
6 151 / THE TREATMENT WITH OUABAIN ANTAGONIST REDUCES BLOOD PRESSURE AND IMPROVES ENDOTHELIAL FUNCTION OF RESISTANCE ARTERIES FROM DOCA-SALT HYPERTENSIVE RATSC.F. Wenceslau, L.V. RossoniSao Paulo-BRAZIL
6 152 / ENDOTHELIAL DYSFUNCTION AND INSULIN RESISTANCE IN PERSONS WITH VARIOUS CARDIOVASCULAR RISK FACTORSE. Kolesova, O. Rotar, E. Moguchaya, A. Erina, E. Dudorova, A. Konradi, E. ShlyakhtoSt. Petersburg-RUSSIA
6 153 / NON-INVASIVE EVALUATION OF THE ENDOTHELIAL FUNCTION IN MENOPAUSAL WOMENF. Margulis, A. Villamil, M. Romero, J. ZilbermanBuenos Aires-ARGENTINA
6 154 / ADVANCING AGE INCREASES CONTRACTILE PROSTANOIDS RELEASE IN AORTA OF FEMALE SENESCENCE ACCELERATED MOUSES. Novella (1), C. Hermenegildo (1), A.P. Dantas (2), C. Bueno-Betí (1), L. Novensá (2), G. Segarra (1), P. Medina (1)(1) Valencia, (2) Barcelona-SPAIN
14.00 - 15.30Ground Floor
Poster Session 06
ENDOTHELIUM
ROOM 6 / POSTERS FROM 143 TO 164
Chairperson: G. Bilo (Milan-ITALY)
6 143 / CAN LOW VITAMIN D LEVELS IN SUMMER BE ASSOCIATED WITH DECREASED ENDOTHELIAL VASODILATATOR FUNCTION IN NORMOTENSIVE, NORMOLIPIDEMIC WOMEN?S. Ertek (1), E. Akgul (1), A.F. Cicero (2), S. Cehreli (1), G. Erdogan (1)(1) Ankara-TURKEY; (2) Bologna-ITALY
6 144 / VISCERAL OBESITY IS A “NEW” MARKER OF ENDOTHELIAL DYSFUNCTION AMONG SUBJECTS AFFECTED BY CHRONIC KIDNEY DISEASES. Vettoretti, C. Cafforio, C. Alfi eri, C. Bonanomi, R. Floreani, G. Danzi, P. MessaMilan-ITALY
6 145 / A COMPARATIVE ANALYSIS OF THE LEVEL OF HIGH SENSITIVE C-REACTIVE PROTEIN IN THE PEOPLE WITH AND WITHOUT HYPERTENSIONB. Naghshtabrizi, F. Dadras, F. Emami, F. Khoshjou, M. Gharakhani, A.H. Moadab, A. MozayanimonfaredHamedan-IRAN
6 146 / HEART RATE DEPENDENT ASSOCIATION BETWEEN ENDOTHELIAL FUNCTION AND HEART RATE VARIABILITYT. Horvath, A. Pinter, M. KollaiBudapest-HUNGARY
6 147 / DYNAMICS OF INDEXES OF ENDOTHELIAL FUNCTION IN PATIENTS WITH MYOCARDIAL INFARCTION AT THE BACKGROUND OF ARTERIAL HYPERTENSIONI. Malynovska, V. Shumakov, L. Tereshkevysh, L. Prohna, O. Yanus Kiev-UKRAINE
Saturday
18
154Saturday 18154 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011155
Saturday 18 6 162 / ALBUMINURIA IS RELATED TO CIRCULATING SOLUBLE RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS AND BIOMARKERS OF ENDOTHELIAL FUNCTION IN HYPERTENSIONK. Dimitriadis, C. Tsioufi s, M. Almyroudi, K. Kintis, L. Lioni, D. Flessas, D. Syrseloudis, C. StefanadisAthens-GREECE
6 163 / ANTIHYPERTENSIVE MEDICATION IMPROVES ENDOTHELIAL DYSFUNCTION IN HEMODIALYSIS PATIENT?M. Benítez Sánchez, I. Gonzalez, R. Valverde, R. Calurano, S. Cruz, E. Rodriguez, F. Fernandez Mora, M.J. Merino, F. Fernandez G., J. Gonzalez, J.M. Onaindia, C. SuarezHuelva-SPAIN
6 164 / ENDOTHELIAL FUNCTION AND INTIMA-MEDIA THICKNESS IN PATIENTS WITH HYPOTHYROIDISM AND HYPERTENSIONM. Gvozdyk, O. Mitchenko, V. RomanovKyiv-UKRAINE
6 155 / ENDOTHELIAL DYSFUNCTION AND VITAMIN D STATUS IN ESSENTIAL HYPERTENSION. PRELIMARY RESULTSF. Tornese, C. Scazzone, R. Arsena, L. Guarino, A. Ocello, A. Bono, G. Cerasola, S. CottonePalermo-ITALY
6 156 / MICROALBUMINURIA AND ENDOTHELIAL DYSFUNCTION IN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROMEM.O. Gonzalez Albarran, S. Calvo, M. Carrasco, M. Cano, G. Perez, J. GomezMadrid-SPAIN
6 157 / HAEMOSTASIS PARAMETERS DISTURBANCES IN HEALTHY INDIVIDUALS WITH HIGH NORMAL BLOOD PRESSUREA. Kotrotsou, D.P. Papadopoulos, I. Mourouzis, A. Dellaportas, M. Bonios, I. Vlahodimitris, P. Kribas, C. EkonomouAthens-GREECE
6 158 / ENDOTHELIAL FUNCTION DYNAMICS UNDER THE INFLUENCE OF DIFFERENT VASOACTIVE ANTIHYPERTENSIVE AGENTSO. Fedorishina (1), K. Protasov (1), A. Dzizinsky (1), E. Trunova (2), M. Makarenko (2), N. Gakh (2)(1) Irkutsk, (2) Angarsk-RUSSIA
6 159 / CORRELATION OF LIPID, CARBOHYDRATE AND PURINE METABOLISM AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH ARTERIAL HYPERTENSION AND ABDOMINAL OBESITYK. Hanchar, L. Yankovskaya, I. Karaulko, E. Kezhun, E. Trojan, A. Lelevich, L. KezhunGrodno-BELARUS
6 160 / ENDOTHELIAL DYSFUNCTION AND ARTERIAL STIFFNESS IN HYPERTENSIVE PATIENTS WITH OBESITYN. Demikhova, M. Vlasenko, T. RudenkoKharkov-UKRAINE
6 161 / SALT LOADING IN CANOLA OIL FED SHRSP RATS INDUCES ENDOTHELIAL DYSFUNCTIONA. Papazzo (1), L. Lexis (2), P. Lewandowski (1)(1) Geelong, (2) Melbourne-AUSTRALIA
Saturday
18
156Saturday 18156 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011157
Saturday 18 7 169 / RETINAL MICROCIRCULATION IMPROVEMENT AFTER THE CONTROL OF BLOOD PRESSURE WITH ARB-II IN HYPERTENSIVE PATIENTSM. Pena-Seijo (1), J.L. Díaz Díaz (2), J.A. Díaz Peromingo (3), M. Suárez Tembra (2), R. Monte Secades (4), M. González Penedo (2), I. Méndez Naya (1), A. Hermida Ameijeiras (1), J.E. López Paz (1), C. Calvo Gómez (1), F. Gómez-Ulla Irazazabal (1), A. Pose Reino (1)(1) Santiago De Compostela, (2) A Coruña, (3) Ribeira, (4) Lugo-SPAIN
7 170 / MYOENDOTHELIAL GAP JUNCTIONS INVOLVEMENT TO THE SUSTAINED PHASE OF HYPOXIC PULMONARY VASOCONSTRICTION DEVELOPMENTI. Kizub (1), I. Strielkov (1), A. Soloviev (1), J. Ward (2)(1) Kiev-UKRAINE, (2) London-UK
7 171 / RELEVANCE OF GLOMERULAR FILTRATION RATE TO THE DEFORMABILITY AND OXYGEN PERMEABILITY OF ERYTHROCYTE MEMBRANE IN PATIENTS WITH UNTREATED ESSENTIAL HYPERTENSIONM. Fornal, K. Burda, M. Kaczmarska, R. Korbut, T. GrodzickiCracow-POLAND
7 172 / IMPAIRED CORONARY MICROCIRCULATION IS RELATED TO SUBENDOCARDIAL VIABILITY RATIO AS IN UNTREATED HYPERTENSIVES. AN INVASIVE APPROACHD. Tsiachris, C. Tsioufi s, D. Rousos, D. Syrseloudis, K. Kintis, G. Latsios, S. Patsilinakos, C. StefanadisAthens-GREECE
7 173 / URIC ACID AND MICROVASCULAR DILATATION RESERVE IN THE HYPERTENSIVE PATIENTSE. Oschepkova, I. Atyunina, A. Rogoza, A. Fedorovich, V. Dmitriev, V. TitovMoscow-RUSSIA
7 174 / URIC ACID, ARTERIAL STIFFNESS AND BASAL MICROVASCULAR ENDOTHELIAL VASOMOTOR FUNCTION IN THE HYPERTENSIVE PATIENTSI. Atyunina, E. Oschepkova, A. Rogoza, A. Fedorovich, V. Dmitriev, V. TitovMoscow-RUSSIA
7 175 / EVALUATION OF MICROVASCULAR CORONARY LESION IN HYPERTENSIVES WITH LEFT VENTRICULAR HYPERTROPHY AND ISCHEMIC-LIKE ST SEGMENT CHANGESA. Kisko, J. Kmec, M. Babcak, M. Vereb, M. Vytykacova, J. Cencarik, P. Gazdic, J. StaskoPresov-SLOVAK REPUBLIC
14.00 - 15.30Ground Floor
Poster Session 07
SMALL VESSELS
ROOM 7 / POSTERS FROM 165 TO 183
Chairperson: M.P. Schlaich (Melbourne-AUSTRALIA)
7 165 / MECHANISMS OF PERIPHERAL TISSUE BLOOD FLOW INFLUENCED BY HIGH SALT DIET IN YOUNG HEALTHY FEMALE HUMAN SUBJECTSA. Cavka (1), I. Grizelj (1), B. Jelakovic (2), J.H. Lombard (3), I. Mihaljevic (1), A. Koller (4), I. Drenjancevic (1)(1) Osijek, (2) Zagreb-CROATIA; (3) Milwaukee-USA; (4) Pecs-HUNGARY
7 166 / ASSESSMENT OF PERIPHERAL VASCULAR FUNCTION WITH PHOTOPLETHYSMOGRAPHIC PULSE AMPLITUDE: A POPULATION STUDYT. Kuznetsova (1), G. Szczesny (2), L. Thijs (1), D. Jozeau (2), J. Dhooge (1), J. Staessen (1)(1) Leuven, (2) Brussels-BELGIUM
7 167 / SPHINGOSINE-1-PHOSPHATE IN CALCIUM SENSITIZATION OF SMALL MESENTERIC ARTERIES IN SPONTANEOUSLY HYPERTENSIVE RATSC. Aoqui, R. Eissler, S. Chmielewski, C. Schmaderer, D. Sollinger, U. Heemann, M. BaumannMunich-GERMANY
7 168 / THERE IS A PARALLEL ESCALATION BETWEEN RETINAL VASCULAR ALTERATIONS AND ARTERIAL STIFFNESS IN ESSENTIAL HYPERTENSIONV. Katsi, G. Souretis, I. Vlasseros, S. Christakopoulos, A.N. Koumoulidis, D. Mparlagiannis, D. Tsiachris, N. Alexopoulos, C.H. Vlachopoulos, C. Masoura, C.H. Stefanadis, I. KallikazarosAthens-GREECE
Saturday
18
158Saturday 18158 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011159
Saturday 1814.00 - 15.30Ground Floor
Poster Session 08
RENAL ASPECTS
ROOM 8 / POSTERS FROM 184 TO 220
Chairperson: M.P. Schlaich (Melbourne-AUSTRALIA)
8 184 / α2A-ADRENERGIC RECEPTOR DEFICIENCY AMELIORATES PROGRESSION OF CHRONIC KIDNEY DISEASEH. Hoch (1), J. Stegbauer (1), S.A. Potthoff (1), E. Koenigshausen (1), L. Hein (2), L.C. Rump (1), O. Vonend (1)(1) Duesseldorf, (2) Freiburg-GERMANY
8 185 / RENAL FUNCTIONAL DETERIORATION DECREASES INTRARENAL EXPRESSION OF HUMAN ANGIOTENSIN RECEPTOR BINDING AND INHIBITORY MOLECULEK. Tamura, H. Wakui, S. Masuda, T. Dejima, A. Maeda, T. Kanaoka, M. Ohsawa, S. Haku, K. Azushima, K. Azuma, T. Ishigami, Y. Toya, S. UmemuraYokohama-JAPAN
8 186 / VENTRICULAR REPOLARISATION IN PATIENTS WITH RENOVASCULAR HYPERTENSIONS. Maule, V. Milazzo, C. Di Stefano, A. Fabbri, D. Leone, M. Covella, A. Vairo, F. VeglioMoncalieri-ITALY
8 187 / “ANGIOPROTECTIN”: AN ANG-II LIKE PEPTIDE CAUSING VASODILATORY EFFECTSV. Jankowski, M. Toelle, M. Van Der Giet, M. Bader, W. Zidek, J. JankowskiBerlin-GERMANY
8 188 / MICROALBUMINURIA IN THE GENERAL POPULATION: ITS PREVALENCE AND CLINICAL SIGNIFICANCES. Tanaka (1), H. Takase (2), Y. Dohi (1), G. Kimura (1)(1) Nagoya, (2) Hamamatsu-JAPAN
7 176 / WALL-TO-LUMEN RATIO OF RETINAL ARTERIOLES IS RELATED TO ALTERATIONS OF AORTIC PULSE WAVE IN PATIENTS WITH A HISTORY OF A CEREBROVASCULAR EVENTM. Ritt (1), J. Harazny (2), P. Schellinger (1), D. Baleanu (1), S. Schwab (1), G. Michelson (1), R. Schmieder (1)(1) Erlangen-GERMANY; (2) Olsztyn-POLAND
7 177 / CARDIAC REMODELLING AND POSTISCHEMIC SKIN RESPONSE IN SUBJECTS WITH LOW CARDIOVASCULAR RISKB. Gryglewska, M. Cwynar, T. GrodzickiCracow-POLAND
7 178 / A SIX-MONTH PERIOD OF PHARMACOLOGICAL THERAPY INCREASES CAPILLARY DENSITY IN HYPERTENSIVE PATIENTSS. Kaiser, B. Benedito, F. Bevilacqua, A. Sanjuliani, M. Gomes, E. TibiriçáRio De Janeiro-BRAZIL
7 179 / SOLUBLE FMS-LIKE TYROSINE KINASE 1 (SFLT) IS ELEVATED IN ANCA ASSOCIATED VASCULITIS AND DECLINES DURING THERAPYS. Lovric, T. Kirsch, H. Haller, M. HaubitzHannover-GERMANY
7 180 / IMPAIRED MICROCIRCULATION AND CEREBROVASCULAR PERFUSION IN MILD HYPERTENSIVES ALONG THE PROGRESSION OF METABOLIC SYNDROMEP. Nazzaro, G. Schirosi, D. Mezzapesa, M. Petruzzellis, G. Grandolfo, L. De Benedittis, L. Pascazio, F. FedericoBari-ITALY
7 181 / ANGIOGENIC THERAPY IN HYPERTENSIVE PATIENTS WITH CHRONIC LIMB ISCHEMIA IMPROVES MICROCIRCULATION AND PROMOTES COLLATERAL FORMATIONK. Talitskiy, O. Bulkina, A. Fedorovich, A. Samko, Y. Parfyonova, Y. KarpovMoscow-RUSSIA
7 182 / RHEOLOGICAL DISTURBANCES IN PATIENTS WITH STROKEM. Kruchinina, A. Gromov, V. Generalov, A. Rabko, M. ShakirovNovosibirsk-RUSSIA
7 183 / SIRIUS, COMPUTERIZED TOOL FOR AUTOMATIC ANALYSIS OF RETINAL MICROCIRCULATIONM. Pena-Seijo (1), M. González Penedo (2), M. Orteg Hortas (2), S. González (2), F. Gomez-Ulla Irazazabal (1), A. Pose-Reino (1)(1) Santiago De Compostela, (2) A Coruña-SPAIN
Saturday
18
160Saturday 18160 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011161
Saturday 18 8 196 / CAROTID INTIMA-MEDIA THICKNESS IS ASSOCIATED WITH COGNITIVE-MOTOR ABILITIES IN HEMODIALYSIS PATIENTSJ. Radic (1), D. Ljutic (1), M. Radic (1), V. Kovacic (1), M. Sain (1), K. Dodig Curkovic (2)(1) Split, (2) Osijek-CROATIA
8 197 / INFRADIAGNOSED RENAL INSUFFICIENCY AMONG HOSPITALIZED PATIENTSC. Luque-Amado, M. Gonzalez-Benitez, M. Godoy-Guerrero, A. Ruz-Zafra, I. Gallardo-Romero, A. Muñoz-Claros, A. Perez-Rivera, V. Castellanos-Guerrero, V. Diaz-Morant, A. Ruiz-CanteroRonda-SPAIN
8 198 / CLINICAL EVALUATION OF CARDIOVASCULAR RISK FACTORS IN IRREVERSIBLE RENAL FAILURE IN TRANSPLANT PATIENTSM.I. González Carmelo (1), M.I. Lozano Fdez-Salguero (2), I. González Gómez (1), M.J. Merino (1), L. Arenas (2), F. Fernández (1),M. Benítez (1), J.M. Onaindía (1), C. Suárez (1)(1) Huelva, (2) Alicante-SPAIN
8 199 / HEMODYNAMIC EFFECTS OF ALISKIREN ARE SUSTAINED IN THE SYSTEMIC, BUT NOT THE RENAL CIRCULATIONM. Schneider, R. Janka, U. Raff, M. Ritt, C. Ott, M. Uder, R. SchmiederErlangen-GERMANY
8 200 / SPECTRAL ANALYSIS OF CAROTID DISTENSION RATE IS USEFUL TO EVALUATE THE BAROREFLEX SENSITIVITY IN PATIENTS WITH MODERATE RENAL DYSFUNCTIONL. Zanoli, M. Alivon, N. Estrugo, H. Ketthab, J.F. Pruny, S. Yanes, K. Bean, J.P. Empana, X. Jouven, R.D. Laude, S. Laurent, P. BoutouyrieParis-FRANCE
8 201 / HYPERTENSION IN POLYCYSTIC KIDNEY DISEASE: RELATIONSHIP BETWEEN RENAL FUNCTION AND RENAL VOLUME MEASURED BY MAGNETIC RESONANCE IMAGINGN. Oliva, M.J. Torres, R.J. Esteban, M.A. Esteban, R. Fernandez-CastilloGranada-SPAIN
8 202 / RELATION BETWEEN NONDIPPER STATUS, PULSE PRESSURE AND SERUM CALCIUM IN HYPERTENSIVE PATIENTS WITH MILD-TO- MODERATE CHRONIC RENAL DYSFUNCTIONC. Feldstein, M. Akopian, A. Olivieri, D. GarridoBuenos Aires-ARGENTINA
8 189 / RELATIONSHIP BETWEEN OXIDATIVE STRESS AND AORTIC STIFFNESS IN HYPERTENSIVE PATIENTS WITH CHRONIC KIDNEY DISEASEG. Mulè, P. Cusimano, T. Viola, M. Costanzo, A.C. Foraci, A. Palermo, A. Castiglia, E. Nardi, G. Cerasola, S. CottonePalermo-ITALY
8 190 / ARTERIAL STIFFNESS AND COGNITIVE FUNCTION IN CHRONIC KIDNEY DISEASED. Karasavvidou, R. Kalaitzidis, S.E. Pelidou, S. Kountouris, O. Balafa, K. SiamopoulosIoannina-GREECE
8 191 / COMPARISON OF THE MDRD AND THE CKD-EPI EQUATIONS TO ESTIMATE THE GLOMERULAR FILTRATION RATE IN UNTREATED HYPERTENSIVE PATIENTSA. Troshina (1), Y. Kotovskaya (2), N. Bagmanova (2), J. Koblava (2)(1) Dolgoprudni, (2) Moscow-RUSSIA
8 192 / AMONG SUBJECTS AFFECTED BY CHRONIC KIDNEY DISEASE ABDOMINAL OBESITY IS A MARKER OF SUBCLINICAL CARDIAC DAMAGEC. Alfi eri , S. Vettoretti, C. Cafforio, C. Bonanomi, R. Floreani, G. Danzi, P. MessaMilan-ITALY
8 193 / GENETIC VARIANT OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM AND RENAL SURVIVAL IN JAPANESE PATIENTS WITH CHRONIC KIDNEY DISEASEY. Makino, T. Konoshita, T. Kimura, M. Fujii, S. Wakahara, K. Arakawa, I. Inoki, I. MiyamoriEiheiji-JAPAN
8 194 / REDUCTION IN GLOMERULAR FILTRATION RATE PREDICTS NEW ONSET OF HYPERTENSION IN THE GENERAL POPULATIONH. Takase (1), Y. Dohi (2), T. Toriyama (1), T. Okado (1), S. Tanaka (2), H. Sonoda (2), A. Agikura (1), T. Hashimoto (1), G. Kimura (2)(1) Hamamatsu, (2) Nagoya-JAPAN
8 195 / COMPARISON OF HYDRATION STATE AND THE DEGREE OF HYPERTENSION IN PATIENTS IN DIFFERENT FORMS OF PERITONEAL DIALYSISJ. Bordignon, A. Manonelles, A. Andújar, C. González-Segura, M.T. GonzálezBarcelona-SPAIN
Saturday
18
162Saturday 18162 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011163
Saturday 18 8 210 / A NEW EQUATION TO ESTIMATE GLOMERULAR FILTRATION RATE VERSUS OLD ONES FOR CLASSIFICATION OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH ARTERIAL HYPERTENSION AND GLUCOSE INTOLERANCEV. Tolkacheva, S. Villevalde, E. Tyukhmenev, Z. KobalavaMoscow-RUSSIA
8 211 / INVESTIGATION OF RESISTANT HYPERTENSION IN PATIENTS WITH CHRONIC RENAL FAILUREA. Tsipis, G. Chatzivasileiou, G. Kastanas, C. Giannopoulos, I. PapadakisAthens-GREECE
8 212 / RELATIONSHIP BETWEEN RENAL HEMODYNAMICS AND FUNCTIONAL OPTIONS IN PATIENTS WITH RESISTANT ARTERIAL HYPERTENSIONA. Zherzhova, N. Savelieva, N. Antipina, L. GaponTyumen-RUSSIA
8 213 / POTENTIAL UTILITY OF RENAL FRACTONAL FLOW RESERVE IN RENAL ARTERY STENTINGJ. Kadziela, A. Witkowski, A. Januszewicz, A. Prejbisz, I. Michalowska, K. Cedro, M. Januszewicz, B. Pregowska-Chwala, E. Florczak, L. Kalinczuk, B. Norwa-Otto, E. Warchol, W. RuzylloWarsaw-POLAND
8 214 / PREVALENCE OF CHRONIC KIDNEY DISEASE IN THE GENERAL CZECH POPULATION. CZECH POST-MONICA STUDYR. Cifková, V. Teplan, J. Bruthans, A. Jabor, M. Jozifova, P. Wohlfahrt, A. Krajcoviechova, V. Adamkova, M. Galovcova, V. LanskaPrague-CZECH REPUBLIC
8 215 / PREVALENCE AND CONTROL OF HYPERTENSION IN CHRONIC HEMODIALYSIS PATIENTS: RESULTS OF A SINGLE-CENTRE CLINICAL AUDITA. Del Giudice (1), C. Di Giorgio (2), A. Cicchella (1), M. Piemontese (1), G. Pompa (1), M. Prencipe (1), F. Aucella (1)(1) San Giovanni Rotondo, (2) Bari-ITALY
8 216 / INSULIN RESISTANCE AND RENAL FUNCTION IN HYPERTENSIVE NEPHROPATHY PATIENTSV. Bezrodnyy, Y. Svyshchenko, L. Mishchenko, L. BezrodnaKiev-UKRAINE
8 203 / IMPACT OF SERUM URIC ACID ON RENAL FUNCTION AND CARDIOVASCULAR EVENTS IN HYPERTENSIVE PATIENTS WITH CHRONIC KIDNEY DISEASES. Ito (1), H. Naritomi (2), T. Ogihara (3), K. Shimada (4), K. Shimamoto (5), H. Tanaka (6), N. Yoshiike (7)(1) Sendai, (2) Toyonaka, (3) Suita, (4) Tochigi, (5) Sapporo, (6) Atugi, (7) Aomori-JAPAN
8 204 / BLOOD PRESSURE CONTROL AND RENAL FUNCTION PROGRESSION IN PATIENTS OVER 65 YEARSP. J. Labrador, P. M. Gonzalez CastilloPlasencia-SPAIN
8 205 / HYPERTENSION IN HAEMODIALYSIS PATIENTS: STUDY OF PREVALENCEM.J. Torres Sánchez, M.J. Ruiz, R.J. Esteban, M. Peña, N. Oliva, K. Lucana, P. Galindo, A. OsunaGranada-SPAIN
8 206 / CHRONIC KIDNEY DISEASE AS ADDITIONAL DIAGNOSTIC CRITERIA FOR METABOLIC SYNDROME IN PATIENTS WITH ARTERIAL HYPERTENSION AND GLUCOSE INTOLERANCEV. Tolkacheva, S. Villevalde, Z. KobalavaMoscow-RUSSIA
8 207 / RELATION BETWEEN CIRCADIAN BLOOD PRESSURE VARIABILITY AND ESTIMATED VALUE OF GLOMERULAR FILTRATION RATE IN UNKNOWN HYPERTENSIONF. Cipollini, E. Arcangeli, E. Greco, G. SeghieriPistoia-ITALY
8 208 / RELATIONSHIP BETWEEN KIDNEY AND CARDIOVASCULAR DAMAGE IN HYPERTENSIVE PATIENTSE. Tyukhmenev, A. Klimenko, S. Villevalde, Z. KobalavaMoscow-RUSSIA
8 209 / DISCREPANCIES IN HYPERTENSION CONTROL RATES EVALUATED BY MEANS OF OFFICE BP AND AMBULATORY BP MONITORING IN HYPERTENSIVE PATIENTS WITH AND WITHOUT CHRONIC KIDNEY DISEASEM. Gorostidi (1), J. Segura (2), A. De La Sierra (3), J.J. De La Cruz (2), P. Aranda (4), J.R. Banegas (2), L.M. Ruilope (2)(1) Oviedo, (2) Madrid, (3) Barcelona, (4) Malaga-SPAIN
Saturday
18
164Saturday 18164 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011165
Saturday 1814.00 - 15.30Ground Floor
Poster Session 09
OBESITY
ROOM 9 / POSTERS FROM 221 TO 257
Chairperson: P. Pauletto (Treviso-ITALY)
9 221 / COPEPTIN, A PREDICTOR OF CARDIOMETABOLIC RISK FACTORS AND ORGAN DAMAGES. Enhörning (1), L. Bankir (2), N. Bouby (2), J. Struck (3), B. Hedblad (1), P. Nilsson (1), N. Morgenthaler (3), O. Melander (1)(1) Malmö-SWEDEN; (2) Paris-FRANCE; (3) Hennigsdorf-GERMANY
9 222 / OBESITY CONCURRENTLY INFLUENCES EFFECTS OF BIRTH WEIGHT ON BLOOD PRESSURE VALUES IN YOUNG MENV. Premuzic, M. Laganovic, D. Kuzmanic, I. Vukovic-Lela, L.J. Banfi c, M. Vrkic-Kirhmajer, S. Karanovic, T. Zeljkovic-Vrkic, M. Milosevic, B. JelakovicZagreb-CROATIA
9 223 / NEUTRAL ENDOPEPTIDASE INHIBITION FOR THE TREATMENT OF THE METABOLIC SYNDROMEY. Eizenberg, E. Grossman, E. Peleg, Z. Shabtay, Y. SharabiTel Hashomer-ISRAEL
9 224 / THE INFLUENCE OF ZOFENOPRIL ON BLOOD PRESSURE, ADYPOKINES ACTIVITY AND ENDOTHELIN-1 IN OBESE HYPERTENSIVE PATIENTST. Morozova, T. Romantsova, S. Oshorova, T. Andruschishina Moscow-RUSSIA
9 225 / WHAT DOES METABOLIC SYNDROME ADD IN PREDICTION ABOUT FUTURE CARDIOVASCULAR EVENTS IN HYPERTENSIVE NON-DIABETIC PATIENTS IN PRIMARY PREVENTION?J.A. Costa, E. Rodilla, J. Cardona, C. Gonzalez, J.M. PascualPuerto De Sagunto(Valencia)-SPAIN
8 217 / USEFULNESS OF LOW DOSE THRICE WEEKLY ADMINISTRATION OF SPIRONOLACTONE IN PATIENTS WITH OR WITHOUT CHRONIC KIDNEY DISEASE AND RESISTANT HYPERTENSIONM. Mazioti, A. Raptis, A. Drakou, D. Bacharaki, D. VlahakosAthens-GREECE
8 218 / CONTRAST NEPHROPATHY IN PATIENTS WITH HYPERTENSION: A DIFFERENT REALITY?I. Almeida, F. Caetano, J. Silva, L. Seca, P. Mota, A. Leitao-MarquesCoimbra-PORTUGAL
8 219 / ANTI-HYPERTENSIVE, ANTI-THROMBOTIC MEDICATION AND SURVIVAL IN VASCULAR ACCESS FOR HEMODIALYSISM. Benítez Sánchez, I. Gonzalez Carmelo, T. Moreno Sanchez, F. Moreno Rodriguez, O. Elgaut, S. Cruz Muñoz, E. Rodriguez Gomez, F. Fernandez Mora, J. Merino Perez, F. Fernandez Giron, J. Gonzalez Martinez, J.M. Onaindia Rico, C. Suarez RodriguezHuelva-SPAIN
8 220 / THE RELATIONSHIP BETWEEN ANTIHYPERTENSIVE THERAPY AND RENAL FUNCTION IN 152 HYPERTENSIVESL. Liu, Y. Zhang, S. Zhao, J. Wang , W. Yu, A. Wang, X. CuiBeijing-CHINA
Saturday
18
166Saturday 18166 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011167
Saturday 18 9 233 / IS THERE AN INFLUENCE ON ADIPOSE TISSUE RAAS BY DIRECT RENIN INHIBITION? A POST-MARKETING SURVEY OF ALISKIREN ON EFFICACY IN OBESE PATIENTS AND IN PATIENTS WITH METABOLIC SYNDROMEH.M.H. Schäfer (1), I. Sudano (2), D. Häberer (3), G. Noll (2)(1) Cape Town-SOUTH AFRICA; (2) Zurich, (3) Zug-SWITZERLAND
9 234 / RAPID INCREASE IN BLOOD PRESSURE AND SYMPATHETIC ACTIVITY DURING A HIGH FAT DIET IN RABBITSG. Head, S. Burke, L. Prior, B. Barzel, J. ArmitageMelbourne-AUSTRALIA
9 235 / ESTIMATION OF SKELETAL MUSCLE MASS FROM APPENDICULAR LEAN SOFT MASS MEASURED BY DUAL-ENERGY X-RAY ABSORPTIONMETRY IN CHINESEW.F. Zeng, Y. Zhang, H.E. Chen, Y. Li, J.G. WangShanghai-CHINA
9 236 / AMBULATORY BLOOD PRESSURE AND NOCTURNAL DIPPING WITH REDUCED CARBOHYDRATE AND REDUCED FAT HYPOCALORIC DIETSS. Engeli (1), S. Haufe (1), P. Kast (2), S. Wiesner (2), F.C. Luft (2), M. Boschmann (2), J. Tank (1), J. Jordan (1)(1) Hannover, (2) Berlin-GERMANY
9 237 / ADIPONECTIN, INSULIN RESISTANCE AND BLOOD PRESSURE IN A PAEDIATRIC POPULATIONF. Pieruzzi (1), M.E. Street (2), P. Brambilla (1), M. Giussani (1), S. Galbiati (1), A. Smerieri (2), M.A. Ziveri (2), S. Bernasconi (2), G.V. Zuccotti (1), A. Stella (1), S. Genovesi (1)(1) Milan, (2) Parma-ITALY
9 238 / RISK FACTORS METABOLIC SYNDROME AND NON-ALCOHOLIC FATTY LIVER DISEASE IN RUSSIAN FEDERATION IN NATIONAL-WIDE DIREG-L-01903 STUDYO. Drapkina, V. IvashkinMoscow-RUSSIA
9 239 / MICRORNA 155 A CANDIDATE BIOMARKER FOR METABOLIC SYNDROMEM. Anton, I.V. Iancu, A. Botezatu, M. Muraru, I. Bruckner, D. Isacoff, E. Lupeanu, G. AntonBucharest-ROMANIA
9 226 / THE PECULIARITIES OF LEFT VENTICULAR REMODELING IN ESSENTIAL HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME AND WITHOUT ITS. Gurgenyan, S. Vatinyan, K. NikoghosyanYerevan-ARMENIA
9 227 / METABOLIC EFFECTS OF ALISKIREN, FOSINOPRIL, TELMISARTAN IN PATIENTS WITH METABOLIC SYNDROMEO. Rekovets, Y.U. Sirenko, S. Savistkiy, K. Mikheeva, E. Pavlyuk, S. Kushnir, G. Primak, A. Vaschilko, V. Granich, S. Polischuk, P. Sidorenko, G. Radchenko, G. PonomariovaKiev-UKRAINE
9 228 / INCREASED INFLAMMATORY MARKERS IN HYPERTENSIVE PATIENTS IN THE CONTEXT OF THE METABOLIC SYNDROMES.R. Gotia, C. Serban, S.L. Gotia, C. Borza, L. Susan, A. PacurariTimisoara-ROMANIA
9 229 / CLINICAL EFFICACY OF THE FIRST RENIN INHIBITOR - ALISKIREN IN PATIENTS WITH HYPERTENSION AND METABOLIC SYNDROMEY. Zhernakova, V. Mychka, I. Chazova, M. Kirillova, Y. Ponomarev, K. IvanovMoscow-RUSSIA
9 230 / LEVELS OF LEPTIN, ADIPONECTIN, INFLAMMATORY FACTORS AND ANTHROPOMETRIC PARAMETERS IN PATIENTS WITH ABDOMINAL OBESITY AND ARTERIAL HYPERTENSIONA. Berezina, O. Belyaeva, 0. Berkovich, E. Shlyakhto, E. BaranovaSaint-Petersburg-RUSSIA
9 231 / THE EFFECTIVENESS OF THERAPY PERINDOPRIL ARGININE IN TREATMENT OF PATIENTS WITH HYPERTENSION AND METABOLIC SYNDROME IN NATIONAL PROGRAM “PREMIA”J. Prokhorova, V. Mychka, K. Ivanov, S. Olimpieva, V. Kilikovsky, V. Masenko, I. ChazovaMoscow-RUSSIA
9 232 / ASSOCIATION OF ERECTILE DYSFUNCTION AND ANDROGEN DEFICIENCY WITH METABOLIC SYNDROME IN MEN CHARACTERIZED BY HIGH CARDIOVASCULAR RISKM. Mamedov, G. Sharvadze, E. PoddubskayaMoscow-RUSSIA
Saturday
18
168Saturday 18168 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011169
Saturday 18 9 247 / CAROTID ARTERIES SUBCLINICAL DAMAGE IN HYPERTENSIVE AND NORMOTENSIVE PATIENTS WITH ABDOMINAL OBESITYE. Baranova, O. Belyaeva, O. Bolshakova, E. Chubenko, A. Berezina, O. Berkovich, T. Karonova, S. Kozlova, E. Bazenova, E. ShlyakhtoSt. Petersburg-RUSSIA
9 248 / FACTORS AFFECTING SERUM LEPTIN LEVELS IN PATIENT WITH ABDOMINAL OBESITYE. Chubenko, O. Belyaeva, O. Bolshakova, O. Berkovich, E. Bazhenova, E. Chernetcova, K. Monosova, E. Baranova, E. ShlyakhtoSt. Petersburg-RUSSIA
9 249 / METABOLIC SYNDROME AND AMBULATORY ARTERIAL STIFFNESS INDEX IN ADOLESCENTSA. Gonzalez, J. Ferrer, E. Silva, C. Esis, M. Bracho, J.J. Villasmil, S. Briceño, G. BermudezMaracaibo-VENEZUELA
9 250 / RELATIONSHIP BETWEEN AMBULATORY ARTERY STIFFNESS INDEX AND METABOLIC SYNDROME COMPONENTS IN PATIENTS WITH CORONARY ARTERY DISEASEW. Sobiczewski, M. Wirtwein, M. Nedoszytko, M. Gruchala, A. RynkiewiczGdansk-POLAND
9 251 / EFFECTS OF INCREASING ADIPOSITY INDEX ON NIGHT-TIME BLOOD PRESSURE AND CARDIAC DAMAGE IN 1827 PATIENTSR. Sarzani, F. Guerra, M. Fedecostante, E. Giannini, L. Lancioni, L. Mancinelli, E. Franchi, P. Barbatelli, E. Espinosa, P. Dessì-FulgheriAncona-ITALY
9 252 / THE DYSLIPIDEMIA IN METABOLIC SYNDROME PATIENTS: THE ROLE OF THE LIVERL. Zhuravlyova, O. LavrinenkoKharkiv-UKRAINE
9 253 / THE COMPARISON OF SELECTED METABOLIC PARAMETERS AND COMMON CAROTID ARTERY INTIMA-MEDIA THICKNESS IN YOUNG POPULATION WITH OVERWEIGHT OR OBESITYK. Hoffmann, A. Strazynska, W. Bryl, D. Poplawski, D. Pupek-MusialikPoznan-POLAND
9 240 / SERUM 25(OH)D INSUFFICIENCY AS A HYPERTENSION RISK FACTOR IN ABDOMINAL OBESITY WOMENI. Mamina, O. Belyaeva, E. Micheeva, E. Konoplyannikova, E. Bazhenova, O. Galkina, T. Karonova, E. Grineva, E. Baranova, E. ShlyakhtoSt. Petersburg-RUSSIA
9 241 / SYSTEMIC INFLAMATION’S TREATMENT IN PATIENTS WITH METABOLIC SYNDROME: EFFECTS OF STATINE THERAPYS. Bychkova, O. KrasyukKyiv-UKRAINE
9 242 / DIFFERENT MECHANISMS IN WEIGHT LOSS-INDUCED BLOOD PRESSURE REDUCTION BETWEEN A CALORIC RESTRICTED DIET AND EXERCISEK. Masuo (1), H. Rakugi (2), T. Ogihara (2), G.W. Lambert (1)(1) Melbourne-AUSTRALIA; (2) Suita-JAPAN
9 243 / EFFECT OF MENOPAUSE ON THE PREVALENCE OF METABOLIC SYNDROME IN A HELLENIC COHORTC. Thomopoulos, M. Daskalaki, O. Papazachou, N. Rodolakis, D. Papadopoulos, A. Komnou, M. Papavassiliou, T. MakrisAthens-GREECE
9 244 / DOES THE ASSOCIATION BETWEEN LIPID PROFILE AND OBESITY INDICES VARY THROUGH DECADES IN ESSENTIAL HYPERTENSIVE PATIENTS?S.M. Kyvelou, G. Vyssoulis, E. Karpanou, V. Tzamou, T. Gialernios, C. StefanadisAthens-GREECE
9 245 / STUDY OF METABOLIC AND INFLAMMATORY MARKERS IN A “HEALTHY” BLOOD DONOR POPULATIONF. Leite, A. Santos, M. Lima, L. RibeiroPorto-PORTUGAL
9 246 / CREATINE KINASE IS ASSOCIATED WITH OBESITY IN THE GENERAL POPULATIONI. Oudman (1), Z. Jagernath (2), P. Kewalbansing (1), J. Clark (3), G. Van Montfrans (1), L. Brewster (1)(1) Amsterdam-THE NETHERLANDS, (2) Paramaribo-SURINAM, (3) Cincinnati-USA
Saturday
18
170Saturday 18170 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011171
Saturday 1814.00 - 15.30Ground Floor
Poster Session 10
SLEEP APNOEA
ROOM 10 / POSTERS FROM 258 TO 280
Chairperson: P. Pauletto (Treviso-ITALY)
10 258 / THE COMPARISON ARTERIAL STIFFNESS AND CEREBROVASCULAR REACTIVITY IN HYPERTENSIVE PATIENTS WITH AND WITHOUT OBSTRUCTIVE SLEEP APNEAT. Ripp, S. Zapodovnikov, V. MordovinTomsk-RUSSIA
10 259 / HYPERCAPNIA-INDUCED CEREBROVASCULAR RESERVE OF PATIENTS WITH HYPERTENSION AND OBSTRUCTIVE SLEEP APNEAT. Ripp, S. Zapodovnikov, E. Ripp, V. MordovinTomsk-RUSSIA
10 260 / THE INFLUENCE OF HYPOXIA ON THE REACTIVE OXYGEN SPECIES PRODUCTION IN GRANULOCYTES OF NORMAL AND OBSTRUCTIVE SLEEP APNEA PATIENTSM. Hoffmann (1), P. Singh (2), V. Somers (2), K. Polonis (1), K. Narkiewicz (1)(1) Gdansk-POLAND; (2) Rochester-USA
10 261 / HEART RHYTHM AND CONDUCTIVE DISTURBANCES IN HYPERTENSIVE PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROMEN. Lisovskaya, L. Korostovtseva, M. Monogarova, Y. Sviryaev, A. KonradiSt. Petersburg-RUSSIA
10 262 / REPRODUCIBILITY OF BERLIN QUESTIONNAIRE TO EVALUATE RISK OF SLEEP APNEA IN PATIENTS WITH RESISTANT HYPERTENSIONV. Margallo, Es. Muxfeldt, G. Salles, F. Souza, R. FiszmanRio De Janeiro-BRAZIL
9 254 / THERE IS DISCORDANCE BETWEEN ARTERIAL STIFFNESS AND PERIPHERAL WAVE REFLECTIONS IN HYPERTENSIVES WITH VISCERAL ADIPOSITYV. Katsi, G. Souretis, C. Vlachopoulos, D. Tousoulis, C. Stefanadis, I. KallikazarosAthens-GREECE
9 255 / METABOLIC SYNDROME IN HYPERTENSIVE PERIMENOPAUSAL WOMEN: PREDOMINATING ROLE OF ABDOMINAL OBESITY OR DEFICIENCY OF ESTROGENS?A. IlyuschinaKyiv-UKRAINE
9 256 / GRADUAL CHANGES OF LEFT VENTRICULAR GEOMETRY IN OBESE HYPERTENSIVE PATIENTSB. Jakovljevic (1), D. Lovic (2), V. Stojanov (1)(1) Belgrade, (2) Niš-SERBIA
9 257 / INCREASING NUMBER OF COMPONENTS OF THE METABOLIC SYNDROME AND CIRCULATING PROGENITOR CELL LEVELSM. Abad-Cardiel, E. Villar, A. Ortega-Hernandez, D. Gomez-Garre, P. Muñoz-Pacheco, M. Avila, M. Fuentes-Ferrer, A. Fernandez-Cruz, N. Martell-ClarosMadrid-SPAIN
Saturday
18
172Saturday 18172 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011173
Saturday 18 10 270 / IMPACT OF SHORT-TERM CONTINUOUS POSITIVE AIRWAY PRESSURE THERAPY ON LEFT VENTRICLE SYSTOLIC FUNCTION ASSESSED BY TWO-DIMENSIONAL STRAIN IMAGING IN HYPERTENSIVE PATIENTS WITH OBSTRUCTIVE SLEEP APNEAK. Kunicka, E. Swierblewska, J. Wolf, W. Kuchraska, R. Nowak,A. Korzon-Burakowska, L. Bieniaszewski, K. NarkiewiczGdansk-POLAND
10 271 / RELATIONSHIP BETWEEN GENDER, FAT DISTRIBUTION, METABOLIC ABNORMALITIES AND OBSTRUCTIVE SLEEP APNEA IN TRUE RESISTANT HYPERTENSIVE PATIENTSE. Florczak (1), E. Szwench (1), T. Oleksiuk (1), A. Januszewicz (1), A. Prejbisz (1), P. Sliwinski (1), P. Bielen (1), E. Warchol (1), I. Michalowska (1), M. Kabat (1), A. Klisiewicz (1), K. Belka (1), P. Hoffman (1), A. Wiecek (2), K. Narkiewicz (3)(1) Warsaw, (2) Katowice, (3) Gdansk-POLAND
10 272 / ENDOTHELIAL FUNCTION AND BLOOD PRESSURE IN PATIENTS WITH MODERATE/SEVERE HYPERTENSION AND OBSTRUCTIVE SLEEP APNOEA SYNDROMEP. Galitsin, A. Litvin, T. Balakhonova, O. Pogorelova, E. Ellfi mova, A. Aksenova, M. Tripoten, I. ChazovaMoscow-RUSSIA
10 273 / INCIDENCE OF OBSTRUCTIVE SLEEP APNEA AND COMMON SECONDARY HYPERTENSION CAUSES IN PATIENTS WITH TRUE RESISTANT HYPERTENSIONE. Florczak (1), E. Warchol (1), A. Prejbisz (1), P. Bielen (1), P. Sliwinski (1), A. Klisiewicz (1), I. Michalowska (1), H. Janaszek-Sitkowska (1), M. Januszewicz (1), I. Cendrowska-Demkow (1), E. Szwench (1), P. Hoffman (1), A. Januszewicz (1), A. Wiecek (2), K. Narkiewicz (3)(1) Warsaw, (2) Katowice, (3) Gdansk-POLAND
10 274 / INFLUENCE OF OBSTRUCTIVE SLEEP APNEA ON AMBULATORY BLOOD PRESSURE MEASUREMENTS REPEATABILITY IN NEVER TREATED HYPERTENSIVE PATIENTSA. Prejbisz, G. Kowalewski, M. Makowiecka-Ciesla, E. Florczak, P. S liwnin ski,P. Bielen, B. Puciłowska-Jankowska, K. Paschalis-Purtak, M. Kluk, M. Kabat, A. JanuszewiczWarsaw-POLAND
10 263 / IS ARTERIAL STIFFNESS RELATED TO SLEEP APNEA?L. Korostovtseva (1), Yu. Sviryaev (1), V. Ivanenko (1), N. Zvartau (1), A. Kozlenok (1), A. Kalinkin (2), A. Konradi (1)(1) St. Petersburg, (2) Moscow-RUSSIA
10 264 / SNORE SEVERITY: POLISOMNOGRAPHY FINDING AND MASKED HYPERTENSION IN PATIENTS WITH RECENT DIAGNOSIS OF HYPERTENSIONG. Caruso, D. Fernández, M. Perez, M. SmurraCaba-ARGENTINA
10 265 / FEATURES OF AUTONOMIC CONTROL IN HYPERTENSIVE PATIENTS WITH SLEEP APNEA SYNDROMEO. Mamontov, J. Sviryaev, A. Konrady, E. ShlyakhtoSt. Petersburg-RUSSIA
10 266 / OBSTRUCTIVE SLEEP APNEA SYNDROME AND OBESITY AS THE CAUSE OF PRIMARY HYPERALDOSTERONISM IN A POPULATION WITH RESISTANT HYPERTENSIONR. Muscherà, M. D’avino, G. Caruso, A. Ilardi, F. Capasso, D. CarusoNaples-ITALY
10 267 / EFFECT OF CPAP ON BLOOD PRESSURE CONTROL IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROMEA. Panoutsopoulos (1), A. Pappas (2), E. Koroboki (1), A. Kallianos (1), K. Kostopoulos (1), E. Manios (1), E. Lagoudianakis (2), F. Rozi (2), C.H. Kostopoulos (1), N. Zakopoulos (1)(1) Nafplio, (2) Argos-GREECE
10 268 / OBSTRUCTIVE SLEEP APNEA IN UNTREATED HYPERTENSIVE PATIENTS: ASSOCIATIONS OF DISEASE SEVERITY WITH DIVERSE ATHEROSCLEROTIC MARKERSA. Kasiakogias, C. Tsioufi s, C. Thomopoulos, E. Andrikou, A. Kordalis, K. Kintis, M. Almyroydi, C. StefanadisAthens-GREECE
10 269 / ACUTE APPLICATION OF CPAP LOWERS BLOOD PRESSURE WITHOUT REDUCING PLASMA RENIN ACTIVITY, PLASMA ALDOSTERONE AND OVERNIGHT URINARY CATECHOLAMINES IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROMEA. Morganti, A. Giavarini, A. Bianchi, A. GrittiMilan-ITALY
Saturday
18
174Saturday 18174 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011175
Saturday 1814.00 - 15.30Ground Floor
Poster Session 11
DIABETES
ROOM 11 / POSTERS FROM 281 TO 312
Chairperson: M.P. Schlaich (Melbourne-AUSTRALIA)
11 281 / RENAL RESISTIVE INDEX AS A NEW INDEPENDENT RISK FACTOR FOR NEW-ONSET DIABETES MELLITUS AFTER KIDNEY TRANSPLANTATIONP. Mutinelli-Szymanski, A. Caille, F. Tranquart, A. Al Najjar, M. Buchler, C. Barbet, J.F. Marliere, P. Gatault, J. Reault, C. Boin, V. Chatelet, I. Louad, H. Nivet, Y. Lebranchu, J.M. HalimiTours-FRANCE
11 282 / BLOOD PRESSURE AND KIDNEY FUNCTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: RESULTS OF THE PROSPECTIVE STUDY SKIF-2B. Mankovsky, D. IvanovKiev-UKRAINE
11 283 / PULSE WAVE ANALYSES IN TYPE 2 DIABETIC SUBJECTS WITH HYPERTENSIONA. Lieber, M.E. Safar, Y. Zhang, D. Agnoletti, J. Peroz-Froz, A. Protogerou, B.I. Levy, J. BlacherParis-FRANCE
11 284 / EFFECTS OF TIME OF DAY OF HYPERTENSION TREATMENT ON THE AMBULATORY BLOOD PRESSURE PATTERN OF PATIENTS WITH DIABETES: THE HYGIA PROJECTJ.J. Crespo (1), M. Dominguez-Sardiña (1), M.T. Rios (1), A. Moya (2), S.M. Gomara (2), L. Meijide (2), A. Mojon (1), D.E. Ayala (1), R.C. Hermida (1), on behalf of Hygia Project Investigators(1) Vigo, (2) Pontevedra-SPAIN
10 275 / EFFECT ON CEREBRAL BLOOD FLOW OF THE THERAPY OF CONTINUOUS POSITIVE AIRWAY PRESSURE IN PATIENTS WITH MODERATE HYPERTENSION AND OBESITYA. Aksenova, A. Litvin, P. Galitsin, M. Bugriy, E. Elfi mova, M. Bolotova, V. Sergienko, I. ChazovaMoscow-RUSSIA
10 276 / HYPERTENSION IN ACUTE CORONARY SYNDROME PATIENTS WHO ARE AT HIGH RISK OF OBSTRUCTIVE SLEEP APNOEAF.M. Szymanski, K.J. Filipiak, A. Hrynkiewicz-Szymanska, G. Karpinski, G. OpolskiWarsaw-POLAND
10 277 / APPLICABILITY OF BERLIN QUESTIONNAIRE FOR OBSTRUCTIVE SLEEP APNEA DIAGNOSIS IN HYPERTENSIVE PATIENTS WITH TYPE-2 DIABETESJ. Wolf, J. Kanarek, D. S wietlik, R. Nowak, M. Kulas, E. Orłowska-Kunikowska, K. NarkiewiczGdansk-POLAND
10 278 / RELATIONSHIP BETWEEN ARTERIAL STIFFNESS AND OBSTRUCTIVE SLEEP APNEA SYNDROME WITH METABOLIC SYNDROMEH. Mitsubayashi, M. Ootsu, A. Komori, T. Ishii, M. Nakauma, A. Suzuki, Y. Nakahara, H. MitsuyasuTokyo-JAPAN
10 279 / THE PARADOXICAL DISTRIBUTION OF SLEEP APNEA AND ARTERIAL STIFFNESS AMONG HYPERTENSIVE IMMIGRANTSV. Katsi, G. Souretis, C. Vlachopoulos, D. Tousoulis, C. Stefanadis, I. KallikazarosAthens-GREECE
10 280 / THE RELATION OF HYPERTENSION, METABOLIC SYNDROME AND OBSTRUCTIVE SLEEP APNOEA SYNDROMEYe.A. Pavlyuk, Yu.N. Sirenko, Yu.N. Pogoretskiy, O.L. RecovetsKiev-UKRAINE
Saturday
18
176Saturday 18176 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011177
Saturday 18 11 292 / DYNAMICS OF INTRARENAL VASCULAR RESISTANCE UNDER LONG-TERM ANTIHYPERTENSIVE MONOTHERAPY WITH ACE INHIBITORS AND CALCIUM ANTAGONISTS IN HYPERTENSIVE DIABETIC PATIENTSO. Koshelskaya, R. KarpovTomsk-RUSSIA
11 293 / AMBULATORY BLOOD PRESSURE PROFILES IN TYPE 2 DIABETIC PATIENTSE. Nelaj, M. Gjata, M. TaseTirana-ALBANIA
11 294 / THE EFFECTIVENESS OF THERAPY PERINDOPRIL ARGININE IN TREATMENT OF PATIENTS WITH HYPERTENSION AND DIABETES TYPE 2 IN NATIONAL PROGRAM “PREMIA”K. Ivanov, V. Mychka, J. Prokhorova, S. Olimpieva, V. Kilikovsky, V. Masenko, I. ChazovaMoscow-RUSSIA
11 295 / COMBINED EFFECTS OF CALCIUM CHANNEL BLOCKER AND ANGIOTENSIN II RECEPTOR ANTAGONIST IN HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETEST. Yokoi, S. Nakade, H. Masaki, H. TakahashiMoriguchi-JAPAN
11 296 / RENAL IMPAIRMENT AND ALL-CAUSE MORTALITY IN HIGH RISK VASCULAR PATIENTS: EFFECT MODIFICATION BY DIABETESS. Selvarajah (1), J. Haniff (1), Y. Graaf (2), F. Visseren (2), C. Uiterwaal (2), M. Bots (2)(1) Kuala Lumpur-MALAYSIA; (2) Utrecht-THE NETHERLANDS
11 297 / ACCURACY OF A NOVEL IONTOPHORESIS TECHNOLOGY BASED DEVICE FOR THE DIAGNOSIS OF DIABETES MELLITUS IN CHINESEC. Sheng (1), Y. Li (1), W. Zeng (1), Q. Huang (1), J. Deslypere (2), J. Wang (1)(1) Shanghai-CHINA; (2) Paris-FRANCE
11 298 / GLYCATED HAEMOGLOBIN, FASTING GLUCOSE AND CARDIOVASCULAR RISK FACTORS IN A HYPERTENSIVE POPULATIONL. Vigil, M. Lopez, M. Varela, R. García-Carretero, D. Ferrero, J. RuizMadrid-SPAIN
11 285 / THE PROGNOSTIC VALUE OF ULTRASOUND ASSESSMENT OF EXTRACRANIAL CEREBRAL CIRCULATION IN HYPERTENSIVE PATIENTS WITH OR WITHOUT DIABETES MELLITUSA. Gavrila, C. Searpe, A. Rosu, M. Ciobanu, M. Chirion, C. Mogosanu, S. Marinescu, I. Sosea, V. SbarceaCraiova-ROMANIA
11 286 / TREATMENT MANAGEMENT AND COMPLIANCE WITH INTERNATIONAL GUIDELINES FOR PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES IN PATIENTS WITH TYPE II DIABETES MELLITUS IN OUTPATIENT CARE INSTITUTION IN MOSCOW (PHARMACOEPIDEMIOLOGICAL STUDY)Y. TsirulevaMoscow-RUSSIA
11 287 / THE FEATURES OF APO-LIPOPROTEIN METABOLISM IN PATIENTS WITH CORONARY HEART DISEASE AND DIABETES MELLITUS TYPE 2O. SheludchenkoDonetsk-UKRAINE
11 288 / GLYCEMIC CONTROL IN TYPE 2 DIABETES MELLITUS: RELATIONSHIP WITH LEFT VENTRICULAR DIASTOLIC DYSFUNCTION AND MATRIX METALLOPROTEINASESC. Marchesi, A.M. Maresca, C. Mongiardi, F. Annoni, L. Merletti, E. Nicolini, I. Franzetti, A. Passi, A. Bertolini, A.M. Grandi, A. VencoVarese-ITALY
11 289 / THE DIFFERENCES IN THE 24-H BLOOD PRESSURE PROFILE HYPERTENSIVES AND DIABETIC HYPERTENSIVESF. Adl, A. Shahvaran, S. Ahsant, A. Asghar TavassoliShiraz-IRAN
11 290 / EVALUATION OF EFFECTS OF GENDER ON ANTHROPOMETRIC PARAMETERS AND GLYCEMIC CONTROL IN TYPE 2 DIABETES MELLITUSM. PiccaMilan-ITALY
11 291 / DIFFERENTIAL EXPRESSION PROFILES OF MICRORNA IN THE HEART OF DIABETIC RATSG. Castoldi (1), C. Bombardi (1), B. Corradi (1), F. Giollo (2), M. Antoniotti (2), C. Di Gioia (3), G. Zerbini (2), A. Stella (1)(1) Monza, (2) Milan, (3) Rome-ITALY
Saturday
18
178Saturday 18178 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011179
Saturday 18 11 306 / ENDOTHELIN 1-21 LEVEL IN PATIENTS WITH TYPE 2 DIABETES AND ARTERIAL HYPERTENSION LIVING IN THE EXTREME NORTHD. Isakova, E. Salahova, A. Efanov, E. Dorodneva, I. MedvedevaTyumen-RUSSIA
11 307 / TRANSFORMING GROWTH FACTOR-BETA 1 AND HEART REMODELING IN 2ND TYPE 2 DIABETES MELLITUS PATIENTS ASSOCIATED WITH LEFT VENTRICULAR DIASTOLIC DYSFUNCTIONA. Berezin, A. GlavatskiyZaporozhye-UKRAINE
11 308 / PREDICTORS OF REGRESSION OF DIABETIC NEPHROPATHY IN ADOLESCENTSI. AleksandrovaMoscow-RUSSIA
11 309 / SERUM SFAS AND SFASL LEVELS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND ARTERIAL HYPERTENSIONN. Stoynev, G. Kirilov, T. TankovaSofia-BULGARIA
11 310 / DISLIPIDEMIA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS PRESENTED WITH ACUTE CORONARY SYNDROME IN EMERGENCY ROOME. Zaimi, V. Hoxha, E. PetrelaTirana-ALBANIA
11 311 / ABOUT THE PREVENTION OF DIABETES IN THE WOMEN. WHAT IS THE OPINION OF THE SPANISH DOCTORS?J. Iturralde-Iriso, D. Ramirez-Puerta, A. De Santiago-Nocito, E. Redondo-Marguello, J. Vazquez-Castro, J.C. Aguirre-Rodriguez, J. Camarero-Palacios, M.C. Gomez-Gonzalez, F. Zubiri, N. Fernandez De Cano, A. Cano-Espin, E. Garcia-VirosteSPAIN
11 312 / HYPERGLYCEMIA AND DIABETES MELLITUS ON ADMISSION – WHO IS JUDGE AND SENTENCED?L. Paiva, R. Providencia, S. Barra, P. Gomes, C. Faustino, A. Botelho, A. Leitao-MarquesCoimbra-PORTUGAL
11 299 / THE INFLUENCE OF RILMENIDINE ON PLASMA LIPID PROFILE AND HYPERTENSION IN PATIENTS WITH TYPE 2 DIABETES MELLITUSA. Ordyan, E. Ter-Stepanyants, L. Aleksanyan, A. NaghdalyanYerevan-ARMENIA
11 300 / PREDICTORS OF NON-FATAL MYOCARDIAL INFARCTION EVENTS OF PATIENTS WITH TYPE 2 DIABETESK. Samedova, V. MirzazadaBaku-AZERBAIJAN
11 301 / DIFFERENT STATISTICAL METHODS TO PRESENT THE EFFECT OF ATTAINED BLOOD PRESSURE ON CVD RISK IN DIABETES BY USE OF COX REGRESSIONP. M. Nilsson (1), J. Cederholm (2), B. Eliasson (3), K. Eeg Olofsson (3), B. Zethelius (2), S. Gudbjörnsdottir (3), on behalf of The National Diabetes Register (NDR) of Sweden(1) Malmö, (2) Uppsala, (3) Göteborg-SWEDEN
11 302 / ECHOCARDIOGRAPHIC DATA IN PATIENTS WITH ESSENTIAL HYPERTENSION AND TYPE 2 DIABETES MELLITUSL. PopescuBucharest-ROMANIA
11 303 / INFLUENCE OF GENDER ON CARDIAC GEOMETRY AND FUNCTION IN NORMOTENSIVE DIABETIC PATIENTSM. Picca, F. AgozzinoMilan-ITALY
11 304 / IMPAIRED GLUCOSE METABOLISM IN NORMOTENSIVES IS ASSOCIATED WITH EXAGGERATED INOTROPIC RESPONSE IN STRESS TESTM. Daskalaki, O. Papazachou, C. Thomopoulos, N. Rodolakis, D. Papadopoulos, A. Komnou, C. Grassos, T. MakrisAthens-GREECE
11 305 / CIRCADIAN BLOOD PRESSURE PROFILE IN TYPE 2 DIABETIC PATIENTS: INFLUENCE OF CARDIAC AUTONOMIC NEUROPATHY AND METABOLIC SYNDROMEE. Lunina, I. PetrukhinTver-RUSSIA
Saturday
18
180Saturday 18180 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011181
Saturday 18 12 318 / PREDICTION OF SPONTANEOUS RHYTHM CONVERSION IN CASE OF ATRIAL FIBRILLATION OF LESS THAN 48 HOURS DURATIONY. Vidergold, I. Osipova, T. Tavrovskaya, Y. Galkina, A. TimofeevBarnaul-RUSSIA
12 319 / ATRIAL FIBRILLATION. EPIDEMIOLOGY AND ASSOCIATED FACTORS IN EMERGENCY DEPARTMENTSJ. Martínez (1), L. Lapuerta (2), S. Rousell (1), C. Flaño (1), J. Ochoa (1)(1) Logroño, (2) Soria-SPAIN
12 320 / THE INFLUENCE OF RAMIPRIL ON ECHOCARDIOGRAPHIC PARAMETERS AND ATRIAL FIBRILLATION RECURRENCE IN HYPERTENSIVE PATIENTS WITH RECURRENT ATRIAL FIBRILLATIONL. Aleksanyan, E. Ter-Stepanyanc, A. Ordyan, A. NagdalyanYerevan-ARMENIA
12 321 / HOW RELEVANT IS ATRIAL FIBRILLATION IN A LARGE COHORT OF HYPERTENSIVE PATIENTS?V. Moñivas, J. Segura, J.A. Garcia-Donaire, C. Cerezo, L. Guerrero, L. Fernandez, L.M. RuilopeMadrid-SPAIN
12 322 / INFLUENCE OF ATRIAL FIBRILLATION PERSISTENCE ON ENDOTHELIAL FUNCTION AMONG PATIENTS WITH HYPERTENSIONK. Rewiuk, T. GrodzickiKrakow-POLAND
12 323 / EPIDEMIOLOGICAL GENDER DIFFERENCES IN HYPERTENSIVE PATIENTS OVER 65 YEARS. ASSOCIATED FACTORS OF ATRIAL FIBRILLATION. FAPRES REGISTRYV. Pallares (1), L. Facila (2), P. Morillas (3), J.L. Llisterri (4), C. Sanchis (5), V. Gil (6), A. Cordero (3), J. Redon (4), V. Bertomeu (3)(1) Burriana, (2) Castellon, (3) Alicante, (4) Valencia, (5) Algemesi, (6) San Juan-SPAIN
12 324 / PREDICTIVE MODEL OF DIFFERENT ATRIAL FIBRILLATION TYPES APPLIED IN THE CLINICAL SETTINGI. Zacharopoulou, C. Bale, M.S. Kallistratos, N. Koyremenos, T. Zamfi r, V. Lezos, V. German, C.H. Antonakoudis, A.J. ManolisAthens-GREECE
14.00 - 15.30Ground Floor
Poster Session 12
ATRIAL FIBRILLATION
ROOM 12 / POSTERS FROM 313 TO 327
Chairperson: C. Borghi (Bologna-ITALY)
12 313 / WHICH IS THE BEST RISK SCORE FOR THROMBOEMBOLIC RISK PREDICTION IN HYPERTENSIVE PATIENTS WITH ATRIAL FIBRILLATION?R. Providencia, S. Barra, J. Trigo, A. Botelho, N. Quintal, J. Nascimento, P. Mota, A.M. Leitao-MarqueCoimbra-PORTUGAL
12 314 / WHY DO HYPERTENSIVE PATIENTS WITH ATRIAL FIBRILLATION HAVE A HIGHER THROMBOEMBOLIC RISK?R. Providencia, S. Barra, J. Trigo, A. Botelho, N. Quintal, J. Nascimento, P. Mota, A.M. Leitao-MarquesCoimbra-PORTUGAL
12 315 / STRATIFICATION OF STROKE RISK , ANTICOAGULATION AND FREQUENCY OF VISITS OF HYPERTENSIVE PATIENTS WITH ATRIAL FIBRILLATIONT. Gijón, J. Swan, T. Rua, C. Rodriguez, I. Pitillas, B. Valero, M. Ramirez, S. JonesSPAIN
12 316 / THE CONTROL OF ARTERIAL HYPERTENSION AND THE PREVALENCE OF ATRIAL FIBRILLATION IN PATIENTS AT 80 AND OLDERP. MikusBratislava-SLOVAK REPUBLIC
12 317 / LARGE AND SMALL PREDICTORS OF THE RELAPSE OF ATRIAL FIBRILLATION AMONG PATIENTS WITH ARTERIAL HYPERTENSIONM. Arakelyan, P. Mogutova, N. PoteshkinaMoscow-RUSSIA
Saturday
18
182Saturday 18182 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011183
Saturday 1814.00 - 15.30Ground Floor
Poster Session 13
CLINICAL ASPECTS
ROOM 13 / POSTERS FROM 328 TO 372
Chairperson: S. Padmanabhan (Glasgow-UK)
13 328 / EFFECT OF ANTIHYPERTENSIVE MEDICINES (TAKEN FOR CONTROL OF BLOOD PRESSURE), ON QUALITY OF LIFE IN ASYMPTOMATIC HYPERTENSIVE INDIVIDUALSS.C. Mishra, S. Prakash, A. Banerji, R. Kalra, S. GargKanpur-INDIA
13 329 / INCREASED CARDIOVASCULAR RISK IN PATIENTS SUBJECTED TO LUNG TRANSPLANTATIONS. Perlini, S. Surbone, I. Giovi, G. Savioli, F. Salinaro, P. Preti, T. OggionniPavia-ITALY
13 330 / CORRELATION OF HIGH-SENSITIVE CRP PLASMA LEVELS AND ANKLE BRACHIAL INDEX IN HYPERTENSIVE PATIENTSV. Riegelnik, S. Perl, T. Augustin, C. Colantonio, C. Kos, B.M. Pieske, R. ZweikerGraz-AUSTRIA
13 331 / PREVALENCE AND RISK FACTORS OF HYPERTENSION IN RHEUMATOID ARTHRITISV. Duraj, M. Gjata, L. Collaku, A. TafajTirana-ALBANIA
13 332 / PRIMARY CARE PHYSICIANS’ BEHAVIOUR IN INADEQUATE BLOOD PRESSURE CONTROL (THE PRESCAP STUDY 2010)F.J. Alonso Moreno (1), J.L. Llisterri Caro (2), G.C. Rodríguez Roca (1), M. Ferreiro Madueño (3), S. Lou Arnal (4), E. Carrasco Carrasco (5), P. Beato Fernández (6), Ma. Prieto Díaz (7), O. García Vallejo (8), J. Ocaña López-Cepero (6), on behalf of the Working Group of Arterial Hypertension of the Spanish Society of Primary Care physicians (Group HTA / SEMERGEN) and the PRESCAP 2010 investigators(1) Toledo, (2) Valencia, (3) Sevilla, (4) Zaragoza, (5) Murcia, (6) Barcelona, (7) Oviedo, (8) Madrid-SPAIN
12 325 / THE ROLE OF MULTIPLE RISK FACTORS FOR ATRIAL FIBRILLATION IN HYPERTENSIVE PATIENTSI. Zacharopoulou, C. Bale, M.S. Kallistratos, N. Kouremenos, I. Molos, T. Zamfi r, C.H. Manetos, A. Kalogiros, K. Spanos, K. Kyfnidis, A.J. ManolisAthens-GREECE
12 326 / RISK FACTORS AND CHANGE OF NT-PROBNP AND CRP VALUES IN PATIENTS WITH ATRIAL FIBRILLATIONR. Labrova, J. Spinar, R. Karlik, J. Kanovsky, P. Lokaj, R. MiklikBrno-CZECH REPUBLIC
12 327 / ATRIUM SIZE IS PREDICTOR OF ATRIAL FIBRILLATION RISK DEVELOPMENTO. Drapkina, V. IvashkinMoscow-RUSSIA
Saturday
18
184Saturday 18184 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011185
Saturday 18 13 340 / HYPERTENSION, VASCULAR EVENTS AND AUTOIMMUNE PROCESSES ORGAN SPECIFIC LIKE CLINICAL MANIFESTATIONS ASSOCIATED TO B12 VITAMIN DEFICIENCYS. Suarez Ortega, Y. Hernandez Aguiar, J. Arencibia Borrego, J.M. Sanchez Hernandez, J.C. Rodriguez Perez, P. Betancor LeonSanta Brigida-SPAIN
13 341 / IMPORTANCE OF THE NUMBER OF TABLETS IN THE CONTROL OF BLOOD PRESSURE IN VERY ELDERLY HYPERTENSIVESP. J. Labrador, P. M. Gonzalez CastilloPlasencia-SPAIN
13 342 / PRECEREBRAL ARTERIES STATUS IN PATIENTS WITH RESISTANT HYPERTENSIONI. Emelyanov, N. Avdonina, E. Sokalyskaya, A. Konrady, E. ShlyakhtoSt. Petersburg-RUSSIA
13 343 / ANXIETY-DEPRESSIVE DISORDERS IN HYPERTENSIVE PATIENTS, ASSOCIATION WITH COGNITIVE IMPAIRMENT AND 24- HOURS BLOOD PRESSURE PROFILEN. Afanasyeva, V. MordovinTomsk-RUSSIA
13 344 / EVALUATION OF BPHR AS AN INDEX TO SIMPLIFY DIAGNOSTIC CRITERIA OF HYPERTENSION IN CAUCASIAN ADOLESCENTSF. Rabbia, I. Rabbone, S. Totaro, E. Testa, M. Covella, E. Berra, C. Di Stefano, M.C. Bertello, E. Gioia, F. Cerutti, F. VeglioTurin-ITALY
13 345 / PLASMA INSULIN LEVELS ARE ASSOCIATED TO BODY WATER DISTRIBUTION IN HYPERTENSIVE PATIENTS: A BIOELECTRICAL IMPEDANCE ANALYSIS EVALUATIONG.L. Colussi, C. Catena, C. Petri, F. Pezzutto, L.A. SechiUdine-ITALY
13 346 / CHARACTERISTICS OF HYPERTENSION AMONG ELDERLY RESIDENTS OF LONG TERM CARE FACILITIESB. Gryglewska, J. Wojkowska-Mach, T. Grodzicki, P. HeczkoCracow-POLAND
13 333 / CELLULAR CA++/MG++ RATIO AS A MARKER FOR BORDERLINE HYPERTENSIONK. Kisters (1), F. Tokmak (2), M.Q. Nguyen (2), B. Gremmler (1), M. Cziborra (1), M. Hausberg (3)(1) Herne, (2) Bochum, (3) Karlsruhe-GERMANY
13 334 / HYPERTENSION IN THE ELDERLY. DO DIFFERENCES REALLY EXIST?M.Á. Barón Ramos, C. Luque Amado, M.I. Grana Costa, F.M. Godoy Guerrero, A. Muñoz Claros, A. Ruiz CanteroRonda-SPAIN
13 335 / RELATIONSHIP BETWEEN BLOOD PRESSURE RESPONSE TO EXERCISE AND ANTHROPOMETRIC INDEXES IN HEALTHY ADOLESCENTSE. Silva, J. Villasmil, G. Bermudez, A. Gonzalez, M. Bracho, C. Esis, G. Calmon, E. ClavellMaracaibo-VENEZUELA
13 336 / THE FREQUENCY AND THE LOCALIZATION OF HEADACHES IN AMBULATORY TREATED HYPERTENSIVE PATIENTSM. Klocek (1), M. Deren (2), K. Kawecka-Jaszcz (1)(1) Cracow, (2) Lezajsk-POLAND
13 337 / QUALITY OF LIFE IN PATIENTS WITH ESSENTIAL HYPERTENSION - 6 YEAR FOLLOW-UPM. Klocek, K. Kawecka-JaszczCracow-POLAND
13 338 / BLOOD PRESSURE MANAGEMENT IS INADEQUATE AFTER SURGERY FOR ACUTE TYPE A AORTIC SYNDROMEJ. Baguet, L. Boggetto-Graham, G. Barone-Rochette, H. Pierre, O. Ormezzano, E. Vautrin, O. ChavanonGrenoble-FRANCE
13 339 / INFLUENCE OF ARTERIAL HYPERTENSION AT THE REHABILITATION PATIENTS AFTER ACUTE MYOCARDIAL INFARCTIONV. Shumakov, I. Malynovska, L. Tereshkevych, L. Prohna, O. YanusKiev-UKRAINE
Saturday
18
186Saturday 18186 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011187
Saturday 18 13 354 / LACK OF EFFICACY OF THE ELECTROCARDIOGRAM TO DIAGNOSE NEW LEFT VENTRICULAR HYPERTROPHYD. Piskorz, A. TommasiRosario-ARGENTINA
13 355 / ASSOCIATION OF HEART AND VASCULAR DAMAGE IN SUBJECTS WITH CARDIOMETABOLIC RISK FACTORSE. Moguchaya, O. Rotar, O. Dubrovskaya, N. Dzubenko, E. Sokalskaya, V. Ivanenko, E. Kolesova, A. Erina, E. Malev, V. Solntsev, E. Litvinenko, A. KonradiSt. Petersburg-RUSSIA
13 356 / ORGAN DAMAGE AND CARDIOVASCULAR PROGNOSIS IN HYPERTENSIONS. Cinza Sanjurgo (1), Je López Paz (2), A. Hermida Ameijeiras (2), M. Pena Seijo (2), G. Calvo González (2), Ml Romero Miguez (2), V. Martinez Durán (2), A. Pascual Montes (2), Jm Paz Fernández (2), C. Calvo Gómez (2)(1) Malpica, (2) Santiago De Compostela-SPAIN
13 357 / DIASTOLIC DYSFUNCTION IN HYPERTENSIVE PATIENTS WITHOUT LEFT VENTRICULAR HYPERTROPHYD. Piskorz, A. TommasiRosario-ARGENTINA
13 358 / INCREASED RENAL VASCULAR RESISTANCE IS ASSOCIATED WITH IMPAIRED CORONARY MICROCIRCULATION, ENDOTHELIAL DYSFUNCTION AND ALBUMINURIA LEVELS. AN INVASIVE APPROACHC. Tsioufi s, D. Tsiachris, G. Latsios, K. Dimitriadis, A. Kasiakogias, C. Thomopoulos, A. Kordalis, C. StefanadisAthens-GREECE
13 359 / OXIDATIVE STRESS IN CHILDREN WITH PRIMARY HYPERTENSION BEFORE AND AFTER 1 YEAR OF STANDARD ANTIHYPERTENSIVE THERAPYJ. Sladowska-Kozlowska, M. Litwin, A. Niemirska, A. WierzbickaWarsaw-POLAND
13 360 / MICROALBUMINURIA IS A POOR MARKER OF VASCULAR DAMAGE IN HYPERTENSIVE PATIENTS WITHOUT CARDIOVASCULAR DISEASEA. Szyndler (1), R. Nowak (1), K. Czechowicz (1), A. Dubiela (1), K. Polonis (1), W. Kucharska (1), M. Hoffmann (1), P. Boutouyrie (2), S. Laurent (2), K. Narkiewicz (1), on behalf of CareNorth research group(1) Gdansk-POLAND; (2) Paris-FRANCE
13 347 / HYPERTENSION AND SYSTEMIC LUPUS ERYTHEMATOSUSL. Baili, I. Rachdi, B. Ben Dhaou, F. Boussema, S. Ketari, S. Kochbati, O. Cherif, L. RokbaniTunis-TUNISIA
13 348 / THE IMPACT OF DIFFERENT TYPES OF CIRCADIAN RHYTHM OF BLOOD PRESSURE AND NOCTURNAL LEVEL OF THAT PRESSURE IN RELATION TO THE STAGE OF OPTIC NERVE NEUROPATHY AND ON THE CHARACTERISTICS OF BLOOD FLOW IN SELECTED ARTERIES OF THE EYEBALL AND ORBIT OF PATIB. Krasinska, M. Karolczak-Kulesza, Z. Krasinski, K. Pawlaczyk-Gabriel, A. Niklas, J. Gluszek, A. TykarskiPoznan-POLAND
13 349 / ENHANCED PERSISTENCE IN HYPERTENSIVE PATIENTS TREATED WITH ANGIOTENSIN RECEPTOR BLOCKERS IN THE UKL. Breitscheidel (1), A. Sandberg (2), K. Kostev (1), B. Holz (1), M.S.A. Oberdiek (2)(1) Munich & Frankfurt, (2) Munich-GERMANY
13 350 / EACH HYPERTENSIVE PATIENT IS UNIQUE, BUT NOT THAT MUCH: THE CLINICAL FORMS OF ESSENTIAL HYPERTENSIONX. Girerd, D. Rosenbaum D, P. Laroche, V. Katsadze, on behalf of the investigators of the CARAVAGE StudyParis-FRANCE
13 351 / OCCUPATIONAL EXPOSURE TO LEAD AND SERUM CYSTATIN C CONCENTRATION IN PATIENTS WITH ARTERIAL HYPERTENSIONR. Poreba, P. Gac, M. Poreba, J. Antonowicz-Juchniewicz, R. AndrzejakWroclaw-POLAND
13 352 / PULSE PRESSURE AND COGNITIVE IMPAIRMENT IN TREATED HYPERTENSIVE PATIENTST. Yaneva-Sirakova, R. Tarnovska-Kadreva, L. TraykovSofia-BULGARIA
13 353 / VASCULAR INJURY IN HYPERTENSIVE PATIENTS. ARE MEN AND WOMEN EQUAL? PARITE STUDYC. Mounier-Vehier (1), T. Simone (2), D. Guedj (2), A. Achouba (3), E. Ghannad (4), S. Quere (3), M. Guenoun (5)(1) Lille, (2) Paris, (3) Rueil-Malmaison, (4)Yvette, (5) Marseille-FRANCE
Saturday
18
188Saturday 18188 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011189
Saturday 18 13 368 / CLINICAL AND ECHOCARDIOGRAPHIC FINDINGS IN ST ELEVATION MYOCARDIAL INFARCTION ACCORDING TO GENDERN. Ali-Tatar Chentir, Y. Bouhouita, M.T. ChentirAlger-ALGERIA
13 369 / PSYCHOLOGICAL PREDICTORS OF THE TREATMENT EFFICACY IN PATIENTS WITH STABLE HYPERTENSIONG. Andreeva, O. Isaikina, A. Deev, V. GorbunovMoscow-RUSSIA
13 370 / DIFFERENT DEFINITIONS OF PREHYPERTENSION (ESH/ESC VS. JNC-7) AND FEATURES OF METABOLIC SYNDROMEM. Fistrek (1), S. Karanovic (1), V. Premuzic (1), M. Laganovic (1), A. Cvitkovic (2), D. Juric (2), M. Bitunjac (2), Z. Dika (1), J. Kos (1), V. Capkun (3), I. Vukovic Lela (1), B. Jelakovic (1)(1) Zagreb, (2) Slavonski Brod, (3) Split-CROATIA
13 371 / METABOLIC SYNDROME AND INCREASING LEVELS OF C-REACTIVE PROTEIN IN PATIENTS WHO RECENTLY HAD HYPERTENSION DURING PREGNANCYA.J. Vallejo Vaz, M.L. Miranda Guisado, P. Stiefel García-Junco, E. Pamies Andreu, S. García Morillo, O. Muñiz Grijalvo, J. Villar OrtizSevilla-SPAIN
13 372 / INCREASED PLASMA LEVELS OF INFLAMMATORY CYTOKINES IN PREGNANT WOMEN WITH PREECLAMPSIAM. Craina, P. Stanciu, E. Bernad, C. Serban, R. NituTimisoara-ROMANIA
13 361 / THE NEW METHOD TO DIAGNOSE SUBCLINICAL CARDIAC INJURY IN PATIENTS WITH ARTERIAL HYPERTENSION WITHOUT LEFT VENTRICULAR HYPERTROPHYN. Koziolova, A. Bushmakina, E. Polyanskaya, N. KovalevskayaPerm-RUSSIA
13 362 / INITIAL ORTHOSTATIC REACTIONS AND CEREBROVASCULAR PATHOLOGY IN PATIENTS WITH ESSENTIAL HYPERTENSIONE. Oschepkova , N. Lazareva, Y. Kuzmina, T. Balakhonova, S. Gorieva, A. RogozaMoscow-RUSSIA
13 363 / ARE DISCREPANCIES BETWEEN ELECTROCARDIOGRAPHIC AND ECHOCARDIOGRAPHIC DIAGNOSIS OF LEFT VENTRICULAR HYPERTROPHY RELATED TO THE TYPE RATHER THAN THE EXTENT OF THE HYPERTROPHY?C.C. Beladan, F. Matei, A. Calin, M. Rosca, B.A. Popescu, D. Muraru, R. Enache, F. Curea, C. GinghinaBucharest-ROMANIA
13 364 / RELATIONSHIP BETWEEN BLOOD PRESSURE AND SUBCLINICAL TARGET ORGAN DAMAGE IN HYPERTENSIVE PATIENTSR.E. Peñuela Rodriguez, J. Lopez, I. Bastidas, R. Hernandez, M. Serrano, W. Zerpa, B. Roman, T. Peñuela, S. PereiraSan Cristobal-VENEZUELA
13 365 / PREDICTORS OF NORMALIZATION OF LEFT VENTRICULAR GEOMETRY AFTER 1 YEAR OF STANDARD ANTIHYPERTENSIVE TREATMENT IN CHILDREN WITH PRIMARY HYPERTENSIONJ. Sladowska-Kozlowska, M. Litwin, A. Niemirska, A. Wierzbicka, R. JanasWarsaw-POLAND
13 366 / MYOCARDIAL REMODELING IN PATIENTS WITH ARTERIAL HYPERTENSION AND TYPE 2 DIABETES MELLITUS OR IMPAIRED TOLERANCE OF GLUCOSEI. Sapozhnikova, E. Tarlovskaya, A. Tarlovsky, Y. Balandina, N. MaksimchukKirov-RUSSIA
13 367 / GENDER SPECIFIC PROGNOSTIC DIFFERENCES IN REGARD TO THE REGRESSION OF HYPERTENSIVE LEFT VENTRICULAR HYPERTROPHY (12 YEARS FOLLOW-UP STUDY)I. Tasic (1), S. Kostic (1), M. Kostic (2), G. Lazarevic (2), D. Djordjevic (1), D. Lovic (2)(1) Niska Banja, (2) Nis-SERBIA
Saturday
18
190Saturday 18190 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011191
Saturday 18 14 378 / LOW DOSE ATORVASTATIN TREATMENT REDUCES AMBULATORY BLOOD PRESSURE IN PATIENTS WITH MILD HYPERTENSION AND HYPERCHOLESTEROLEMIA. A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY.A. Kanaki, P. Sarafi dis, P. Georgianos, P. Stafylas, I. Tziolas, A. Sioulis, E. Geropoulou, P. Zebekakis, S. Gavrilidis, V. Tyradelli, A. LasaridisThessaloniki-GREECE
14 379 / THE INFLUENCE OF BODY MASS INDEX ON BLOOD PRESSURE CONTROL AND TOLERABILITY IN HYPERTENSIVE PATIENTS UNDER SINGLE PILL FIXED-DOSE COMBINATION OF ANGIOTENSIN RECEPTOR BLOCKER AND CALCIUM CHANNEL BLOCKERB. Boyaci (1), P. Kizilirmak (2), M. Berktas (2)(1) Ankara, (2) Istanbul-TURKEY
14 380 / OLMESARTAN/HYDROCHLOROTHIAZIDE COMBINATION THERAPY IMPROVES HYPERTENSION GRADE CLASSIFICATION IN UNCONTROLLED HYPERTENSIONX. Girerd (1), L.C. Rump (2), D. Rosenbaum (1), B. Ammentorp (3), J. Schmitt (3)(1) Paris-FRANCE; (2) Duesseldorf, (3) Munich-GERMANY
14 381 / EFFICACY AND SAFETY OF THE LOSARTAN/HYDROCHLOROTHIAZIDE COMBINATION (PREMINENT®) AFTER SWITCHING FROM AN ANGIOTENSIN II RECEPTOR BLOCKER: THE CLINICAL EVALUATION OF COMBINATION THERAPY FOR HYPERTENSIVE PATIENTS IN OMIYA (CONCERTO) STUDYK. Hirata, Y. Sugawara, C. Suga, T. Iijima, S. Saihara, K. Takahashi, T. Hasegawa, Y. Hayakawa, S. Momomura, on behalf of the CONCERTO STUDY INVESTIGATORS GROUPSaitama-JAPAN
14 382 / FIXED-DOSE COMBINATION OF AZILSARTAN MEDOXOMIL/CHLORTHALIDONE PROVIDES SUPERIOR BP REDUCTION TO MONOTHERAPIES IN STAGE 2 HYPERTENSIOND. Sica (1), G.L. Bakris (2), W.B. White (3), M.A. Weber (4), W.C. Cushman (5), A. Roberts (6), C. Cao (6), S. Kupfer (6)(1) Richmond, (2) Chicago, (3) Farmington, (4) New York, (5) Memphis, (6) Deerfield-USA
14 383 / SAFETY AND EFFICACY OF ALISKIREN IN CHILDREN: AN 8-DAY, MULTIPLE-DOSE, OPEN-LABEL STUDYJ.E. Sullivan (1), D. Keefe (2), Y. Zhou (2), L. Satlin (2), J. Yan (2)(1) Louisville, (2) East Hanover-USA
14.00 - 15.30Ground Floor
Poster Session 14
CLINICAL TRIALS
ROOM 14 / POSTERS FROM 373 TO 391
Chairperson: S. Padmanabhan (Glasgow-UK)
14 373 / RELATIONSHIP BETWEEN SLEEP-TIME BLOOD PRESSURE CONTROL AND REDUCTION OF URINARY ALBUMIN EXCRETION AFTER TIMED-TREATMENT WITH OLMESARTAN IN ESSENTIAL HYPERTENSIONR. Hermida, D.E. Ayala, M.J. Fontao, A. Mojon, J.R. FernandezVigo-SPAIN
14 374 / EFFECTS ON AMBULATORY BLOOD PRESSURE OF ADDING LOW-DOSE ASPIRIN AT BEDTIME IN SUBJECTS WITH TREATED HYPERTENSIOND.E. Ayala, R. HermidaVigo-SPAIN
14 375 / INFLUENCE OF CIRCADIAN TIME OF BLOOD PRESSURE-LOWERING TREATMENT ON CARDIOVASCULAR RISK IN RESISTANT HYPERTENSIONR. Hermida, D.E. Ayala, A. Mojon, J.R. FernandezVigo-SPAIN
14 376 / ADMINISTRATION-TIME-DEPENDENT EFFECTS OF ANGIOTENSIN RECEPTOR BLOCKERS IN HYPERTENSIVE PATIENTS WITH CHRONIC KIDNEY DISEASER.C. Hermida (1), D.E. Ayala (1), A. Mojon (1), M.J. Fontao (1), L. Chayan (2), M.J. Dominguez (2), J.R. Fernandez (1)(1) Vigo, (2) Santiago de Compostela-SPAIN
14 377 / EFFICACY AND SAFETY OF CARVEDILOL VERSUS METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITYE.A. Gofman, N.P. Kutishenko, S.Y. Martsevich, A.D. Deev, S.A. Shalnova, R.G. Oganov, on behalf of the Camelia WorkgroupMoscow-RUSSIA
Saturday
18
192Saturday 18192 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011193
Saturday 18 14 390 / ALISKIREN/HYDROCHLOROTHIAZIDE COMBINATION THERAPY LOWERS CENTRAL AORTIC BLOOD PRESSURE MORE EFFECTIVELY THAN HYDROCHLOROTHIAZIDE ALONE IN OLDER PATIENTS WITH STAGE 2 HYPERTENSIONJ. Basile (1), S. Babazadeh (2), M. Lillestol (3), J. Botha (4), R. Weitzman (5)(1) Charleston, (2) Santa Ana, (3) Fargo-USA; (4) Basel-SWITZERLAND; (5) East Hanover-USA
14 391 / THE EFFECT OF INDAPAMIDE SR ON AMBULATORY BLOOD PRESSURE IN THE HYPERTENSION IN THE VERY ELDERLY (HYVET) TRIALC. Rajkumar (1), N. Beckett (2), R. Peters (2), E. Cheek (1), C. Bulpitt (2), on behalf of THE HYVET INVESTIGATORS(1) Brighton, (2) London-UK
14 384 /EFFECTS OF OLMESARTAN MEDOXOMIL/AMLODIPINE COMBINATION THERAPY ON AMBULATORY SYSTOLIC BLOOD PRESSURE IN PATIENTS WITH MODERATE-TO-SEVERE HYPERTENSIONG. Parati (1), G. Bilo (1), W. Koch (2)(1) Milan-ITALY; (2) Schriesheim-GERMANY
14 385 / LONG-TERM CARDIOVASCULAR SAFETY OF CRYSTALLINE GLUCOSAMINE SULFATE: A RETROSPECTIVE ANALYSIS OF TWO RANDOMIZED CONTROLLED TRIALSR. Palma Dos Reis (1), A. Bonazzi (2), R. André (3), G. Giacovelli (2), L. Rovati (2)(1) Caxias-PORTUGAL; (2) Monza-ITALY; (3) Lisboa-PORTUGAL
14 386 / RENAL DAMAGE IN HYPERTENSIVE WOMEN IN ITALY: PREVALENCE AND ASSOCIATED CARDIOVASCULAR RISK FACTORS: THE I-DEMAND STUDYE. Agabiti Rosei (1), M.L. Muiesan (1), M. Salvetti (1), E. Ambrosioni (2), A. Pessina (3), B. Trimarco (4), F. Costa (2), M. Volpe (5), R. Pontremoli (6), G. Leonetti (7), G. Deferrari (6)(1) Brescia, (2) Bologna, (3) Padua, (4) Naples, (5) Rome, (6) Genoa, (7) Milan-ITALY
14 387 / INCREASED DIETARY PROTEIN INTAKE LOWERS BLOOD PRESSURE IN OVERWEIGHT SUBJECTSJ. Dopheide (1), J.M. Geleijnse (2) S.J.L. Bakker (3) E.J. Brink (4) M.A. van Baak (1), on behalf of Top Institute Food and Nutrition, Wageningen(1) Maastricht, (2) Wageningen, (3) Groningen, (4) Zeist-THE NETHERLANDS
14 388 / FIRST RESULTS OF THE RUSSIAN MULTICENTER PROGRAM STRATEGY A: PERINDOPRIL ARGININE / INDAPAMIDE FOR HYPERTENSIVE HIGH RISK PATIENTS WITH INADEQUATE BLOOD PRESSURE CONTROLI.Ye. Chazova, L.G. Ratova, T.V. MartynyukMoscow-RUSSIA
14 389 / ANTIHYPERTENSIVE AND METABOLIC EFFECTS AND SAFETY OF HIGH-DOSE PERINDOPRIL/INDAPAMIDE IN HYPERTENSIVES: PERINDOPRIL/INDAPAMIDE COMBINATION BLOOD PRESSURE REDUCTION (PICASSO) STUDYC. Farsang, on behalf of PICASSO InvestigatorsBudapest-HUNGARY
Saturday
18
194Saturday 18194 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011195
Saturday 18 15-16 397 / LONG-TERM EFFECTS OF LISINOPRIL TREATMENT ON HAEMODYNAMIC PARAMETERS IN HYPERTENSIVE PATIENTSV. Stojanov (1), B. Jakovljevic (1), D. Lovic (2)(1) Belgrade, (2) Niš-SERBIA
15-16 398 / EFFECT OF INTENSIVE VERSUS MODERATE BLOOD PRESSURE LOWERING ON TOLL-LIKE RECEPTORS 4 GENE EXPRESSION IN PATIENTS WITH ESSENTIAL HYPERTENSIONM. Marketou, J. Kontaraki, E. Zacharis, A. Giaouzaki, K. Stokos, G. Kochiadakis, P. VardasHeraklion-GREECE
15-16 399 / DRUG PREFERENCE AND DRUG PRESCRIPTION FOR THE TREATMENT OF PRIMARY HYPERTENSIONB. Georgiev, N. Gotcheva, D. GotchevSofia-BULGARIA
15-16 400 / HIGH PREVALENCE OF NON-COMPLIANCE TO ANTIHYPERTENSIVE THERAPY IN RESISTANT HYPERTENSIONB. Strauch, O. Petrak, J. Rosa, T. Zelinka, Z. Somloova, L. Chytil, I. Kurcova, R. Holaj, J. Widimsky JrPrague-CZECH REPUBLIC
15-16 401 / INTERPHERONE INDUCED EFFECT OF CYLASAPRIL IN ESSENTIAL HYPERTENSIVE PATIENTSM. Mospan, L. MishchenkoKyiv-UKRAINE
15-16 402 / COMPARISON OF CONTROLLED RELEASE CALCIUM ANTAGONISTS AND OTHER ANTIHYPERTENSIVE DRUG IN THE MANAGEMENT OF HYPERTENSION IN SUBARACHNOID HAEMORRHAGEN. Akiashvili, M. Janelidze, M. Beridze, N. Lobjanidze, S. Kapianidze, M. Alpaidze, N. Kvirkvelia, M. KapianidzeTbilisi-GEORGIA
15-16 403 / BLOOD PRESSURE-LOWERING EFFECT OF ALISKIREN AND ITS ROLE ON CARDIAC AND RENAL DAMAGE IN HIGH-RISK HYPERTENSIVE SUBJECTS: A 12-MONTHS STUDYA. Mazza (1), D. Montemurro (2), L. Schiavon (1), A. Zanier (1), M. Zuin (1), S. Zorzan (1), S. Cuppini (1), E. Ramazzina (1)(1) Rovigo, (2) Adria-ITALY
14.00 - 15.30Ground Floor
Poster Session 15
THERAPEUTIC ASPECTS
ROOMS 15-16 / POSTERS FROM 392 TO 440
Chairperson: C. Borghi (Bologna-ITALY)
15-16 392 / NEW COMBINATION THERAPY FOR TREATMENT OF HYPERTENSION (EXPERIMENTAL STUDY)T. Zvyagintseva, K. Storozhenko, I. KhalinKharkov-UKRAINE
15-16 393 / ALISKIREN PROVIDES MORE PROLONGED REDUCTIONS IN 24-HOUR MEAN AMBULATORY BLOOD PRESSURE DURING TREATMENT WITHDRAWAL THAN TELMISARTANR. Düsing (1), F. Baschiera (2), I.Y. Baek (2), P. Brunel (2)(1) Bonn-GERMANY; (2) Basel-SWITZERLAND
15-16 394 / ALISKIREN: EVALUATION OF EFFICACY AND SAFETY OF ADMINISTRATIONK. Gkogkos, O. Siarkou, C. Miggos, M. Manou, I. Lampropoulou, G. PavlidisThessaloniki-GREECE
15-16 395 / IMPACT OF TELMISARTAN TREATMENT ON POSTPRANDIAL FIBRINOLYSIS IN ESSENTIAL HYPERTENSIONS. Solomou (1), I. Anyfantis (2), C. Basagiannis (2), D. Tsalta (2), I. Papargyriou (2), D. Papadogiannis (2)(1) Piraeus, (2) Athens-GREECE
15-16 396 / CARDIOVASCULAR PREVENTION: RELATIONSHIPS BETWEEN ARTERIAL AGING AND CHRONIC DRUG TREATMENTA. Lieber, M.E. Safar, D. Agnoletti, Y. Zhang, J. Peroz-Froz, A. Protogerou, B.I. Levy, J. BlacherParis-FRANCE
Saturday
18
196Saturday 18196 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011197
Saturday 18 15-16 411 / EFFECT OF SHORT-TERM TREATMENT WITH TELMISARTAN OR NIFEDIPINE ON INSULIN SIGNALLING IN LYMPHOMONOCYTES OF ESSENTIAL HYPERTENSIVE PATIENTSE. Porteri (1), V. Flati (2), E. Pasini (1), C. De Ciuceis (1), C. Platto (1), L. Giacomelli (1), E. La Boria (1), D. Assanelli (1), S. Speca (2), C. Donini (1), D. Rizzoni (1), E. Agabiti Rosei (1)(1) Brescia, (2) L’Aquila-ITALY
15-16 412 / MELATONIN, FREE RADICAL ACTIVITY AND CONVENTIONAL TREATMENT IN HYPERTENSIONC. Grigore (1), A.M. Vintila (1), I. Stoian (1), Ov. Grigore (1), L. Dawkins (2), D. Isacoff (1), I.V. Bruckner (1)(1) Bucharest-ROMANIA; (2) Southampton-UK
15-16 413 / THE EXPERIENCE OF USING OF IVABRADINE IN TREATMENT OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSIONI. Lazareva, A. Miadzvedzeva, D. Kovalenko, S. Pashkevich, V. PahudaMinsk-BELARUS
15-16 414 / ESSENTIAL HYPERTENSION IS ASSOCIATED WITH ALTERED SPHINGOLIPID BIOLOGY WHICH CAN BE NORMALISED BY ANTI-HYPERTENSIVE TREATMENTL. Spijkers (1), R. Van Den Akker (1), B. Janssen (2), J. Debets (2), M. Meens (2), J. De Mey (2), E. Stroes (1), B.J. Van Den Born (1), D. Wijesinghe (3), C. Chalfant (3), A. Alewijnse (1), S. Peters (1)(1) Amsterdam, (2) Maastricht-THE NETHERLANDS; (3) Richmond-USA
15-16 415 / THE EFFECT OF RESVERATROL IN THE RAT RENAL ARTERYL. Gojkovic-Bukarica (1), V. Kanjuh (1), J. Markovic-Lipkovski (1), H. Heinle (2)(1) Belgrade-SERBIA; (2) Tuebingen-GERMANY
15-16 416 / PREDICTORS OF ANGIOGENIC THERAPY EFFECTIVENESS IN HYPERTENSIVE PATIENTS WITH CHRONIC LIMB ISCHEMIAK. Talitskiy, O. Bulkina, T. Arefi eva, A. Samko, Y. Parfyonova, Y. KarpovMoscow-RUSSIA
15-16 417 / BLOOD PRESSURE NORMALIZATION BY FIXED PERINDOPRIL/INDAPAMIDE COMBINATION IN PATIENTS WITH DIABETES MELLITUS WITH HYPERTENSION: RESULTS OF NIKA STUDYT. Netchessova, A. Shepelkevich, T. Gorbat, I. LazarevaMinsk-BELARUS
15-16 404 / HIGH SENSITIVE CARDIAC TROPNIN T IS USEFUL FOR STRATIFICATION OF HYPERTENSIVE TREATMENTS. Hoshide, M. Fukutomi, K. Eguchi, T. Watanabe, T. Kabutoya, S. Ishikawa, K. KarioShimotsuke-JAPAN
15-16 405 / MODERN APPROACHES TO PREVENTION OF THROMBOTIC COMPLICATIONS IN HYPERTENSIVE PATIENTS WITH ACUTE CORONARY SYNDROME WITHOUT ST-SEGMENT ELEVATIONT. Poponina, Y. PoponinaTomsk-RUSSIA
15-16 406 / EFFECT OF ORALLY SINGLE DOSE OF EXTENDED ISOSORBIDE-5-MONONITRATE ON CENTRAL BLOOD PRESSURE IN HEALTHY MALE VOLUNTEERSX. Jiang, P. Wang, Y. Liu, S. Du, Q. Dong, L. Xu, Y. LiBeijing-CHINA
15-16 407 / TREATMENT OF ANXIETY-DEPRESSIVE DISORDERS IN PATIENTS WITH ARTERIAL HYPERTENSION ASSOCIATED WITH CORONARY HEART DISEASEY. Poponina, T. Poponina, B. Portnyagin, K. GunderinaTomsk-RUSSIA
15-16 408 / DIPPING STATUS IS CHARACTERIZED BY AUGMENTED ADMINISTRATION OF BENZODIAZEPINES AND ELEVATED ARTERIAL STIFFNESSV. Katsi, G. Souretis, An. Koumoulidis, K. Benekos, N. Alexopoulos, I. Vlasseros, D. Papoutsis, S. Christakopoulos, D. Barlagiannis, M. Divani, C.H. Stefanadis, I. KallikazarosAthens-GREECE
15-16 409 / A COMPARATIVE ANALYSIS OF LERCANIDIPINE AND AMLODIPINE IN THE MANAGEMENT OF HYPERTENSIONA. Alharf, S. Padmanabhan, S. Muir, P. Meredith, G. McInnesGlasgow-UK
15-16 410 / HIGH PILL BURDEN IS THE MAIN CONTRIBUTING FACTOR TO NON-ADHERENCE IN HYPERTENSIONJ.J. Mourad (1), C. Mounier-Vehier (2), B. Vaïsse (3), V. Katsadze (4)(1) Bobigny, (2) Lille, (3) Marseille, (4) Paris-FRANCE
Saturday
18
198Saturday 18198 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011199
Saturday 18 15-16 424 / SINGLE-PILL COMBINATION OF TELMISARTAN 80 MG/AMLODIPINE 10 MG PROVIDES SUPERIOR BLOOD PRESSURE REDUCTIONS TO AMLODIPINE IN ADDED-RISK HYPERTENSIVE PATIENTS: SUB-ANALYSIS OF THE OBESE PATIENTS IN THE TEAMSTA DIABETES STUDYA.M. Sharma (1), G. Bakris (2), T.W. Littlejohn (3), J.M. Neutel (4), M. Kobe (5), N. Ting (5), L. Ley (6)(1) Edmonton-CANADA; (2) Chicago, (3) Winston Salem, (4) Tustin, (5) Ridgefield-USA; (6) Ingelheim-GERMANY
15-16 425 / PHARMACOLOGICALLY MEDIATED HYPOTENSION DURING THE SUMMERD. Gourlis, E. Dimitrellos Maroussi-GREECE
15-16 426 / FEATURES OF TREATMENT AND PROGNOSIS OF NON-ST ELEVATION ACUTE CORONARY SYNDROME IN PATIENTS WITH IRON DEFICIENCY ANEMIAA. Skotnikov, A. Vertkin, F. VilkoviskiiMoscow-RUSSIA
15-16 427 / 24-HOUR AMBULATORY BLOOD PRESSURE REDUCTION WITH A PERINDOPRIL/AMLODIPINE FIXED-DOSE COMBINATIONV. Nagy, E. Lantos, N. HabonyBudapest-HUNGARY
15-16 428 / BLOOD PRESSURE LOWERING RESPONSE, CARDIAC REMODELING AND DIASTOLIC FUNCTION WITH THE FIXED LOW - DOSE COMBINATION PERINDOPRIL/INDAPAMIDE IN 300 NEVER TREATED ROMANIAN HYPERTENSIVE PATIENTSL. PopescuBucharest-ROMANIA
15-16 429 / THE INFLUENCE OF TELMISARTAN IN COMBINATION WITH TORASEMIDE AND ATORVASTATIN ON THE CARDIOVASCULAR RISK FACTORS IN HYPERTENSIVES WITH HEART FAILUREM. Orynchak, O. SheremetaIvano-Frankivsk-UKRAINE
15-16 430 / RENOPROTECTIVE EFFECTS OF COMBINED ANTIHYPERTENSIVE TREATMENT IN HYPERTENSIVES WITH NEPHROPATHYM. Orynchak, I. Gaman, O. Chovganyuk, N. ArtemenkoIvano-Frankivsk-UKRAINE
15-16 418 / COMBINATION ANTIHYPERTENSIVE TREATMENT IN THE GENERAL HYPERTENSIVE POPULATION: RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITORS WITH DIURETICS OR WITH CALCIUM CHANNEL BLOCKERS?K. Tziomalos, M. Baltatzi, A. Pavlidis, K. Koulousios, V. Dourliou, A. Hatzopoulos, V. Bougatsa, L. Kirkineska, C. Savopoulos, A. HatzitoliosThessaloniki-GREECE
15-16 419 / QUINAPRIL AND HYDROCHLORTHIAZIDE FIXED COMBINATION TREATMENT EFFECT ON LEFT VENTRICULAR HYPERTROPHY, BLOOD PRESSURE LEVEL AND METABOLIC DISTURBANCES IN PATIENTS WITH ESSENTIAL HYPERTENSION AND METABOLIC SYNDROMEG. KasprukKyiv-UKRAINE
15-16 420 / EFFECT OF PERINDOPRIL/INDAPAMIDE ON BLOOD PRESSURE AND QUALITY OF LIFE IN PATIENTS WITH ARTERIAL HYPERTENSION ASSOCIATED WITH CARDIOVASCULAR RISK OR OTHER COMORBIDITIESD. PellaPresov-SLOVAK REPUBLIC
15-16 421 / COMPARATIVE STUDY OF ORIGINAL AND GENERIC RAMIPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION AND HIGH RISK OF CARDIOVASCULAR COMPLICATIONSY. Lukina, S. Martsevich, N. Dmitrieva, O. Lerman, S. Tolpygina, V. Voronina, M. Maximova, A. Zakharova, L. Drozdova, E. GofmanMoscow-RUSSIA
15-16 422 / EFFECTS OF FELODIPINE BASED COMBINATION REGIMEN ON THE SEXUAL FUNCTION IN YOUNG AND MIDDLE-AGED PATIENTS WITH HYPERTENSIONJ. Yu, R. Ma, L. Yang, D. Xu, P. Liu, X. Lin, X. Guo, F. Zhao, H. Hu, X. Li, X. Zhang,P. Chang, F. Bai, X. ChenLanzhou-CHINA
15-16 423 / IRBESARTAN/AMLODIPINE FIXED COMBINATION IN PATIENTS UNCONTROLLED ON IRBESARTAN 150 MG (I-ADD STUDY)G. Bobrie, on behalf of the I-ADD investigatorsParis-FRANCE
Saturday
18
200Saturday 18200 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011201
Saturday 18 15-16 437 / DO YOU USE MORE THAN ANGIOTENSIN RECEPTOR BLOCKERS IN THE TREATMENT OF HYPERTENSIVE PATIENTS MENTORS PHYSICIANS IN FAMILY MEDICINE AND COMMUNITY VERSUS THOSE WHO ARE NOT?J. Iturralde-Iriso, G. Mediavilla-Tris, A. Rodriguez-Fernandez, J. Martinez-Gorostiaga, E. Lopez De Uralde-Perez De Alben, M.A. Alarcia-Ceballos, G. Arnaiz-Garcia, A. Alcalde-Lozano, I. Lopez De Viñaspre-Muguerza, A. Ruiz De Loizaga-Arellano, M.E. Ortega-Horillo, T. Esparza-Otero, E. Perez-Urrutia, M.A. Basabe-Perez, M. Pinel-MongeVitoria-SPAIN
15-16 438 / ROSUVASTATIN EFFECT ON BLOOD PRESSURE, IS DOSE-DEPENDENT?M. Pena Seijo, A. Hermida Ameijeiras, J.E. López Paz, M.l. Romero Míguez, G. Calvo Gómez, F. Lado Lado, I. Rodríguez López, A. Pose Reino, C. Calvo GómezSantiago De Compostela-SPAIN
15-16 439 / EFFECTIVENESS AND SAFETY OF VASOACTIVE BETA-ADRENOBLOCKERS UNDER THE CONDITIONS OF ACUTE PHARMACOLOGICAL TEST IN ARTERIAL HYPERTENSION PATIENTS OF DIFFERENT AGESA. Dzizinsky (1), K. Protasov (1), V. Protasova (2), T. Kucherova (2), O. Perkova (2), O. Fedorishina (1)(1) Irkutsk, (2) Angarsk-RUSSIA
15-16 440 / EFFECT OF TELMISARTAN AND INDAPAMIDE ON THE LIPID AND GLUCOSE METABOLISM IN HIGH-NORMAL BLOOD PRESSURE PATIENTSL. Liu, S. Zhao, X. Liu, W. Yu, A. WangBeijing-CHINA
15-16 431 / COMPARATIVE EFFECTIVENESS OF RENIN ANGIOTENSIN SYSTEM BLOCKADES PLUS CCBS OR DIURETICS FOR ESSENTIAL HYPERTENSION: A SYSTEMATIC REVIEWR. Ma, X. Zhang, L. Yang, F. Bai, J. YuLanzhou-CHINA
15-16 432 / THE PATTERNS OF TREATMENT PERSISTENCE WITH ANTIHYPERTENSIVE MEDICATIONS IN FRANCEL. Breitscheidel (1), A. Sandberg (2), K. Kostev (1), B. Holz (1), M.S.A. Oberdiek (2)(1) Munich & Frankfurt, (2) Munich-GERMANY
15-16 433 / COMPARATIVE ANALYSIS OF METABOLIC EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR MONOTHERAPY AND ITS COMBINATION WITH THIAZIDE DIURETICM. Mamedov, M. Stroyeva, M. Kovrigina, E. PoddybskayaMoscow-RUSSIA
15-16 434 / A DATABASE ANALYSIS TO EVALUATE THE RISK OF CARDIOVASCULAR EVENTS IN HYPERTENSIVE PATIENTS BEING TREATED WITH EITHER THE SINGLE PILL COMBINATION OF VALSARTAN AND AMLODIPINE OR THE RESPECTIVE FREE COMBINATIONE. Kaiser (1), S. Klebs (1), T. Lied (1), C. Sieder (1), K. Kostev (2), J. Mathes (1), S. Fuchs (1)(1) Nuernberg, (2) Frankfurt-GERMANY
15-16 435 / COMPLIANCE’S INFLUENCE OF PROGRESSION OF CORONARY ATHEROSCLEROSIS IN PATIENTS WITH TYPE 2 DIABETES AFTER CABG (ONE-YEAR FOLLOW-UP)M. GelmedovaKyiv-UKRAINE
15-16 436 / CLINICAL EFFECTIVENESS AND SAFETY OF A FIXED-DOSE COMBINATION OF RAMIPRIL PLUS FELODIPINE ER IN COMPARISON WITH A FIXED-DOSE COMBINATION OF TRANDOLAPRIL PLUS VERAPAMIL SR AND VALSARTAN PLUS AMLODIPINE IN THE TREATMENT OF ESSENTIAL ARTERIAL HYPERTENSIONK. Widecka (1), P. Kawalec (2), J. Lis (3), M. Ostrowski (3)(1) Szczecin, (2) Krakow, (3) Warsaw-POLAND
Saturday
18
202Saturday 18202 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011203
Saturday 18 17 447 /THE ROLE OF DIABETES MELLITUS PRESENCE IN CORONARY ARTERY DISEASE CONSIDERING RELATIONSHIP BETWEEN HYPERTENSION AND INFLAMMATION MARKERSS. Radovanovic, A. Djokovic, M. Zdravkovic, I. Zivanovic, M. KrotinBelgrade-SERBIA
17 448 /EFFECTS OF THERAPY WITH PURINE (ADENOSINE) RECEPTORS ACTIVATOR ON ENDOTHELIAL FUNCTION IN PATIENTS WITH ARTERIAL HYPERTENSIONA. Bilovol, I. Knyazkova, V. KozlovskiyKharkov-UKRAINE
17 449 /EVALUATION OF THE RELATIONSHIP BETWEEN PLASMA GLUCOSE LEVEL AND SHORT-TERM BEAT-TO-BEAT QT INTERVAL VARIABILITY IN SUBJECTS WITH NORMOGLYCEMIAR. Takács, A. Orosz, É. Halász, M. Vöröslakos, T. Várkonyi, I. Baczkó, T. Wittmann, J.G. Papp, A. Varró, C. LengyelSzeged-HUNGARY
17 450 /ASSOCIATION C-REACTIVE PROTEIN WITH ARTERIAL HYPERTENSION AND ABDOMINAL OBESITY IN ELDERLY MOSCOVITESV. Zhukova, S. Shalnova, A. Deev, V. MetelskayaMoscow-RUSSIA
17 451 /THE MUSIC THERAPY IN PATIENTS WITH HYPERTENSION AND MYOCARDIAL INFARCTION AFTER PREVIOUS REVASCULARIZATIONP. Mitrovic, B. Stefanovic, Z. Vasiljevic, A. Paladin, M. Radovanovic, N. Radovanovic, D. Rajic, G. Matic, A. Novakovic, K. LazarevicBeograd-SERBIA
17 452 /BAROREFLEX SENSITIVITY AND SPONTANEOUS ACTIVATION OF THE BAROREFLEX ARE TWO ADDITIONAL PARAMETERS. DATA FROM HEALTHY AND HYPERTENSIVE POPULATIONSO. Ormezzano, G. Barone, J.P. BaguetGrenoble-FRANCE
17 453 /DIMINISHED CARDIAC RESPONSES TO POSTURAL MANEUVRES ARE ASSOCIATED WITH INCREASED LEFT VENTRICLE MASS INDEXH. Mayrovitz, A. TrifAventura-USA
14.00 - 15.30Ground Floor
LATE-BREAKER POSTER SESSION 1
ROOM 17 / POSTERS FROM 441 TO 453
Chairperson: C. Borghi (Bologna-ITALY)
17 441 /CARDIAC NATRIURETIC PEPTIDES INDUCE BROWNING OF HUMAN ADIPOCYTE PHENOTYPE BEHAVING AS CARDIOMETABOLIC HORMONESM. Bordicchia (1), S. Collins (2), D. Liu (2), E. Amri (3), G. Ailhaud (3), P. Dessì-Fulgheri (1), R. Sarzani (1)(1) Ancona-ITALY; (2) Lake Nona-Orlando-USA; (3) Nice-FRANCE
17 442 /CHANGES OF THE BAROREFLEX-SENSITIVITY IN HEALTHY UNIVERSITY STUDENTS DURING A SEMESTER AND AN EXAM PERIODI. Fejes, P. Legrady, D. Bajcsi, G. AbrahamSzeged-HUNGARY
17 443 /RETINAL ARTERIOLAR AND VENULAR PHENOTYPES IN A FLEMISH POPULATION: REPRODUCIBILITY AND CORRELATESY. Liu (1), T. Richart (2), H. Struijker-Boudier (2), J. Staessen (1)(1) Leuven-BELGIUM; (2) Maastricht-THE NETHERLANDS
17 444 /RETINAL VENOUS PULSATILITY IS REDUCED IN PATIENTS WITH CYANOTIC CONGENITAL HEART DISEASEM. Golzan, S. Graham, J. Leaney, R. Cordina, D. Celemajer, A. AvolioSydney-AUSTRALIA
17 445 /CENTRALLY-ACTING ANTIHYPERTENSIVE DRUGS REVERSE MICROVASCULAR RAREFACTION IN A RAT MODEL OF METABOLIC SYNDROME AND HYPERTENSIONA. Nascimento, P. Jotha, M. Machado, F. Gomes, N. Jesus, I. Bonomo, E. TibiriçaRio De Janeiro-BRAZIL
17 446 /FEATURES OF PHARMACOTHERAPY AND DYNAMICS OF HEART RATE VARIABILITY IN PATIENTS WITH ESSENTIAL HYPERTENSION IN THE TREATMENT OF BISOPROLOL AND AMLODIPINES. Gahramanova, A. BakhshaliyevBaku-AZERBAIJAN
Saturday
18
204Saturday 18204 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011205
Saturday 1814.30 - 15.30Blue Hall
How-To Session
LEFT VENTRICULAR HYPERTROPHY ASSESSMENT BY ECG
Chairperson: P. Verdecchia (Perugia-ITALY)
14.30 - 15.30Auditorium
Clinical Case
HYPERTENSION IN CHILDREN AND ADOLESCENTS
Chairpersons: E. Lurbe (Valencia-SPAIN) K. Kawecka-Jaszcz (Cracow-POLAND)
Management of child with chronic kidney disease and hypertensionD. Drozdz (Cracow-POLAND) Teenager with hypertension and metabolic abnormalitiesS. Stabouli (Thessaloniki-GREECE)
Saturday
18
206Saturday 18206 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011207
Saturday 1814.30 - 15.30Orange Hall 1
Minisymposium for Italian GP’s
PROTEZIONE CARDIOVASCOLARE ED APPROPRIATEZZA PRESCRITTIVA: MODERNA GESTIONE DEL PAZIENTE IPERTESO
Moderatore: B. Trimarco (Napoli)
Nifedipina GITS, unicità, comprovata protezione cardiovascolare e nuove evidenze in terapia di associazioneE. Agabiti Rosei (Brescia) Telmisartan: appropriatezza prescrittiva e compliance per una migliore protezione cardiovascolareV. Costa (Bologna)
14.30 - 15.30Yellow Hall
Minisymposium
Supported by an unrestricted educational grant by Takeda Pharmaceuticals Europe
ANGIOTENSIN RECEPTOR BLOCKERS FOR THE TREATMENT OF HYPERTENSION: CURRENT AND FUTURE PERSPECTIVES
Chairperson: G.T. McInnes (Glasgow-UK)
Welcome and IntroductionG.T. McInnes (Glasgow-UK) Blood pressure control: where we are now?G. Mancia (Milan-ITALY) Treating the insulin resistant patient: case studyG.T. McInnes (Glasgow-UK) Hypertension management using angiotensin receptor blockers: defi ning effectiveness versus effi cacyL.M. Ruilope (Madrid-SPAIN) Panel Q&A, Summary and closeG.T. McInnes (Glasgow-UK)
Saturday
18
208Saturday 18208 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011209
Saturday 1814.30 - 15.30Orange Hall 3
Minisymposium for Italian GP’s
LA GESTIONE DEL PAZIENTE AD ALTO RISCHIO CARDIOVASCOLARE: DALLA PRATICA CLINICA ALLA FARMACOECONOMIA
Moderatori: O. Brignoli (Brescia) G. Mancia (Milano)
Nuovi approcci alla protezione cardiorenale nel paziente ad alto rischio cardiovascolareR. Pontremoli (Genova) La gestione del rischio tra costo e valore terapeuticoE. Degli Esposti (Ferrara)
14.30 - 15.30Orange Hall 2
Minisymposium for Italian GP’s
Supported by Laboratori Guidotti/Istituto Farmacobiologico Malesci
LA GESTIONE DI DIVERSI PAZIENTI IPERTESI: UN PERCORSO COMUNE ATTRAVERSO IL BLOCCO DEL RAAS
Moderatori: A. Morganti (Milano) M. Volpe (Roma)
Strategie terapeutiche nell’ipertensione arteriosa nel paziente anziano: quali valori pressori trattare e raggiungere?G. Parati (Milano) Discussione Il danno d’organo: approccio precoce al continuum cardio-renaleE. Agabiti Rosei (Brescia) Discussione
Saturday
18
210Saturday 18210 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011211
Saturday 1815.30 - 17.00 Auditorium
Workshop on Current Topics
SESSION I
Chairpersons: P.I. Korner (Woolwich-AUSTRALIA) K.H. Rahn (Munster-GERMANY)
Sympathetic hyperactivity and renal failureG. Grassi (Monza-ITALY) Vitamin D and hypertensionA. Tomaschitz (Graz-AUSTRIA) Perioperative management of hypertensionC. Tsioufi s (Athens-GREECE) Hypertension, antihypertensive treatment and cancerM. Burnier (Lausanne-SWITZERLAND) General Discussion
14.30 - 15.30Green Hall 1
Minisymposium for Italian GP’s
Supported by Endotech
IPERTENSIONE RESISTENTE: COME AFFRONTARLA
Moderatori: A. Di Guardo (Catania) A. Rappelli (Ancona)
Ipertensione resistente: dimensione e rilevanza del problemaS. Taddei (Pisa) Come affrontare il problema nella pratica di tutti i giorniA. Filippi (Bergamo)
Saturday
18
212Saturday 18212 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011213
Saturday 1816.10ACETAZOLAMIDE COUNTERACTS AMBULATORY BLOOD PRESSURE INCREASE UNDER ACUTE EXPOSURE TO HIGH ALTITUDEG. Bilo (1), C. Lombardi (1), M. Revera (1), E. Diazzi (1), A. Giuliano (1), A. Faini (1), M.C. Valentini (1), F. Gregorini (1), A. Zambon (1), S. Hoshide (2), G. Corrao (1), G. Mancia (1), G. Parati (1), on behalf of HIGHCARE-ALPS Investigators(1) Milan-ITALY; (2) Tochigi-JAPAN
16.20NON-STEROIDAL ANTI-INFLAMMATORY DRUG RELATED INHIBITION OF ALDOSTERONE GLUCURONIDATION AND ARTERIAL DYSFUNCTION: A PROOF OF CONCEPT STUDYM. Crilly, A. MangoniAberdeen-UK
16.30SYSTEMATIC REVIEW OF THE EFFECT OF ANTI-HYPERTENSIVE DRUG THERAPY ON ARTERIAL STIFFNESSL. D’Elia, R. Ippolito, M. Schiano di Cola, G. Rossi, D. De Palma, F. Galletti, P. StrazzulloNaples-ITALY 16.40WHY DO BLACK PEOPLE RESPOND BETTER TO CALCIUMBLOCKERS AND DIURETICS? A SYSTEMATIC REVIEWL. Brewster (1), Y. Seedat (2)(1) Amsterdam-THE NETHERLANDS; (2) Durban-SOUTH AFRICA 16.50EFFECTS OF NEBIVOLOL AND ATENOLOL ON CENTRAL AORTIC PRESSURE IN HYPERTENSIVE PATIENTSJ. Redon (1), E. Rodilla (2), J.M. Pascual (2), A. Vicente (1), J. Olivan (3), J. Bonet (4), P. Torguet (5), J. Almirall (6)(1) Valencia, (2) Sagunto, (3) Sevilla, (4) Badalona, (5) Girona, (6) Sabadell-SPAIN
15.30 - 17.00Red Hall
Parallel Oral Session 3A
THERAPEUTIC ASPECTS
Chairpersons: G. Cerasola (Palermo-ITALY) I. Chazova (Moscow-RUSSIA) 15.30INADEQUATE MANAGEMENT OF UNCONTROLLED HYPERTENSIVES UNDER BITHERAPY: THE SEVICAP STUDYB. Pannier (1), P. Poncelet (2), P. Clerson (3), C. Koch (4)(1) Fleury-Merogis, (2) Henin-Beaumont, (3) Roubaix, (4) Rueil-Malmaison-FRANCE 15.40ALISKIREN PENETRATES ADIPOSE AND SKELETAL MUSCLE TISSUE, AND REDUCES RENIN–ANGIOTENSIN SYSTEM ACTIVITY IN OBESE HYPERTENSIVE PATIENTSS. Engeli (1), M. Boschmann (2), J. Nussberger (3), A.H.J. Danser (4), C.M. Yeh (5), M.F. Prescott (5), M. Dahlke (6), J. Jordan (1)(1) Hannover, (2) Berlin-GERMANY; (3) Lausanne-SWITZERLAND; (4) Rotterdam-THE NETHERLANDS; (5) East Hanover-USA; (6) Basel-SWITZERLAND 15.50EFFECT OF ACE INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS ON ALL-CAUSE MORTALITY IN HYPERTENSION TRIALSM. Bertrand (1), J.J. Mourad (2), K. Fox (3), E. Boersma (4), L. Van Vark (4)(1) Lambersart, (2) Bobigny-FRANCE; (3) London-UK; (4) Rotterdam-THE NETHERLANDS 16.00ACE-INHIBITOR PHARMACOGENOMICS: CANDIDATE GENES AND GENOME-WIDE SCAN APPROACHS. Pozzoli, C. Lanzani, L. Citterio, S. Delli Carpini, E. Brioni, M. Jankarichova, M. Simonini, P. ManuntaMilan-ITALY
Saturday
18
214Saturday 18214 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011215
Saturday 1815.30 - 17.00Orange Hall 1
Parallel Oral Session 3B
LARGE ARTERIES
Chairpersons: P. Boutouyrie (Paris-FRANCE) J. Filipovsky (Pilsen-CZECH REPUBLIC) 15.306-MERCAPTOPURINE INCREASES MINERALIZATION OF VASCULAR SMOOTH MUSCLE CELLS IN VITROJ. Prüfer, M. Schuchardt, M Tölle, T. Huang, W. Zidek, M. van der GietBerlin-GERMANY 15.40PHENOTYPE SWITCH OF VASCULAR SMOOTH MUSCLE CELLS UPON UP4A INDUCED P2Y2/6 ACTIVATIONM. Schuchardt, J. Prüfer, V. Jankowski, J. Jankowski, W. Zidek, M. van der Giet, M. TölleBerlin-GERMANY
15.50THE PREDICTIVE CAPACITY OF AORTIC PULSE WAVE VELOCITY FOR MAJOR CARDIOVASCULAR EVENTS IS STRONGER IN LOW CARDIOVASCULAR RISK PATIENTS. A SUB-ANALYSIS OF THE EDIVA STUDYJ. Maldonado (1), T. Pereira (1), J. Polónia (2), J.A. Silva (2), J. Morais (3), M. Marques (4)(1) Coimbra, (2) Matosinhos, (3) Leiria, (4) Lisbon-PORTUGAL 16.00THE CHANGE IN PULSE WAVE VELOCITY OVER THE CARDIAC CYCLE IS INDEPENDENTLY ASSOCIATED WITH LEFT VENTRICULAR MASS INDEX IN MIDDLE-AGED HEALTHY SUBJECTSE. Hermeling (1), S. Vermeersch (2), E. Rietzschel (2), M. De Buyzere (2), T. Gillebert (2), R. van de Laar (1), I. Ferreira (1), A. Hoeks (1), L. Van Bortel (2), R. Reneman (1), P. Segers (2), K. Reesink (1)(1) Maastricht-THE NETHERLANDS; (2) Ghent-BELGIUM
15.30 - 17.00Blue Hall
Topical WorkshopA joint Session with the European Stroke Conference
HYPERTENSION, COGNITIVE DYSFUNCTION AND DEMENTIA
Chairpersons: S. Laurent (Paris-FRANCE) A. Coca (Barcelona-SPAIN)
From hypertension to cognitive dysfunction and dementiaM. Hennerici (Heidelberg-GERMANY) Carotid IMT, arterial stiffness and central BP as a risk markers for vascular cognitive impairmentA. Scuteri (Rome-ITALY) Can antihypertensive treatment delay progression of white matter lesions and cognitive decline in hypertensive patients?C. Tzourio (Paris-FRANCE) General discussion: Cognitive dysfunction as target organ damage requiring evaluation in clinical practice
Saturday
18
216Saturday 18216 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011217
Saturday 1815.30 - 17.00Orange Hall 2
Parallel Oral Session 3C
GENETICS/MOLECULAR BIOLOGY
Chairpersons: A. Persu (Bruxelles-BELGIUM) G. Zalba (Pamplona-SPAIN) 15.30A WEIGHTED GENETIC RISK SCORE PREDICTS OBESITY POORLY IN TWO DIFFERENT SPANISH POPULATIONSF. Martínez (1), M.L Mansego (1), G. Rojo (2), G. De Marco (1), S. Morcillo (2), F. Soriguer (2), J. Redón (1), M. Pineda (3), J.C. Escudero (3), R.S. Cooper (4), F.J. Chaves (1)(1) Valencia, (2) Malaga, (3) Valladolid-SPAIN; (4) Maywood-USA
15.40SYNERGIC EFFECT OF TWO QTLS ON CHROMOSOME 1 AND 18 ACCOUNTS FOR THE DIFFERENCE OF STROKE-SUSCEPTIBILITY BETWEEN SHR AND SHRSP; A STUDY ON DOUBLE-CONGENIC STRAINST. Nabika, Z.H. Cui, T. Ogawa, T.A. Gandolgor, K. Kawakami, H. OharaIzumo-JAPAN 15.50ANGIOTENSIN-(1-7) INDUCES MAS RECEPTOR INTERNALIZATIONM. Gironacci (1), H. Adamo (1), G. Corradi (1), R. Santos (2), P. Ortiz (3), O. Carretero (3)(1) Buenos Aires-ARGENTINA; (2) Belo Horizonte-BRAZIL; (3) Detroit-USA 16.00NETWORK OF SALT-SENSITIVE HYPERTENSION: TIME EFFECT ON A GENETIC HUBM. Simonini, G. Gatti, S. Delli Carpini, S. Pozzoli, L. Citterio, C. Lanzani, E. Brioni, L. Zagato, P. ManuntaMilan-ITALY
16.10INAPPROPRIATE LEFT VENTRICULAR MASS IS ASSOCIATED WITH VASCULAR ORGAN DAMAGE INDEPENDENTLY ON LEFT VENTRICULAR HYPERTROPHY IN HYPERTENSIONC. Giannattasio (1), F. Cesana (1), F. Soriano (1), M. Alloni (1), M. Cairo (1), G. Colombo (1), M. Pozzi (1), C. Menni (2), G. Trocino (1), A. Fontana (1), A. Capra (1), P. Canova (1), G. Grassi (1), G. Mancia (1)(1) Monza, (2) Milan-ITALY
16.20THE LONGITUDINAL ASSOCATION BETWEEN ARTERIAL STIFFNESS AND RENAL DAMAGE IN A PRIMARY CARE POPULATIONB. van Varik, H. Stoffers, F. Soomers, A. Plat, P. de Leeuw, A. KroonMaastricht-THE NETHERLANDS
16.30THE PRESSURE DEPENDENCE OF ARTERIAL STIFFNESS AS A NOVEL MARKER OF VASCULAR FUNCTION OBTAINED FROM PWV AND BRACHIAL BP TAKEN AT DIFFERENT ARM HEIGHTSG. Schillaci (1), B. Gavish (2), G. Pucci (1), L. Settimi (1), E. Mannarino (1)(1) Perugia-ITALY; (2) Lod-ISRAEL 16.40ARTERIAL STIFFNESS, CENTRAL BLOOD PRESSURE AND MICROCIRCULATION EVIDENCE FOR A CLOSE RELATIONSHIP IN HYPERTENSIVE PATIENTSM.L. Muiesan, D. Rizzoni, M. Salvetti, A. Paini, C. Agabiti Rosei, C. Aggiusti, F. Bertacchini, F. Beschi, A. Agazzi, E. Porteri, C. De Ciuceis, E. Agabiti RoseiBrescia-ITALY
16.50EFFECT OF AGING ON AORTIC STIFFNESS IN CAMEROONIAN PYGMIESD. Lemogoum (1), W. Ngatchou (1), C. Janssens (1), M. Leeman (1), L. Van Bortel (2), J.P. Degaute (1), Ph. Van de Borne (1)(1) Brussels, (2) Ghent-BELGIUM
Saturday
18
218Saturday 18218 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011219
Saturday 1815.30 - 17.00Orange Hall 3
Parallel Oral Session 3D
HEART
Chairpersons: M. Banach (Lodz-POLAND) M.A. Weber (New York, NY-USA) 15.30THE MECHANISM OF CARDIOPROTECTIVE ACTION OF OXYTOCINJ. Gutkowska, A. Menaouar, M. JankowskiMontreal-CANADA 15.40PREVALENCE OF LEFT VENTRICULAR HYPERTROPHY IN HYPERTENSION: AN UP-DATED ANALYSIS OF ECHOCARDIOGRAPHIC STUDIESC. Cuspidi, F. Negri, C. Sala, M. Masaidi, G. ManciaMilan-ITALY 15.50CARDIOTROPHIN-1 IS A NEW KEY PLAYER IN CARDIAC AND VASCULAR FIBROSIS AND IN CARDIOVASCULAR DYSFUNCTION BEYOND HYPERTENSIONN. Lopez-Andres (1), L. Calvier (1), C. Inigo (2), C. Labat (1), N. Sloboda (1), M.A. Fortuno (2), J. Diez (2), F. Zannad (1), P. Lacolley (1), P. Rossignol (1)(1) Nancy-FRANCE; (2) Pamplona-SPAIN 16.00RIGHT VENTRICULAR MYOCARDIAL DEFORMATION ASSESSED BY TISSUE DOPPLER IMAGING AS AN INDICATOR OF THE SEVERITY OF PULMONARY HYPERTENSION OF VARIOUS ETIOLOGYY.A. Andreeva, M.A. Saidova, T.V. Martynyuk, V.P. Masenko, A.V. Volkov, I.Ye. ChazovaMoscow-RUSSIA
16.10THE ROLE OF MICRORNA IN CARDIAC HYPERTROPHY INDEPENDENT OF BLOOD PRESSUREF.J. Charchar (1), E. Porrello (2), L.M. Delbridge (3), S.B. Harrap (3)(1) Ballarat-AUSTRALIA; (2) Texas-USA; (3) Melbourne-AUSTRALIA 16.20PATHOLOGICAL INCREASE IN LEFT VENTRICULAR MASS INDEX AND CHANGING MICRORNA PROFILE IN STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATA. Monkeviciute, D. Graham, A.F. Dominiczak, S.A. Nicklin, M.W. McbrideGlasgow-UK 16.30DYNAMIC GENETIC LINKAGE OF BLOOD PRESSURE PHENOTYPESI. Arenas (1), J. Tremblay (1), B. Deslauriers (1), J. Sandoval (1), O. Šeda (1), D. Gaudet (1), E. Merlo (1), T. Kotchen (2), A.W. Jr Cowley (2), P. Hamet (1)(1) Montreal-CANADA; (2) Milwaukee-USA
16.40LECTURENOVEL GENE DISCOVERIES FOR BLOOD PRESSUREM. Caulfi eldLondon-UK
Saturday
18
220Saturday 18220 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011221
Saturday 1815.30 - 16.30Green Hall 1
Minisymposium for Italian GP’s
ACE-INIBITORI E CA-ANTAGONISTI: UNA COMBINAZIONE IDEALE PER IL TRATTAMENTO DELL’IPERTENSIONE
Moderatore: M.L. Muiesan (Brescia)
ACE-Inibitori e Ca-antagonisti: una combinazione ideale per il trattamento dell’ipertensioneA. Morganti (Milano)
16.10UP-REGULATION OF CARDIOTROPHIN-1 IN THE SURVIVAL RESPONSE OF CARDIOMYOCYTES TO HYPOXIAG. San José Enériz (1), P.A. Robador (1), A. Guadall (2), M.U. Moreno (1), C. Rodríguez (2), A. Fortuño (1), J. Diez (1), J. Martínez-González (2), G. Zalba (1)(1) Pamplona, (2) Barcelona-SPAIN 16.20STAT3 MEDIATED ACTIVATION OF PROAPOPTOTIC GENES IN DIABETIC CARDIOMYOPATHYG.E. Cambi (1), McH. Djeokeng (1), G. Lucchese (2), M. Bonacchi (1), G. Sani (1), A. Modesti (1), P.A. Modesti (1)(1) Florence, (2) Verona-ITALY 16.30ETANERCEPT INDUCES A DECREASE IN LEFT VENTRICULAR MASS IN PATIENTS WITH RHEUMATOID ARTHRITISC. Immediato Daïen, J. Morel, G. du Cailar, A.M. Dupuy, J.P. Cristol, A. Mimran, B. Combe, J. Ribstein, P. FeslerMontpellier-FRANCE 16.40INCREASED LEFT VENTRICLE APICAL ROTATION UNDER EXPOSURE TO HYPOBARIC HYPOXIA AT VERY HIGH ALTITUDE: A SIGN OF SUBENDOCARDIAL ISCHEMIA? DATA FROM THE HIGHCARE PROJECTG. Osculati, M. Revera, G. Branzi, A. Faini, F. Ciambellotti, G. Bilo, G. Mancia, G. Parati, on behalf of HIGHCARE investigatorsMilan-ITALY
16.50LEFT ATRIAL STRAIN IN NORMAL INDIVIDUALS IS INFLUENCED BY AGE AND LEFT ATRIAL VOLUME: IMPLICATIONS FOR EVALUATION OF ATRIAL FUNCTION IN HYPERTENSIVE PATIENTS WITH DIASTOLIC DYSFUNCTIONM. Chinali (1), G.P. Aurigemma (1), U. Khan (1), J.C. Hill (1), G. De Simone (2), D.A. Tighe (1)(1) Worcester-USA; (2) Naples-ITALY
Saturday
18
222Saturday 18222 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011223
Saturday 1817.00 - 18.30Auditorium
Plenary Session
Chairpersons: E.L. Schiffrin (Montreal-CANADA) P. Sleight (Oxford-UK)
17.00 - 17.20Presidential LectureCardiovascular risk factors in artsK. Narkiewicz (Gdansk-POLAND) 17.20 - 17.55DebateCentral blood pressure should be preferred to conventional blood pressure Pro: B. Williams (Leicester-UK)Against: S. Laurent (Paris-FRANCE) 17.55 - 18.30DebateCells have the machinery to synthetize angiotensin II Pro: J. Diez (Pamplona-SPAIN)Against: A.H.J. Danser (Rotterdam-THE NETHERLANDS)
16.00 - 17.00Yellow Hall
Minisymposium
Supported by an unrestricted educational grant by Abbott Products Operations AG
PUTTING HEART AND BRAIN IN THE FRAME: ARB-BASED STATEGY IN HYPERTENSION
Chairperson: G. Parati (Milan-ITALY)
IntroductionG. Parati (Milan-ITALY) SBP and the evolution of CV risk according to the Score® risk chartA. Rynkiewicz (Gdansk-POLAND) Cerebrovascular health in the management of hypertensive patientsA. Pathak (Toulouse-FRANCE)
ConclusionG. Parati (Milan-ITALY)
Saturday
18
224Saturday 18224 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011225
Saturday 1818.30 - 20.00Blue Hall
Satellite Symposium
Sponsored by Servier
IS HYPERTENSION A FATAL DISEASE TODAY ?
Chairpersons: A.M. Heagerty (Manchester-UK) S. Laurent (Paris-FRANCE)
IntroductionS. Laurent (Paris-FRANCE) Mortality patterns in hypertensionJ. Chalmers (Sydney-AUSTRALIA) Evidence for improvement in survival with antihypertensive treatmentF. Ruschitzka (Zurich-SWITZERLAND) A new dimension to hypertension management with the perindopril/amlodipine combinationN.R. Poulter (London-UK) Which patients benefi t the most from the perindopril/amlodipine combinationJ.J. Mourad (Bobigny-FRANCE) ConclusionA.M. Heagerty (Manchester-UK)
18.30 - 20.30Red Hall
ESH Working Group ON HYPERTENSION IN OBESITY, DIABETES, AND HIGH RISK PATIENTS
FIRST SESSION OF THE EUROPEAN SOCIETY OF HYPERTENSION JOINT WORKING GROUP ON “HYPERTENSION IN OBESITY, DIABETES, AND HIGH RISK PATIENTS”
FROM CARDIOMETABOLIC RISK ASSESSMENT TO TREATMENT – NEW DEVELOPMENTS
Chairpersons: P. Nilsson (Malmö-SWEDEN) J. Jordan (Hannover-GERMANY)
Added metabolic risks in arterial hypertension: Epidemiology and clinical risk assessmentS. Eckert (Bad Oeynhausen-GERMANY) Weight loss infl uences on arterial hypertension: Myth or reality?G. Grassi (Monza-ITALY) Blood pressure-lowering aspects of lipid-lowering and anti-diabetic drugsR. Cifková (Prague-CZECH REPUBLIC) Is there a risk of strict blood pressure control in high risk hypertension?L.M. Ruilope (Madrid-SPAIN)
Saturday
18
226Saturday 18226 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011227
Saturday 1818.30 - 20.30Orange Hall 1
ESH Working Group ON BLOOD PRESSURE AND HEART RATE VARIABILITY
RENAL DENERVATION AND REFLEX BLOOD PRESSURE CONTROL
Chairpersons: G. Parati (Milan-ITALY) P. van de Borne (Bruxelles-BELGIUM)
What do we know about refl ex regulation of renal sympathetic activity and blood pressure?P. van de Borne (Bruxelles-BELGIUM) Renal denervation and neurohumoral control of blood pressureM. Schlaich (Melbourne-AUSTRALIA) Renal denervation and blood pressure variabilityM. Azizi (Paris-FRANCE) Future ideas for researchG. Parati (Milan-ITALY) Q/A and General Discussion Denervation of rEnal symPathetic Activity and hypeRTension (DEPART) study:study protocol and rationaleP. van de Borne (Bruxelles-BELGIUM) General Assembly
18.30 - 20.30Yellow Hall
ESH Working Group ON HYPERTENSION AND SEXUAL DYSFUNCTION
Joint ESH-ISMH Session
WHAT HYPERTENSIOLOGISTS SHOULD KNOW ABOUT SEXUAL DYSFUNCTION
Chairpersons: S. Meryn (Wien-AUSTRIA) M. Viigimaa (Tallinn-ESTONIA)
Testosterone in the hypertensive patient with ED: a secret player? C. Vlachopoulos (Athens-GREECE) Treatment of ED in the hypertensive patient S. Meryn (Wien-AUSTRIA) Sleep apnea, hypertension and sexual dysfunction J. Wolf (Gdansk-POLAND) The role of different beta-blockers on sexual/endothelial dysfunction and arterial stiffness M. Middeke (Munich-GERMANY)
Saturday
18
228Saturday 18228 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011229
Saturday 1818.30 - 20.30 Orange Hall 3
ESH Working Group ON NURSES AND PATIENT EDUCATION
Chairpersons: R.E. Schmieder (Erlangen-GERMANY) J.M. Gutiérrez Vilaplana (Lleida-SPAIN)
Introduction:Involvement of nurses/physician assistants on managing hypertension in EuropeR.E. Schmieder (Erlangen-GERMANY) Knowledge and skills needed by nurses/physician assistants for managing hypertension(Results from the ESH Working Group survey)S.S. Kennedy (Glasgow-UK) Research on the nurses’ role in the management of patients with hypertension and cardiovascular riskE. Drevenhorn (Lund-SWEDEN) Hypertension education for culturally diverse patients: What we should be aware ofT.M. Ho Wong (Barcelona-SPAIN) Business meeting
18.30 - 20.30 Orange Hall 2
ESH Working Group ON VASCULAR STRUCTURE AND FUNCTION
Chairpersons: L. Van Bortel (Ghent-BELGIUM) P. Chowienczyk (London-UK)
New advances in retinal imagingE. Agabiti Rosei (Brescia-ITALY) Heterogeneity of the vascular treeJ. Van de Voorde (Ghent-BELGIUM) Links between arterial stiffness, pulse pressure and anticoagulant factorsV. Regnault (Nancy-FRANCE) Plaque mechanicsP. Boutouyrie (Paris-FRANCE) Refl ections on aortic pulse pressureP. Chowienczyk (London-UK) Progress reports reference values- Carotid stiffness and IMTL. Engelen (Paris/Maastricht-FRANCE/THE NETHERLANDS)
- Femoral stiffnessS. Vermeersch (Ghent-BELGIUM)
- Central blood pressureA. Herbert (Paris/Manchester-FRANCE/UK)
The European NetworkS. Laurent (Paris-FRANCE) ConclusionsL. Van Bortel (Ghent-BELGIUM)
Sunday
19
230Saturday 18230 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011231
Sunday 1918.30 - 20.30 Green Hall 1
ESH Working Group ON HYPERTENSION, HEART, THROMBOSIS AND ARRHYTHMIAS
SESSION I: HYPERTENSION AND AF
Chairpersons: A.J. Manolis (Athens-GREECE) K. Wachtell (Copenhagen-DENMARK) Defi nition of AF and prevalence of HTN in AFA. Pittaras (Athens-GREECE) Risk factors and consequence of AFA. Coca (Barcelona-SPAIN) Risk scores in AFJ. Redon (Valencia-SPAIN) Why hypertension plays a key role in the prevention and treatment of AF?A.J. Manolis (Athens-GREECE) SESSION II: CLINICAL TRIALS IN HTN AND AF Chairpersons: E. Agabiti Rosei (Brescia- ITALY) S. Erdine (Istanbul-TURKEY) Antihypertensive treatment and AFS.E. Kjeldsen (Oslo-NORWAY) RELY TrialC. Borghi (Bologna-ITALY) ROCKET – AF TrialK. Tsioufi s (Athens-GREECE)
AVERROES TrialT. Kahan (Stockholm-SWEDEN) New drugs for rhythm controlE. Agabiti Rosei (Brescia- ITALY)
07.45 - 08.45 Orange Hall 1
Breakfast Workshop
ECONOMICAL ASPECTS IN HYPERTENSION
Chairperson: E. Ambrosioni (Bologna-ITALY) Costs of hypertension and its complicationsL.M. Ruilope (Madrid-SPAIN) Costs of antihypertensive drug therapyL.G. Mantovani (Naples-ITALY)
Sunday
19
232Sunday 19232 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011233
Sunday 1907.45 - 08.45 Orange Hall 3
Breakfast Workshop
HYPERTENSION AND PREECLAMPSIA
Chairpersons: R. Cifková (Prague-CZECH REPUBLIC) A.F. Dominiczak (Glasgow-UK) Preeclampsia and future maternal healthD. Carty (Glasgow-UK) Why is treatment of hypertension in pregnancy still so diffi cult?R. Cifková (Prague-CZECH REPUBLIC)
07.45 - 08.45 Orange Hall 2
Breakfast Workshop
ANTIAGGREGANT AND ANTITHROMBOTIC TREATMENT OF HYPERTENSION: STATE-OF-THE-ART
Chairperson: A.J. Manolis (Athens-GREECE) Prevalence and risk factors for atrial fi brillationA. Coca (Barcelona-SPAIN) Clinical trials in hypertension and atrial fi brillationE. Agabiti Rosei (Brescia-ITALY)
Sunday
19
234Sunday 19234 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011235
Sunday 1909.00 - 11.00 Auditorium
Parallel Oral Session 4A
THERAPEUTIC ASPECTS
Chairpersons: P. Aranda (Malaga-SPAIN) C. Farsang (Budapest-HUNGARY) 9.00TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION - SAFE BUT NO ANTI-HYPERTENSIVE ALTERNATIVEJ. Silverdal (1), G. Mourtzinis (2), E. Stener-Victorin (1), C. Mannheimer (1), K. Manhem (1)(1) Göteborg, (2) Mölndal-SWEDEN 9.10COMPARISON OF BLOOD PRESSURE, POTASSIUM, RENIN AND ALDOSTERONE EFFECTS OF ALDOSTERONE SYNTHASE INHIBITION VS MINERALOCORTICOID BLOCKADE IN PATIENTS WITH PRIMARY ALDOSTERONISML. Amar, M. Azizi, J. Menard, S. Peyrard, P.F. PlouinParis-FRANCE 9.20THERAPEUTIC INERTIA FOR CARDIOVASCULAR PREVENTION IN HYPERTENSIVE PATIENTS: PLATELET AGGREGATION INHIBITORS PRESCRIPTIONM.J. Martinez (1), Z. Perseguer (1), V. Gil-Guillen (1), D. Orozco-Beltran (1), M. Mayor (1), V. Pallares-Carratala (2), J. Redon (3)(1) San Juan, (2) Burriana, (3) Valencia-SPAIN
9.30EFFICACY AND TOLERABILITY OF TRIPLE COMBINATION THERAPY WITH OLMESARTAN MEDOXOMIL (O) PLUS AMLODIPINE (A) PLUS HYDROCHLOROTHIAZIDE COMPARED WITH DUAL COMBINATION THERAPY WITH O PLUS AM. Volpe (1), A. Januszewicz (2)(1) Rome-ITALY; (2) Warsaw-POLAND
07.45 - 08.45 Green Hall 1
Breakfast Workshop
CAROTID ARTERY ABNORMALITIES AND STROKE
Chairpersons: S. Laurent (Paris-FRANCE) M.H. Olsen (Glostrup-DENMARK) Carotid IMT and strokeF. Mattace-Raso (Rotterdam-THE NETHERLANDS) Carotid stiffness and strokeP. Boutouyrie (Paris-FRANCE)
Sunday
19
236Sunday 19236 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011237
Sunday 1910.30CARDIORESPIRATORY RESPONSE TO EXERCISE AFTER RENAL SYMPATHETIC DENERVATION IN PATIENTS WITH RESISTANT HYPERTENSIONC. Ukena (1), F. Mahfoud (1), I. Kindermann (1), M. Kindermann (1), M.C. Brandt (2), U. Hoppe (2), H. Krum (3), M. Esler (3), P. Sobotka (4), M. Böhm (1)(1) Homburg/Saar, (2) Köln-GERMANY; (3) Melbourne-AUSTRALIA; (4) Columbus-USA 10.40EFFECT OF A LANOSTEROL SYNTHASE POLYMORPHISM AFFECTING BLOOD PRESSURE AND ENDOGENOUS OUABAIN BIOSYNTHESIS IN TWO DIFFERENT CLINICAL SETTINGSG. Gatti, E. Messaggio, C. Lanzani, S. Delli Carpini, L. Citterio, S. Pozzoli, E. Brioni, N. Casamassima, G. Bianchi, P. ManuntaMilan-ITALY 10.50SINGLE CENTRE EXPERIENCE: BAROREFLEX STIMULATION IN PATIENTS WITH RESISTANT HYPERTENSIONJ. Menne, B.M.W. Schmidt, M. Pichlmeier, H. HallerHannover-GERMANY
9.40REAL-LIFE BLOOD PRESSURE REDUCTIONS IN HYPERTENSION PATIENTS TREATED WITH ALISKIREN. INTERIM RESULTS OF THE CANADIAN ANCHOR REGISTRYP. René de Cotret (1), A. Steele (2), J-M. Leclerc (3), M. Hubert (3), L. Tran (3), R. Rigal (4)(1) Québec, (2) Ontario, (3) Dorval, (4) Montréal-CANADA 9.50INFLUENCE OF RENAL ARTERY DENERVATION ON BLOOD PRESSURE VARIABILITY AND BAROREFLEX SENSITIVITY: A PROSPECTIVE CONSECUTIVE CASE-SERIESV. Baudrie, M. Frank, O. Steichen, J.L. Elghozi, M. Sapoval, G. Bobrie, P.F. Plouin, M. AziziParis-FRANCE
10.00DIRECT ANGIOTENSIN AT2-RECEPTOR STIMULATION IMPROVES SURVIVAL AND NEUROLOGICAL OUTCOME IN EXPERIMENTAL STROKE (MCAO) IN MICEK. Schwengel (1), C. Thöne-Reineke (1), K. Lucht (1), P. Namsolleck (1), S. Müller (1), M. Horiuchi (2), M. Iwai (2), B. Dahlöf (3), A. Hallberg (4), T. Unger (1), U.M. Steckelings (1)(1) Berlin-GERMANY; (2) Ehime-JAPAN; (3) Gothenburg, (4) Uppsala-SWEDEN 10.10CARDIOVASCULAR PROTECTION BY INITIAL AND SUBSEQUENT COMBINATION OF ANTIHYPERTENSIVE DRUGS IN DAILY LIFE PRACTICEG. Mancia, F. Nicotra, A. Parodi, A. Zambon, F. Heiman, L. Merlino, I. Fortino, G. Cesana, G. CorraoMilan-ITALY
10.20EFFICACY AND SAFETY OF AZILSARTAN MEDOXOMIL/CHLORTHALIDONE WITH OLMESARTAN/HYDROCHLOROTHIAZIDE COMBINATIONS IN STAGE 2 SYSTOLIC HYPERTENSIONW.C. Cushman (1), D. Sica (2), G.L. Bakris (3), M.A. Weber (4), W.B. White (5), C. Cao (6), A. Roberts (6), S. Kupfer (6)(1) Memphis, (2) Richmond, (3) Chicago, (4) New York, (5) Farmington, (6) Deerfield-USA
Sunday
19
238Sunday 19238 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011239
Sunday 1909.00 - 10.30Blue Hall
Educational Session
Supported by an unrestricted educational grant by Boehringer Ingelheim
PREVENTING CARDIOVASCULAR EVENTS: EVIDENCE-BASED FOUNDATIONS
Chairpersons: S. Jarvis (London-UK) G. Mancia (Milan-ITALY)
Welcome and Introduction What really matters for CVD preventionS.E. Kjeldsen (Oslo-NORWAY) RAS blockade: where is the evidence?M. Volpe (Rome-ITALY) Getting to goal earlier with initial combinationsB. Williams (Leicester-UK) ARB-CCB: the optimal evidence-based combinationG. Mancia (Milan-ITALY)
09.00 - 10.30 Red Hall
Topical Workshop
THE UNHOLY ALLIANCE OF OBESITY AND ARTERIAL HYPERTENSION
Chairpersons: G. Grassi (Monza-ITALY) J. Jordan (Hannover-GERMANY) How obesity increases cardiometabolic risk in hypertensive patients - an update on the role of insulin resistance - still relevant?P. Nilsson (Malmö-SWEDEN) Infl uences of low carbohydrate and low fat diets on ectopic lipid storage with management implicationsS. Engeli (Hannover-GERMANY) Renal nerves and renal denervation in obesity and insulin resistanceM. Schlaich (Melbourne-AUSTRALIA) Obesity drugs and cardiovascular outcomes: Chances, challenges, or both?J. Jordan (Hannover-GERMANY)
Sunday
19
240Sunday 19240 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011241
Sunday 199.40REFRACTORY HYPERTENSION: EFFECTS OF NIGHTTIME ANTIHYPERTENSIVE DRUGS ADMINISTRATION ON LEFT VENTRICULAR MASS AND URINARY ALBUMIN EXCRETIONJ.E. López Paz, A. Hermida Ameijeiras, M. Pena Seijo, M.L. Romero Míguez, G. Calvo Gonzalez, V. Martinez Durán, A. Pascual Montes, I. Rodríguez López, A. Pose Reino, C. Calvo GómezSantiago De Compostela-SPAIN 9.50HYPERURICEMIA AS MARKER OF CARDIOVASCULAR RISK IN TYPE 2 DIABETIC PATIENTSJ. Cebollada, J.A. Gimeno, P. Burillo, P. Gonzalez, B. Garcia, A. Ilundain, P. Martin, C. Cabrejas, L. Clavel, J. Altemir, M.J. Iguzquiza, A.B. Mañas, A. Gascon, A.L. MedranoZaragoza-SPAIN 10.00CAROTID RESISTIVE INDEX IN PATIENTS WITH ARTERIAL HYPERTENSION: A NEW MARKER OF TARGET ORGAN DAMAGE?I. Mateo Rodriguez, P. Morillas, H. Andrade, J. Roldan, P. Agudo, J. Castillo, M.D. Masia, B. Miralles, J. Quiles, V. BertomeuSan Juan-SPAIN 10.10SEVERE AND LONG-STANDING “PENILE ANGINA” ARE ADDITIVELY ASSOCIATED WITH POOR EXERCISE PERFORMANCE IN ERECTILE DYSFUNCTION PATIENTS WITH ESSENTIAL HYPERTENSIONN. Ioakeimidis, C. Vlachopoulos, D. Terentes-Printzios, A. Aggelis, A. Samentzas, P. Xaplanteris, K. Aznaouridis, K. Rokkas, T. Askitis, C. StefanadisAthens-GREECE
10.20INFLUENCE OF INFLAMMATORY AND PROTHROMBOTIC FACTORS IN LEFT VENTRICULAR STRUCTURE AND FUNCTION IN ESSENTIAL HYPERTENSIVE PATIENTSG. Vyssoulis, E. Karpanou, S.-M. Kyvelou, C. Liakos, I. Barbetseas, C. StefanadisAthens-GREECE 10.30FETUIN-A AND SUBCLINICAL ORGAN DAMAGE IN RENAL DYSFUNCTIONF. Tornese, R. Arsena, G. Geraci, F. Incalcaterra, L. Guarino, G. Cerasola, S. CottonePalermo-ITALY
09.00 - 11.00 Orange Hall 1
Parallel Oral Session 4B
CLINICAL ASPECTS
Chairpersons: K.L. Christensen (Aarhus-DENMARK) A. Roca-Cusachs (Barcelona-SPAIN) 9.00HEART RATE VARIABILITY CORRELATES WITH SUBCLINICAL TARGET ORGAN DAMAGE IN ACTIVE TREATED HYPERTENSIVE SUBJECTSH. Li, P.J. Gao, S.L. ChuShanghai-CHINA
9.10AGING WITH SYSTEMIC HYPERTENSION IMPAIRS LEFT VENTRICULAR TWIST MECHANICS IN NEVER TREATED HYPERTENSIVE PATIENTS : COMPARISON WITH YOUNG HEALTHY VOLUNTEERSE. J. Cho, K.Y. Choi, B.J. Kwon, D.B. Kim, S.W. Jang, J.H. KimSeoul-SOUTH KOREA 9.20PLASMA MATRIX METALLOPROTEINASE-9 AND TISSUE INHIBITOR OF MMPS-1 IN HYPERTENSION: A META-ANALYSISC. Marchesi (1), F. Dentali (1), E. Nicolini (1), A.M. Maresca (1), M.H. Tayebjee (2),M. Franz (3), E.L. Schiffrin (4), A. Venco (1), G.Y.H. Lip (2), A.M. Grandi (1)(1) Varese-ITALY; (2) Birmingham-UK; (3) Jena-GERMANY; (4) Montreal-CANADA 9.30CORRELATION OF TARGET ORGAN DAMAGE WITH CENTRAL BLOOD PRESSURE MEASUREMENTS IN DIABETIC AND PRE-DIABETIC PATIENTSA. Oliveras (1), J. Segura (2), C. Suarez (2), M. Gomez-Marcos (3), L. Garcia-Ortiz (3),N. Martell-Claros (2), M. Abad (2), L. Vigil (4), D. Ferrero (4), S. Vazquez (1), J.J. De La Cruz (2), L.M. Ruilope (2), A. De La Sierra (5), on behalf of the PRESCEN Study, Spain(1) Barcelona, (2) Madrid, (3) Salamanca, (4) Móstoles, (5) Terrassa-SPAIN
Sunday
19
242Sunday 19242 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011243
Sunday 1909.00 - 11.00 Orange Hall 2
Parallel Oral Session 4C
HEART FAILURE
Chairpersons: S. Filipova (Bratislava-SLOVAKIA) F. Magrini (Milan-ITALY) 9.00ARTERIAL STIFFNESS AND PULSE WAVE REFLECTIONS ARE ASSOCIATED WITH INCREASED FILLING PRESSURES AND REDUCED EXERCISE CAPACITY IN PATIENTS WITH HEART FAILURE WITH NORMAL EJECTION FRACTIONA. Haiden (1), T. Weber (2), A. Schmidt (1), B. Pieske (1), E. Kraigher-Krainer (1), V. Riegelnik (1), C. Colantonio (1), R. Zweiker (1)(1) Graz, (2) Wels-AUSTRIA 9.10PULSATILE HEMODYNAMICS IN DIASTOLIC HEART FAILURET. Weber (1), M. Ammer (1), A. Haiden (2), V. Riegelnik (2), R. Zweiker (2), S. Wassertheurer (3), B. Eber (1)(1) Wels, (2) Graz, (3) Vienna-AUSTRIA 9.20PROGNOSTIC VALUE OF 24H BLOOD PRESSURE VARIABILITY IN CHRONIC HEART FAILUREM. Berry, J. Fourcade, O. Lairez, J. Roncalli, D. Carrie, B. Chamontin, L. Perez,A. Pathak, M. GalinierToulouse-FRANCE 9.30HEART FAILURE WITH PRESERVED EJECTION FRACTION: AORTIC STIFFNESS, BIOHUMORAL MARKERS AND ECOCARDIOGRAPHIC EVALUATIONM. Alloni, G. Castoldi, B. Corradi, F. Cesana, A. Cirò, A. Vincenzi, G. Trocino, E. Montemerlo, P. Campadello, R. Facchetti, A. Stella, G. Grassi, C. Giannattasio, G. ManciaMonza-ITALY
10.40EFFECTS OF HYPOBARIC HYPOXIA AT HIGH ALTITUDE ON OXIDATIVE STRESS PARAMETERS. RESULTS OF THE HIGHCARE PROJECTE. Kaschina (1), T. Unger (1), M. Sommerfeld (1), G. Bilo (2), M. Revera (2), A. Piperno (2), V. Mainini (2), A. Guiliano (2), M. Tamplenizza (2), A. Faini (2), A. Dubini (2), G. Caldara (2), G. Mancia (2), G. Parati (2)(1) Berlin-GERMANY; (2) Milan-ITALY
10.50NONDIPPERS HAVE HIGHER INCIDENCE OF ERECTILE DYSFUNCTION AND ABNORMAL STRUCTURAL DIASTOLIC AND URIC ACID CHANGES IN PRE-HYPERTENSIVE AND HYPERTENSIVE MENA. Pittaras (1), M. Doumas (2), C. Faselis (2), M. Papavasiliou (2), H. Grassos (1), D. Gourlis (1), I. Athanasiadis (1), P. Kokkinos (2)(1) Athens-GREECE; (2) Washington, DC-USA
Sunday
19
244Sunday 19244 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011245
Sunday 1910.30MONOAMINOXIDASE-A AND B INTERACTION WITH PRESYNAPTIC NOREPINEPHRINE REUPTAKE MECHANISM IN THE DEVELOPMENTAL PHASE OF HEART FAILURE IN AGED SPONTANEOUSLY HYPERTENSIVE RATS: AN IN VIVO EVIDENCE ON NORADRENERGIC TURNOVER IN WHITE ADIPOSE TISSUEA. Cabassi, S. Halpert, M. Theullet, S. Vinci, L. Moschini, P. Govoni, A. Borghetti, S. Tedeschi, S. Binno, P. Coghi, A. Montanari, E. Parenti, E. Cremaschi, G. Regolisti, E. FiaccadoriParma-ITALY 10.40LECTUREPREVENTION AND TREATMENT OF HEART FAILURE IN HYPERTENSIONF. Zannad Nancy-FRANCE
9.40ASSOCIATIONS OF PLASMA RENIN WITH 10-YEAR CARDIOVASCULAR MORTALITY, SUDDEN CARDIAC DEATH AND DEATH DUE TO HEART FAILUREA. Tomaschitz (1), S. Pilz (1), E. Ritz (2), A. Morganti (3), T. Grammer (2), K. Amrein (1), B.O. Boehm (4), W. März (1)(1) Graz-AUSTRIA; (2) Heidelberg-GERMANY; (3) Milan-ITALY; (4) Ulm-GERMANY 9.50ASSOCIATION OF TIMP-2 WITH SYSTOLIC HEART FAILURE IN PATIENTS WITH HYPERTENSIVE HEART DISEASEA. González, B. Lopez, J. DíezPamplona-SPAIN 10.00PREVENTION OF PRESSURE OVERLOAD-INDUCED MYOCARDIAL FIBROSIS AND PATHOLOGICAL REMODELING BY ANGIOTENSIN CONVERTING ENZYME 2J.C. Zhong (1), H.Y. Jin (1), W.L. Shen (1), W.Q. Niu (1), Y. Li (1), P.J. Gao (1), D.L. Zhu (1), Z. Kassiri (2), G.Y. Oudit (2)(1) Shanghai-CHINA; (2) Edmonton-CANADA
10.10PROGNOSTIC AND PREDICTIVE VALUE OF NT PRO BNP AT PEAK EXERCISE OVER RESTING LEVELS IN HYPERTENSIVE PATIENTS WITH IMPAIRED LEFT VENTRICULAR SYSTOLIC FUNCTIONM. Kallistratos, A. Pavlidis, C. Bale, L.E. Poulimenos, E. Chamodraka, A. Dritsas, I.D. Laoutaris, D.V. Cokkinos, A.J. ManolisAthens-GREECE 10.20PERIPHERAL CHEMOREFLEX ACTIVATION CONTRIBUTES TO SYMPATHETIC BAROREFLEX IMPAIREMENT IN HEART FAILUREF. Despas, A. Vaccaro, M. Labrunee, N. Franchitto, M. Castel, M. Galinier,J.M. Senard, A. PathakToulouse-FRANCE
Sunday
19
246Sunday 19246 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011247
Sunday 199.40INFLUENCE OF ERYTHROPOIETIN ON VASCULAR FUNCTION IN RENAL TRANSPLANT RECIPIENTSV. Bartels (1), U. Hillebrand (1), S. Reiermann (1), M. Kosch (1), K. Kisters (2), D. Lang (3), G. Di Marco (1), H. Pavenstädt (1), M. Hausberg (4)(1) Muenster, (2) Herne, (3) Nordhorn, (4) Karlsruhe-GERMANY 9.50INVESTIGATION OF THE EFFECTS INDUCED ON ENDOTHELIAL FUNCTION BY THE HUMAN T2238C ANP GENE MOLECULAR VARIANTS. Rubattu (1), S. Sciarretta (2), C. Calvieri (2), L. Castello (2), A. Battistoni (2), M. De Giusti (2), E. Dito (2), A. Marra (2), I. Laurino (2), B. Pagliaro (2), M. Volpe (2)(1) Pozzilli, (2) Rome-ITALY 10.00ESTRADIOL-INDUCED NITRIC OXIDE PRODUCTION AND VASCULAR RELAXATION ARE MEDIATED THROUGH ANGIOTENSIN 1-7 MAS RECEPTORC. Hermenegildo (1), A. Sobrino (1), E. Monsalve (1), C. Bueno-Betí (1), A. Laguna-Fernández (1), C.F. Sánchez-Ferrer (2), C. Peiró (2), S. Novella (1)(1) Valencia, (2) Madrid-SPAIN 10.10ENDOTHELIAL DYSFUNCTION AFTER PREECLAMPTIC PREGNANCYD. Carty, L. Anderson, C. Duncan, A. Dominiczak, C. DellesGlasgow-UK 10.20ENDOTHELIAL PROGENITOR CELLS RELATIONSHIPS WITH CLINICAL AND BIOCHEMICAL FACTORS IN A HUMAN MODEL OF BLUNTED ANGIOTENSIN II SIGNALINGL. Calò, M. Facco, E. Pagnin, L. Dal Maso, M. Puato, P. Caielli, C. Agostini, A.C. Pessina Padua-ITALY 10.30CHRONIC ANGIOTENSIN-(1-7) TREATMENT IMPROVES RENAL ENDOTHELIAL DYSFUNCTION IN APOLIPOPROTEINE DEFICIENT MICES.A. Potthoff, J. Stegbauer, I. Quack, E. Mergia, T. Clasen, S. Friedrich, O. Vonend, M. Woznowski, E. Königshausen, L. Sellin, L.C. RumpDuesseldorf-GERMANY
09.00 - 11.00 Orange Hall 3
Parallel Oral Session 4D
ENDOTHELIUM
Chairpersons: A. Salvetti (Pisa-ITALY) M.Schneider (Glasgow-UK) 9.00EFFECTS OF ANTIRETROVIRAL THERAPY ON ENDOTHELIAL FUNCTION IN HIV PATIENTSD. Dozio, A. Maloberti, F. Citterio, F. Cesana, M. Alloni, P. Villa, E. Scanziani, A. Bandera, F. Sabatini, M. Cairo, G. Grassi, A. Gori, C. Giannattasio, G. ManciaMonza-ITALY 9.10ACUTE EXPOSURE TO DIESEL PARTICLE MATTER IMPAIRS NO-MEDIATED MICROVASCULAR FUNCTIONC. Dreyfuss, A. Wauters, D. Adamopoulos, C. Moentack, P. Hendrick, G. Berkenboom, P. Van De Borne, J.F. ArgachaBrussels-BELGIUM 9.20TORCETRAPIB IMPAIRS ENDOTHELIAL FUNCTION IN HYPERTENSIONB. Simic (1), M. Hermann (1), S. Shaw (2), L. Bigler (1), U. Stalder (1), C. Dörries (1), C. Besler (1), T.F. Lüscher (1), F. Ruschitzka (1)(1) Zurich, (2) Bern-SWITZERLAND
9.30ALISKIREN RESTORES NITRIC OXIDE AVAILABILITY IN THE FOREARM MICROCIRCULATION OF ESSENTIAL HYPERTENSIVE PATIENTSA. Virdis, G. Lorenzini, E. Duranti, A. Magagna, L. Masi, L. Ghiadoni, S. TaddeiPisa-ITALY
Sunday
19
248Sunday 19248 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011249
Sunday 1909.30 - 10.30Yellow Hall
Minisymposium
Supported by an unrestricted educational grant by Ferrer International
GENETICS AND CARDIOVASCULAR RISK
Chairperson: A. Fernandez-Cruz (Madrid-SPAIN)
Genomics and primary prevention of cardiovascular diseasesA.F. Dominiczak (Glasgow-UK) Contribution of genomics to improve the effi ciency of cardiovascular risk functionsJ. Marrugat (Barcelona-SPAIN)
10.40DO CONNEXINS 37, 40 AND 43 PLAY A ROLE IN ENDOTHELIAL DYSFUNCTION IN CREMASTER ARTERIES FROM TYPE-2 DIABETIC RATS?J. Reid, M. Youssef, J. HartMelbourne-AUSTRALIA 10.50HIGH GLUCOSE IMPAIRS ENDOTHELIUM-DEPENDENT VASODILATION THROUGH PKC-MEDIATED NADPH-OXIDASE ACTIVATIONY. Huang, J. Menne, A. Melk, N. Shushakova, F. Güler, T. Kirsch, H. Haller, B. SchmidtHannover-GERMANY
Sunday
19
250Sunday 19250 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011251
Sunday 1912.15PROSPECTIVE EVALUATION OF THE PHARMACOLOGICAL MANAGEMENT OF HYPERTENSION IN CLINICAL PRACTICE IN GREECE: THE DEMANT STUDYG. Stergiou (1) A. Lasaridis (2), on behalf of Hellenic Society for the Study of Hypertension; Hellenic Society of Hypertension(1) Athens, (2) Thessaloniki-GREECE
11.00 - 12.30Auditorium
Late-Breaker Session 2
Chairpersons: A.M. Heagerty (Manchester-UK) T. Unger (Berlin-GERMANY)
11.00CENTRAL HEMODYNAMIC INDICES AS PREDICTORS OF COGNITIVE PERFORMANCE IN MIDLIFEM. Pase, A. Pipingas, M. Kras, K. Nolidin, A. Gibbs, A. Scholey, C. StoughHawthorn-AUSTRALIA 11.15EPIGENETIC MODULATION OF RENAL β-ADRENERGIC-WNK4 PATHWAY IN SALT-SENSITIVE HYPERTENSIONT. Fujita, S.Y. MuBunkyo-Ku-JAPAN 11.30A NEW SENSITIVE APPROACH FOR THE ASSESSMENT OF J-CURVE FINDINGS FROM THE FEVER TRIALX. Zhang (1), Y. Zhang (1), L. Liu (1), A. Zanchetti (2)(1) Beijing-CHINA; (2) Milan-ITALY 11.45ALDOSTERONE REDUCTION BY UNILATERAL ADRENALECTOMY REDUCES SALT APPETITE IN PATIENTS CURED OF PRIMARY ALDOSTERONISME. Pimenta, R. Gordon, A. Ahmed, D. Cowley, D. Robson, C. Kogovsek, M. StowasserBrisbane-AUSTRALIA 12.00THE HIGH CREATINE KINASE, HYPERTENSION-PRONE PHENOTYPE MAY HAVE GREATER BLEEDING TENDENCYD. Horjus, A. Sturk, R. Nieuwland, M. Schaap, L. BrewsterAmsterdam-THE NETHERLANDS
Sunday
19
252Sunday 19252 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011253
Sunday 1911.00 - 12.30Blue Hall
Parallel Oral Session 5A
ATRIAL FIBRILLATION
Chairpersons: C. Grassos (Athens-GREECE) B. Trimarco (Naples-ITALY) 11.00EFFECT OF TELMISARTAN ON PAROXYMAL ATRIAL FIBRILLATION IN HYPERTENSIVE PATIENTS WITH DIFFERENT LEFT ATRIAL SIZER. Fogari, A. Mugellini, A. Zoppi, G. DerosaPavia-ITALY
11.10PREVALENCE AND CORRELATION OF LEFT ATRIAL ENLARGEMENT IN TYPE 2 DIABETES WITH AND WITHOUT CHRONIC KIDNEY DISEASEA. Sato, K. Sakai, T. Kunugi, M. Harada, K. Nagai, Y. IwamotoTokyo-JAPAN 11.20DEMOGRAPHIC, ANTHROPOMETRIC, HAEMODYNAMIC AND METABOLIC DETERMINANTS OF LEFT ATRIAL SIZE IN THE GENERAL POPULATION: DATA FROM THE PAMELA STUDYM. Bombelli (1), C. Cuspidi (1), D. Fodri (1), M. Peronio (1), E. Toso (1), H. Polo Friz (2), L. Primitz (2), C. Zazzeron (2), R. Facchetti (1), G. Grassi (1), R. Sega (2), G. Mancia (1)(1) Monza, (2) Vimercate-ITALY
11.30RISK OF ATRIAL FIBRILLATION IN RELATION TO THE PULSATILE AND STEADY COMPONENTS OF CONVENTIONAL AND AMBULATORY BLOOD PRESSURE IN 4 EUROPEAN POPULATIONSV. Tikhonoff (1), T. Kuznetsova (2), K. Stolarz-Skrzypek (3), L. Thijs (2), S. Malyutina (4), Y. Nikitin (4), K. Kawecka-Jaszcz (3), E. Casiglia (1), J.A. Staessen (2)(1) Padua-ITALY; (2) Leuven-BELGIUM; (3) Krakow-POLAND; (4) Novosibirsk-RUSSIA
11.00 - 12.30Red Hall
Workshop on Current Topics
SESSION II
Chairpersons: R.H. Fagard (Leuven-BELGIUM) M. Volpe (Rome-ITALY)
Prognostic value of masked hypertensionJ.M. Mallion (Grenoble-FRANCE) Early organ damage in hypertension and diabetes: the lesson from offspring studiesC. Giannattasio (Monza-ITALY) Nutrition and hypertensionA. Coca (Barcelona-SPAIN) Treating hypertension in the old elderly. What we know and what we don’t?C.J. Bulpitt (London-UK)
General Discussion
Sunday
19
254Sunday 19254 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011255
Sunday 1911.00 - 12.30Yellow Hall
Educational Session
Supported by an unrestricted educational grant by The Menarini Group
THE VASODILATOR BETA-BLOCKERS
Chairpersons: G. Mancia (Milan-ITALY) A. Zanchetti (Milan-ITALY)
Beta-blockers issue in recent guidelinesG. Mancia (Milan-ITALY) How far can cardiovascular risk be reduced? An insight in vasodilator beta-blockersA. Zanchetti (Milan-ITALY) Beta-blockers and hydrochlorothiazide: a valid combination?A.J. Manolis (Athens-GREECE)
11.40HOW TO MANAGE PATIENTS WITH ATRIAL FIBRILLATION AND HYPERTENSION IN EMERGENCY DEPARTMENT? NOVEL INSIGHT FROM THE REAL WORLDY. Mariannini, A. Conti, E. Canuti, M. Luzzi, C. Nanna, T. Focosi, B. Paladini, G. Cerini, G. Viviani, C. Poggioni, S. Squarciotta, E. De Villa, C. Casula, S. Vicidomini Florence-ITALY
11.50LEFT ATRIAL ENLARGEMENT IN ESSENTIAL HYPERTENSION: ROLE IN THE ASSESSMENT OF HYPERTENSIVE CARDIOMYOPATHYA. Milan, E. Puglisi, C. Magnino, E. Avenatti, A. Fabbri, D. Leone, A. Vairo, C. Di Stefano, V. Crudo, M. Covella, M. Chiarlo, F. Tosello, F. VeglioTurin-ITALY 12.00DEBATEBLOCKERS OF THE RAS PREVENT OR DELAY ATRIAL FIBRILLATIONPro: R.E. Schmieder (Erlangen-GERMANY)Against: A.P. Maggioni (Florence-ITALY)
Sunday
19
256Sunday 19256 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011257
Sunday 1911.50SHORT-TERM HEART RATE VARIABILITY AND FUNCTIONAL OUTCOME AFTER ACUTE ISCHEMIC STROKEB. Graff (1), A. Rojek (1), D. Gasecki (1), W. Kucharska (1), P. Boutouyrie (2), W. Nyka (1), S. Laurent (2), K. Narkiewicz (1)(1) Gdansk-POLAND; (2) Paris-FRANCE 12.00NIGHTTIME PULSE PRESSURE IS A DETERMINANT OF ARTERIAL STIFNESS AND EARLY VASCULAR AGEING IN ACUTE ISCHEMIC STROKE PATIENTSV. Kotsis, L. Gamvrili, S. Papakatsika, G. Karafi llis, S. Goulopoulou, M. SionThessaloniki-GREECE 12.10SUBACUTE BLOOD PRESSURE VARIABILITY AND HEART RATE PREDICT FUNCTIONAL OUTCOME AFTER ISCHEMIC STROKED. Gasecki (1), M. Kwarciany (1), A. Rojek (1), K. Kowalczyk (1), P. Boutouyrie (2), W. Nyka (1), S. Laurent (2), K. Narkiewicz (1)(1) Gdansk-POLAND; (2) Paris-FRANCE 12.20CHANGE IN COGNITIVE FUNCTIONS DURING ACUTE EXPOSURE TO HYPOBARIC HYPOXIA AT HIGH ALTITUDEB. Poletti, A. Lafronza, F. Solca, S. Raspelli, P. Cuzziol, F. Cadeo, L. Carelli, P. Meriggi, C. Lombardi, G. Bilo, M. Revera, G. Caldara, V. Silani, G. Mancia, G. Parati, on behalf of the HIGHCARE-ALPS investigatorsMilan-ITALY
11.00 - 12.30Orange Hall 1
Parallel Oral Session 5B
BRAIN
Chairpersons: A. Konradi (St. Petersburg-RUSSIA) M. Walters (Glasgow-UK) 11.00LECTUREMIGRAINE AND HYPERTENSIONE. Agabiti-RoseiBrescia-ITALY 11.20PULSE WAVE VELOCITY IS ASSOCIATED WITH ONE-YEAR COGNITIVE DECLINE IN THE ELDERLY OVER 80 YEARS: THE PARTAGE STUDYG. Watfa (1), S. Gautier (1), O. Hanon (2), P. Salvi (1), F. Fantin (3), O. Toulza (4), P. Manckoundia (5), D. Agnoletti (6), C. Labat (1), A. Benetos (1)(1) Nancy, (2) Paris-FRANCE; (3) Verona-ITALY; (4) Toulouse, (5) Dijon-FRANCE; (6) Bologna-ITALY 11.30ASSOCIATION BETWEEN COGNITIVE IMPAIRMENT AND MILD KIDNEY DYSFUNCTION: A WARNING SIGN?C. Alonzo, L. Brescacin, C. Zurrú, M. Schapira, F. Martín Bertuzzi, C. Poggio, L. Cámera, E. Cristiano, G. WaismanBuenos Aires-ARGENTINA 11.40NON-INVASIVE ASSESSMENT OF CEREBRAL COMPLIANCE FROM CENTRAL AORTIC PRESSURE: COMPARISON IN NORMOTENSIVE, HYPERTENSIVE AND NORMAL PRESSURE HYDROCEPHALUS SUBJECTSM.O. Kim (1), A. Avolio (1), Y. Li (2), P. K. Eide (3)(1) Sydney-AUSTRALIA; (2) Shanghai-CHINA; (3) Oslo-NORWAY
Sunday
19
258Sunday 19258 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011259
Sunday 1911.00 - 12.30Orange Hall 3
Parallel Oral Session 5C
LARGE ARTERIES
Chairpersons: M. Safar (Paris-FRANCE) S. Taddei (Pisa-ITALY) 11.00DNA REPAIR CAPACITY DETERMINES AGE-RELATED VASCULAR DYSFUNCTIONM. Durik (1), M. Kavousi (1), I. van der Pluijm (1), A. Isaacs (1), R.Y. Ridwan (1), R. Brandt (1), A. Loot (2), I. Flemming (2), C.M. Duijn (1), J.C.M. Witteman (1), J. Hoeijmakers (1), A.H.J. Danser (1), D.J. Duncker (1), A.J.M. Roks (1)(1) Rotterdam-THE NETHERLANDS; (2) Frankfurt-GERMANY 11.10DETERMINANTS OF ARTERIAL STIFFNESS IN CHILDREN AND ADOLESCENTSG. Stergiou, A. Kollias, P. Giovas, L.G. RoussiasAthens-GREECE 11.20ANTIHYPERTENSIVE DRUG TREATMENT DOES NOT ALLOW TO ACHIEVE A FULL NORMALIZATION OF THE ARTERIAL STIFFNESS AND METALLOPROTEINASES ALTERATIONS SEEN IN HYPERTENSIONF. Cesana (1), G. Castoldi (1), B. Corradi (1), M. Alloni (1), M. Galbiati (1), M. Stucchi (1), M. Corciulo (1), P. Sormani (1), C. Menni (2), V. Bagnardi (2), A. Stella (1), G. Grassi (1), C. Giannattasio (1), G. Mancia (1)(1) Monza, (2) Milan-ITALY
11.30ARTERIAL STIFFNESS IS A MAJOR INDEPENDENT DETERMINANT OF VISIT-TO-VISIT VARIABILITY IN SBP: A 9.1 YEAR FOLLOW-UP IN TREATED HYPERTENSIVESJ. Varinot, C. Collin, V. N’guyen, P. Boutouyrie, S. LaurentParis-FRANCE
11.00 - 12.30 Orange Hall 2
Topical Workshop
GENOME STUDIES IN HYPERTENSION AND RELATED CARDIOVASCULAR DISEASES
Chairpersons: A.F. Dominiczak (Glasgow-UK) M. Caulfi eld (London-UK) Novel blood pressure genesD. Levy (Framingham-USA) Exome sequencing and other new strategies for hypertensionS. Padmanabhan (Glasgow-UK) Discovery of new blood pressure genes using the CVD50 BeadChip arrayP. Munroe (London-UK)
Sunday
19
260Sunday 19260 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011261
Sunday 1911.00 - 12.30Green Hall 1
Parallel Oral Session 5D
BASIC PHARMACOLOGICAL ASPECTS
Chairpersons: R. Kreutz (Berlin-GERMANY) J. Polonia (Oporto-PORTUGAL) 11.00IS THE ENHANCED VASOCONSTRICTOR RESPONSE TO ANGIOTENSIN II IN PREECLAMPSIA MEDIATED BY AT2 RECEPTORS?K. Verdonk, J.H.M. van Esch, W. Visser, E.A.P. Steegers, A.H.J. Danser, A.H. van den MeirackerRotterdam-THE NETHERLANDS
11.10PRE AND POST JUNCTIONAL ALPHA-ADRENOCEPTOR MEDIATED RESPONSES IN THE AORTA OF NEWBORN RABBITSP. Melo, M. Moreira-Rodrigues, M. Pereira, P. Mendes, L. Graça, D. MouraPorto-PORTUGAL 11.20THE MODULATION OF AORTIC THICKENING AND STIFFNESS IN L-NAME-INDUCED HYPERTENSION: THE ROLE OF AT2 RECEPTOR STIMULATIONS. Becker (1), K. Schwengel (1), K. Lucht (1), S. Slavic (1), E. Kaschina (1),J. Leonhardt (1), J. Baulmann (2), T. Unger (1), U.M. Steckelings (1), L. Paulis (3)(1) Berlin, (2) Würzburg-GERMANY; (3) Bratislava-SLOVAK REPUBLIC 11.30HYPERTENSION AND RENAL FUNCTIONAL TOXICITY DURING VEGF-RECEPTOR INHIBITION WITH SUNITINIB: FOCUS ON ENDOTHELIN-1 AND OXIDATIVE STRESSM. Kappers (1), F. Smedts (2), J. van Esch (1), S. Sleijfer (1), F. Leijten (1), S. Wesseling (3), A. Danser (1), A. van den Meiracker (1)(1) Rotterdam, (2) Delft, (3) Utrecht-THE NETHERLANDS
11.40AMBULATORY ARTERIAL STIFFNESS INDEX: A USEFUL MARKER OF ARTERIAL STIFFNESS?J. Kips (1), S. Vermeersch (1), P. Reymond (2), P. Boutouyrie (3), N. Stergiopulos (2), S. Laurent (3), L. Van Bortel (1), P. Segers (1)(1) Ghent-BELGIUM; (2) Lausanne-SWITZERLAND; (3) Paris-FRANCE
11.50MATRIX GLA PROTEIN, A MARKER OF INSUFFICIENT INHIBITION OF CALCIFICATION, IS RELATED TO BLOOD PRESSURE AND ARTERIAL STIFFNESS: THE HOORN STUDYR. Rennenberg (1), L. Engelen (1), R. Henry (1), L. Schurgers (1), C. Vermeer (1), A. Kroon (1), J. Dekker (2), G. Nijpels (2), C. Stehouwer (1)(1) Maastricht, (2) Amsterdam-THE NETHERLANDS 12.00EFFECT OF HEMODIALYSIS ON LARGE ARTERIES IN PATIENTS WITH INTRADIALYTIC HYPERTENSIONC. Sierra (1), M. Briet (1), C. Edwards (1), P. Boutouyrie (2), M. Davidman (1), D. Bercovitch (1), G. Frisch (1), S.J. Nessim (1), M.L. Lipman (1), E.L. Schiffrin (1)(1) Montréal-CANADA; (2) Paris-FRANCE
12.10PSORIATIC ARTHRITIS IS ASSOCIATED WITH INCREASED ARTERIAL STIFFNESS IN THE ABSENCE OF KNOWN CARDIOVASCULAR RISK FACTORSL. D’Elia, L. Costa, F. Caso, R. Peluso, M. Atteno, A. Del Puente, R. Scarpa, P. StrazzulloNaples-ITALY 12.20THE ROLE OF VITAMIN D IN TOTAL AORTIC STIFFNESS, AND REGIONAL AORTIC ZONES MEASURED BY MAGNETIC RESONANCE IMAGING, IN MEN AT DIFFERING CORONARY RISKR. Rezai (1), J. Finn (1), F. Wu (1), N. Sattar (2), J.K. Cruickshank (1)(1) Manchester, (2) Glasgow-UK
Sunday
19
262Sunday 19262 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011263
Sunday 1912.45 - 14.15Auditorium
Teaching Session
SESSION 2 - HYPERTENSION RELATED PROBLEMS AND THEIR MANAGEMENT
Chairpersons: S. Erdine (Istanbul-TURKEY) A.M. Heagerty (Manchester-UK)
Erectile dysfunctionW. Kiowski (Zurich-SWITZERLAND)P.A. van Zwieten (Amsterdam-THE NETHERLANDS) Sport and hypertensionC. Giannattasio (Monza-ITALY) Statins and hypertension: to be given to all patients?H.A.J. Struijker Boudier (Maastricht-THE NETHERLANDS) Blood pressure variability: a new life?D.L. Clement (Gent-BELGIUM)
11.40INTERMITTENT TREATMENT WITH VALSARTAN CHRONICALLY ENHANCES SBP AMPLITUDE AND FAILS TO PREVENT END ORGAN DAMAGES IN SPONTANEOUSLY HYPERTENSIVE RATSC. Bouissou-Schurtz (1), H. Dabire (1), Y. Zhang (2), M. Safar (2), D. Laude (2), P. Lacolley (3), Y. Bezie (2)(1) Maison-Alfort, (2) Paris, (3) Nancy-FRANCE 11.50SELECTIVE SEROTONIN REUPTAKE INHIBITORS EXERT A NEGATIVE EFFECT ON PERIPHERAL WAVE REFLECTIONSV. Katsi, G. Souretis, K. Kontoaggelos, K. Koundi, I. Vlasseros, A.N. Koumoulidis, M. Divani, S. Christakopoulos, P. Sakkas, C. Stefanadis, G. Papadimitriou,I. KallikazarosAthens-GREECE
12.00OFFSPRING OF MOTHER RATS EXPOSED TO CIGARETTE SMOKE CONDENSATE ARE CHARACTERIZED BY ELEVATED BLOOD PRESSURE AND REDUCED SODIUM URINARY EXCRETIONM. Zarzecki (1), M. Adamczak (1), A. Wystrychowski (1), M.L. Gross (2), E. Ritz (2), A. Wiecek (1)(1) Katowice-POLAND; (2) Heidelberg-GERMANY
12.10POLYETHYLENE GLYCOL CATALASE REDUCES THE RENAL MEDULLARY EXPRESSION OF NOX4 AND AT1 RECEPTOR BUT MARKEDLY INCREASES SYSTEMIC ANGIOTENSINOGEN LEVELS IN ANGIOTENSIN II-INFUSED RATST. Sousa, S. Oliveira, J. Afonso, M. Morato, D. Patinha, S. Fraga, F. Carvalho, A. Albino-TeixeiraPorto-PORTUGAL 12.20THE RENIN INHIBITOR ALISKIREN IMPROVES VASCULAR REMODELING IN DOUBLE TRANSGENIC RATSC. Savoia, E. Arrabito, R. Parente, L. Zezza, L. Sada, L. Madaro, C. Nicoletti, M. D’agostino, L. Pucci, A. Alonzo, C. Rossi, M. VolpeRome-ITALY
Sunday
19
264Sunday 19264
12.45 - 14.15Blue Hall
Satellite Symposium
Sponsored By Servier
ANTIHYPERTENSIVE TREATMENT IN DIABETES: STATE-OF-THE-ART IN 2011
Chairpersons: G. Mancia (Milan-ITALY) L.M. Ruilope (Madrid-SPAIN)
IntroductionG. Mancia (Milan-ITALY) Current objectives for antihypertensive treatment in diabetesP.M. Nilsson (Malmö-SWEDEN) Antihypertensive treatment for diabetic patients: making a choice based on evidenceL.M. Ruilope (Madrid-SPAIN) Improving microvascular function in diabetic patients: why and howP. Camici (London-UK) Concomitant antihypertensive and antidiabetic treatment: friends or foes?S. Colagiuri (Sydney-AUSTRALIA) ConclusionL.M. Ruilope (Madrid-SPAIN)
Sunday
19
266Sunday 19266 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011267
Sunday 1914.00 - 15.30Ground FloorATTENDED POSTER SESSIONS
Chairperson: J. Segura (Madrid-SPAIN)
PS 16. EPIDEMIOLOGY ROOM 1 / POSTERS FROM 1 TO 41
PS 29. CLINICAL ASPECTS ROOMS 14-15 / POSTERS FROM 399 TO 441
Chairperson: G.S. Stergiou (Athens-GREECE)
PS 17. BLOOD PRESSURE MEASUREMENT ROOM 2 / POSTERS FROM 42 TO 80
PS 23. HEART ROOM 8 / POSTERS FROM 208 TO 241
Chairperson: R. Sanchez (Buenos Aires-ARGENTINA)
PS 18. BASIC PHARMACOLOGICAL ASPECTS ROOM 3 / POSTERS FROM 81 TO 102
PS 20. GENETICS/MOLECULAR BIOLOGY ROOM 5 / POSTERS FROM 121 TO 147
PS 25. RENIN ANGIOTENSIN SYSTEM AND VASOACTIVE SUBSTANCES
ROOM 10 / POSTERS FROM 277 TO 309
Chairperson: J. Jordan (Hannover-GERMANY)
PS 19. ATHEROSCLEROSIS ROOM 4 / POSTERS FROM 103 TO 120
PS 26. OBESITY ROOM 11 / POSTERS FROM 310 TO 348
PS 27. DIABETES ROOM 12 / POSTERS FROM 349 TO 381
LATE-BREAKER POSTER SESSION 2 ROOM 17 / POSTERS FROM 442 TO 454
Chairperson: M. de Buyzere (Gent-BELGIUM)
PS 21. ENDOTHELIUM ROOM 6 / POSTERS FROM 148 TO 171
PS 22. LARGE ARTERIES ROOM 7 / POSTERS FROM 172 TO 207
PS 24. RENAL ASPECTS ROOM 9 / POSTERS FROM 242 TO 276
PS 28. HEART FAILURE ROOM 13 / POSTERS FROM 382 TO 398
Sunday
19
268Sunday 19268 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011269
Sunday 19 1 6 / 10-YEAR POPULATION-BASED FOLLOW UP STUDY OF INFLAMMATORY, PROTHROMBOTIC MARKERS AND THE MARKERS FOR THE RISK OF ALL-CAUSE DEATHK. Ogata, T. Miyamoto, H. Adachi, Y. Hirai, M. Enomoto, A. Fukami, M. Otsuka, Y. Nanjo, K. Yoshikawa, E. Esaki, E. Kumagai, A. Kasahara, E. Tsukagawa, K. Murayama, T. ImaizumiKurume-SHI-JAPAN
1 7 / CARDIOVASCULAR RISK IN PATIENTS AT THE TIME OF ARTERIAL HYPERTENSION DIAGNOSIS IN SPAIN: RISCOR-E STUDY (FINAL RESULTS)J.L. Llisterri (1), J. Garcia-Puig (2), M.A. Orellana (2), L. Bermudez (2)(1) Valencia, (2) Madrid-SPAIN
1 8 / CARDIOVASCULAR RISK STRATIFICATION IN HYPERTENSIVE PATIENTSR.E. Peñuela Rodriguez, J. Lopez, I. Bastidas, R. Hernandez, M. Serrano, W. Zerpa, B. Roman, T. Peñuela, S. PereiraSan Cristobal-VENEZUELA
1 9 / MANAGEMENT OF HYPERTENSIVE PATIENTS IN FRANCE AS A FUNCTION OF GENDER AND CARDIOVASCULAR RISK. PARITE STUDYT. Simone (1), C. Mounier-Vehier (2), D. Guedj (1), E. Ghannad (3), A. Achouba (4), S. Quere (4), M. Guenoun (5)(1) Paris, (2) Lille, (3) Gif/Yvette, (4) Rueil-Malmaison, (5) Marseille-FRANCE
1 10 / SCREENING OF CARDIOVASCULAR RISK FACTORS ON THE SAINT-PETERSBURG STREETSO. Rotar, A. Tanicheva, L. Korostovtseva, V. Ivanenko, N. Lisovskaya, A. Kandinskii, N. Egin, A. Kazymly, N. Avdonina, E. Kolesova, A. KonradiSt. Petersburg-RUSSIA
1 11 / PREHYPERTENSION IN ASTURIAS. ANNUAL EVOLUTION OF THE PREVASTURIAS STUDYJ. Baños Martinez (1), C. Vidal Gonzalez (2), M.B. Gonzalez Lopez (3), V. Lopez Fernandez (3), A. Iglesias Garcia (4), D. Gonzalez Corral (4), J.A. Tarrazo Suarez (5), J.M. Fernandez Rodriguez-Lacin (6), S. Tranche Iparraguirre (3), A. Soler Sanchez (7), M.J. Fernandez Menendez (3), R. Abad Rodriguez (5), M. Fernandez Menendez (3), R. Marin Iranzo (3), M.A. Prieto Diaz (3), on behalf of THE PREVASTURIAS STUDY(1) Pola De Laviana, (2) Aviles, (3) Oviedo, (4) Luanco, (5) Pola De Siero, (6) Gijon, (7) Luarca-SPAIN
14.00 - 15.30Ground Floor
Poster Session 16
EPIDEMIOLOGY
ROOM 1 / POSTERS FROM 1 TO 41
Chairperson: J. Segura (Madrid-SPAIN)
1 1 / HYPERTENSION IN DEVELOPING COUNTRIESO. Rice (1), M. Ahmad (1), R. Sahibzada (2), M. Rehan (2), N. Heeney (2)(1) Gillingham, (2) London-UK
1 2 / PREVALENCE OF HYPERTENSION IN CEMENT PLANT WORKERSM. Kilic, A. DoganYozgat-TURKEY
1 3 / EPIDEMIOLOGY OF HYPERTENSION IN RUSSIAN FEDERATION. RESULTS OF FEDERAL MONITORING PROGRAM IN 2003-2010Y. Balanova, T. Timofeeva, V. Konstantinov, I. Koltunov, A. Kapustina, I. Lelchuk, G. Muromsteva, A. Deev, S. ShalnovaMoscow-RUSSIA
1 4 / PHARMACOEPIDEMIOLOGY OF ARTERIAL HYPERTENSION IN RUSSIA (PYFAGOR III STUDY)M. Leonova, Y. Belousov, A. Galitskii, L. ShteinbergMoscow-RUSSIA
1 5 / PROGNOSIS OF LEFT VENTRICULAR HYPERTROPHY AND OTHER CARDIOVASCULAR STRUCTURAL AND FUNCTIONAL PARAMETERS IN THE VERY ELDERLY: THE PROTEGER STUDYY. Zhang (1), D. Agnoletti (2), J. Peroz (2), A. Lieber (2), P. Iaria (2), A.D. Protogerou (3), M.E. Safar (2), J Blacher (2)(1) Shanghai-CHINA; (2) Paris-FRANCE; (3) Athens-GREECE
Sunday
19
270Sunday 19270 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011271
Sunday 19 1 19 / IS DIASTOLIC HEART FAILURE VERY PREVALENT IN ELDERLY HYPERTENSIVE PATIENTS?J. Borges, A. Carvalho, N. Araujo, S. Grespan, H. Demmler, M. Borges, D. Coelho, R. Souza, F. Neto, M. Bertolami, L. PiegasSao Paulo-BRAZIL
1 20 / CARDIOVASCULAR OUTCOME OF BLACK HYPERTENSIVE PATIENTS IN THE OASIS OF ALGERIAN SAHARAA. Bachir Cherif (1), F. Hamida (1), A. Taleb (1), S. Benkhedda (2), M. Safar (3), A. Benetos (4), M. Bouafi a (1), M. Temmar (5)(1) Blida, (2) Mustapha-ALGERIA; (3) Paris, (4) Nancy-FRANCE; (5) Ghardaia-ALGERIA
1 21 / HIGH PREVALENCE OF UNDIAGNOSED HYPERTENSION IN YOUNG MALE SUBJECTS: DATA FROM THE BRISIGHELLA HEART STUDYM. Rosticci, A. Cicero, A. Dormi, S. D’Addato, C. Borghi, on behalf of Brisighella Heart Study staffBologna-ITALY
1 22 / SCREENING OF LIFESTYLE RISK FACTORS IN VISITORS OF MUSEUMA. Tanicheva, O. Rotar, L. Korostovtseva, A. Erina, E. Moguchaya, A. Kazymly, N. Avdonina, A. Konradi, E. ShlyakhtoSt. Petersburg-RUSSIA
1 23 / DIFFERENCES IN THE CONTROL LEVEL OF BLOOD PRESSURE AND CARDIOVASCULAR RISK BY GENDER IN A HYPERTENSIVE POPULATION WITH METABOLIC SYNDROME SEEN AT PRIMARY CARE. OPENMET STUDYO. González, A. Galgo, C. Álvarez, P. TarilonteMadrid-SPAIN
1 24 / ANTIHYPERTENSIVE MEDICATION NONADHERENCE IN ZAGREB, CROATIA; CROSS-SECTIONAL STUDYM. Leppée, J. Culig, J. BoskovicZagreb-CROATIA
1 25 / RELATIONSHIP BETWEEN QUALITY OF LIFE AND LEVEL OF CARDIOVASCULAR RISK IN SPANISH HYPERTENSIVE PATIENTSJ. Abellán (1), A. Roca-Cusachs (2), R. Lahoz (2), J. Salazar (2)(1) San Andrés, (2) Barcelona-SPAIN
1 12 / COULD INTRATHORACIC FAT BE RELATED TO HYPERTENSION?A. Faustino, R. Providencia, L. Paiva, P. Mota, M. Costa, A. Leitão-MarquesCoimbra-PORTUGAL
1 13 / IS HIGH PREVALENCE OF ELEVATED HEART RATE IN HUNGARIAN HYPERTENSIVES A FACTOR FOR THE HIGH CARDIOVASCULAR AND CEREBROVASCULAR MORTALITY IN HUNGARY?B. Sonkodi (1), S. Sonkodi (2), E. Helis (3), G. Abraham (2), P. Legrady (2), P. Turton (3), G. Fodor (3), S. Steiner (3)(1) Budapest, (2) Szeged-HUNGARY; (3) Ottawa-CANADA
1 14 / HYPERTENSION AND INCREASED RISK OF STROKE AS RESULT OF LIFESTYLE CHANGES IN A SOUTH AFRICAN BLACK POPULATION: THE THUSA AND SABPA STUDIESN. Malan, L. Malan, A. Schutte, J. Van Rooyen, H. Huisman, R. Schutte, C. FouriePotchefstroom-SOUTH AFRICA
1 15 / RISK OF SUSTAINED HYPERTENSION IN MASKED AND WHITE-COAT HYPERTENSION: A FOLLOW-UP STUDY OF AN ELDERLY COMMUNITY-BASED COHORTC. Cacciolati, O. Hanon, A. Alperovitch, C. Dufouil, C. TzourioParis-FRANCE
1 16 / PREVALENCE OF METABOLIC SYNDROME IN BADAJOZ - SPAIN WITH THE NEW WHO RECOMMENDATIONSD. Fernández-Bergés (1), F. Félix Redondo (1), L. Lozano (2), J. Pérez-Castán (3), H. Sanz (4), A. Cabrera De León (5), A. Hidalgo (1), Y. Morcillo (1), V. Tejero (1), P. Álvarez-Palacios (1)(1) Villanueva de la Serena, (2) Mérida, (3) Don Benito, (4) Barcelona, (5) Santa Cruz de Tenerife-SPAIN
1 17 / INFLUENCE OF HORMONAL STATUS ON FORMATION OF THE ARTERIAL HYPERTENSION IN WOMEN WITH CHD IN DIFFERENT AGE GROUPSF. GasimovaBaku-AZERBAIJAN
1 18 / PREVALENCE OF HYPERTENSION IN HIGH RISK ELDERLY PATIENTS FOR PERIPHERAL ARTERIAL DISEASE. IS ABI HELPFUL IN DISCRIMINATING CARDIOVASCULAR RISK FACTORS AND CORONARY ARTERY DISEASE?J. Borges, N. Araujo, S. Grespan, N. Izukawa, A. Prakasan, H. Demmler, M. Borges, D. Coelho, R. Souza, F.S. Neto, M. Bertolami, L. PiegasSao Paulo-BRAZIL
Sunday
19
272Sunday 19272 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011273
Sunday 19 1 32 / METABOLIC CHARACTERISTICS AND HEART RATE OF NEWLY DIAGNOSED NON-TREATED HYPERTENSIVE, PREHYPERTENSIVE AND NORMOTENSIVE SUBJECTSS. Karanovic (1), D. Juric (2), J. Juras (1), V. Capkun (3), Z. Dika (1), I. Vukovic Lela (1), M. Fistrek (1), J. Kos (1), M. Laganovic (1), A. Cvitkovic (2), V. Premuzic (1), I. Pecin (1), M. Bitunjac (2), N. Leko (2), B. Jelakovic (1)(1) Zagreb, (2) Slavonski Brod, (3) Split-CROATIA
1 33 / METABOLIC SYNDROME IN THE POPULATION ATTENDED IN PRIMARY CARE SETTINGF. Valls-Roca (1), V. Pallares-Carratala (2), V. Gil-Guillen (3), D. Orozco-Beltran (3), J.L. Llisterri-Caro (4), T. Fuster (5), J. Redon (4), A. Fernandez (3), J.C. Andres (3)(1) Beniganim, (2) Burriana, (3) San Juan, (4) Valencia, (5) Gandia-SPAIN
1 34 / EVALUATING PREVALENCE OF CARDIOVASCULAR RISK FACTORS , HYPERTENSION AND EFFECTIVENESS OF THEIR CONTROL AMONG PHYSICIANS OF SEVERAL REGIONS IN RUSSIAL. Drozdova, S. Martsevich, V. VoroninaMoscow-RUSSIA
1 35 / DIFFERENCE OF AGE CHARACTERISTICS BETWEEN MONOTHERAPY AND COMBINATION THERAPYE. Arslan (1), S. Erdine (1), M. Senocak (1), A.M. Erdem (1), A. Kaya (2)(1) Istanbul, (2) Konya-TURKEY
1 36 / KNOWLEDGE AND BEHAVIOUR CONSIDERING NUTRITIONAL RECOMMENDATIONS - COMPARISON BETWEEN TREATED MIGRANT AND NATIVE HYPERTENSIVE PATIENTS FOLLOWED AT PRIMARY CARE HEALTH CENTERSA.M. Pinto, V. Alarcão, S. Guiomar, P. Nicola, E. RochaLisbon-PORTUGAL
1 37 / THE EFFECTS OF ENRICHED POTASSIUM SALT ON BLOOD PRESSURE IN CHINA RURAL POPULATIONH.Y. Zhang (1), S. Liang (2), X. Wang (1), L. Liu (1)(1) Beijing, (2) Xingtai-CHINA
1 38 / ASSESSMENT OF THERAPEUTIC BEHAVIOUR IN UNCONTROLLED HYPERTENSIVE PATIENTSF.J. Alonso Moreno (1), J.R. Banegas (2), J.J. De La Cruz (2), C. Álvarez (2), P. Tarilonte (2)(1) Toledo, (2) Madrid-SPAIN
1 26 / QUALITY OF LIFE ACCORDING TO BLOOD PRESSURE AND COMORBIDITIES IN HYPERTENSIVE SPANISH PATIENTSA. Roca-Cusachs (1), J. Abellán (2), B. Font (1), R. Lahoz (1), J. Salazar (1)(1) Barcelona, (2) San Andrés-SPAIN
1 27 / PREVALENCE OF TARGET ORGAN DAMAGE IN HYPERTENSIVE SUBJECTS ATTENDING PRIMARY CARE: C.V.P.C. STUDY (EPIDEMIOLOGICAL CARDIO-VASCULAR STUDY IN PRIMARY CARE)E. Skliros, A. Papazafi ropoulou, A. Sotiropoulos, C. Papafragos, A. Gikas, O. Apostolou, C. Xipnitos, C. Tountas Athens-GREECE
1 28 / PREVALENCE OF ARTERIAL HYPERTENSION AND OTHER CARDIOVASCULAR RISK FACTORS IN AN ETHNIC GROUP VERSUS ROMANIAN ADULT POPULATION – ARE THEY DIFFERENT?M. Dorobantu, D. Bartos, E. Badila, G. Oprea, S. Ghiorghe, R. Lungu, M. Hostiuc, A. NastacBucharest-ROMANIA
1 29 / MAIN CARDIOVASCULAR RISK FACTORS AND HYPERTENSION IN A SUBGROUP OF WOMEN POPULATION IN TALLINN DURING 10 YEARS OF FOLLOW - UPT. Shipilova, J. Abina, I. Pshenichnikov, D. Karai, J. Ripulk, J. KaikTallinn-ESTONIA
1 30 / GLUCOSE METABOLISM IN ELDERLY PATIENTS WITH ESSENTIAL HYPERTENSION AND RISK OF CARDIOVASCULAR DISEASESX. Zhang, Y. ZhangChengdu-CHINA
1 31 / EASTERN EUROPEAN HYPERTENSIVE IMMIGRANTS ARE CHARACTERIZED BY POOR HEALTH-RELATED QUALITY OF LIFE IN COMPARISON TO NATIVE HYPERTENSIVESV. Katsi, G. Souretis, N. Alexopoulos, I. Vlasseros, A.N. Koumoulidis, M. Divani, D. Barlagiannis, C.H. Stefanadis, I. KallikazarosAthens-GREECE
Sunday
19
274Sunday 19274 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011275
Sunday 1914.00 - 15.30Ground Floor
Poster Session 17
BLOOD PRESSURE MEASUREMENT
ROOM 2 / POSTERS FROM 42 TO 80
Chairperson: G.S. Stergiou (Athens-GREECE)
2 42 / AUSCULTATORY VERSUS OSCILLOMETRIC MEASUREMENT OF BLOOD PRESSURE IN OCTOGENARIANSI.A. Jacobsen, J.U. Rosholm, S. Arnspang, L. MatzenOdense-DENMARK
2 43 / THE RELATIONSHIP OF VARIABILITY OF ARTERIAL BLOOD PRESSURE, PULSE PRESSURE AND EARLY MORNING PRESSURE FROM AMBULATORY ARTERIAL BLOOD PRESSURE MONITORING WITH TISSUE DOPPLER ECHOCARDIOGRAPHIC PARAMETERS IN PATIENTS UNDER ANTIHYPERTENSIVE THERAPYD. Bastac (1), Z. Joksimovic (2), on behalf of SERBIAN SOCIETY OF HYPERTENSION(1) Zajecar-SERBIA; (2) Bor-JUGOSLAVIJA
2 44 / THE NOCTURNAL BLOOD PRESSURE FALL IS ASSOCIATED WITH SIGNIFICANT PROGRESS OF PRIMARY OPEN ANGLE GLAUCOMA IN HYPERTENSIVE PATIENTSB. Krasinska, M. Karolczak-Kulesza, Z. Krasinski, K. Pawlaczyk-Gabriel, A. Niklas, J. Gluszek, A. TykarskiPoznan-POLAND
2 45 / IS THE DIFFERENCE BETWEEN CLINIC AND HOME BLOOD PRESSURE A BETTER ESTIMATE OF THE TRUE WHITE-COAT EFFECT THAN THE DIFFERENCE BETWEEN CLINIC AND 24-HOUR BLOOD PRESSURE?F. Saladini, E. Benetti, P. Bratti, E. Bonso, D. Palomba, P. PalatiniPadua-ITALY
2 46 / ASSOCIATION OF HOME BLOOD PRESSURE WITH LEFT VENTRICULAR MASS INDEX: A META-ANALYSISG.S. Stergiou, I.A. Bliziotis, A. DestounisAthens-GREECE
1 39 / ANTIHYPERTENSIVE THERAPY IN SCREENING OF RUSSIAN MENTALLY WORKING SUBJECTSO. Rotar, V. Ivanenko, L. Korostovtseva, I. Fursova, K. Kitalaeva, A. Konradi, E. ShlyakhtoSt. Petersburg-RUSSIA
1 40 / HYPERTENSIVE URGENCY AND EMERGENCY - A PROSPECTIVE STUDYC. Carmo, A. Joosten, C. Maltez, M. Fernandes, J. Rodrigues Lavradio-PORTUGAL
1 41 / AUGMENTED SALT INTAKE MAY EXPLAIN THE EXCESSIVE CARDIOVASCULAR BURDEN OF HYPERTENSIVE IMMIGRANTSV. Katsi, G. Souretis, C. Vlachopoulos, D. Tousoulis, C. Stefanadis, I. KallikazarosAthens-GREECE
Sunday
19
276Sunday 19276 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011277
Sunday 19 2 54 / SHORT TERM REPRODUCIBILITY OF AUTOMATED OSCILLOMETRIC ANKLE BRACHIAL INDEX MEASUREMENTA. Kollias, A. Xilomenos, A. Protogerou, E. Dimakakos, G.S. StergiouAthens-GREECE
2 55 / ASSESSMENT OF PATIENTS’ AWARENESS OF HIGH BLOOD PRESSURE IN LITHUANIAN UNIVERSITY OF HEALTH SCIENCES HOSPITALG. Sakalyte, R. Slapikas, R.M. Babarskiene, R. Karaliute, E. RumbinaiteKaunas-LITHUANIA
2 56 / BLOOD PRESSURE MEASUREMENT METHOD AND INTER-ARM DIFFERENCES, A META-ANALYSISW. Verberk (1), F. Kessels (2), T. Thien (3)(1) Taipei-TAIWAN; (2) Maastricht, (3) Nijmegen-THE NETHERLANDS
2 57 / HIGHER PHYSICAL ACTIVITY IS ASSOCIATED WITH LOWER NIGHTTIME SYSTOLIC BLOOD VARIABILITY: A CROSS SECTIONAL STUDYG. Wuerzner, M. Bochud, M. Pruijm, C. Zweiacker, S. Tremblay, M. BurnierLausanne-SWITZERLAND
2 58 / DYNAMICS OF THE CIRCADIAN BLOOD PRESSURE PROFILE IN PATIENTS WITH ARTERIAL HYPERTENSION RECEIVING RILMENIDINE MONOTHERAPYE. Velizhanina, A. RudakovTyumen-RUSSIA
2 59 / THE INFLUENCE OF CHRONOTHERAPY ON CIRCADIAN BLOOD PRESSURE RHYTHM IN HYPERTENSIVE PATIENTSE. Fedorova, V. Gorbunov, E. Platonova, A. Deev, V. BelolipetskayaMoscow-RUSSIA
2 60 / OFFICE AND AMBULATORY BLOOD PRESSURE MEASUREMENTS: CONCEPTIONS AND MISCONCEPTIONS OF BELGIAN PHYSICIANS (SHARE-BELGIUM)A. Persu, P. Van der Niepen, on behalf of the Supporting Hypertension Awareness and Research Europe-wide (SHARE) Steering CommitteeBrussels-BELGIUM
2 61 / REPRODUCIBILITY OF NON-DIPPING STATUS IN ACUTE ISCHEMIC STROKE PATIENTSV. Kotsis, L. Gamvrili, S. Papakatsika, G. Karafi llis, S. Goulopoulou, M. SionThessaloniki-GREECE
2 47 / SEVEN-DAY AMBULATORY BLOOD PRESSURE MONITORING AND NIGHT-TO-DAY BLOOD PRESSURE RATIOJ. Dusek (1), J. Siegelova (1), A. Havelkova (1), B. Fiser (1), M. Pohanka (1), J. Pochmonova (1), G. Cornelissen (2), F. Halberg (2)(1) Brno-CZECH REPUBLIC; (2) Minneapolis-USA
2 48 / PROGNOSTIC VALUE OF CLINIC AND AMBULATORY BLOOD PRESSURE MEASUREMENTS IN RESISTANT HYPERTENSIOND.E. Ayala (1), R.C. Hermida (1), A. Mojon (1), L. Chayan (2), M.J. Dominguez (2), M.J. Fontao (1), I. Alonso (1), J.R. Fernandez (1)(1) Vigo, (2) Santiago de Compostela-SPAIN
2 49 / INTER-ARM DIFFERENCE IN AUTOMATED OFFICE BLOOD PRESSURE MEASUREMENTSE. Andreadis, A. Tsakanikas, E. Angelopoulos, G. Agaliotis, G. MousoulisAthens-GREECE
2 50 / ACCURACY OF A 14.5 X 32 CM CUFF FOR SELF BLOOD PRESSURE MEASUREMENT IN OBESE SUBJECTS OVER A WIDE RANGE OF ARM CIRCUMFERENCESS. Masiero (1), C. Fania (1), F. Saladini (1), G. Frick (2), P. Palatini (1)(1) Padua-ITALY; (2) Widnau-SWITZERLAND
2 51 / PRACTICAL SOLUTION FOR ACCURATE AUTOMATIC ASSESSMENT OF MORNING BP SURGE, NIGHT BP DIP AND OTHER ABPM INDICES AFFECTED BY INDIVIDUAL VARIABILITY OF DAYTIME/NIGHTTIME PATTERNS. Pekarskiy, V. Mordovin, M. Kolodina, G. SemkeTomsk-RUSSIA
2 52 / IN TYPE 2 DIABETIC PATIENTS HIGH 24-H AMBULATORY PULSE PRESSURE AND LOW 24H DIASTOLIC PRESSURE VALUES PREDICT CARDIOVASCULAR EVENTS WITHIN A J SHAPE PATTERNT. Teixeira (1), J.N. Figueiredo (1), M. Bastos (1), J. Nobre dos Santos (1),J. Polonia (2)(1) Aveiro, (2) Oporto-PORTUGAL
2 53 / AUTOMATED OSCILLOMETRIC ANKLE BRACHIAL INDEX ASSESSMENT: HOW MANY MEASUREMENTS ARE REQUIRED?A. Kollias, A. Xilomenos, A. Protogerou, E. Dimakakos, G.S. StergiouAthens-GREECE
Sunday
19
278Sunday 19278 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011279
Sunday 19 2 70 / BLOOD PRESSURE AND GLOBAL RISK ASSESSMENTJ. Eckner (1), C.A. Larsson (2), E. Bog-Hansen (1), L. Rastam (2), U. Lindblad (1)(1) Gothenburg, (2) Malmö-SWEDEN
2 71 / THE EFFECT OF THE ANTIHYPERTENSIVE TREATMENT ON THE DIFFERENCE BETWEEN CLINICAL AND AMBULATORY BLOOD PRESSURE LEVELS IN PATIENTS WITH STABLE ARTERIAL HYPERTENSIONG. Andreeva, L. Zhigareva, A. Deev, V. GorbunovMoscow-RUSSIA
2 72 / BP VARIABILITY, CARDIOVASCULAR RISK FACTORS AND ANTIHYPERTENSIVE MEDICATIONSJ. Al-Said (1), K. Mzayen (1), A. Koubba Manama-BAHRAIN
2 73 / PROGNOSTIC SIGNIFICANCE OF MASKED AND WHITE-COAT HYPERTENSION IN THE GENERAL POPULATION: THE FINN-HOME STUDYM.R. Hänninen, T. Niiranen, P. Puukka, J. Johansson, A. JulaTurku-FINLAND
2 74 / THE NORMALIZATION QUOTIENT AVOIDS THE INTERFERENCE FROM SYMPATHIC IN AMBULATORY BLOOD PRESSURE MONITORINGG. MalgieriSant’Agata Dei Goti-ITALY
2 75 / PREDICTORS OF ISOLATED CLINIC AND MASKED HYPERTENSION BASED ON HOME OR AMBULATORY BLOOD PRESSURE: THE MEDIT-HABP (MEDITERRANEAN HOME VS. AMBULATORY BP) STUDYG. Parati (1), S. Omboni (2), G.S. Stergiou (3), E.G. Nasothimiou (3), A. De La Sierra (4), L.M. Ruilope (5)(1) Milan, (2) Varese-ITALY; (3) Athens-GREECE; (4) Terrassa, (5) Madrid-SPAIN
2 76 / RELEVANCE OF BLOOD PRESSURE VARIABILITY AMONG THE ELDERLY: FINDINGS FROM THE MARACAIBO AGING STUDYL. Mena (1), J.D. Melgarejo (2), C. Chavez (2), S. Pineda (2), G. Calmon (2), E.R. Silva (2), G.E. Maestre (2)(1) Mazatlan-MEXICO; (2) Maracaibo-VENEZUELA
2 77 / GENDER DIFFERENCES IN BLOOD PRESSURE TRENDS IN LEVEL 1 MEDICAL STUDENTSS. Kultygina, C.H. Lyashenko, Y. Venevtseva, A. MelnikovTula-RUSSIA
2 62 / COMPARISON OF BLOOD PRESSURE CHANGES IN THE STANDING POSITION AFTER SUPINE- VERSUS SEATED- REST IN ESSENTIAL HYPERTENSIVESM. Rescaldani, C. Sala, F. Magrini Milan-ITALY
2 63 / FACTORS ASSOCIATED WITH HOME BLOOD PRESSURE MEASUREMENTS. Pereira, C. Paulo, M.J. LimaPorto-PORTUGAL
2 64 / DIFFERENCES IN DAY TIME PULSE PRESSURE VARIABILITY BETWEEN THE BRACHIAL ARTERY AND THE AORTA IN HEALTHY SUBJECTSA. Protogerou (1), T. Papaioannou (1), P. Sfi kakis (1), J. Blacher (2), E. Karatzis (1),J. Lekakis (1), D. Papadogiannis (1), C. Stefanadis (1), M. Safar (2)(1) Athens-GREECE; (2) Paris-FRANCE
2 65 / GENDER DIFFERENCES AND TIME RATE OF BLOOD PRESSURE VARIATIONE. Koroboki, E. Manios, G. Barlas, F. Michas, E. Alexaki, A. Panoutsopoulos, V. Chouzouri, K. Vemmos, N. Zakopoulos Athens-GREECE
2 66 / BLOOD PRESSURE MONITORING AND LVM IN CENTENARIANSD. Solari (1), S. Carugo (1), A. Esposito (1), A. Pernigotti (1), C. Redaelli (1),M. Maisaidi (1), F. Magrini (1), G. Mancia (2)(1) Milan, (2) Monza-ITALY
2 67 / A METHOD TO IMPROVE EFFICACY OF ABPM IN EVALUATION OF HYPERTENSIONS. Pekarskiy, V. Mordovin, G. Semke, T. RippTomsk-RUSSIA
2 68 / ESTIMATION OF CENTRAL SYSTOLIC BLOOD PRESSURE FROM ARM CUFF PRESSUREA. Guilcher, S. Brett, B. Clapp, P. ChowienczykLondon-UK
2 69 / THE IMPORTANCE OF 24-HOUR AMBULATORY BLOOD PRESSURE MONITORING IN TAKAYASU ARTERITISO. Sivakova, N. Chikhladze, A. Rogoza, I. ChazovaMoscow-RUSSIA
Sunday
19
280Sunday 19280 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011281
Sunday 1914.00 - 15.30Ground Floor
Poster Session 18
BASIC PHARMACOLOGICAL ASPECTS
ROOM 3 / POSTERS FROM 81 TO 102
Chairperson: R. Sanchez (Buenos Aires-ARGENTINA)
3 81 / COMPARISON OF ABDOMINAL AORTA MECHANICS AND STRUCTURE IN LONG-TERM CHEMICAL-SYMPATHECTOMIZED VS. SINOAORTIC-DENERVATED RATSC. Bouissou-Schurtz (1), M. Safar (1), P. Lacolley (2), G. Gabella (3), P. Challande (1), V. Molinie (1), Y. Bezie (1)(1) Paris, (2) Nancy-FRANCE; (3) London-UK
3 82 / CATALASE INHIBITION INTO THE FOURTH CEREBRAL VENTRICLE AFFECTS BEZOLD-JARISCH REFLEX IN SPONTANEOUSLY HYPERTENSIVE RATSL.C. De Abreu (1), C. Ferreira (2), P.H.N. Saldiva (2), V.E. Valenti (2)(1) Santo André, (2) São Paulo-BRAZIL
3 83 / MODULATION OF NADPH OXIDASE ACTIVITYA. Schulz, V. Jankowski, W. Zidek, J. JankowskiBerlin-GERMANY
3 84 / ANTIHYPERTENSIVE EFFECT OF THE MOSS RHODOBRYUM ONTARIENSE IN VIVOB. Pejin (1), S. Newmaster (2), M. Sabovljevic (1), Z. Miloradovic (1), J. Grujic-Milanovic (1), M. Ivanov (1), N. Mihailovic-Stanojevic (1), D.J. Jovovic (1), V. Tesevic (1), V. Vajs (1)(1) Belgrade-SERBIA; (2) Guelph-CANADA
3 85 / IMPLICATION OF MYOCARDIAL NOS AND CONNEXIN-43 IN THE MECHANISMS OF OMEGA-3 FATTY ACIDS-RELATED CARDIOPROTECTION OF RATS SUFFERING FROM HYPERTENSIONJ. Radosinska, B. Bacova, I. Bernatova, V. Knezl, T. Benova, N. TribulovaBratislava-SLOVAK REPUBLIC
2 78 / RELATIONSHIP BETWEEN KIDNEY DAMAGE AND BLOOD PRESSURE MEASUREMENTS IN THE COMMUNITY PHARMACY, AT HOME AND IN THE PHYSICIAN’S OFFICE. THE PALMERA STUDYJ. Sendra-Lillo (1), D. Sabater-Hernández (2), A. Sendra-Ortolá (1), F. Martínez-Martínez (2)(1) Palmera, (2) Granada-SPAIN
2 79 / CIRCADIAN PATTERNS AND REST/ACTIVITY INDEX: THE CORRELATION WITH VASCULAR RISK IN THE AMBULATORY MONITORING BLOOD PRESSURES. Suarez Ortega, J. Artiles Vizcaíno, B. Alonso Ortiz, A. Gil Diaz, P. Jimenez Santana, J.C. Rodriguez Perez, P. Betancor LeonSanta Brigida-SPAIN
2 80 / MASKED HYPERTENSION PREDICTION IN TREATED HYPERTENSIVE PATIENTSM. Smirnova, A. Deev, V. Gorbunov, G. AndreevaMoscow-RUSSIA
Sunday
19
282Sunday 19282 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011283
Sunday 19 3 93 / ACTIVITY OF VASORELAXATION AND VASOCONSTRICTION MECHANISMS IN RATS WITH EARLY AND ESTABLISHED STRESS-INDUCED HYPERTENSIONO. Semyachkina-Glushkovskaya, V. Berdnikova, Ya. Kuznecova, I. Semyachkin-Glushkovskij, S. Syndeev, O. Bibikova, A. Sjestnova, A. VinogradovSaratov-RUSSIA
3 94 / IMPACT OF HIGH FRUCTOSE CONSUMPTION ON VASCULAR REACTIVITY AND CARDIAC FUNCTION IN HIGH SODIUM FED RATSC. Oudot (1), S. Tanguy (2), G. Du Cailar (1), B. Jover (1), C. Rugale (1)(1) Montpellier, (2) Avignon-FRANCE
3 95 / PHOSPHODIESTERASE 5 ACTIVATION ATTENUATES VASODILATORY RESPONSE IN RENOVASCULAR HYPERTENSIONJ. Stegbauer (1), E. Mergia (2), S.A. Potthoff (1), I. Quack (1), S. Friedrich (1), D. Koesling (2), L.C. Rump (1)(1) Düsseldorf, (2) Bochum-GERMANY
3 96 / CILIARY NEUROTROPHIC FACTOR PLAYS AN IMPORTANT ROLE IN AGE-DEPENDENT VASCULAR FUNCTIONS.A. Potthoff, Y. Mori, J. Stegbauer, H. Hoch, E. Königshausen, M. Woznowski, O. Vonend, L. Sellin, L.C. Rump, I. QuackDuesseldorf-GERMANY
3 97 / THE PHARMACOKINETICS AND MYOCARDIAL LEVELS OF COENZYME Q10 AFTER INTRAMUSCULAR INJECTION OF ITS SOLUBILIZED FORME. Kalenikova, E. Gorodetskaya, E. Charitonova, O. MedvedevMoscow-RUSSIA
3 98 / GW9662, A PPARγ-ANTAGONIST, INHIBITS TELMISARTAN- MEDIATED GENE MODULATION, AND ACTIVATED PPARαF. Younis, Y. Oron, N. Stern, R. Limor, T. RosenthalTel Aviv-ISRAEL
3 99 / MONONUCLEAR AND BINUCLEAR DINITROSYL-IRON COMPLEXES AS POTENT HYPOTENSIVE AND CARDIOPROTECTIVE SUBSTANCES IN MAMMALIAN ORGANISMA.A. Timoshin, D.Yu. Drobotova, V.L. Lakomkin, O.V. Tskitishvili, L.I. Serebryakova, A.F. VaninMoscow-RUSSIA
3 86 / BENEFICIAL EFFECTS OF RED PALM OIL DEMONSTRATED IN SPONTANEOUSLY HYPERTENSIVE RATSB. Bacova (1), C. Viczencz (1), J. Radosinska (1), V. Knezl (1), I. Bernatova (1), R. Sotnikova (1), J. Navarova (1), J. Van Royen (2), N. Tribulova (1)(1) Bratislava-SLOVAK REPUBLIC; (2) Bellwille-SOUTH AFRICA
3 87 / CARDIOPROTECTIVE EFFECTS OF P38MAPK INHIBITOR ON ADIPONECTIN AND ROS IN DAHL SALT-SENSITIVE HYPERTENSIVE RATSH. Takeshima, N. Kobayashi, W. Koguchi, M. Ishikawa, F. Sugiyama, T. IshimitsuTochigi-JAPAN
3 88 / DIFFERENTIAL RESPONSE TO ENDOTHELIN-1 IN NORMAL AND UREMIC RATS TREATED WITH ERYTHROPOIETINB. Falardeau, S. Bélanger, R. Larivière, M. LebelQuebec-CANADA
3 89 / EARLY ARTERY REMODELING IN RATS WITH FETAL ZINC RESTRICTIONC. Arranz, R. Sanchez, L. Veiras, S. Massara, M. Cernielo, A. Costa, A. TomatBuenos Aires-ARGENTINA
3 90 / THE GENDER PARTICULARITIES IN ACTIVITY OF THE NO-ERGIC SYSTEM IN NORMOTENSIVE AND HYPERTENSIVE RATS UNDER NORMAL AND STRESS CONDITIONSY. Kuznetsova, O. Semyachkina-Glushkovskaya, T. Anishchenko, I. Semyachkin-Glushkovsky, O. Bibikova, S. Sindeev, A. Sjestnova Saratov-RUSSIA
3 91 / GLUTATHIONE PEROXIDASE, GLUTATHIONE REDUCTASE, SUPEROXIDE DISMUTASE, AND CATALASE ACTIVITY IN THE KIDNEY OF SPONTANEOUSLY HYPERTENSIVE RATS: EFFECT OF WILD THYMEN. Mihailovic-Stanojevic, B. Bugarski, D. Komes, Z. Miloradovic, J. Grujic Milanovic, M. Ivanov, D. Bugarski, D.J. JovovicBelgrade-SERBIA
3 92 / REDUCTION OF SUPEROXIDE RADICALS (O2-) REVERTS THE EARLY HYPERTENSIVE RESPONSE TO ACUTE RENAL DENERVATION IN RATS ON HIGH SODIUM DIETA. Walkowska, E. Kompanowska - Jezierska, K.H Olszynski, J. Sadowski Warsaw-POLAND
Sunday
19
284Sunday 19284 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011285
Sunday 1914.00 - 15.30Ground Floor
Poster Session 19
ATHEROSCLEROSIS
ROOM 4 / POSTERS FROM 103 TO 120
Chairperson: J. Jordan (Hannover-GERMANY)
4 103 / FETUIN-A AND INTIMA-MEDIA THICKNESS IN ESSENTIAL HYPERTENSIVESF. Incalcaterra, C. Geraci, R. Arsena, F. Tornese, R. Riccobene, F. Vaccaro, C. Altieri, G. Cerasola, S. CottonePalermo-ITALY
4 104 / KNOWN HISTORY OF HYPERTENSION AND MYOCARDIAL INFARCTION AS ONSET MANIFESTATION OF CORONARY ARTERY DISEASEA. Ioannidis, D. TsounisPatra-GREECE
4 105 / HYPERTENSION AND HEALTH RELATED QUALITY OF LIFE ONE YEAR AFTER MYOCARDIAL INFARCTIONA. Ioannidis, D. TsounisPatra-GREECE
4 106 / USEFULNESS OF OXIDIZED-LDL-CHOLESTEROL EVALUATIONS TO ESTIMATE CARDIOVASCULAR ORGAN DAMAGE IN THE EARLY STAGE OF HYPERTENSION AND METABOLIC SYNDROMEE. Geshi, S. Irie, T. Katagiri, S. GotoYokohama-JAPAN
4 107 / FASTING INSULIN AS A PREDICTOR OF INTIMA-MEDIA THICKNESS OF CAROTID ARTERY IN ESSENTIAL HYPERTENSIVE PATIENTSL. Mishchenko, O. Yarynkina, S. Savytskyi, L. MkhitarianKyiv-UKRAINE
3 100 / OLIVE LEAF EXTRACT MODULATES OXIDATIVE STATUS IN SPONTANEOUSLY HYPERTENSIVE RATD. Dekanski, Z. Miloradovic, N. Mihailovic-Stanojevic, J. Grujic-Milanovic, M. Ivanov, D. Jovovic Belgrade-SERBIA
3 101 / EFFECTS OF CLONIDINE AND MOXONIDINE ON NEUROTRANSMITTER RELEASE IN GUINEA PIG ILEUM: INVOLVEMENT OF α2-ADRENOCEPTORS OR IMIDAZOLINE I1-RECEPTORSL. Kozaeva, N. Korobov, O. Medvedev Moscow-RUSSIA
3 102 / POSTJUNCTIONAL β-ADRENOCEPTOR-MEDIATED RESPONSES IN THE AORTA OF NEWBORN AND YOUNG ADULT RABBITSM. Moreira-Rodrigues, L. Graça, P. Mendes, M. Pereira, P. Serrão, D. MouraPorto-PORTUGAL
Sunday
19
286Sunday 19286 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011287
Sunday 19 4 115 / ASSOCIATION OF CAROTID ATHEROSCLEROSIS WITH POLYMORPHISM OF MATRIX METALLOPROTEINASE AND ENDOTHELIAL NITRIC OXIDE SYNTHASE GENESA. Ryabikov (1), E. Mazdorova (1), S. Malyutina (1), V. Maximov (1), M. Voevoda (1), T. Kuznetsova (2), J.A. Staessen (3), Y. Nikitin (1)(1) Novosibirsk-RUSSIA; (2) Leuven-BELGIUM; (3) Maastricht-THE NETHERLANDS
4 116 / EFFECT OF HYDROXYCHLOROQUINE TREATMENT ON ATHEROSCLEROSIS IN APOE DEFICIENT MICEK. Makaritsis, M. Ioannou, K. Kapatou, E. Kouvaras, E. Begas, G. Koukoulis, G. DalekosLarissa-GREECE
4 117 / ALISKIREN IN LONG-TERM BRACHIAL AND CENTRAL BLOOD PRESSURE REDUCTION IN PATIENTS UNDERGOING CAROTID ENDOARTERECTOMY: PRELIMINARY DATA FROM THE ASPIV STUDYF. Guerra, A. Giovagnoli, A. Buglioni, V. Pierini, V. Cesari, M. D’Anzeo, A. Pocognoli, P. Dessì-Fulgheri, R. SarzaniAncona-ITALY
4 118 / THE ANKLE-BRACHIAL INDEX AS A PREDICTOR OF CORONARY ARTERY DISEASES. Kostic, D. Mijalkovic, I. TasicNiska Banja-SERBIA
4 119 / THE ATHEROGENIC INDEX OF PLASMA CAN EASILY IDENTIFY AN INCREASED TREND FOR ATHEROSCLEROSIS IN HYPERTENSIVE PATIENTSS. Dragan, C. Serban, R. Christodorescu, M. Badalica, D. Velimirovici, M. RadaTimisoara-ROMANIA
4 120 / CORRELATION BETWEEN INTIMA-MEDIA THICKNESS AND ESTIMATED CARDIOVASCULAR RISK IN THE GROUP OF HYPERTENSIVE PATIENTSL. Woznicka-Leskiewicz, A. Posadzy-MalaczynskaPoznan-POLAND
4 108 / HIGHER RISK OF SUBCLINICAL ATHEROSCLEROSIS IN PATIENTS WITH PSORIASIS: A CALL TO ACTION?P. Forcada, C. Kotliar, C. Busso, C. Lagodin, S. Obregon, S. Gonzalez, C. Castelaro, J. Chiabaut, F. Inserra, L. Eimer, L. SuarBuenos Aires-ARGENTINA
4 109 / CORRELATION OF C-PEPTIDE WITH THE CAROTID ATHEROMATOSIS OF TREATED HYPERTENSIVE PATIENTSM.V. Papavasileiou, I. Vasiliadis, I. Tsiantis, G. Lambropoulou, G. Papadimitriou, S. Charizopoulos, S. KarasAthens-GREECE
4 110 / A COMPARATIVE STUDY OF COMMON CAROTID INTIMA-MEDIA THICKNESS AS A DIRECT SIGN OF ATHEROSCLEROTIC SUBCLINICAL DISEASE IN RUSSIAN AND GERMAN POPULATIONSI. Sobenin (1), R. Erbel (2)(1) Moscow-RUSSIA; (2) Essen-GERMANY
4 111 / VITAMIN D DEFICIENCY IS ASSOCIATED WITH VASCULAR DAMAGE INDEPENDENTLY OF BLOOD PRESSUREC. Castellaro, M. Princz, F. Inserra, D. Olano, P. Forcada, S. Gonzalez, S. Obregon, J. Chiabaut Svane, E. Cavanagh, C. KotliarPilar-ARGENTINA
4 112 / GAMMA-GLUTAMYLTRANSFERASE AND ADIPONECTIN AS DETERMINANTS OF PRESENCE AND ACOUSTIC PROPERTIES OF EARLY CAROTID PLAQUES IN NORMAL SUBJECTSM. Kozakova, C. Palombo, C. Morizzo, M. Paterni, E. FerranniniPisa-ITALY
4 113 / THE INFLUENCE OF CHRONIC HEMODIALYSIS ON CAROTID INTIMA-MEDIA THICKNESS PROGRESSIONV. Kovacic, D. Ljutic, M. Sain, J. Radic, I. JelicicSplit-CROATIA
4 114 / NO RELATIONSHIP BETWEEN GAMMA-GLUTAMYLTRANSFERASE LEVELS AND INTIMA-MEDIA THICKNESS IN HIGH RISK REFERRALSM. Nuti, C. Grigoratos, P. Spontoni, G. Dell’Omo, A. Balbarini, R. PedrinelliPisa-ITALY
Sunday
19
288Sunday 19288 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011289
Sunday 19 5 125 / ASSOCIATION STUDY OF THE β2-ADRENERGIC RECEPTOR GENE POLYMORPHISMS AND HYPERTENSION IN THE NORTHERN HAN CHINESES. Wen (1), Y. Lou (1), J. Liu (1), Y. Li (2), Y. Liu (1), Z. Wang (1), K. Liu (1), H. Wu (2), Q. Niu (1), W. Gu (1), Y. Guo (1), Z. Li (1)(1) Beijing, (2) Shanghai-CHINA
5 126 / A-ADDUCIN GLY460TRP POLYMORPHISM AND ESSENTIAL HYPERTENSION RISK IN CHINESE: A META-ANALYSISS. Wen (1), K. Liu (1), Y. Liu (1), J. Liu (1), Z. Wang (1), Y. Lou (1), Y. Huang (2), Q. Niu (1), W. Gu (1), X. Zhu (1)(1) Beijing, (2) Shanghai-CHINA
5 127 / BLOOD PRESSURE AND URINARY SODIUM EXCRETION IN RELATION TO 16 GENETIC POLYMORPHISMS IN THE NATRIURETIC PEPTIDE SYSTEM IN CHINESEB. HuShanghai-CHINA
5 128 / THE INTERACTION BETWEEN ENOS AND CAVEOLIN-1 GENE POLYMORPHISMS IN ESRD PATIENTS: A PROOF OF CONCEPT STUDYA. Testa, M.C. Sanguedolce, B. Spoto, F. Mallamaci, L. Malatino, G. Tripepi, C. ZoccaliReggio Calabria-ITALY
5 129 / THE CC VARIANT OF LOCUS 9P21 INCREASES CORONARY DISEASE RISK WITH HIGH VALUES OF HS-CRPR. Palma dos Reis (1), B. Silva (2), H. Café (2), M. Serrão (2), A.C. Sousa (2), A. Pereira (2), G. Guerra (2), A.I. Freitas (2), S. Freitas (2), C. Freitas (2), I. Ornelas (2), A. Brehm (2), J.J. Araújo (2), I. Mendonça (2)(1) Lisbon, (2) Funchal-PORTUGAL
5 130 / IDENTIFICATION OF THE INTEGRIN ITGA11 AS A NEW CANDIDATE GENE FOR ALBUMINURIAA. Schulz (1), A. Sietmann (2), J. Hänsch (1), M. Stoll (2), R. Kreutz (1)(1) Berlin, (2) Münster-GERMANY
5 131 / SINGLE NUCLEOTIDE POLYMORPHISM INFLUENCE ON ARTERIAL STIFFNESS IN HYPERTENSIONF. Cesana (1), S. Nava (1), L. Boffi (1), C. Menni (2), M. Betelli (1), A. Cereda (1), M. Stucchi (1), F. Soriano (1), M. Rigoldi (1), F. Bertola (1), G. Grassi (1), C. Giannattasio (1), G. Mancia (1)(1) Monza, (2) Milan-ITALY
14.00 - 15.30Ground Floor
Poster Session 20
GENETICS/MOLECULAR BIOLOGY
ROOM 5 / POSTERS FROM 121 TO 147
Chairperson: R. Sanchez (Buenos Aires-ARGENTINA)
5 121 / DAILY BLOOD PRESSURE PROFILES IN HYPERTENSIVE PATIENTS DEPENDING ON FIVE GENES POLYMORPHISM UNDER THE INFLUENCE OF PHARMACOGENETICALLY DETERMINED TREATMENTJ. Ursuliak (1), L. Sydorchuk (1), K. Amosova (2), R. Sydorchuk (1), A. Sydorchuk (1), I. Sydorchuk (1)(1) Chernivtsi, (2) Kyiv-UKRAINE
5 122 / HAPTOGLOBIN POLYMORPHISM IN WOMEN WITH PREECLAMPSIA IN ISRAELF. Nakhoul (1), R. Samour (2), R. Miller-Lotan (2), N. Nakhoul (2), R. Gonen (2), G. Ohel (2)(1) Galilee, (2) Haifa-ISRAEL
5 123 / THE 936C/T POLYMORPHISM IN THE VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) GENE ASSOCIATED WITH FREE PLASMA VEGF LEVELS AS A RISK FACTOR FOR PREECLAMPSIA IN ROMANIAN WOMEN. CORRELATION WITH THE DEGREE OF SEVERITY OF PREECLAMPSIAL.M. Procopciuc, G.M. Hazi, G. Caracostea, G. Nemeti, G. Dragatoiu, I. Olteanu, F. StamatianCluj-Napoca-ROMANIA
5 124 / PLASMA LIPIDS DISPLAY INCREASED MEAN ALIPHATIC CHAIN LENGTH IN HUMAN HYPERTENSIVE HEART DISEASEM. Berry, F. Desmoulin, F. Smih, A. Turkieh, B. Chamontin, L. Perez, P. Rouet, M. GalinierToulouse-FRANCE
Sunday
19
290Sunday 19290 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011291
Sunday 19 5 139 / HERITABILITY OF STEROID SYNTHESIS IN THE SWISS KIDNEY PROJECT ON GENES IN HYPERTENSIOND. Ackermann (1), G. Ehret (2), I. Guessous (2), B. Ponte (3), M. Prujim (2), B. Dick (1), M. Burnier (2), F. Frey (1), P.Y. Martin (3), F. Paccaud (2), M. Bochud (2)(1) Bern, (2) Lausanne, (3) Geneva-SWITZERLAND
5 140 / INCREASED MIGRATION OF MONOCYTES IN ESSENTIAL HYPERTENSION IS ASSOCIATED WITH INCREASED TRANSIENT RECEPTOR POTENTIAL CHANNEL CANONICAL TYPE 3 CHANNELSZ. Zhao, Z. Yan, Z. Luo, D. Liu, Z. ZhuChongqing-CHINA
5 141 / EFFECT OF HYDROGEN SULFIDE ON MECHANISMS COUPLING EXCITATION OF SMOOTH MUSCLE CELLS GUINEA PIG URETERI. Kovalev (1), S. Gusakova (1), M. Baskakov (1), A. Popov (1), O. Melnik (1), T. Vtorushina (1), D. Nosov (1), A. Zheludeva (1), L. Smagliy (1), M. Medvedev (1), S. Orlov (2)(1) Tomsk-RUSSIA; (2) Montreal-CANADA
5 142 / MECHANISMS OF ACTION OF HYDROGEN SULFIDE ON CONTRACTILE ACTIVITY VASCULAR SMOOTH MUSCLEM. Baskakov (1), S. Gusakova (1), A. Zheludeva (1), L. Smagly (1), I. Kovalev (1), M. Medvedev (1), S. Orlov (2)(1) Tomsk-RUSSIA; (2) Montreal-CANADA
5 142 / HYDROGEN SULFIDE INFLUENCE ON VASCULAR SMOOTH MUSCLE CELLS CONTRACTILE PROPERTIESL. Smagly, A. Zheludeva, S. Gusakova, M. BaskakovTomsk-RUSSIA
5 143 / INFLUENCE OF MAGNETITE NANOPARTICLES CAUSE OF PE-INDUCED CONTRACTILITY OF SMOOTH MUSCLES OF A PULMONARY ARTERY OF GUINEA PIGA. Nosarev, T. Zaytceva, A. Savelieva, L. Kapilevich, O. Nosareva Tomsk-RUSSIA
5 144 / LYS 109 ARG AND GLU 223 ARG POLYMORPHISMS IN THE LEPTIN RECEPTOR GENE AND LEPTIN RECEPTOR NUMBER IN HEALTHY PREHYPERTENSIVESA. Kotrotsou, D.P. Papadopoulos, I. Mourouzis, A.A. Dellaportas, M. Bonios, I. Vlahodimitris, P. Kribas, C. EkonomouAthens-GREECE
5 132 / EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY AND BLOOD PRESSURE REDUCTION CORRELATE WITH POLYMORPHISMS OF FIVE GENESL. Sydorchuk (1), K. Amosova (2), A. Sydorchuk (1), R. Sydorchuk (1), J. Ursuliak (1), I. Sydorchuk (1)(1) Chernivtsi, (2) Kyiv-UKRAINE
5 133 / HETEROPLASMIC MTDNA DEFECTS ASSOCIATED WITH HUMAN HYPERTENSIONA. Postnov, I. Sobenina, M. Sazonovaa, A. OrekhovMoscow-RUSSIA
5 134 / ALTERED EXPRESSION PROFILE AND THE ASSOCIATION OF CYTOKINE GENES WITH ESSENTIAL HYPERTENSIONY. Timasheva (1), T. Nasibullin (2), I. Tuktarova (2), A. Zakirova (2), O. Mustafi na (2)(1) Tartu-ESTONIA; (2) Ufa-RUSSIA
5 135 / RELATIONSHIP BETWEEN VKORC1-1639G/A, CYP2C9*2 AND *3 POLYMORPHISMS AND WARFARIN DOSAGE IN CHINESEY. Shen, X. Wang, X. Liu, L. LiuBeijing-CHINA
5 136 / FUNCTIONAL SNPS OF KLOTHO GENE ARE RELATED WITH SERUM CHOLESTEROL LEVEL AMONG KOREAN MIDDLE-AGED SUBJECTSM.H. Cha, M.M. Ko, J.H. Lim, B.K. Kang, M.S. LeeDaejeon-SOUTH KOREA
5 137 / THE PREVALENCE AND RELATIONSHIP TO HYPERTENSION OF THE R563Q MUTATION OF β-CHAIN OF THE EPITHELIAL SODIUM CHANNEL IN SOUTHERN AFRICAB. Rayner, E. Jones, E. OwenCape Town-SOUTH AFRICA
5 138 / THE IMPACT OF THE ALA379VAL POLYMORPHISM OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN INFLAMMATORY AND THROMBOTIC PROCESSES IN HYPERTENSIVE PATIENTSD. Kardara, D. Tousoulis, C. Antoniades, N. Koumallos, P. Xaplanteris, N. Papageorgiou, C. Vasiliadou, C. StefanadisAthens-GREECE
Sunday
19
292Sunday 19292 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011293
Sunday 1914.00 - 15.30Ground Floor
Poster Session 21
ENDOTHELIUM
ROOM 6 / POSTERS FROM 148 TO 171
Chairperson: M. de Buyzere (Gent-BELGIUM)
6 148 / THE ROLE OF INFLAMMATION AND ENDOTHELIAL CELL ACTIVATION IN HYPERTENSIVE CHILDREN WITH ENDOTHELIAL DYSFUNCTIONM. Andor, O. Margineanu, M. Tomescu, D. Lighezan, R. Christodorescu, A. ThanarajTimisoara-ROMANIA
6 149 / REDUCED NITRIC OXIDE AVAILABILITY IN SMALL ARTERIES FROM PATIENTS WITH PHEOCHROMOCYTOMA. ROLE OF COX-2-DERIVED CONTRACTING PROSTANOIDSA. Virdis, E. Duranti, A. Bacca, D. Carrara, V. Tantardini, S. Taddei, G. BerniniPisa-ITALY
6 150 / EFFECTS OF EXERCISE AEROBIC TRAINING ON ENDOTHELIAL REACTIVITY AND DNA METHYLATION IN HYPERTENSIVE PATIENTSM. Vicenzi, V. Bollati, V. Rossi, F. Barretta, A. Mercurio, M. Guazzi, P. BertazziMilan-ITALY
6 151 / EFFECT OF FELODIPINE ON CIRCADIAN BLOOD PRESSURE RHYTHM AND ENDOTHELIAL DYSFUNCTION IN HYPERTENSIVE PATIENTSV.F. Mordovin, A.Yu. FalkovskayaTomsk-RUSSIA
6 152 / EFFECTS OF EXERCISE TRAINING ON ENDOTHELIAL FUNCTION IN OLDER HYPERTENSIVE PATIENTSS. Ilic, M. Deljanin Ilic, G. Kocic, R. PavlovicNis-SERBIA
5 145 / MICE LACKING ATP2B1 GENE, THE NEW HYPERTENSION CANDIDATE GENE, IN VASCULAR SMOOTH MUSCLE SHOWS BLOOD PRESSURE ELEVATIONY. Kobayashi (1), N. Hirawa (1), M. Fujita (1), N. Miyazaki (1), A. Fujiwara (1), Y. Yamamoto (1), S. Yoshida (1), S. Saka (1), H. Wakui (1), K. Yatsu (1), Y. Toya (1), G. Yasuda (1), H. Ueshima (2), T. Miki (3), S. Umemura (1)(1) Yokohama, (2) Otsu, (3) Toon-JAPAN
5 146 / BLOCKADE OF ALPHA1 ADRENERGIC RECEPTOR AMELIORATES INDOXYL SULFATE-INDUCED MONOCYTE CHEMOATTRACTANT PROTEIN-1 EXPRESSION IN HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS BY INHIBITING NADPH OXIDASE-NF-κB PATHWAYT. Morita, J. Tatebe, N. Masai, G. Yoshino, J. YamasakiTokyo-JAPAN
5 147 / UPREGULATION OF GENE EXPRESSION OF BRADYKININ RECEPTORS TYPE 1 AND 2 IN PERIPHERAL MONOCYTES IN PATIENTS WITH ESSENTIAL HYPERTENSIONM. Marketou (1), J. Kontaraki (1), E. Zacharis (1), G. Kochiadakis (1), I. Gavras (2), H. Gavras (2), P. Vardas (1)(1) Heraklion-GREECE; (2) Boston-USA
Sunday
19
294Sunday 19294 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011295
Sunday 19 6 160 / CHRONIC OUABAIN TREATMENT IMPAIRS ENDOTHELIAL FUNCTION IN MESENTERIC RESISTANCE ARTERIES FROM SPONTANEOUSLY HYPERTENSIVE RATSH.T. Oliveira (1), A.P. Davel (2), F.E. Xavier (3), L.V. Rossoni (1)(1) Sao Paulo, (2) Campinas, (3) Recife-BRAZIL
6 161 / ENDOTHELIAL DYSFUNCTION IN HEART TRANSPLANTATIONF. Margulis, D. Radlovachki, A. Ini, L. AhualliBuenos Aires-ARGENTINA
6 162 / CIRCULATING ENDOTHELIAL PROGENITOR CELLS IN HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHYE. Karelkina, O. Moiseeva, V. Moroshkin, O. Irtuga, E. ShlyakhtoSt. Petersburg-RUSSIA
6 163 / CYSTATIN C, ENDOTHELIAL DYSFUNCTION AND CAROTID INTIMA MEDIA THICKNESSR. Arsena, F. Tornese, C. Geraci, G. Giammarresi, M. Guarneri, M. Mogavero, A. Ocello, G. Cersaola, S. Cottone Palermo-ITALY
6 164 / THE NOVEL VASODILATION INDEX OF “FRACTION OF DILATION DEFICIT” AND NITRIC OXIDE METABOLITESS. Malyutina, M. Ryabikov, Yu. Ragino, A. RyabikovNovosibirsk-RUSSIA
6 165 / ACUTE ORAL SALT LOADING IN UNTREATED HYPERTENSIVES: EFFECTS ON ENDOTHELIAL FUNCTION AND ARTERIAL BLOOD PRESSUREM. Vicenzi (1), A. Dallacìa (1), A. Caretti (1), V. Rossi (1), P. Bianciardi (1), M. Samaja (1), T. Gnecchi Ruscone (2), M. Guazzi (1)(1) Milan, (2) Merate-ITALY
6 166 / ENDOTHELIAL DYSFUNCTION POSSIBLY RELATED TO LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN HYPERTENSIVE PATIENTS WITH OR WITHOUT TYPE 2 DIABETES MELLITUSA. Vintila, C. Grigore, A. Ionicioiu, M. Muraru, I. BrucknerBucharest-ROMANIA
6 153 / DOSE-DEPENDENT EFFICACY OF THERAPY WITH NONSELECTIVE ENDOTHELIN RECEPTOR ANTAGONIST BOSENTAN IN PATIENTS WITH IDIOPATHIC PULMONARY HYPERTENSIONO. Arkhipova, E. Kobal, N. Danilov, T. Martynyuk, L. Samoilenko, I. ChazovaMoscow-RUSSIA
6 154 / PDE5 INHIBITION IMPROVES DIASTOLIC FUNCTION IN RESISTANT HYPERTENSIVE PATIENTS BY BLOOD PRESSURE INDEPENDENT MECHANISM AND ENDOTHELIAL FUNCTIONH. Moreno (1), R.C. Santos (1), V.N. Figueiredo (1), T. Quinaglia (1), A.P. Faria (1), C.T. Demacq (1), J.E. Tanus-Santos (2), J.R. Mattos (1), O.R. Coelho (1), L.C. Martins (1)(1) Campinas, (2) Ribeirão Preto-BRAZIL
6 155 / DIETARY CALCIUM INTAKE AND ITS RELATIONSHIP WITH INTRACELLULAR CALCIUM, ADIPOSITY, METABOLIC PROFILE, BLOOD PRESSURE AND ENDOTHELIAL FUNCTIONT. Ferreira, M. Torres, D. Valença, M. Rodrigues, S. Nascimento, J. Nogueira Neto, S. Argolo, C. Lima, M. Guedes, A. Sanjuliani Rio de Janeiro-BRAZIL
6 156 / ENDOTHELIAL DYSFUNCTION AND VASCULAR REACTIVITY IN HYPERTENSIONK. Keramida, E. Karpanou, G. VyssoulisAthens-GREECE
6 157 / CORRELATION OF ERECTILE FUNCTION WITH ENDOTHELIAL FUNCTIONM.V. Papavasileiou (1), M. Doumas (2), A. Pittaras (1), P. Arsenos (1), I. Tsiantis (1), C. Giannakopoulos (1), S. Karas (1)(1) Athens, (2) Thessaloniki-GREECE
6 158 / MECHANISMS OF MICROVASCULAR PERMEABILITY MEDIATED BY NITRIC OXIDEF. Sánchez (1), N. Marin (1), D. Hirigoyen (2), R. Carrasco (1), P. Zamorano (1), M. Boric (2), W. Duran (3)(1) Valdivia, (2) Santiago-CHILE; (3) Newark-USA
6 159 / ENDOTHELIAL FUNCTION OF HYPERTENSIVE PATIENTSM.V. Papavasileiou, A. Anastasopoulou, D. Mitas, I. Tsiantis, I. Vasiliadis, G. Lambropoulou, S. KarasAthens-GREECE
Sunday
19
296Sunday 19296 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011297
Sunday 1914.00 - 15.30Ground Floor
Poster Session 22
LARGE ARTERIES
ROOM 7 / POSTERS FROM 172 TO 207
Chairperson: M. de Buyzere (Gent-BELGIUM)
7 172 / THE PROGNOSTIC VALUE OF THE AUGMENTATION INDEX IN HYPERTENSIVE PATIENTS WITH RHEUMATOID ARTHRITISE. Belu, R. Musetescu, A.E. Musetescu, D.D. IonescuCraiova-ROMANIA
7 173 / EFFECTS OF ACETAZOLAMIDE ON BLOOD PRESSURE AND PULSE WAVEFORM CHANGES INDUCED BY HIGH ALTITUDE EXPOSUREM. Revera (1), P. Salvi (2), A. Giuliano (1), A. Faini (1), G. Bilo (1), F. Gregorini (1), C. Lombardi (1), S. Salerno (1), E. Lisi (1), C. Ramos (1), G. Mancia (1), G. Parati (1), on behalf of HIGHCARE-ALPS Investigators(1) Milan, (2) Bologna-ITALY
7 174 / INCREASED CAROTID IMT IN EARLY HYPERTENSION REPRESENTS AN ADAPTIVE MECHANISM TO INCREASED PULSATILE LOADC. Palombo (1), M. Kozakova (2), C. Morizzo (1), G. Bini (1), A. Corciu (1), A.M. Sironi (1), G. Dell’Omo (1), R. Pedrinelli (1)(1) Pisa, (2) Genoa-ITALY
7 175 / ENDOTHELIAL FUNCTION IS ASSOCIATED WITH PULSE PRESSURE AMPLIFICATIONU. Neisius, P. Higgins, J. Dawson, M. Walters, A. Dominiczak, C. DellesGlasgow-UK
7 176 / LEFT VENTRICULAR HYPERTROPHY AND ABDOMINAL AORTA SIZE IN ESSENTIAL HYPERTENSIONC. Cuspidi (1), S. Meani (2), F. Negri (1), C. Sala (1), G. Mancia (1)(1) Milan, (2) Rho-ITALY
6 167 / ENDOTHELIAL FUNCTION EVALUATED BY MEANS OF CHANGES IN CAROTID-RADIAL PULSE WAVE VELOCITY ASSOCIATED WITH REACTIVE HYPERAEMIA: DEPENDENCE ON THE BASAL VELOCITY LEVELS AND ON THE TRANSIENT ISCHEMIA LENGTHJ. Torrado (1), I. Farro (1), Y. Zócalo (1), F. Farro (1), M. Valero (2), D. Bia (1), R. Armentano (1)(1) Montevideo-URUGUAY; (2) Buenos Aires-ARGENTINA
6 168 / THE ENDOTHELIAL FUNCTION AND INTIMA-MEDIA THICKNESS IN PATIENTS WITH HYPERTENSION UNDER THE INFLUENCE OF FIXED COMBINATION OF AMLODIPINE AND ATORVASTATINK. YanovskaKyiv-UKRAINE
6 169 / ROLE OF ESTROGEN AND ENDOTHELIN-1 IN GENDER DIFFERENCES IN EXPERIMENTAL HYPOXICN. Medvedeva, M. Ilatovskaya, M. Artemieva, Yu. Kovaleva, O. MedvedevMoscow-RUSSIA
6 170 / VALIDATION OF A NEW AND NON INVASIVE METHOD TO ASSESS NO-MEDIATED VASODILATATION IN HUMANS: IONTOPHORESIS OF L-NAME ASSOCIATEDC. Dreyfuss, A. Wauters, A. Khaldi, D. Adamopoulos, S. Pochet, G. Berkenboom, P. Van De Borne, J.F. ArgachaBrussels-BELGIUM
6 171 / OBESITY IS ASSOCIATED WITH IMPAIRED ENDOTHELIAL FUNCTION IN THE POSTPRANDIAL STATEA. Jonk (1), A. Houben (1), N. Schaper (1), P. De Leeuw (1), E. Serné (2), Y. Smulders (2), C. Stehouwer (1)(1) Maastricht, (2) Amsterdam-THE NETHERLANDS
Sunday
19
298Sunday 19298 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011299
Sunday 19 7 184 / INCREASED ARTERIAL STIFFNESS ESTIMATED BY PULSE PRESSURE LEADS TO IMPAIRED MAXIMUM AEROBIC EXERCISE IN NEWLY DIAGNOSED HYPERTENSIVE PATIENTSH. Triantafyllidi, K. Kontsas, P. Trivilou, I. Ikonomidis, S. Tzortzis, C. Kotakos, J. Lekakis, D. Kremastinos, M. Anastasiou-NanaAthens-GREECE
7 185 / CAROTID INTIMA-MEDIA THICKNESS, ABDOMINAL AORTA, INTESTINAL DYSBIOSIS AND POLYMORPHISM OF ACE (I/D), AGTR1 (A1166C) GENES IN ARTERIAL HYPERTENSIONL. Sydorchuk, O. Kushnir, J. Ursuliak, A. Sydorchuk, A. Sokolenko, R. Sydorchuk, I. SydorchukChernivtsi-UKRAINE
7 186 / PATIENTS WITH INFLAMMATORY BOWEL DISEASES HAVE INCREASED ARTERIAL STIFFNESSL. Zanoli (1), M. Cannavo’ (2), S. Rastelli (2), L. Di Pino (2), I. Monte (2), G. Inserra (2), P. Castellino (2)(1) Paris-FRANCE; (2) Catania-ITALY
7 187 / AORTIC STIFFNESS IS A DETERMINANT OF CAROTID INTIMA MEDIA THICKNESS IN PATIENTS AT INTERMEDIATE CARDIOVASCULAR RISKR. Ferré, N. Plana, J. Merino, C. Buixadera, M. Heras, L. MasanaReus-SPAIN
7 188 / IMPAIRED BARORECEPTOR SENSITIVITY IS ASSOCIATED WITH INCREASED AUGMENTATION INDEXF. Michas (1), E. Manios (1), K. Stamatelopoulos (1), E. Koroboki (1),V. Chouzouri (1), A. Dimitriou (1), R. Panerai (2), N. Zakopoulos (1)(1) Athens-GREECE; (2) Leicester-UK
7 189 / EFFECTIVENESS OF EUROPEAN RECOMMENDATIONS IN SECONDARY PREVENTION AMONG CORONARY PATIENTS TO IMPROVE ARTERIAL RIGIDITYT. Denolle (1), A. Richard (1), S. Nicolas (1), A.M. Dib (1), I. Cimarosti (2),F. Revault D’Allonnes (1)(1) Dinard, (2) Rennes-FRANCE
7 190 / DIFFERENT EFFECT OF ALISKIREN AND RAMIPRIL ON ARTERIAL STIFFNESS AND WAVE REFLECTION IN PREVIOUSLY UNTREATED ESSENTIAL HYPERTENSION PATIENTSL. Ghiadoni, R.M. Bruno, G. Cartoni, F. Stea, A. Magagna, A. Virdis, S. TaddeiPisa-ITALY
7 177 / THE INFLUENCE OF ANTIHYPERTENSIVE TREATMENT ON ARTERIAL STIFFNESS AND ARTERIAL WALL SHEAR STRESSM. Rajzer, W. Wojciechowska, M. Klocek, K. Kawecka-JaszczKrakow-POLAND
7 178 / PULSE WAVE SEPARATION ANALYSIS – RELATIONSHIP TO HYPERTENSIVE END-ORGAN DAMAGET. Weber (1), S. Wassertheurer (2), M. Rammer (1), B. Hametner (2), J. Kropf (2), C. Mayer (2), B. Eber (1)(1) Wels, (2) Vienna-AUSTRIA
7 179 / COMPARATIVE STUDY OF ARTERIAL PROPERTIES AFTER AN ISCHEMIC ATHEROTHROMBOTIC STROKE OR AN ACUTE CORONARY SYNDROMEG. Barone-Rochette, G. Vanzetto, O. Detante, M. Hommel, J.M. Mallion, J.P. BaguetGrenoble-FRANCE
7 180 / THE INFLUENCE OF ANTIHYPERTENSIVE TREATMENT ON ARTERIAL STIFFNESS AND SELECTED MATRIX METALOPROTEINASES PLASMA ACTIVITYM. Rajzer, W. Wojciechowska, D. Fedak, M. Klocek, K. Kawecka-JaszczKrakow-POLAND
7 181 / PULSE WAVE VELOCITY AND BIOLOGIC CARDIOVASCULAR RISK FACTORSM.A. Gomez-Marcos, J.I. Recio-Rodriguez, E. Rodriguez-Sanchez, M.C. Patino-Alonso, C. Agudo-Conde, C. Castaño-Sanchez, C. Rodriguez-Martin, P. Delgado-Benito, J. Prieto-Mateos, L. Garcia-OrtizSalamanca-SPAIN
7 182 / LONG-TERM REDUCTION IN AORTIC STIFFNESS IN ROUTINE CLINICAL PRACTICEI. Orlova, I. Patrusheva, I. Barinova, Z. Blankova, F. AgeevMoscow-RUSSIA
7 183 / ARTERIAL STIFFNESS AND CENTRAL PULSE WAVE ANALYSIS IN HYPERTENSIVE PATIENTS WITH SYSTOLIC HEART FAILURER. Akhmetov, I. Goncharov, Y. Kotovskaya, S. Villevalde, L. Alexandria, A. Safarova, V. MoiseevMoscow-RUSSIA
Sunday
19
300Sunday 19300 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011301
Sunday 19 7 198 / PERIPHERAL ARTERIAL DISEASE IN HYPERTENSIVE PATIENTS IN THE VALENCIAN COMMUNITYV. Pallares-Carratala (1), V. Gil-Guillen (2), D. Orozco-Beltran (2), C. De La Sen (3), F. Valls-Roca (4), J. Redon (5), J.L. Martinez (2), J. Navarro-Perez (5), C. Fluixá (5), C. Carratala (2), A. Fernandez (2), J.C. Andres (2)(1) Burriana, (2) San Juan, (3) Alicante, (4) Beniganim, (5) Valencia-SPAIN
7 199 / PULSE WAVE REFLECTION BUT NOT ENDOTHELIAL FUNCTION IS POSITIVELY INFLUENCED BY AT1-RECEPTOR-ANTAGONISM IN PATIENTS WITH STAGE I AND II ARTERIAL HYPERTENSIONA. Mitchell (1), U. Rushentsova (1), S. Klebs (2), H. Bruck (1), A. Kribben (1), Th. Philipp (1), J. Nürnberger (1)(1) Essen, (2) Nürnberg-GERMANY
7 200 / CHRONIC PERINDOPRIL TREATMENT DECREASES AORTIC STIFFNESS AND CALCIFICATION IN AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE RATSK. Ng, C. Hildreth, J. Phillips, A. AvolioSydney-AUSTRALIA
7 201 / INCREASED TISSUE TRANGLUTAMINASE ACTIVITY IN THE RAT AORTA FOLLOWING SINGLE EXPOSURE WHOLE BODY GAMMA-IRRADIATIONY.-Y. Liu (1), L. Santhanam (2), D. Berkowitz (2), A. Avolio (1)(1) Sydney-AUSTRALIA; (2) Baltimore-USA
7 202 / INCREASED CENTRAL BLOOD PRESSURE IN BLACK YOUNG ADULTS IS ASSOCIATED WITH ELEVATED PERIPHERAL VASCULAR RESISTANCE BUT REDUCED LARGE ARTERY STIFFNESSC. McEniery (1), Y. Yasmin (1), A. Garrett (2), N. Baber (2), J. Cockcroft (3), I. Wilkinson (1)(1) Cambridge, (2) Hatfield, (3) Cardiff-UK
7 203 / SURGERY FOR ABDOMINAL AORTIC HYPOPLASIA: LONG-TERM RESULTS OF SINGLE-CENTER EXPERIENCEJ.N. Albertini, A. Duprey, G. Nourissat, J.P. Favre, X. BarralSaint-Etienne-FRANCE
7 204 / ARTERIAL STIFFNESS IN SUBTYPES OF ACUTE ISCHEMIC STROKEL. Gamvrili, S. Papakatsika, G. Karafi llis, S. Goulopoulou, V. KotsisThessaloniki-GREECE
7 191 / INFLAMMATORY MARKERS AND RELATIONSHIP WITH ARTERIAL STIFFNESS IN UNTREATED PATIENTS WITH ESSENTIAL HYPERTENSIONE. Gkaliagkousi, S. Douma, M. Doumas, K. Vogiatzis, P. Anyfanti, E. Gavriilaki, A Triantafyllou, K. Petidis, C. ZamboulisThessaloniki-GREECE
7 192 / ARTERIAL STIFFNESS IN WOMEN WITH MODERATE RISK OF CARDIOVASCULAR DISEASE AND POSTMENOPAUSAL OSTEOPOROSISI. Barinova, E. Seredenina, F. AgeevMoscow-RUSSIA
7 193 / STENT IMPLANTATION IN THE AORTIC ISTHMIC REGION IN AN ANIMAL MODELL. Semplicini, H. Poser, I. Iacopetti, N. Maschietto, E. Valerio, G. Ceolotto, T. Pilla, G.M. De Benedictis, G. Gerardi, F. Stella, D. Bernardini, L. Aresu, O. Milanesi, A. Semplicini Padua-ITALY
7 194 / THORACIC AORTIC DILATATION IN PATIENTS WITH OR WITHOUT ARTERIAL HYPERTENSIONO. Irtyuga, A. Redko, V. Uspensky, O. MoiseevaSt. Petersburg-RUSSIA
7 195 / THE IMPORTANCE OF AORTIC PULSE WAVE VELOCITY FOR CARDIOVASCULAR RISK STRATIFICATIONJ. Strizova (1), J. Filipovsky (1), J. Seidlerova (1), M. Dolejsova (1), O. Mayer, Jr. (1), R. Cifková (2)(1) Pilsen, (2) Prague-CZECH REPUBLIC
7 196 / AGE-RELATED PROGRESSION OF CENTRAL BLOOD PRESSURE COMPONENTS AND THE IMPACT OF NITROVASODILATION: A PROSPECTIVE STUDY IN FEMALE TWINSM. Cecelja, B. Jiang, T. Spector, P. ChowienczykLondon-UK
7 197 / DIFFERENTIAL EFFECTS OF VASODILATORS ON HUMAN FOREARM MUSCULAR CONDUIT ARTERIES AND RESISTANCE VESSELSH. Fok, B. Jiang, A. Donald, P. ChowienczykLondon-UK
Sunday
19
302Sunday 19302 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011303
Sunday 1914.00 - 15.30Ground Floor
Poster Session 23
HEART
ROOM 8 / POSTERS FROM 208 TO 241
Chairperson: G.S. Stergiou (Athens-GREECE)
8 208 / IMPACT OF AGE ON ELECTROCARDIOGRAPHIC CHANGES IN HYPERTENSIVE PATIENTS OVER 65 YEARSV. Pallares-Carratala (1), J. Castillo (2), P. Morillas-Blasco (2), L. Facila-Rubio (2), V. Bertomeu-Maritnez (2), J. Redon (3)(1) Burriana, (2) Alicante, (3) Valencia-SPAIN
8 209 / INDEXING CARDIAC PARAMETERS IN ECHOGRAPHIC PRACTICE: DO ESTIMATES DEPEND ON HOW WEIGHT AND HEIGHT HAVE BEEN ASSESSED? A STUDY ON LEFT ATRIAL DILATATIONC. Cuspidi, F. Negri, M.L. Muiesan, A.M. Grandi, L. Lonati, A. Ganau, D. Degli Esposti, A. Milan, C. Sala, R. Facchetti, G. Mancia on behalf of Working Group on Heart and Hypertension of the Italian Society of HypertensionMilan-ITALY
8 210 / PREVALENCE AND CHARACTERISTICS OF ELECTROCARDIOGRAPHIC ALTERATIONS IN SUBJECTS WITH MASKED HYPERTENSIONM. Camafort, J. Sobrino, M. Domenech, E. Vinyoles, J.I. Cornago, C. Fernandez, F. Pazos, C. Gonzalez, J.R. Gomez-Martino, F. Cabades, J. Bronsoms, B. Climent, F.L. Martinez, R. Molero, A. Coca, on behalf of the ESTHEN Study GroupSPAIN
8 211 / SOME PREDICTORS OF ASYMMETRIC LEFT VENTRICULAR HYPERTROPHY FORMING IN ESSENTIAL HYPERTENSIONA. Barsukov, E. Pronina, S. Shoustov, M. ResvantzevSt. Petersburg-RUSSIA
8 212 / PREVALENCE OF DIASTOLIC DYSFUNCTION AND RISK FACTORS IN ELDERLY MALES FROM A RURAL COMMUNITYW. Tsai, H. Hsiao, J. Chen, P. Liu, L. Tsai, C. WuTainan-TAIWAN
7 205 / ARTERIAL STIFFNESS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IS CORRELATED WITH IMT AND IS DEPENDENT OF TRIGLYCERIDESS. Parra, R. Ferré, J. Ribalta, G. Vives, F. Marimon, A. CastroReus-SPAIN
7 206 / SEX-SPECIFIC DIFFERENCES IN ARTERIAL STIFFNESS ASSOCIATIONS IN CHILDREN GOING TO ELEMENTARY SCHOOLH. Triantafyllidi, P. Trivilou, C. Varounis, K. Kontsas, B. Souridis, S. Tzortzis, C. Arvaniti, G. Gasparinatos, A. Karagkiouli, J. Lekakis, D. Kremastinos, M. Anastasiou-NanaAthens-GREECE
7 207 / BEHAVIOUR OF CENTRAL PRESSURE AND PULSE PRESSURE IN PRE AND POST MENOPAUSE WOMEN WITH HYPERTENSIONR. Cabrera Sole (1), S. Garcia Ruiz (1), E. Luepke (2), C. Turpin Lucas (1), R. Fernandez (1), M. Aguilera Saldaña (1)(1) Albacete, (2) Madrid-SPAIN
Sunday
19
304Sunday 19304 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011305
Sunday 19 8 221 / BLOOD FLOW VELOCITIES IN THE DISTAL SEGMENT OF THE LEFT ANTERIOR DESCENDING CORONARY ARTERY IN ARTERIAL HYPERTENSION PATIENTS WITH LEFT VENTRICULAR HYPERTROPHYE. Pavlyukova, R. KarpovTomsk-RUSSIA
8 222 / EXTERNAL COUNTERPULSATION IN ARTERIAL HYPERTENSION COMBINED WITH ST ELEVATION MYOCARDIAL INFARCTIONA. Vasilyev, V. Ryabov, V. Markov, R. KarpovTomsk-RUSSIA
8 223 / CHANGES OF APPROPRIATENESS OF LEFT VENTRICULAR MASS DURING ANTIHYPERTENSIVE TREATMENTS. Villevalde, A. Safarova, M. Vorobyeva, Z. KobalavaMoscow-RUSSIA
8 224 / THE CORRELATION WITH THE RESPOSIVENESS OF THE PULSE WAVE VELOCITY RELATIVE TO ACUTE BLOOD PRESSURE REDUCTION AND LEFT VENTRICULAR DIASTOLIC FUNCTIONJ.K. Park (1), J.H. Shin (1), S.H. Kim (2), Y.H. Lim (1), J.H. Shin (1), J.U. Lee (2), K.S. Kim (1), S.K. Kim (2), J.H. Kim (1), H.K. Lim (1)(1) Seoul, (2) Guri-SOUTH KOREA
8 225 / PREDICTORS OF 90 DAY MORTALITY IN PATIENTS WITH HYPERTENSION WHO PRESENT WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTIONM. Liew, J. Chow, V.H. Tan, P.P. Goh, S.H. Ong, H.W. Gan, C.H. Tan, K.L. Tong, G. LeongSingapore-SINGAPORE
8 226 / EVALUATION CONTRACTILE RESERVE FREE WALL OF THE LEFT VENTRICLE USING POSTURAL TEST IN SELECTION OF PATIENTS FOR CARDIAC RESYNCHRONIZATION THERAPYM. Zlobina, E. KaygorodovaTomsk-RUSSIA
8 227 / RELATIONSHIP BETWEEN THE REPOLARIZATION DISPERSION AND LEFT VENTRICULAR MUSCLE MASS IN ELITE ATHLETES AND IN SEDENTARY HEALTHY MENZ. Major, Z. Kneffel, Z. Komka, A. Udvardy, M. Tóth, G. PavlikBudapest-HUNGARY
8 213 / RELATIONS OF LEFT VENTRICULAR STRUCTURE TO ENDOTHELIAL DYSFUNCTION IN HYPERTENSIVE SUBJECTSV. Aursulesei, A. Cozma, M.D. DatcuIasi-ROMANIA
8 214 / LEFT CARDIAC GEOMETRY AND FUNCTION IN ISOLATED SYSTOLIC HYPERTENSION: INFLUENCE OF GENDERM. Picca, F. AgozzinoMilan-ITALY
8 215 / COMPARISON OF THE EFFECTS OF MANIDIPINE AND AMLODIPINE IN HYPERTENSIVE PATIENTS WITH CONCENTRIC LEFT VENTRICULAR HYPERTROPHYM. Picca, F. AgozzinoMilan-ITALY
8 216 / SHOULD WE AVOID BLOCKING THE RENIN-ANGIOTENSIN SYSTEM IN PATIENTS WITH AORTIC STENOSIS? A SYSTEMATIC REVIEWB. Flam, T. KahanStockholm-SWEDEN
8 217 / EFFECT OF COMBINATION THERAPY WITH BONE-MARROW MONONUCLEAR CELLS IMPLANTATION AND EICOSAPENTAENOIC ACID ON CARDIAC PERFORMANCE IN MYOCARDIAL ISCHEMIAW. Koguchi, N. Kobayashi, H. Takeshima, M. Ishikawa, F. Sugiyama, T. IshimitsuTochigi-JAPAN
8 218 / CARDIOVASCULAR RISK IN SUBJECTS WITH LEFT VENTRICULAR CONCENTRIC REMODELING AT BASELINE EXAMINATION: A META-ANALYSISS. Pierdomenico, M. Di Nicola, A. Pierdomenico, D. Lapenna, F. CuccurulloChieti-ITALY
8 219 / THE QT INTERVAL AND T WAVE VARIABLES IN AGING HYPERTENSIVE PATIENTSI. Mozos, R. Patrascu, C. Serban, A. Pacurari, L. SusanTimisoara-ROMANIA
8 220 / THE ANTIHYPERTENSIVE TREATMENT-MEDIATED IMPROVEMENT OF LEFT VENTRICULAR DIASTOLIC FUNCTION IS REFLECTED IN EXERCISE ELECTROCARDIOGRAM AS REDUCED PREVALENCE OF HUMP SIGN AND OF FALSE POSITIVE RESULTSC. Liakos, A. Michaelides, G. Vyssoulis, E. Chatzistamatiou, A. Synetos, A. Tsokanis, I. Giatrakos, A. Bratsas, M. Markou, C. StefanadisAthens-GREECE
Sunday
19
306Sunday 19306 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011307
Sunday 19 8 235 / CORRELATIONS BETWEEN P-HIRES AND ECHOCARDIOGRAPHIC PARAMETERS OF FILLING PRESSURE IN HYPERTENSIVE PATIENTS WITH ACUTE MYOCARDIAL INFARCTIOND. Toader, E. Belu, R. Radu, M. Popescu, R. Musetescu, D.D. IonescuCraiova-ROMANIA
8 236 / ECHOCARDIOGRAPHIC PARAMETERS OF INCREASED FILLING PRESSURE AFTER ACUTE MYOCARDIAL INFARCTION IN HYPERTENSIVE PATIENTSD. Toader, E. Belu, R. Radu, M. Popescu, R. Musetescu, D.D. IonescuCraiova-ROMANIA
8 237 / PATHOPHYSIOLOGY OF AORTIC VALVE CALCIFICATION – UNDERSTANDING THE ROLE OF ARTERIAL HYPERTENSIONA. Faustino, R. Providência, L. Paiva, P. Mota, M. Costa, A. Leitão-MarquesCoimbra-PORTUGAL
8 238 / 4-D TOMOGRAPHIC RADIONUCLIDE VENTRICULOGRAPHY IN THE ASSESSMENT OF NONSELECTIVE ENDOTHELIN RECEPTOR ANTAGONIST BOSENTAN INFLUENCE ON RIGHT VENTRICLE PERFORMANCE IN PATIENTS WITH IDIOPATHIC PULMONARY ARTERIAL HYPERTENSIONO. Arkhipova, T. Martynyuk, L. Samoilenko, I. ChazovaMoscow-RUSSIA
8 239 / PULMONARY VASCULAR CHANGES IN PULMONARY ARTERY HYPERTENSION: OPTICAL COHERENCE TOMOGRAPHY - CLINICAL APPLICATIONE. Belyatko, N. Danilov, R. Atanesjn, M. Mitroshkin, Y. Matchin, I. ChazovaMoscow-RUSSIA
8 240/ HIGH FIELD 31P MAGNETIC RESONANCE SPECTROSCOPY TO MEASURE MYOCARDIAL METABOLITES IN NORMOTENSIVES AND PATIENTS WITH ARTERIAL HYPERTENSIONV. Mazaev, I. Chazova, S. TernovoyMoscow-RUSSIA
8 241 / EPICARDIAL TO ENDOCARDIAL SYSTOLIC CONTRACTILE GRADIENT IN NORMAL INDIVIDUALS BY TWO DIMENSIONAL STRAIN IMAGING: IMPLICATIONS FOR THE EVALUATION OF LEFT VENTRICULAR SHEARM. Chinali (1), G.P. Aurigemma (1), Z. Zachittella (1), N. Metha (1), H. Pokrel (1), J. Hill (1), G. de Simone (2), D. Tighe (1)(1) Worcester-USA; (2) Naples-ITALY
8 228 / THE ELECTROCARDIOGRAPHIC ABNORMALITIES OF REPOLARIZATION, ARRHYTHMIA AND THE VOLTAGE OF R WAVE IN AVL ARE A DETERMINANT IN CARDIOVASCULAR DISEASE ON HYPERTENSIONE. Martín-Rioboó, J. Redondo Sanchez, L.A. Perula De Torres, J.E. Garcia Criado, A. Lopez Granados, E. Camacho Navarro, M. Gimenez-PimentelCórdoba-SPAIN
8 229 / ASSESSEMENT OF LEFT VENTRICULAR PRESSURE-VOLUME RELATIONSHIP IN EXTREME ENVIRONMENT: VALIDATION OF A NEW NON INVASIVE TOOLF. Faita (1), S. Rimoldi (2), E. Rexhaj (3), D. Hutter (2), E. Bianchini (1), V. Gemignani (1), T. Bombardini (1), U. Scherrer (3), C. Sartori (3), L. Pratali (1)(1) Pisa-ITALY; (2) Bern, (3) Lausanne-SWITZERLAND
8 230 / EXERCISE PERFORMANCE AND HEALTH RELATED QUALITY OF LIFE IN PATIENTS WITH EISENMENGER SYNDROMEN. Goncharova, O. Moiseeva, E. Andreeva, A. AlehinSt. Petersburg-RUSSIA
8 231 / ISOPROTERENOL-INDUCED CARDIAC HYPERTROPHY IS PRECEDED BY AN OVEREXPRESSION OF CARDIOMYOCYTE GROWTH FACTORS IN VIVOP. Krenek, L. Pivackova, H. Cernecka, K. Turcekova, M. Olvedy, J. Klimas, P. Ochodnicky, B. Gajdacova, A. Adameova, J. KyselovicBratislava-SLOVAK REPUBLIC
8 232 / ECHOCARDIOGRAPHIC OPTIMIZATION OF THE AV INTERVAL MAY IMPROVE THE OUTCOME OF THE DDD PACEMAKER HYPERTENSIVE PATIENTSE. Belu, R. Musetescu, C. Bataiosu, M. Popescu, D. Toader, R. Mustafa, M. Cosulschi, N. Florescu, D.D. IonescuCraiova-ROMANIA
8 233 / THE IMPACT OF BLOOD PRESSURE PATTERN ON LEFT VENTRICULAR STRUCTURE AND FUNCTIONB. Ivanovic, M. TadicBelgrade-SERBIA
8 234 / LEFT VENTRICULAR HYPERTROPHY INHIBITION IN EXPERIMENTAL HYPERTENSIONH. Gómez Llambí, D. Suárez, G. Ottaviano, A. Müller, N. Paglia, M. Otero Losada, J. MileiBuenos Aires-ARGENTINA
Sunday
19
308Sunday 19308 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011309
Sunday 19 9 247 / LOW NORMAL RANGE OF ESTIMATED GLOMERULAR FILTRATION RATE AND MICROALBUMINURIA ARE INDEPENDENTLY ASSOCIATED WITH INCREASED ARTERIAL STIFFNESS IN NEVER TREATED HYPERTENSIVESM.Y. Rhee (1), Y.S. Kim (1), Y.K Kim (1), M.M. Lee (1), D.K. Na (2), J.H. Bae (2), S.Y. Kim (2), C.Y. Lim (1)(1) Goyang, (2) Gyeongju-SOUTH KOREA
9 248 / LONG-TERM TOLERABILITY OF ULTRAHIGH DOSES OF ANGIOTENSIN II RECEPTOR BLOCKERS IN PATIENTS WITH STAGE 3-4 CHRONIC KIDNEY DISEASEP. Aranda, P. Hidalgo, T. Jiménez, C. Jironda, D. Martínez, D. HernándezMalaga-SPAIN
9 249 / THE CKD-EPI’S NEW GLOMERULAR FILTRATE RATE EQUATION COULD AFFECT THE CLASSIFICATION OF CHRONIC KIDNEY DISEASE RESPECT OF THE MDRD’S EQUATIONJ.M. Elorza-Ricart, A. Oliveras-Puig, A. Dalfó-Baqué, E. Hermosilla-Pérez, F. Fina-Avilés, E. Gibert-Llorach, N. Camprodon-Tuneu, J. Ros-BaróBarcelona-SPAIN
9 250 / IF WE USE GLOMERULAR FILTRATE RATE EQUATIONS, THE NUMBER OF PATIENTS WITH THE DIAGNOSE OF CHRONIC KIDNEY INSUFFICIENCY COULD BE FOUR-FOLDEDJ.M. Elorza-Ricart, A. Oliveras-Puig, F. Fina-Avilés, E. Hermosilla-Pérez, E. Gibert-Llorach, S. Bonvehí-Nadeu, E. Bolívar-Puigoriol, A. Dalfó-BaquéBarcelona-SPAIN
9 251 / PLASMA RENIN ACTIVITY AND URINARY ALBUMIN EXCRETION INDEPENDENTLY PREDICTS RENAL OUTCOME IN ESSENTIAL HYPERTENSIVE PATIENTS WITH DIABETIC NEPHROPATHYR. Sanchez, M.J. Sanchez, A.J. RamirezBuenos Aires-ARGENTINA
9 252 / RENAL HEMODYNAMIC STATUS AND AGING - USEFULNESS OF THE RESISTIVE INDEX IN RENAL DOPPLER ULTRASONOGRAPHY AS AN INDICATOR OF VASCULAR DAMAGET. Kawai, K. Kamide, M. Onishi, K. Hongyo, I. Shimaoka, Y. Takeya, M. Ohishi, H. RakugiSuita-JAPAN
14.00 - 15.30Ground Floor
Poster Session 24
RENAL ASPECTS
ROOM 9 / POSTERS FROM 242 TO 276
Chairperson: M. de Buyzere (Gent-BELGIUM)
9 242 / EFFECT OF POTASSIUM SUPPLEMENTATION ON RENAL TUBULAR FUNCTION, AMBULATORY BLOOD PRESSURE AND PULSE WAVE VELOCITY IN HEALTHY CONTROL SUBJECTS IN A RANDOMIZED, PLACEBO-CONTROLLED, CROSSOVER STUDYS.K. Matthesen, P.H. Gjorup, T. Larsen, T.G. Lauridsen, K.M. Nykjaer, H. Vase, E.B. PedersenHolstebro-DENMARK
9 243 / LOSARTAN DECREASES RENAL VASCULAR RESISTANCE AND INCREASES HIGH-DENSITY LIPOPROTEINS LEVEL IN SPONTANEOUSLY HYPERTENSIVE RATS WITH ACUTE RENAL FAILUREM. Ivanov, Z. Miloradovic, N. Mihailovic-Stanojevic, J. Grujic Milanovic, D.J. JovovicBelgrade-SERBIA
9 244 / PREVALENCE AND AGREEMENT OF CLINICAL DIAGNOSIS IN RENAL DISEASE AND ITS EVALUATION BY ESTIMATED GLOMERULAR FILTRATION RATE IN HYPERTENSIVE PATIENTST. Gijon, J. Swan, T. Rua, I. Pitillas, B. Valero, C. Rodriguez, M.L. Lopez, B. ArtolaMadrid-SPAIN
9 245 / URIDINE ADENOSINE TETRAPHOSPHATE ACTS AS AN AUTOCRINE HORMONE AFFECTING GLOMERULARV. Jankowski (1), A. Patzak (1), S. Herget-Rosenthal (2), W. Zidek (1),J. Jankowski (1)(1) Berlin, (2) Essen-GERMANY
9 246 / CHRONIC KIDNEY DISEASE IS PREDICTABLE BY URIC ACID LEVELS IN THE GENERAL POPULATIONH. Sonoda (1), H. Takase (2), S. Tanaka (1), Y. Dohi (1), G. Kimura (1)(1) Nagoya, (2) Hamamatsu-JAPAN
Sunday
19
310Sunday 19310 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011311
Sunday 19 9 260 / FETAL ZINC DEFICIENCY: INFLUENCE ON RENAL NITRIC OXIDE AND OXIDATIVE STRESSC. Arranz, S. Aguirre, L. Savignano, D. Cardelli Alcalde, F. Mendes Garrido, M. Mac Laughlin, R. Elesgaray, C. Caniffi , A. Costa, A. TomatBuenos Aires-ARGENTINA
9 261 / PREVALENCE OF TRADITIONAL RISK FACTORS IN ISCHEMIC HYPERTENSIVE NEPHROPATHY PATIENTSS. Radenkovic, V. Kalezic, P. VuksanovicNis-SERBIA
9 262 / HYPERTENSION PREVALENCE, TREATMENT, AND CONTROL IN PATIENTS WITH IGA NEPHROPATHY AFTER LONG-TERM FOLLOW-UP PERIODV. Monhart, V. HamplovaPrague-CZECH REPUBLIC
9 263 / TREATMENT OF HYPERTENSION IN PREDIALYSIS CHRONIC RENAL FAILURE PATIENTSI. PrkacinZagreb-CROATIA
9 264 / MICROALBUMINURIA IS THE MOST INTEGRATED SIGN OF TARGET ORGAN DAMAGE IN HYPERTENSIVE PATIENTSS. Villevalde, E. Tuykhmenev, A. Klimenko, Z. KobalavaMoscow-RUSSIA
9 265 / RENOPROTECTIVE EFFECT OF PERINDOPRIL IN PATIENTS WITH HYPERTENSIVE CHRONIC KIDNEY DISEASEV. Radchenko, L. Mishchenko, V. Bezrodnyi, O. MatovaKyiv-UKRAINE
9 266 / THE RENAL DOPAMINERGIC SYSTEM AND AMINO ACID TRANSPORTER EXPRESSION IN AGED WKY AND SHR RATSV. Pinto, M.J. Pinho, J. Amaral, E. Silva, S. Simão, M.P. Serrão, J. Afonso, P. Gomes, P. Soares-Da-SilvaPorto-PORTUGAL
9 267 / THE EFFECT OF ANTIHYPERTENSIVE DRUGS ON ESTIMATED GLOMERULAR FILTRATION RATE OF HYPERTENSIVE PATIENTS OVER THE COURSE OF THEIR TREATMENTA. Ptinopoulou (1), I. Tziolas (1), M. Pikilidou (1), B.H. Stricker (2), P. Zebekakis (1), A. Lasaridis (1)(1) Thessaloniki-GREECE; (2) Rotterdam-THE NETHERLANDS
9 253 / HYPERTENSION IS RELATED WITH RENAL STRUCTURE IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASEA. Idrizi, M. Barbullushi, A. Koroshi, N. Spahia, V. Bajrami, X.H. Xhaferri, S. Kodra, N. ThereskaTirana-ALBANIA
9 254 / THE IMPORTANCE OF ARTERIAL HYPERTENSION AT THE ONSET OF CLINICAL LUPUS NEPHRITIST. Backa, A. Idrizi, M. Barbullushi, A. Koroshi, X.H. XhaferriTirana-ALBANIA
9 255 / CORRELATES OF RENAL FUNCTION WITH HEMODYNAMIC, METABOLIC AND STRUCTURAL PARAMETERS IN NEVER TREATED NON-DIABETIC GRADE 1 ESSENTIAL HYPERTENSIONA. Berbari, S. Mallat, N. DaoukBeirut-LEBANON
9 256 / THE SPECTRAL ANALYSIS OF CAROTID DISTENSION RATE IS ASSOCIATED WITH CARDIOVASCULAR RISK OF PATIENTS WITH MODERATE RENAL DYSFUNCTIONL. Zanoli, M. Alivon, N. Estrugo, H. Ketthab, J.F. Pruny, S. Yanes, K. Bean, J.P. Empana, X. Jouven, S. Laurent, P. BoutouyrieParis-FRANCE
9 257 / IMPAIRED CORONARY FLOW RESERVE IS ASSOCIATED WITH INCREASED ALBUMINURIA LEVELS IN UNTREATED HYPERTENSIVESD. Tsiachris, C. Tsioufi s, K. Dimitriadis, D. Syrseloudis, A. Kasiakogias, I. Bafakis, D. Rousos, C. StefanadisAthens-GREECE
9 258 / VASCULAR DYSFUNCTION AND REMODELING OCCURRED IN ACCORDANCE WITH RENAL IMPAIRMENT IN NEPHRECTOMIZED RATSH. Toba, S. Murata, Y. Oshima, Y. Kojima, K. Nakashima, K. Noda, J. Wang, M. Kobara, T. NakataKyoto-JAPAN
9 259 / PREVALENCE OF CHRONIC KIDNEY DISEASE IN HYPERTENSIVE PATIENTS WITH AND WITHOUT TYPE 2 DIABETES MELLITUSJ. Pigareva, S. Avdoshina, M. Efremovtseva, Z. KobalavaMoscow-RUSSIA
Sunday
19
312Sunday 19312 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011313
Sunday 19 9 275 / LOWERING OF NADROPARIN DECREASES SYSTOLIC, MEAN AND PULSE PRESSURE IN HEMODIALYSED PATIENTS YOUNGER THAN 65 BUT NOT OLDER THAN 65 YEARS OF AGEM. Sain, V. Kovacic, D. Ljutic, J. Radic, I. JelicicSplit-CROATIA
9 276 / ARTERIAL HYPERTENSION IN DIALYSIS PATIENTSD. Loncar, D. Hadzovic, E. Zukic, E. Smajic, V. HabulTuzla-BOSNIA HERZEGOVINA
9 268 / RENAL FUNCTION PROGRESSION IN PATIENTS WITH RENAL ARTERY STENOSIS UNDERGOING INTENSIVE MEDICAL THERAPYK. Flores, E. Espinel, I. Gil, A. Marin, E. Jatem, I. Torres, J.L. Tovar, D. SeronBarcelona-SPAIN
9 269 / HIGH SALT INDUCED GLOMERULAR DAMAGE IS ASSOCIATED WITH LOCAL DOWN-REGULATION OF ACE2S. Bernardi (1), B. Toffoli (2), C. Zennaro (2), R. Candido (2), P. Losurdo (2),N. Sabato (2), R. Carretta (2), G. Bellini (2), C. Tikellis (1), M.C. Thomas (1), F. Fallo (3), P. Mulatero (4), F. Veglio (4), B. Fabris (2)(1) Melbourne-AUSTRALIA; (2) Trieste, (3) Padua, (4) Turin-ITALY
9 270 / EFFECT OF 2-CHLOROADENOSINE ON RENAL REDOX STATUS IN DIABETIC WISTAR AND SPONTANEOUSLY HYPERTENSIVE RATSM. Morato, D. Patinha, J. Afonso, T. Sousa, A. Albino-TeixeiraPorto-PORTUGAL
9 271 / PREVALENCE AND MANAGEMENT OF CHRONIC KIDNEY DISEASE USING MDRD-4 AND CKD-EPI FORMULA IN PRIMARY CAREL. Carrascal García, I. Gamboa Apéstegui, I. Rodriguez-Miñón Otero, J.M. Lobos Bejarano, L. Egido Flores, J. Castellanos Maroto, C. Cervantes Guijarro, X. De Castro Caillaux, R. Clemente Vargas, N. Del Río Hernández, M. Vicente CuevasMadrid-SPAIN
9 272 / FACTORS ASSOCIATED WITH ARTERIAL HYPERTENSION IN THE EARLY POST-TRANSPLANT PERIODA. Laucyte, M. MiglinasVilnius-LITHUANIA
9 273 / N-DOMAIN ANGIOTENSIN I-CONVERTING ENZYME WITH 90 KDA EXPRESSION IN RENAL TRANSPLANT MODELC. Aparecido Leite (1), T. Sousa Cunha (1), M.C. Camargo De Andrade (1), F. Aparecida Ronchi (1), D. Yuri Arita (1), F. Klein (2), F. Barrinha Fernandes (1), A. Barrinha Fernandes (1), I. Kazue Mizuno (1), A. Alves Leitao (1), D.E. Casarini (1)(1) Sao Paulo, (2) Campinas-BRAZIL
9 274 / BLOOD RHEOLOGY AND RENAL TRANSPLANTATION: AN INTRIGUING RELATIONSHIP FOR ASSESSING CARDIOVASCULAR RISKM. Zanazzi, C. Fatini, A. Larti, E. Sticchi, N. Paudice, L. Moscarelli, L. Mannini, R. AbbateFlorence-ITALY
Sunday
19
314Sunday 19314 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011315
Sunday 19 10 282 / THE INITIATORY SOURCE OF LOCAL ANG II TO INDUCE VASCULAR REMODELING COMES FROM THE APOPTOTIC ENDOTHELIAL CELLST. Hsieh (1), M. Kou (1), F. Chiang (2), M. Hébert (3), S. Wu (1)(1) Kaohsiung City, (2) Taipei-TAIWAN; (3) Montreal-CANADA
10 283 /CHANGES IN HEMOGLOBIN AND ERYTHROPOIETIN LEVEL AFTER INITIATION OF ANGIOTENSIN CONVERTING ENZYME-INHIBITORS IN GENERAL HYPERTENSIVE PATIENTS: A 4-MONTHS PROSPECTIVE STUDYW. Treesutat, P. Gojaseni, A. ChittinandanaBangkok-THAILAND
10 284 / ASSOCIATION OF BIRTH WEIGHT, BLOOD PRESSURE LEVELS AND ANGIOTENSIN-CONVERTING ENZYME ACTIVITY IN CHILDHOODA. Ajala, M. Rangel, A. Febba, M.W. Strufaldi, R. Sesso, D.E. Casarini, M. FrancoSão Paulo-BRAZIL
10 285 / THE RENIN INHIBITOR VTP-27999 BLOCKS STORED RENIN MORE POTENTLY THAN ALISKIRENM. Krop (1), R. Gregg (2), G. McGeehan (2), A. Danser (1)(1) Rotterdam-THE NETHERLANDS; (2) Washington-USA
10 286 / GALECTIN-3 IS A POTENTIAL MEDIATOR OF ALDOSTERONE EFFECTS IN VASCULAR REMODELINGL. Calvier (1), B. Martin-Fernãndez (2), V. Lahera (2), F. Zannad (1), V. Cachofeiro (2), P. Lacolley (1), P. Rossignol (1), N. Lopez-Andrés (1)(1) Nancy-FRANCE; (2) Madrid-SPAIN
10 287 / UPREGULATION OF RENIN ANGIOTENSIN SYSTEM IN TYPE 1 DIABETES MELLITUS ASSOCIATED WITH HYPERTENSIONL. Morais, I. Watanabe, M. Franco, D. Arita, M. Gabbay, D. Casarini, S. DibSão Paulo-BRAZIL
10 288 / IMPACT OF ANGIOTENSIN-CONVERTING ENZYME INSERTION/DELETION POLYMORPHISM ON BLOOD PRESSURE AND PROTEIN EXCRETION IN PATIENTS WITH OVERT PROTEINURIAM. Zivko (1), R. Kusec (2), K. Galesic (2)(1) Virovitica, (2) Zagreb-CROATIA
10 289 / RENAL ENHANCEMENT OF AT1 RECEPTOR-ASSOCIATED PROTEIN PREVENTS SALT-INDUCED HYPERTENSIONK. Tamura, H. Wakui, Y. Tsurumi-Ikeya, T. Dejima, A. Maeda, M. Ohsawa, T. Kanaoka, J. Oshikawa, Y. Kobayashi, S. Minegishi, S. Yoshida, S. Masuda, K. Azuma, T. Ishigami, S. UmemuraYokohama-JAPAN
14.00 - 15.30Ground Floor
Poster Session 25
RENIN ANGIOTENSIN SYSTEM AND VASOACTIVE SUBSTANCES
ROOM 10 / POSTERS FROM 277 TO 309
Chairperson: R. Sanchez (Buenos Aires-ARGENTINA)
10 277 / C-TYPE NATRIURETIC PEPTIDE EFFECTS ON VASCULAR REACTIVITY IN HYPERTENSION. PARTICIPATION OF NITRIC OXIDE SYSTEMM.A. Costa, C. Caniffi , D. Suarez Di Salvo, F. Mendes Garrido, M. Cerniello, C. ArranzBuenos Aires-ARGENTINA
10 278 / PRE-PUBERTAL BLOCKADE OF ANGIOTENSIN II TYPE 1 RECEPTOR EXERTS LONG-TERM THERAPEUTIC EFFECTS THROUGH SUSTAINED ENHANCEMENT OF RENAL ATRAP EXPRESSION IN DAHL SALT-SENSITIVE HYPERTENSIVE RATST. Dejima, K. Tamura, H. Wakui, A. Maeda, M. Ohsawa, T. Kanaoka, S. Haku, S. Masuda, A. Shigenaga, K. Azuma, M. Matsuda, M. Yabana, K. Uchino, S. UmemuraYokohama-JAPAN
10 279 / SUPPRESSION OF PLASMA RENIN CONCENTRATION AND ANGIOTENSIN II AFTER INHIBITION OF SYSTEMIC NITRIC OXIDE SYNTHESIS IN HEALTHY SUBJECTS. A DOSE-RESPONSE STUDYT. Larsen, F.H. Christensen, J.N. Bech, E.B. PedersenHolstebro-DENMARK
10 280 / ARE BNP AND COLLAGEN PEPTIDE PREDICTING THE PRESENCE OF LV REMODELING IN PATIENTS WITH NEWLY DEVELOPED HYPERTENSION?B. YooWonju-SOUTH KOREA
10 281 / GENETIC POLYMORPHISMS IN ANGIOTENSINOGEN AND ALDOSTERONE SYNTHASE ARE DIFFERENTIALLY ASSOCIATED WITH THE ANTIHYPERTENSIVE EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND CALCIUM-CHANNEL BLOCKERY. Feng, Y. Zhou, H. Dong, S. LinGuangzhou-CHINA
Sunday
19
316Sunday 19316 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011317
Sunday 19 10 296 / CIRCULATING RENIN ANGIOTENSIN SYSTEM PROFILE IN OBESE ADOLESCENTSF. Barrinha Fernandes (1), A. Barrinha Fernandes (1), A.C. da Silva Febba (1), C. Aparecido Leite (1), M.S. de Souza Vitalle (1), F. Fernandes Jung (2), D.E. Casarini (1)(1) Sao Paulo,-BRAZIL, (2) Washington, D.C-USA
10 297 / A PROXIMAL DIRECT REPEAT MOTIF CHARACTERIZED AS A NEGATIVE REGULATORY ELEMENT IN THE HUMAN RENIN GENET. Konoshita, S. Mizuno, Y. Makino, S. Wakahara, K. Arakawa, I. Inoki, I. MiyamoriEiheiji-JAPAN
10 298 / HYPERKALEMIA AND COUGH WITH ANGIOTENSIN-CONVERTING ENZYME INHIBITORS MONOTHERAPY IN ESSENTIAL HYPERTENSION. A META-ANALYSISJ. Romero, J. Kahan, W. GonzalezNew York-USA
10 299 / RENIN AND ALDOSTERONE IN NEVER-TREATED HYPERTENSIVES WITH ERECTILE DYSFUNCTIOND. Terentes-Printzios, C. Vlachopoulos, G. Vyssoulis, N. Ioakeimidis, A. Aggelis, A. Samentzas, P. Pietri, N. Alexopoulos, K. Aznaouridis, P. Xaplanteris, C. StefanadisAthens-GREECE
10 300 / MODULATION OF EXTRACELLULAR MATRIX AND MAPK BY SUBPRESSOR DOSE OF ANGIOTENSIN II AND AT1 RECEPTOR BLOCKADEK.A.S. Viegas, T.C. Souza, N.B. Rabechi, C.J. Piva, J.C.S. Silva, V.G. Barauna, L.C.G. Campos, A.A. Miyakawa, J.E. Krieger, S. LacchiniSao Paulo-BRAZIL
10 301 / RENIN-ANGIOTENSIN SYSTEM PARTICIPATION IN REMODELING OF CARDIAC ARTERIES OF CHRONIC SODIUM-OVERLOADED MICEC.T. Lima, J.C.S. Silva, T.C. Souza, K.A.S. Viegas, S. LacchiniSao Paulo-BRAZIL
10 302 / PROINFLAMMATORY EFFECT MEDIATED BY ANGIOTENSIN II ON CARDIAC VESSELS INDEPENDENT OF HEMODYNAMIC ALTERATIONST.C. Souza De Oliveira, K.A.S Viegas, N.B. Rabechi, T. Alba-Loureiro, L.E. Souza, R. Curi, M.C. Irigoyen, S. LacchiniSao Paulo-BRAZIL
10 290 / DIFFERENCES AMONG RENIN-ANGIOTENSIN SYSTEM BLOCKADES FOR THE TARGET ORGAN DAMAGE IN THE MODEL OF SODIUM SENSITIVE HYPERTENSIONT. Ishigami, S. Minegishi, N. Araki, M. Umemura, H. Ushio, K. Abe, K. Uchino, S. UmemuraYokohama-JAPAN
10 291 / THE EFFICACY OF ADDING EPLERENONE, A SELECTIVE MINERALOCORTICOID RECEPTOR ANTAGONIST, IN PATIENTS WITH RESISTANT HYPERTENSION - SUBGROUP ANALYSIS ON DIFFERENT LEVELS OF PLASMA RENIN ACTIVITYF. Satoh, R. Morimoto, Y. Iwakura, Y. Ono, M. Kudo, S. ItoSendai-JAPAN
10 292 / OPPOSITE CHANGES OF PLASMA RENIN ACTIVITY AND ALDOSTERONE INDUCED BY SUNITIB TREATMENT IN NEOPLASTIC PATIENTSM. Rescaldani, D. Gambini, L. Turolo, G. Bolla, M. Tomirotti, F. Magrini, C. SalaMilan-ITALY
10 293 / HYPERKALEMIA WITH ANGIOTENSIN RECEPTOR BLOCKERS MONOTHERAPY IN ESSENTIAL HYPERTENSION. A META-ANALYSISJ. Romero, W. Gonzalez, J. Kahan, A. Shah, F. MesserliNew York-USA
10 294 / EFFECTS OF EXERCISE ON PLASMA RENIN ACTIVITY AND BLOOD PRESSURE: DIFFERENTIAL EFFECTS OF DIRECT RENIN INHIBITION (ALISKIREN) VERSUS ANGIOTENSIN RECEPTOR BLOCKADE (VALSARTAN)B. Williams (1), F. Baschiera (2), P.S. Lacy (1), M.F. Prescott (3), J. Botha (2), P. Brunel (2)(1) Leicester-UK; (2) Basel-SWITZERLAND; (3) East Hanover-USA
10 295 / PROSPECTIVE STUDY TO INVESTIGATE THE PREVALENCE OF THE 90 KDA ISOFORM OF ANGIOTENSIN CONVERTING ENZYME IN VITÓRIA - BRAZIL – PRELIMINARY RESULTSA.C. Da Silva Febba (1), F. Barrinha Fernandes (1), D. Sanches Aragao (1), R. de Castro Cintra Sesso (1), J. Geraldo Mill (2), M. do Carmo Franco (1), D.E. Casarini (1)(1) Sao Paulo, (2) Vitoria-BRAZIL
Sunday
19
318Sunday 19318 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011319
Sunday 1914.00 - 15.30Ground Floor
Poster Session 26
OBESITY
ROOM 11 / POSTERS FROM 310 TO 348
Chairperson: J. Jordan (Hannover-GERMANY)
11 310 / RENAL DENERVATION REDUCES CENTRAL SYMPATHETIC DRIVE AND IMPROVES INSULIN SENSITIVITY IN PCOSM. Schlaich (1), N. Straznicky (1), M. Grima (1), C. Ika Sari (1), E. Lambert (1), R. Chopra (1), G. Lambert (1), F. Mahfoud (2), M. Boehm (2), M. Esler (1)(1) Melbourne-AUSTRALIA; (2) Homburg/Saar-GERMANY
11 311 / AMBULATORY BLOOD PRESSURE MONITORING IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE AND METABOLIC SYNDROMEO. Korneeva, O. Drapkina, N. Korneev, V. IvashkinMoscow-RUSSIA
11 312 / HEMODYNAMIC CHARACTERISTICS OF HYPERTENSION IN METABOLIC SYNDROMEE. Praskurnichiy, N. PozdnyakovaMoscow-RUSSIA
11 313 / VALUE CONSENSUS DEFINITION OF METABOLIC SYNDROME (2009) IN IDENTIFYING PATIENTS OF HIGH CARDIOVASCULAR RISKI. Chulaievska, V. Romanov, T. Belayieva, O. MitchenkoKyiv-UKRAINE
11 314 / LEPTIN CONCENTRATIONS IN HYPERTENSIVE WOMEN WITH METABOLIC DISORDERS IN MENOPAUSEN. Pytetska, on behalf of Department of Internal MedicineKharkiv-UKRAINE
10 303 / CYTOKINE’S SERUM PROFILE IN HYPERTENSIVE PATIENTS TREATED WITH CARVEDILOLI. Voloshyna (1), V. Vizir (2)(1) Berdyansk, (2) Zaporozhye-UKRAINE
10 304 / INFLUENCE OF C-REACTIVE PROTEIN AND SERUM URIC ACID ON SUBCLINICAL DAMAGE ARTERIES IN THE ESSENTIAL HYPERTENSIVE PATIENTSE. Oschepkova, V. Dmitriev, O. Gushchina, V. Titov, A. RogozaMoscow-RUSSIA
10 305 / RED CELL DISTRIBUTION WIDTH, METHYLGLYOXAL AND TOTAL ANTIOXIDANT ACTIVITY IN THE ESSENTIAL HYPERTENSIVE PATIENTSV. Dmitriev, E. Oschepkova, V. Titov, A. Rogoza, T. PolevayaMoscow-RUSSIA
10 306 / THE RELATIONSHIP BETWEEN TRANSFORMING GROWTH FACTOR – β1 AND INSULIN - LIKE GROWTH FACTOR-1 AND LEFT VENTRICLE REMODELING IN PATIENTS WITH ESSENTIAL HYPERTENSION AND TYPE 2 DIABETES MELLITUSS. Koval, T. Starchenko, K. Pershyna, L. Reznik, V. ShkapoKharkov-UKRAINE
10 307 / THE EFFECT OF LOSARTAN THERAPY ON SERUM URIC ACID AND MALONDIALDEHYDE IN PATIENTS WITH ESSENTIAL HYPERTENSIONO. Gushchina, E. Oschepkova, V. Dmitriev, V. Titov, N. Lazareva, A. RogozaMoscow-RUSSIA
10 308 / THE INFLUENCE OF LISINOPRIL ON THE LEVEL OF URIC ACID IN SERUM, IN URINE AND RENAL FUNCTION IN HYPERTENSIVE PATIENTSE. Oschepkova, O. Gushchina, V. Dmitriev, V. Titov, N. Lazareva, A. RogozaMoscow-RUSSIA
10 309 / SERUM ADIPOKINES CONCENTRATION AND MOXONIDINE THERAPY IN HYPERTENSIVE POSTMENOPAUSAL WOMEN WITH METABOLIC SYNDROMEE. Chubenko, O. Belyaeva, E. Bazhenova, O. Berkovich, E. Baranova, E. ShlyakhtoSt. Petersburg-RUSSIA
Sunday
19
320Sunday 19320 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011321
Sunday 19 11 323 / THE EFFECTIVENESS OF THERAPY VILDAGLIPTIN IN THE TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION, METABOLIC SYNDROME AND IMPAIRED GLUCOSE TOLERANCEV. Mychka, K. Ivanov, V. MasenkoMoscow-RUSSIA
11 324 / GENE-SPECIFIC DISRUPTION OF ANGIOTENSIN II TYPE 1 RECEPTOR-ASSOCIATED PROTEIN REVEALS A NOVEL ROLE IN THE PATHOGENESIS OF METABOLIC SYNDROMEA. Maeda, K. Tamura, H. Wakui, T. Dejima, M. Ohsawa, T. Kanaoka, S. Haku, S. Masuda, K. Azuma, M. Matsuda, Y. Toya, S. UmemuraYokohama-JAPAN
11 325 / METABOLIC SYNDROME IN YOUNG ADULTS. A RISK FACTOR FOR CARDIOVASCULAR DISEASESA.C. Pacurari, L. Radu, A. Narita, C. Serban, L. Susan, S. Gotia, I. RomosanTimisoara-ROMANIA
11 326 / BLOOD PRESSURE, URINARY OUTPUT AND SODIUM EXCRETION RESPONSE TO LOWER BODY NEGATIVE PRESSURE IN OBESE PATIENTSG. Wuerzner, N. Glatz, V. Forni, S. Tremblay, C. Zweiacker, B. Vogt, M. BurnierLausanne-SWITZERLAND
11 327 / EFFECT OF Q192R POLYMORPHISM OF PARAOXONASE-1 GENE ON METABOLIC SYNDROME COMPONENTSO. Bolshakova, O. Belyaeva, V. Larionova, V. Timoshin, E. BaranovaSt. Petersburg-RUSSIA
11 328 / OBESITY IS AN IMPORTANT DETERMINANT OF SYSTOLIC BLOOD PRESSURE IN YOUNG MEN BORN SMALL FOR GESTATION AGEI. Vukovic Lela, M. Laganovic, V. Premuzic, S. Karanovic, D. Kuzmanic, M. Vrcic Kirhmajer, L.J. Banfi c, M. Fistrek, J. Kos, B. JelakovicZagreb-CROATIA
11 329 / RAMIPRIL IN TREATED PATIENTS WITH METABOLIC SYNDROME AND DIASTOLIC DYSFUNCTIONO. Drapkina, V. IvashkinMoscow-RUSSIA
11 330 / CLINICAL CHARACTERISTIC IN PATIENTS WITH AH AND METABOLIC SYNDROMEO. Drapkina, O. Korneeva, V. IvashkinMoscow-RUSSIA
11 315 / PHYSICIAN’S EXPECTATIONS ABOUT NON-PHARMACOLOGICAL TREATMENTS FOR THE PREVENTION OF OBESITY: THE HYPERTENSION 2020 PROJECTA. Coca (1), J. Ampudia (2), E. Lopez De Sa (3), P. Aranda (4), P. Conthe (3),J.l. Llisterri (2)(1) Barcelona, (2) Valencia, (3) Madrid, (4) Malaga-SPAIN
11 316 / EFFECT OF PROTEIN DIET IN PATIENTS WITH METABOLIC SYNDROMEN. Escribano, P. Zafrilla, J.A. Gomez, J. Abellan, J. MuleroMurcia-SPAIN
11 317 / MANIDIPINE RISES ADIPONECTIN AND REDUCES THE RISK OF NEW ONSET DIABETES IN HYPERTENSIVE PATIENTS WITH THE METABOLIC SYNDROMEF. J. Martinez-Martin, on behalf of the MARCADOR study groupLas Palmas De Gran Canaria-SPAIN
11 318 / BIOLOGICAL MATURITY, METABOLIC ABNORMALITIES AND TARGET ORGAN DAMAGE IN CHILDREN AND ADOLESCENTS WITH PRIMARY HYPERTENSIONM. Litwin, A. Niemirska, P. Pludowsky, E. Jurkiewicz, A. Wierzbicka, Z. WawerWarsaw-POLAND
11 319 / THE EFFECT OF BODY MASS INDEX ON THE SYSTEMIC CATECHOLAMINE AND HAEMODYNAMIC RESPONSE TO INCREASED SYMPATHETIC ACTIVATIONJ. Coulson, J. CockcroftCardiff-UK
11 320 / INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-2 IN THE PATHOGENESIS OF HYPERTENSION AND METABOLIC SYNDROME IN PERIMENOPAUSAL WOMENA. Olszanecka, A. Posnik-Urbanska, K. Kawecka-Jaszcz, D. Czarnecka, D. FedakKrakow-POLAND
11 321 / THICKNESS OF EPICARDIAL FAT AS A POSSIBLE MARKER OF METABOLIC SYNDROMEG. Chumakova (1), N. Veselovskaya (2), A. Kozarenko (2), O. Gritsenko (1)(1) Barnaul, (2) Kemerovo-RUSSIA
11 322 / OLMESARTAN PLUS AMLODIPINE (BUT NOT PLUS HYDROCHLOROTHIAZIDE) MAY IMPROVE OXIDATIVE STRESS AND ENDOTHELIAL DYSFUNCTION IN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROMEF. J. Martinez-Martin (1), H. Rodriguez-Rosas (1), J. Lopez-Fernandez (2)(1) Las Palmas De Gran Canaria, (2) La Laguna-SPAIN
Sunday
19
322Sunday 19322 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011323
Sunday 19 11 338 / CIRCULATING INDICES OF INFLAMMATION/OXIDATIVE STRESS IN NORMOTENSIVE AND HYPERTENSIVE OBESE PATIENTSC. De Ciuceis, A. Pilu, E. Porteri, E. La Boria, C. Corbellini, G.E.M. Boari, F. Mittempergher, E. Di Betta, C. Casella, C. Agabiti Rosei, G. Ruggeri, D. Rizzoni, E. Agabiti RoseiBrescia-ITALY
11 339 / ABDOMINAL OBESITY, METABOLIC SYNDROME AND INSULIN RESISTANCEE. Chubenko, O. Belyaeva, O. Bolshakova, O. Berkovich, E. Bazhenova, T. Karonova, E. Baranova, E. ShlyakhtoSt. Petersburg-RUSSIA
11 340 / RELATIONSHIP BETWEEN METABOLIC SYNDROME COMPONENTS AND 24 HOUR DOUBLE PRODUCT IN PATIENTS WITH STABLE CORONARY ARTERY DISEASEW. Sobiczewski, M. Wirtwein, E. Kowalczys, M. Nedoszytko, M. Gruchala, A. RynkiewiczGdansk-POLAND
11 341 / LEPTIN, METABOLIC SYNDROME AND LEFT VENTRICULAR REMODELING IN HYPERTENSIVE PATIENTSS. PotabenkoKharkiv-UKRAINE
11 342 / HOME VERSUS CLINIC BLOOD PRESSURE REDUCTION IN PATIENTS WITH METABOLIC SYNDROME FOLLOWING A HEALTH TECHNOLOGY LIFESTYLE INTERVENTION IN PRIMARY CAREK. Sabourin, M. Stuckey, S. Shapiro, C. Munoz, R. PetrellaLondon-CANADA
11 343 / EVALUATION OF THE QUALITY OF LIFE IN PATIENTS WITH METABOLIC SYNDROME IN THE PROVINCE OF ALBACETEM.Á. Palomino Medina (1), P.J. Tarraga Lopez (2), J. Lucas Perez Romero (2), M. Lucas Perez Romero (2), P. Rodenas Romero (2), M.T. Tolosa Navalon (2), J.L. Castro Navarro (2), E. Arjona Laborda (2), J. Solera Albero (2), M.L. Marcos Navarro (2)(1) Almodovar Del Pinar, (2) Albacete-SPAIN
11 344 / THERE ARE GENDER DIFFERENCES IN CENTRAL OBESITY AND METABOLIC PROFILE CONCERNING PERIPHERAL ARTERIAL WAVE REFLECTIONSV. Katsi, G. Souretis, D. Tousoulis, C. Vlachopoulos, C. Stefanadis, I. KallikazarosAthens-GREECE
11 331 / LIPID TETRAD INDEX AND LIPID PENTAD INDEX FOR EVALUATION OF THE ATHEROGENIC RISK IN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROMEC. Serban, S. Dragan, I. Mozos, L. Susan, L. Noveanu, A. Pacurari, R. Christodorescu, G. Savoiu, M. Craina, S. Gotia, I. RomosanTimisoara-ROMANIA
11 332 / RISK OF FALL IN THE ELDEST AFFECTED BY METABOLIC SYNDROMEF. D’Amico, T. PipicellaMessina-ITALY
11 333 / RENIN-ANGIOTENSIN-ALDOSTERONE-SYSTEM IN PATIENTS WITH ABDOMINAL OBESITY AND HYPERTENSIONE. Baranova, E. Bazhenova, O. Belyaeva, A. Berezina, T. Karonova, T. Ivanova, T. Nutfullina, O. Berkovich, E. Nikolaychuk, E. ShlyakhtoSt. Petersburg-RUSSIA
11 334 / LONGEVITY-ASSOCIATED GENES IN CIRCULATING PERIPHERAL BLOOD MONONUCLEAR CELL PREDICT METABOLIC SYNDROMEG. Ceolotto, S. Vigili De Kreutzenberg, G.P. Fadini, A. Cattelan, F. Stella, A. Avogaro, A. Semplicini Padua-ITALY
11 335 / DECREASED INSULIN SENSITIVITY BUT COMPARABLE PLASMA LEPTIN AND ADIPONECTIN CONCENTRATIONS IN YOUNG LEAN HYPERTENSIVE MENA. Penesova, Z. Radikova, V. Belan, E. Cizmarova, M. Vlcek, R. ImrichBratislava-SLOVAK REPUBLIC
11 336 / DISORDES OF BLOOD FIBRINOLYTIC ACTIVITY IN PATIENTS WITH METABOLIC SYNDROME AND HYPERURICEMIAE. Salakhova, D. Isakova, A. Efanov, E. Yusupova, E. Dorodneva, I. MedvedevaTyumen-RUSSIA
11 337 / RHO-KINASE INHIBITION IMPROVES NITRIC OXIDE-DEPENDENT VASODILATOR REACTIVITY DURING HYPERINSULINEMIA IN PATIENTS WITH METABOLIC SYNDROMEF. Schinzari, M. Tesauro, V. Rovella, P. Gentileschi, N. Mores, A. Adamo, C. CardilloRome-ITALY
Sunday
19
324Sunday 19324 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011325
Sunday 1914.00 - 15.30Ground Floor
Poster Session 27
DIABETES
ROOM 12 / POSTERS FROM 349 TO 381
Chairperson: J. Jordan (Hannover-GERMANY)
12 349 / MORTALITY RISK IS ATTENUATED IN HYPERTENSIVE INDIVIDUALS WITH TYPE 2 DIABETESA.J. Manolis (1), A. Pittaras (1), M. Doumas (2), M.S. Kallistratos (1), N. Kouremenos (1), C. Faselis (2), E. Nylen (2), J.P. Kokkinos (2), P. Kokkinos (2)(1) Athens-GREECE; (2) Washington, DC-USA
12 350 / CIRCADIAN BLOOD PRESSURE PATTERN AND PREVALENCE OF NOCTURNAL HYPERTENSION IN SUBJECTS WITH AND WITHOUT TYPE 2 DIABETES: THE HYGIA PROJECTM.C. Castiñeira (1), A. Moya (2), J. Perez de Lis (3), L. Pousa (3), J.L. Salgado (3), S. Hernaiz (3), A. Mojon (3), J.R. Fernandez (3), R.C. Hermida (3), on behalf of Hygia Project Investigators(1) Lugo, (2) Pontevedra, (3) Vigo-SPAIN
12 351 / INFLUENCE OF SLEEP-TIME BLOOD PRESSURE FOR THE PROPER IDENTIFICATION OF ISOLATED OFFICE AND MASKED HYPERTENSION AMONG PATIENTS WITH TYPE 2 DIABETES: THE HYGIA PROJECTA. Moya (1), E. Sineiro (1), M.C. Castiñeira (2), S.M. Gomara (1), A. Mojon (3), M.J. Fontao (3), S. Lorenzo (3), D.E. Ayala (3), R.C. Hermida (3), on behalf of Hygia Project Investigators(1) Pontevedra, (2) Lugo, (3) Vigo-SPAIN
12 352 / IMPROVEMENT OF CONTROL IN SUBJECTS WITH TYPE 2 DIABETES AFTER A TWO-SIDED INTERVENTION: DIABETES EDUCATION AND PHYSICAL ACTIVITYV.J. Gavara Palomar, C. Ariza Copado, M. Soto Martinez, F. Aguera Mengual, F. Alcazar Manzanera, J.M. Borrachero Guijarro, J.R. Lorca Serralta, A. Martinez Ureña, V. Martinez Velez, M. Rodriguez Martinez, J.M. Sanchez Gil, A. Lemos MonteiroCartagena-SPAIN
11 345 / THE EFFECT OF ANGIOTENSIN-CONVERTING-ENZYME INHIBITION ON LEFT VENTRICULAR DIASTOLIC FUNCTION IN OBESE HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHYS. Vatinian, S. Gurgenyan, K. NikoghosyanYerevan-ARMENIA
11 346 / LEPTIN AS AN INDEPENDENT PREDICTOR OF HIGH BLOOD PRESSURE IN YOUNG PATIENTS WITH ESSENTIAL HYPERTENSIONE. Loginova, G. Nechaeva, M. Shupina, A. Semenkin, O. Drokina Omsk-RUSSIA
11 347 / BLOOD ADIPONECTIN LEVEL IN HYPERTENSIVE PATIENTS WITH METABOLIC DISTURBANCESV. Bozhko, S. Koval, I. Snegurskaya, L. Tsioma, D. Miloslavsky, O. MysnichenkoKharkov-UKRAINE
11 348 / THE ASSOCIATION BETWEEN METABOLIC SYNDROME, INFLAMMATION AND COGNITIVE DECLINEA. Vicario (1), M. Del Sueldo (2), J. Zilberman (2), G.H. Cerezo (1)(1) Buenos Aires, (2) Villa María-ARGENTINA
Sunday
19
326Sunday 19326 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011327
Sunday 19 12 361 / EFFECTS OF ANGIOTENSIN II RECEPTOR ANTAGONIST VALSARTAN IN HYPERTENSIVE TYPE 2 DIABETIC PATIENTS WITH REDUCED LEFT VENTRICULAR SYSTOLIC FUNCTION TAKING ANGIOTENSIN-CONVERTING-ENZYME INHIBITOR RAMIPRILS. Vatinian, S. Gurgenyan, K. NikoghosyanYerevan-ARMENIA
12 362 / CHANGES IN SYSTOLIC BLOOD PRESSURE AND PULSE INTERVAL VARIABILITY IN CHILDREN WITH TYPE 1 DIABETES MELLITUSE. Zavodna, N. Honzikova, Z. Novakova, H. Hrstkova, M. Pejchlova, L. Brazdova, B. FiserBrno-CZECH REPUBLIC
12 363 / SUPERIOR BLOOD PRESSURE REDUCTION WITH ALISKIREN IN HYPERTENSIVE PATIENTS WITH DIABETES MELLITUS IN REAL LIFE. RESULTS OF THE 3A REGISTRYU. Zeymer (1), R. Dechend (2), E. Deeg (1), E. Kaiser (3), R. Schmieder (4)(1) Ludwigshafen, (2) Berlin, (3) Nürnberg, (4) Erlangen-GERMANY
12 364 / THE LEVEL OF UROTENSIN-II IN BLOOD OF PATIENTS WITH ESSENTIAL HYPERTENSION AND TYPE 2 DIABETES MELLITUSS. Koval, T. Starchenko, A. Zamaziy, O. GubanovaKharkov-UKRAINE
12 365 / PREVALENCE OF ARTERIAL HYPERTENSION AND OTHER MICROANGIOPATHIES IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS IN RUSSIAN FEDERATIONT. Shiryaeva, I. Aleksandrova, E. Titovich, E. Andrianova, Y. SuntzovMoscow-RUSSIA
12 366 / PIOGLITAZONE CAN REDUCE CARDIOVASCULAR RISK IN JAPANESE METABOLIC SYNDROME WITH INSULIN RESISTANCET. Furumoto (1), S. Fujii (2), H. Tsutsui (1)(1) Sapporo, (2) Nagoya-JAPAN
12 367 / EFFECT OF PRODUCTS OF XANTHINE-XANTHINE OXIDASE TO CA2 +-DEPENDENT POTASSIUM PERMEABILITY OF ERYTHROCYTE MEMBRANES PATIENTS WITH ARTERIAL HYPERTENSION ACCOMPANIED BY TYPE 2 DIABETES MELLITUSI. Petrova, O. Trubacheva, A. Sitozhevskiy, T. SuslovaTomsk-RUSSIA
12 353 / RISK OF CARDIOVASCULAR COMPLICATIONS OF ANTI-DIABETIC MEDICATION IN PROTEINURIC DIABETIC NEPHROPATHY PATIENTSJ. Al Wakeel, D. Hammad, A.H. Mitwalli, A. Al Suwaida, M. Al GhonaimRiyadh-SAUDI ARABIA
12 354 / DIFFERENT EFFECTS OF TARGET BLOOD PRESSURE ACHIEVED DURING COMBINED ANTIHYPERTENSIVE THERAPY WITH AND WITHOUT RAAS INHIBITORS ON INTRARENAL VASCULAR RESISTANCE IN HYPERTENSIVE DIABETIC PATIENTSO. Koshelskaya, O. Zhuravleva, R. KarpovTomsk-RUSSIA
12 355 / RISK OF THE DEVELOPMENT OF DIABETES MELLITUS IN MEN OF STRESS PROFESSIONS WITH ARTERIAL HYPERTENSIONI. Osipova (1), I. Kalinina (1), G. Simonova (2), O. Antropova (1), A. Zalzman (1), E. Vorobeva (1)(1) Barnaul, (2) Novosibirsk-RUSSIA
12 356 / EFFECT OF ALISKIREN ON QT DISPERSION IN DIABETIC AND NON DIABETIC HYPERTENSIVE PATIENTSR. Fogari, A. Mugellini, A. Zoppi, G. DerosaPavia-ITALY
12 357 / LEFT VENTRICULAR HYPERTROPHY IN TYPE 2 DIABETES; EFFECT OF INDEXING TO HEIGHT VERSUS BODY SURFACE AREA ON PREVALENCE AND CARDIOVASCULAR EVENTSB. Wai, S.K. Patel, S. Grant, P.M. Srivastava, L.M. BurrellMelbourne-AUSTRALIA
12 358 / HYPOADIPONECTINEMIA AS A RISK FACTOR OF DIABETES MELLITUS 2 TYPE IN OVERWEIGHT PATIENTS WITH ARTERIAL HYPERTENSIONT. Ambrosova, T. AshcheulovaKharkiv-UKRAINE
12 359 / MICROALBUMINURIA AND BLOOD PRESSURE IN NORMOTENSIVE SUBJECTS WITH TYPE 2 DIABETES MELLITUSE. Nelaj, M. Gjata, L. Collaku, E. Sadiku, J. Klosi, M. TaseTirana-ALBANIA
12 360 / INCREASED PULSE PRESSURE AND RISK OF FOOT ULCERS IN TYPE 2 DIABETIC PATIENTSE. Shavarova (1), M. Rennis (2), Z.H. Kobalava (1)(1) Moscow-RUSSIA; (2) Manjeri-INDIA
Sunday
19
328Sunday 19328 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011329
Sunday 19 12 375 / CLINICAL INFLUENCE OF BETA-ADRENOBLOCKER BISOPROLOL IN HYPERTENSIVE PATIENTS WITH CORONARY ARTERY DISEASE AND TYPE 2 DIABETESK. NikoghosyanYerevan-ARMENIA
12 376 / CLINICAL AND ECHOCARDIOGRAPHIC FEATURES OF HYPERTENSIVE DIABETIC PATIENTS WITH AND WITHOUT ACUTE CORONARY SYNDROME:DATA FROM AN ALGERIAN OUTPATIENTN. Ali-Tatar Chentir, F. Djender, N. Belahneche, Y. Bouhouita, M.T. ChentirAlger-ALGERIA
12 377 / IMPACT OF DIABETES AND HYPERTENSION ON LEFT VENTRICULAR SYSTOLIC FUNCTIONA. Banushi, S. Qirko, E. Petrela, A. Deliana, T. Goda, G. Husi, A. GodaTirana-ALBANIA
12 378 / DIABETIC HYPERTENSIVES ARE CHARACTERISED BY POOR QUALITY OF LIFEV. Katsi, G. Souretis, D. Tousoulis, C. Vlachopoulos, C. Stefanadis, I. KallikazarosAthens-GREECE
12 379 / IS DIFFERENT THE MANAGEMENT OF THE DIABETIC PATIENTS IN MENTOR PRACTICES FAMILY PHYSICIAN OR IN NON-MENTOR?J. Iturralde-Iriso, G. Mediavilla-Tris, A. Rodriguez-Fernandez, J.L. Hurtado-Mendoza, E. Lopez De Uralde Perez De Alben, M.L. Alarcia-Ceballos, M. Lasso De La Vega-Martinez, A. Iñiguez De Cirano-Landa, O. Ruiz De Arbulo-Ruiz De Alegria, M.A. Roldan-Marrodan, A. Lamin-Labiad, L.M. Sanchez-Gonzalez, A.I. Gil-Moreno, N. Sanchez-Garrido Lestache, U. Blanco-FuentesVitoria-SPAIN
12 380 / RENOPROTECTIVE EFFECT OF THE LISINOPRIL AND AMLODIPINE FIXED COMBINATION IN PATIENTS WITH ARTERIAL HYPERTENSION AND DIABETES MELLITUSK. Protasov, O. Fedorishina, A. Dzizinsky, N. AntonenkoIrkutsk-RUSSIA
12 381 / GREEN TEA EXTRACT IMPROVES ENDOTHELIAL DYSFUNCTION BY REDUCING NADPH OXIDASE ACTIVITY IN PREDIABETIC STAGE OF TYPE 2 DIABETIC RAT MODELS. Ihm, W. Chung, S. Jang, O. Kim, K. Chang, J. Lee, W. Chung, K. Seung, J. KimBucheon-SOUTH KOREA
12 368 / RELATION BETWEEN CARDIOVASCULAR RISK FACTORS AND DIABETIC FOOT PROGRESSION IN INDIAN DIABETIC POPULATIONM. Rennis (1), E. Shavarova (2), Z. Kobalava (2)(1) Manjeri-INDIA; (2) Moscow-RUSSIA
12 369 / RELATIONSHIP OF AUTONOMIC IMBALANCE AND CIRCADIAN DISRUPTION WITH OBESITY AND TYPE 2 DIABETES IN RESISTANT HYPERTENSIVE PATIENTSL. Boer-Martins (1), V.N. Figueiredo (1), L.C. Martins (1), C. Demacq (1), F. Consolin-Colombo (2), F.P.S. Cannavan (1), M.J. Figueiredo (1), R.C. Santos (1), T. Quinaglia (1), H. Moreno (1)(1) Campinas, (2) Sao Paulo-BRAZIL
12 370 / THE PRESENCE OF DIABETES IN PREGNANT WOMEN AS A RISK FACTOR FOR PREECLAMPSIAP. Stanciu, M. Craina, E. Bernad, S. Pantea, C. Serban, R. NituTimisoara-ROMANIA
12 371 / DUAL INHIBITION OF CLASSICAL PKCALPHA AND BETA ISOFORMS LEADS TO PROTECTION AGAINST EXPERIMENTAL MURINE DIABETIC NEPHROPATHYJ. Menne, J.K. Park, N. Shushakova, H. Haller, M. MeierHannover-GERMANY
12 372 / IMPACT OF HSCRP AND ADIPO-CYTOKINE IN CORONARY ARTERY CALCIFICATIONS IN TYPE 2 DIABETEST. Kunugi (1), A. Sato (1), K. Nagai (1), M. Era (1), K. Sakai (1), S. Hasumi (2), Y. Iwamoto (1)(1) Tokyo, (2) Ibaraki-JAPAN
12 373 / BLOOD PRESSURE VARIABLES AND PREVALENT ELECTROCARDIOGRAPHIC LEFT VENTRICULAR HYPERTROPHY IN SUB-SAHARAN INDIVIDUALS WITH DIABETESA.P. Kengne (1), S.P. Choukem (2), M.Y. Dehayem (3), A.I. Dzudie (2)(1) Cape Town-SOUTH AFRICA; (2) Douala, (3) Yaounde-CAMEROON
12 374 / SIMVASTATIN IN ESCALATION DOSES IMPROVE RENAL FUNCTION IN PATIENTS WITH DIABETES MELLITUS AND MILD-TO-MODERATE PROTEINURIAA. Berezin (1), T. Panasenko (1), V. Seden (2)(1) Zaporozhye, (2) Kherson-UKRAINE
Sunday
19
330Sunday 19330 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011331
Sunday 19 13 387 / AUTONOMIC INDEXES OF HEART RATE VARIABILITY AND BLOOD PRESSURE VARIABILITY ARE SIMILARLY ALTERED IN CONGESTIVE HEART FAILURE AND CORONARY ARTERY DISEASE PATIENTS, INDEPENDENTLY FROM THEIR EJECTION FRACTIONA. Radaelli (1), G. Paolini (1), D. Bonfanti (1), M. Di Rienzo (2), G. Mancia (2), P. Castiglioni (2)(1) Monza, (2) Milan-ITALY
13 388 / HYPERTENSION INCREASES ELECTRICAL INSTABILITY IN POST-INFARCTION HEART FAILUREI. Mozos, M. HancuTimisoara-ROMANIA
13 389 / DIASTOLIC HEART FAILURE OF HYPERTENSIVE PATIENTSD. Mitas, M.V. Papavasileiou, A. Anastasopoulou, I. Tsiantis, I. Vasiliadis, G. Lambropoulou, C. Giannakopoulos, G. Papadimitriou, S. KarasAthens-GREECE
13 390 / PULMONARY ULTRASOUND “COMET TAIL” ARTIFACT IN PATIENTS WITH ARTERIAL HYPERTENSION AND HEART FAILUREM. Tsverava, D. TsveravaTbilisi-GEORGIA
13 391 / PROGNOSTIC ROLE OF PERIPHERAL BLOOD FLOW DEPENDING ON AETIOLOGY OF CHRONIC HEART FAILUREI. ShkuratKyiv-UKRAINE
13 392 / DIASTOLIC HEART FAILURE AND PRESSURE VARIABILITY IN AGEING PATIENTSG. Lombardo, F. D’Amico Messina-ITALY
13 393 / THE EFFECT OF OLMESARTAN ON MYOCARDIAL FIBROSIS IN ANIMAL MODEL OF ADRIAMYCIN INDUCED CARDIOMYOPATHY AND EXPRESSION OF CARDIAC ANKYRIN REPEAT PROTEIN IN H9C2 CELLSW. Chung, J. Kim, Y. Choi, C. Park, S. Ihm, H. Youn, M. LeeSeoul-SOUTH KOREA
13 394 / SERUM CYSTATIN C IS ASSOCIATED WITH DIASTOLIC DYSFUNCTION AND ALTERED COLLAGEN METABOLISM IN HYPERTENSIVE PATIENTS WITH HEART FAILUREA. Huerta, A. González, B. López, O. Beloqui, J. DíezPamplona-SPAIN
14.00 - 15.30Ground Floor
Poster Session 28
HEART FAILURE
ROOM 13 / POSTERS FROM 382 TO 398
Chairperson: M. de Buyzere (Gent-BELGIUM)
13 382 / INFLUENCE OF BETA-BLOCKER ON ENDOTHELIAL FUNCTION, ALBUMINURIA AND FIBRONECTINE IN PATIENTS WITH HEART FAILURE WITH PRESERVED SYSTOLIC FUNCTIONO. Soya, O. Kuryata, A. MiroshnichenkoDnipropetrovsk-UKRAINE
13 383 / A HERBAL MEDICINE (KAMPO): KAMI-SHOYO-SAN COULD PREVENT STRESS INDUCED CARDIAC DYSFUNCTION LIKE α AND β BLOCKERY. Takano, F. Ishikura, M. Egawa, K. Komaru, S. ToyokawaSuita-JAPAN
13 384 / CENTRAL PULSE WAVE ANALYSIS IN HYPERTENSIVE SUBJECTS WITH HEART FAILURE WITH PRESERVED SYSTOLIC FUNCTIONI. Goncharov, R. Akhmetov, Y. Kotovskaya, L. Alexandria, A. Safarova, Z. KobalavaMoscow-RUSSIA
13 385 / CHARACTERISTICS OF ACUTE HEART FAILURE PATIENTS WITH HISTORY OF LONGSTANDING HYPERTENSION MANIFESTED AS PULMONARY OEDEMA (DATA FROM THE AHEAD REGISTRY)M. Felsoci (1), J. Parenica (1), J. Jarkovsky (1), J. Widimsky (2), A. Linhart (2), F. Malek (2), M. Fedorco (3), Z. Coufal (4), R. Miklik (1), J. Spinar (1)(1) Brno, (2) Prague, (3) Olomouc, (4) Zlin-CZECH REPUBLIC
13 386 / EFFECT OF COMBINATION THERAPY WITH BONE-MARROW MONONUCLEAR CELLS IMPLANTATION AND FASUDIL ON ANGIOGENESIS AND CARDIAC PERFORMANCE IN MYOCARDIAL ISCHEMIAN. Kobayashi, H. Takeshima, W. Koguchi, M. Ishikawa, F. Sugiyama, T. IshimitsuTochigi-JAPAN
Sunday
19
332Sunday 19332 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011333
Sunday 1914.00 - 15.30Ground Floor
Poster Session 29
CLINICAL ASPECTS
ROOMS 14-15 / POSTERS FROM 399 TO 441
Chairperson: J. Segura (Madrid-SPAIN)
14-15 399 / ALBUMINURIA IN RELATION TO THE SINGLE AND COMBINED EFFECTS OF SYSTOLIC AND DIASTOLIC BLOOD PRESSURES IN CHINESEC. Sheng, B. Hu, J. Zou, Y. Li, J. Wang Shanghai-CHINA
14-15 400 / COMPARATIVE ANALYSIS OF ESSENTIAL HYPERTENSIVE PATIENTS SURVIVAL IN DEPENDENCE OF CONCOMITANT CONDITIONSA. Barsukov, T. Sveklina, S. ShoustovSt. Petersburg-RUSSIA
14-15 401 / HEART RATE IN PATIENTS WITH ARTERIAL HYPERTENSIONR. Zivkovic, B. Ladjevic, O. Milovic, L.J. Suric Lambic, M. ZdravkovicBelgrade-SERBIA
14-15 402 / THE APELIN CONCENTRATION IN YOUNG HYPERTENSIVE PATIENTS WITH EXCEEDED BODY WEIGHTA. Strazynska, W. Bryl, K. Hoffmann, D. Pupek-MusialikPoznan-POLAND
14-15 403 / PROGNOSTIC IMPORTANCE OF HEART RATE AND INTERACTION WITH BETA-BLOCKER IN RESISTANT HYPERTENSIONE. Muxfeldt, P. Dick, R. Fiszman, F. Souza, G. SallesRio De Janeiro-BRAZIL
14-15 404 / MICROALBUMINURIA IN NON DIABETIC HYPERTENSIVESN. Vijayakumar, J. Rajesh, S. VithiavathiPuducherry-INDIA
13 395 / MYOCARDIAL HIBERNATION IN ARTERIAL HYPERTENSION AND ACUTE MYOCARDIAL INFARCTION AS PREDICTOR OF HEART FAILUREO. Barnett, Y. KyyakLviv-UKRAINE
13 396 / OSTEOPONTIN PLASMA LEVEL AS A TARGET IN THE ASSESSMENT OF SEVERITY HEART FAILURE AND CARDIAC REMODELLINGA. Berezin (1), V. Seden (2)(1) Zaporozhye, (2) Kherson-UKRAINE
13 397 / ASSESSMENT OF RIGHT VENTRICULAR FUNCTION MAY PREDICT THE NEW ONSET DIASTOLIC HEART FAILURE IN HYPERTENSIVE PATIENTSK. Hristova (1), A. La Gerche (2), Tz. Katova (1), V. Kostova (1), I. Simova (1)(1) Sofia-BULGARIA; (2) Leuven-BELGIUM
13 398 / PROGNOSTIC FACTORS OF THE DEPRESSED LEFT VENTRICULAR FUNCTION IN HYPERTENSIVE PATIENTS WITH PACINGE. Belu, R. Musetescu, C. Bataiosu, M. Popescu, M. Cosulschi, N. Florescu, D.-D. IonescuCraiova-ROMANIA
Sunday
19
334Sunday 19334 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011335
Sunday 19 14-15 412 / PROFILE OF THE YOUNG HYPERTENSIVE PATIENTS ADMITTED TO A DEPARTMENT OF INTERNAL MEDICINEM.Á. Barón Ramos, A.A. Perez Rivera, A. Ruz Zafra, M.I. Maiz Jiménez, C. Luque Amado, A. Muñoz Claros, I. Gallardo Romero, F.M. Godoy Guerrero, A. Ruiz CanteroRonda-SPAIN
14-15 413 / PROFILE OF REFERRED HYPERTENSIVE PATIENTS FROM PRIMARY CARE TO SPECIALIZED CAREN. Martell-Claros, J.L. Zamorano, A. Galgo-NafriaMadrid-SPAIN
14-15 414 / ASSOCIATION OF C-REACTIVE PROTEIN AND LIPID PROFILE WITH SUBCLINICAL ORGAN DAMAGE BASED ON ANKLE BRACHIAL INDEX IN THE GROUP OF HYPERTENSIVE PATIENTSL. Woznicka-Leskiewicz, A. Posadzy-MalaczynskaPoznan-POLAND
14-15 415 / ACEI-RELATED ANGIOEDEMA: LONG-TERM STUDY FOLLOW-UP OF 111 PATIENTSL.M. Beltrami, L.C. Zingale, R. Vacchini, L.A. Dalla Vecchia, S. Carugo, M. CicardiMilan-ITALY
14-15 416 / INTERCONNECTION OF AN UNFAVOURABLE BLOOD PRESSURE PROFILE AND ARRHYTHMIAS IN HYPERTESIVE PATIENTSE. Rebeko, A. MrochekMinsk-BELARUS
14-15 417 / THE CORRELATION BETWEEN MICROALBUMINURIA AND THE DETERMINING ACTIVITY FACTORS OF RHEUMATOID ARTHRITISV. Duraj, M. Gjata, L. Collaku, A. TafajTirana-ALBANIA
14-15 418 / INFLUENCE OF SMOKING ON MINERALS STATUS AND SERUM LIPIDS AND GLUCOSE IN HYPERTENSIVE PATIENTSJ. Suliburska, P. Bogdanski, M. Szulinska, D. Pupek-MusialikPoznan-POLAND
14-15 419 / INVESTIGATION OF SUBCLINICAL TARGET ORGAN DAMAGES, CARDIAC AUTONOMIC NEUROPATHY AND BAROREFLEX-SENSITIVITY IN DIABETIC AND NON-DIABETIC HYPERTENSIVESP. Legrady (1), I. Fejes (1), D. Bajcsi (1), P. Kempler (2), A. Kovacs (1), A. Letoha (1), I. Torok (1), G. Abraham (1)(1) Szeged, (2) Budapest-HUNGARY
14-15 405 / COMPLICATIONS DURING THE FIRST WEEK OF HOSPITALIZATION IN HYPERTENSIVE PATIENTS WITH ACUTE MYOCARDIAL INFARCTIONR. Musetescu, D. Toader, E. Belu, A.E. Musetescu, M. Popescu, D.D. IonescuCraiova-ROMANIA
14-15 406 / PREDICTORS AND IMPACT OF MITRAL REGURGITATION IN HYPERTENSIVE PATIENTS WITH A MYOCARDIAL INFARCTIONS. Barra, R. Providência, L. Paiva, P. Gomes, F. Caetano, C. Faustino, A. Leitão MarquesVila Nova De Gaia-PORTUGAL
14-15 407 / PREVALENCE OF MICROALBUMINURIA AND STATINS TREATMENTC. Mena, N.R. Robles, J. Polo, J. Velasco, E. Angulo, J. EspinosaBadajoz-Caceres-SPAIN on behalf of MICREX Investigators Group
14-15 408 / NON STEROIDAL ANTIINFLAMMATORY DRUGS OR ASPIRIN TREATMENT: INFLUENCE ON MICROALBUMINURIA PREVALENCEC. Mena, N.R. Robles, J. Velasco, J. Polo, E. Angulo, J. EspinosaBadajoz-Caceres-SPAIN on behalf of MICREX Investigators Group
14-15 409 / FACTORS ASSOCIATED WITH INCREASED CAROTID INTIMA-MEDIA THICKNESS AND BEING NON-DIPPER ON 24 HOUR AMBULATORY BLOOD PRESSURE IN NON-OBESE NORMOTENSIVE YOUNG PATIENTS AFFECTED BY PCOSS. Ertek (1), E. Akgul (1), A.F. Cicero (2), S. Cehreli (1), G. Erdogan (1)(1) Ankara-TURKEY, (2) Bologna-ITALY
14-15 410 / INFLUENCE OF BLOOD PRESSURE AND BODY MASS INDEX ON THE EFFICACY OF IVABRADINE IN THAI PATIENTS WITH CHRONIC STABLE ANGINA PECTORISD. Piyayotai, P. ChotnoparatpatBangkok-THAILAND
14-15 411 / THE ASSOCIATIONS BETWEEN 24-H AMBULATORY BLOOD PRESSURES MONITORING PARAMETERS, 24-HOUR URINE COLLECTION SODIUM AND POTASSIUM EXCRETION AND MICROALBUMIN/CREATININE RATIO IN PATIENTS WITH ESSENTIAL HYPERTENSIONA. Brzeska, J. Porzezinska-Furtak, K. Widecka, T. MiazgowskiSzczecin-POLAND
Sunday
19
336Sunday 19336 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011337
Sunday 19 14-15 428 / TARGET ORGAN INJURY IN HYPERTENSION: INTESTINAL DYSBIOSIS AND LIPIDS PROFILE IN PATIENTS WITH ARTERIAL HYPERTENSION AND THEIR RELATION TO GENES POLYMORPHISM OF ACE (I/D) AND AGTR1 (A1166S)P. Ursuliak, O. Kushnir, L. Sydorchuk, R. Sydorchuk, A. SydorchukChernivtsi-UKRAINE
14-15 429 / THE POWERFUL ADDITIVE PREDICTIVE EFFECT OF NOCTURNAL HEMODYNAMICS AND ARTERIAL STIFFNESS ON THE DEVELOPMENT OF MICROALBUMINURIA IN HYPERTENSION: A 6-YEAR FOLLOW-UP STUDYE. Andrikou, C. Tsioufi s, C. Thomopoulos, A. Kordalis, I. Andrikou, M. Giakoumis, L. Lioni, K. Kintis, I. Bafakis, C. Stefanadis Athens-GREECE
14-15 430 / EVALUATION OF ESTIMATED GLOMERULAR FILTRATION RATE USING COCKROFT GAULT AND CKD-EPI FORMULAS IN A COHORT OF PATIENTS WITH METABOLIC SYNDROME AND DIABETES MELLITUSL. Rimsevicius, V. Skorniakov, A. Laucevicius, M. MiglinasVilnius-LITHUANIA
14-15 431 / PREDICTORS OF LEFT VENTRICLE HYPERTROPHY DEVELOPMENT IN PATIENTS WITH UNCOMPLICATED ARTERIAL HYPERTENSION SHOWING HIGH COMPLIANCE WITH TREATMENTN. Koziolova (1), I. Shatunova (2)(1) Perm, (2) Moscow-RUSSIA
14-15 432 / RELATIONSHIP BETWEEN CARDIOVASCULAR REACTIVITY TO A MENTAL STRESS TASK AND ENDOTHELIUM-DEPENDENT VASODILATION OR TARGET ORGAN DAMAGE IN RESISTANT HYPERTENSIVE SUBJECTSP. Armario, P. Castellanos, M. Larrousse, R. Hernandez-Del-Rey, S. Vázquez, L. Sans, A. Oliveras, A. De La Sierra, M. Martin-BaraneraBarcelona-SPAIN
14-15 433 / ASSOCIATION BETWEEN EYE VASCULATURE ALTERATIONS AND RENAL DAMAGE IN ESSENTIAL HYPERTENSIVES WITH METABOLIC SYNDROMEV. Katsi, G. Souretis, N. Alexopoulos, D. Papoutsis, I. Vlasseros, A.N. Koumoulidis, D. Barlagiannis, C.H. Stefanadis, I. KallikazarosAthens-GREECE
14-15 434 / GENDER FEATURES OF MICROALBUMINURIA AND ITS ASSOCIATION TO INTRARENAL HEMODYNAMIC AND LEPTIN LEVEL IN ESSENTIAL HYPERTENSIONV.I. Podzolkov, A.E. Bragina, J.N. RodionovaMoscow-RUSSIA
14-15 420 / RISK STRATIFICATION AND EFFECTS OF PERCUTANEOUS CORONARY INTERVENTION AND THE PHARMACOTHERAPY INITIATED IN THE FIRST 24 HOURS ON IN-HOSPITAL MORTALITY IN PATIENTS WITH THE FIRST MYOCARDIAL INFARCTIONJ. Peleska (1), J. Reissigova (1), M. Tomeckova (1), H. Grunfeldova (2), P. Jansky (1), Z. Monhart (3), J. Vojacek (4), P. Widimsky (1), J. Zvarova (1)(1) Prague, (2) Caslav, (3) Znojmo, (4) Hradec Kralove-CZECH REPUBLIC
14-15 421 / THE FEATURES OF METABOLIC SYNDROME IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH HYPERTENSIONR. Yatsyshyn, N. YatsyshynIvano-Frankivsk-UKRAINE
14-15 422 / WATER BALANCE CHANGES IN PATIENTS WITH ARTERIAL HYPERTENSIONN. Bulanova, G. Ivanov, S. Kuznetsova Moscow-RUSSIA
14-15 423 / ADAPTED PHYSICAL EXERCISE AND DAILY ACTIVITIES IN ELDERLY PEOPLE AFFECTED BY COGNITIVE DECLINEF. D’Amico, R. Natoli, P. CrescentiMessina-ITALY
14-15 424 / ASSOCIATION BETWEEN FASTING OR NON-FASTING HYPERTRIGLYCERIDEMIA AND SUBCLINICAL ORGAN DAMAGES AND CARDIOVASCULAR DISEASEC. Park, J. Kim, J. Na, C. Choi, H. Lim, E. Kim, S. Rha, H. Seo, D. OhSeoul-SOUTH KOREA
14-15 425 / LEFT VENTRICULAR HYPERTROPHY NOT ALWAYS REGRESSES WITH THE LOWERING OF BLOOD PRESSURED. Piskorz, A. TommasiRosario-ARGENTINA
14-15 426 / ELECTROCARDIOGRAM AND CHANCE OF REVERSAL OF LEFT VENTRICULAR HYPERTROPHYD. Piskorz, A. TommasiRosario-ARGENTINA
14-15 427 / ANKLE-BRACHIAL INDEX AND CARDIOVASCULAR RISK IN 1057 HYPERTENSIVE PATIENTS. A RETROSPECTIVE ANALYSISJ. Maldonado (1), T. Pereira (1), P. Rodrigues (2), M. Carvalho (2)(1) Coimbra, (2) Aveleira-PORTUGAL
Sunday
19
338Sunday 19338 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011339
Sunday 1914.00 - 15.30Ground Floor
LATE-BREAKER POSTER SESSION 2
ROOM 17 / POSTERS FROM 442 TO 454
Chairperson: J. Jordan (Hannover-GERMANY)
17 442 / SWITCHING THERAPY TO BEDTIME OF UNCONTROLLED HYPERTENSIONR. Farah, Rola FarahNahariya-ISRAEL
17 443 / NEW INDICES DERIVED FROM AMBULATORY BLOOD PRESSURE AND HEART RATE VARIABILITY ARE ASSOCIATED WITH SURVIVALB. Gavish (1), M. Bursztyn (2)(1) Lod, (2) Jerusalem-ISRAEL
17 444 / HYPERTENSION IS DIFFICULT TO CONTROL IN SUBJECTS WITH HIGH CREATINE KINASEL. Brewster (1), I. Oudman (1), J. Clark (2), G Vanmontfrans (1)(1) Amsterdam-THE NETHERLANDS; (2) Cincinnati-USA
17 445 / THE IMPACT OF POORLY CONTROLLED HYPERTENSION ON AMBULATORY CARE RESOURCES IN MALAYSIAQ. Alefan (1), M. Izham (2), T.A.Razak (1), A. Ayub (3)(1) Kuantan, (2) Penang, (3) Petaling Jaya-MALAYSIA
17 446 / RESULTS OF MONITORING OF BLOOD PRESSURE IN POSTMENOPAUSAL WOMEN WITH HYPERTENSION DEPENDING ON THE BONE MINERAL DENSITYI. Golovach, T. Chipko, D. Golovach, O. Lasorenko, A. Vlasenko, O. Avramenko,V. MatijkoKyiv-UKRAINE
17 447 / AMBULATORY BLOOD PRESSURE MONITORING FOR STRATIFICATION OF CARDIOVASCULAR RISK IN OBESE AND NON-OBESE SUBJECTST.W. Hansen (1), K. Asayama (2), L. Thijs (2), J. Boggia (3), Y. Li (4), M. Kikuya (5), T. Ohkubo (5), C. Torp Pedersen (1), K. Stolarz-Skrzypek (6), V. Tikhonoff (7), S. Malyutina (8), L. Lind (9), K. Kawecka-Jaszcz (6), Y. Imai (5), J.A. Staessen (2), on behalf of the IDACO Investigators(1) Copenhagen-DENMARK; (2) Leuven-BELGIUM; (3) Montevideo-URUGUAY; (4) Shanghai-CHINA, (5) Sendai-JAPAN; (6) Krakow-POLAND; (7) Padua-ITALY; (8) Novosibirsk-RUSSIA; (9) Uppsala-SWEDEN
14-15 435 / URINARY ALBUMIN EXCRETION-PREVALENCE IN HYPERTENSIVE PATIENTS IN SLOVENIA AND TELMISARTAN REDUCTION EFFECTJ. Brguljan, R. Accetto, B. Salobir, P. DolencLjubljana-SLOVENIA
14-15 436 / CLINICAL, MORPHOLOGICAL AND DOPPLER CHARACTERISTIC OF OBESE AND NON OBESE HYPERTENSIVE PATIENTS. IT TAKES TWO TO TANGOI. Burazor (1), S. Stefanovic (2), M. Burazor (1), V. Stefanovic (2)(1) Nis-SERBIA; (2) Knjazevac-JUGOSLAVIJA
14-15 437 / HYPERURICEMIA CONTRIBUTES TO HYPERTENSION AND RENAL DYSFUNCTIONK. TakedaKyoto-JAPAN
14-15 438 / THE PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION IN THE HOSPITAL PRACTICEA.U. Gurina, S.U. Volkova, I.V. MedvedevaTyumen-RUSSIA
14-15 439 / VERY PREMATURE BIRTH INFLUENCES BLOOD PRESSURE AND SUBCLINICAL ORGAN DAMAGE IN YOUNG MEN BORN SMALL FOR GESTATIONAL AGEM. Laganovic, D. Kuzmanic, I. Vukovic Lela, M. Vrkic Kirhmajer, L.J. Banfi c, M. Miloševic, V. Premužic, S. Karanovic, L.J. Fodor, B. JelakovicZagreb-CROATIA
14-15 440 / MICROALBUMINURIA AND SERUM URIC ACID LEVELS IN PREECLAMPTIC WOMENM. Craina, P. Stanciu, E. Bernad, C. Serban, R. NituTimisoara-ROMANIA
14-15 441 / ASSOCIATION OF INFLAMMATORY SYNDROME WITH PREECLAMPSIAM. Craina, P. Stanciu, E. Bernad, C. Serban, R. NituTimisoara-ROMANIA
Sunday
19
340Sunday 19340 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011341
Sunday 1914.30 - 15.30Auditorium
Meet-The-Expert Session
HOW TO READ AND INTERPRET THE RESULTS OF TRIALS
Chairperson: B. Dahlöf (Goteborg-SWEDEN)
17 448 / RELATIONSHIP BETWEEN FAT TISSUE DISTRIBUTION, METABOLIC ABNORMALITIES AND TARGET ORGAN DAMAGE IN CHILDREN WITH PRIMARY HYPERTENSION - PROSPECTIVE STUDYA. Niemirska, M. Litwin, E. JurkiewiczWarsaw-POLAND
17 449 / AUTOMATED OFFICE BLOOD PRESSURE RECORDED AT ONE MINUTE INTERVALSM. MyersToronto-CANADA
17 450 / INSULIN PROMOTES VASCULAR SMOOTH MUSCLE CELL PROLIFERATION VIA MICRORNA-208 MEDIATED DOWN-REGULATION OF P21Y. Zhang, Y. Wang, X.K. Wang, Y. Zhang, C. ZengChongqing-CHINA
17 451 / SOLUBLE FORM OF ENDOTHELIN CONVERTING ENZYME-1 IN CEREBROSPINAL FLUID: A POTENTIAL BIOMARKER OF CEREBRAL VASOSPASMS. KuruppuClayton-AUSTRALIA
17 452 / THE RESPONSE OF BLOOD PRESSURE IN SALT-SENSITIVE PATIENTS TO TEST THE LOADA. Kirichenko, Y. Novichkova, N. ZakirovaMoscow-RUSSIA
17 453 / PECULIARITIES OF DAILY RHYTHM IN SALT-SENSITIVE PATIENTS WITH ARTERIAL HYPERTENSIONA. Kirichenko, Y. Novichkova, N. ZakirovaMoscow-RUSSIA
17 454 / 24 HOUR AMBULATORY RECORDING OF AORTIC PULSE WAVE VELOCITY AND CENTRAL SYSTOLIC AUGMENTATION — A FEASIBILITY STUDYL. Luzardo (1), I. Lujambio (1), M. Sottolano (1), A. da Rosa (1), O. Noboa (1), L. Thijs (2), J.A. Staessen (3), J. Boggia (1)(1) Montevideo-URUGUAY; (2) Leuven-BELGIUM; (3) Maastricht-THE NETHERLANDS
Sunday
19
342Sunday 19342 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011343
Sunday 1914.30 - 15.30Blue Hall
How-To Session
Supported by an unrestricted educational grant by Fukuda Denshi
CARDIO-ANKLE VASCULAR STIFFNESS INDEX (CAVI)
Chairperson: R. Asmar (Paris-FRANCE)
CAVI as a novel indicator of vascular functionA. Schmidt-Trucksäss (Basel-SWITZERLAND) Assessment of CAVI in healthy population and subjects with chronic lifestyle-related diseasesP. Dobšák (Brno-CZECH REPUBLIC) Aortic stiffness and cardiac function: insights from CAVIP. Leeson (Oxford-UK)
14.30 - 15.30Red Hall
Minisymposium
Supported by an unrestricted educational grant by Medtronic Ardian
CATHETER-BASED RENAL DENERVATION TREATMENT FOR HYPERTENSION
Chairpersons: G. Grassi (Milan-ITALY) R.E. Schmieder (Erlangen-GERMANY)
IntroductionR.E. Schmieder (Erlangen-GERMANY) Renal denervation in essential hypertension - Physiology and historical perspectiveG. Mancia (Milan-ITALY) Catheter-based renal denervation, clinical results (Symplicity HTN-1 and HTN-2 Trials)M. Esler (Melbourne-AUSTRALIA) Catheter-based renal denervation, additional indications, background and physiologyM. Schlaich (Melbourne-AUSTRALIA) Closing commentsG. Grassi (Milan-ITALY)
Sunday
19
344Sunday 19344 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011345
Sunday 1914.30 - 15.30Orange Hall 2
Clinical Case
PHEOCHROMOCYTOMA AND MEDULLARY CARCINOMA OF THYROID GLAND
Chairperson: M. Castellano (Brescia-ITALY)
14.30 - 15.30Yellow Hall
How-To Session
HOW TO ASSESS PATIENT’S COMPLIANCE TO TREATMENT
Chairpersons: M. Viigimaa (Tallinn-ESTONIA) S. Erdine (Istanbul-TURKEY)
Sunday
19
346Sunday 19346 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011347
Sunday 1915.30 - 17.00 Auditorium
Parallel Oral Session 6A
BLOOD PRESSURE MEASUREMENT
Chairpersons: K. Kiowski (Zurich-SWITZERLAND) B. Waeber (Lausanne-SWITZERLAND) 15.30LECTURETHE CARDIOVASCULAR SYSTEM AT HIGH ALTITUDEG. ParatiMilan-ITALY
15.50VALIDATION OF THE NON-INVASIVE ASSESSMENT OF CENTRAL BLOOD PRESSURE BY THE SPHYGMOCOR AND OMRON DEVICES AGAINST THE INVASIVE CATHETER MEASUREMENTF.H. Ding, Y. Li, R.Y. Zhang, Q. Zhang, W.X. Fan, J.G. WangShanghai-CHINA 16.00TRONCO-CONICAL CUFFS CAN PROVIDE MORE ACCURATE BLOOD PRESSURE MEASUREMENTS THAN CYLINDRICAL CUFFS IN PEOPLE WITH LARGE ARMSE. Benetti (1), S. Masiero (1), C. Fania (1), A. Pimazzoni (2), P. Palatini (1)(1) Padua, (2) Costermano-ITALY
16.10PROGNOSTIC VALUE OF WITHIN-AND BETWEEN-VISIT BLOOD PRESSURE VARIABILITY IN A POPULATION STUDYA. Odili (1), T. Kuznetsova (2), L. Thijs (2), J. Yu (2), J. Staessen (2)(1) Abuja-NIGERIA; (2) Leuven-BELGIUM 16.20PROGNOSTIC ACCURACY OF AMBULATORY BLOOD PRESSURE VARIABILITY IN TREATED HYPERTENSIVES FOLLOWED-UP FOR 8,2 YEARSJ. Bastos (1), S. Bertoquini (2), J. Polonia (2)(1) Aveiro, (2) Porto-PORTUGAL
14.30 - 15.30Orange Hall 3
Minisymposium for Italian GP’s
PROTEZIONE CARDIOVASCOLARE A 360°
Moderatori: E. Ambrosioni (Bologna) A.C. Pessina (Padova)
Moderno inquadramento del paziente cardiovascolare: i criteri di scelta tra la monoterapia e la terapia di associazioneP. Verdecchia (Perugia) Discussione Il ruolo della prevenzione: è vero che non possiamo sostenere i costi?F.V. Costa (Bologna) Discussione
Sunday
19
348Sunday 19348 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011349
Sunday 1915.30 - 17.00 Red Hall
Topical Workshop
PROTECTING THE KIDNEY IN HYPERTENSION: A REAPPRAISAL OF THE EVIDENCE
Chairpersons: J.L. Rodicio (Madrid-SPAIN) J. Redon (Valencia-SPAIN) Debate:Blood pressure should be lowered below 125/75 mmHg
Pro: M. Burnier (Lausanne-SWITZERLAND)Against: L.M. Ruilope (Madrid-SPAIN) Changes in GFR and albuminuria - What does it mean?R.E. Schmieder (Erlangen-GERMANY)
16.30PROGNOSTIC VALUE OF AMBULATORY BLOOD PRESSURE MONITORING IN VERY ELDERLY PATIENTS´ MORTALITYP. Cuffaro, D. Giunta, M.L. Posadas Martínez, M. Rada, M. Morales, J. Barochiner, L. Aparicio, J. Alfi e, C. Galarza, G. WaismanBuenos Aires-ARGENTINA 16.40PREDICTIVE VALUE OF ABPM DERIVED VASCULAR INDICES IN DIFFERENT AGE STRATA. RESULTS OF DUBLIN OUTCOME STUDYG. Bilo (1), B. Gavish (2), E. Dolan (3), E. O’Brian (3), G. Mancia (1), G. Parati (1)(1) Milan-ITALY; (2) Lod-ISRAEL; (3) Dublin-IRELAND
16.50DIAGNOSTIC ACCURACY OF HOME BLOOD PRESSURE MONITORING: THE MEDIT-HABP STUDY (MEDITERRANEAN HOME VS. AMBULATORY BP)G.S. Stergiou (1), E.G. Nasothimiou (1), S. Omboni (2), A. De La Sierra (3), L.M. Ruilope (4), G. Parati (5)(1) Athens-GREECE; (2) Varese-ITALY; (3) Terrassa-SPAIN; (4) Madrid-SPAIN; (5) Milan-ITALY
Sunday
19
350Sunday 19350 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011351
Sunday 1915.30 - 17.00 Orange Hall 1
Parallel Oral Session 6B
HEALTH CARE STRATEGIES
Chairpersons: J.P. Nazaré (Lisbon-PORTUGAL) B.H. Watschinger (Wien-AUSTRIA) 15.30EFFECTS OF A MULTIFACETED INTERVENTION ON GPS ON THE CARDIOVASCULAR RISK FACTORS OF HIGH RISK HYPERTENSIVE PATIENTS. ESCAPE TRIALD. Pouchain (1), D. Huas (1), J.P. Lebeau (1), F. Boutitie (2), M. Lievre (2), E. Bruckert (3), J. Chapman (3), X. Girerd (3)(1) Vincennes, (2) Lyon, (3) Paris-FRANCE
15.40PHYSICIAN INERTIA IN RELATION TO ACHIEVEMENT OF BP GOALS IN HYPERTENSIVE PATIENTS WITH COMORBIDITIES IN THE SHARE SURVEYR.E. Schmieder (1), J. Redon (2)(1) Erlangen-GERMANY; (2) Valencia-SPAIN 15.50RANDOMIZED EVALUATION OF THE EFFECTS OF A STRUCTURED EDUCATIONAL PROGRAM (HERZ.LEBEN) ON BLOOD PRESSURE IN ESSENTIAL HYPERTENSIVE PATIENTSR. Zweiker, S. Perl, V. Riegelnik, C. Kos, P. Mrak, H. Ederer, I. Rakovac, P. Beck, G. Klima, H. Nagy, T. PieberGraz-AUSTRIA 16.00DISCREPANCY BETWEEN ACCEPTANCE AND IMPLEMENTATION OF BLOOD PRESSURE GUIDELINES (SHARE-BELGIUM)A. Persu, P. Van der Niepen, on behalf of the Supporting Hypertension Awareness and Research Europe-wide (SHARE) Steering CommitteeBrussels-BELGIUM
15.30 - 17.00 Blue Hall
Topical Workshop
REGULATORY ASPECTS OF HYPERTENSION DRUGS DEVELOPMENT AND APPROVAL
Chairpersons: E. Ambrosioni (Bologna-ITALY) C. Farsang (Budapest-HUNGARY) The European Medicines Regulatory NetworkC. Avendaño (Madrid-SPAIN)
Discussion
The expanding use of generics. Advantages and problemsE. Degli Esposti (Ferrara-ITALY)
Discussion
The extended role of nurses in the management of chronic diseaseD. Morin (Lausanne-SWITZERLAND) Discussion
Sunday
19
352Sunday 19352 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011353
Sunday 1915.30 - 17.00 Orange Hall 2
Parallel Oral Session 6C
CLINICAL TRIALS
Chairpersons: A. Mimran (Montpellier-FRANCE) J.A. Staessen (Leuven-BELGIUM) 15.30DETAILED ANALYSIS OF VALSARTAN ON STROKE EVENT REDUCTION IN JAPANESE HIGH-RISK HYPERTENSIVE PATIENTS – NEW FINDING FROM KYOTO HEART STUDYT. Sawada, S. Kimura, J. Shiraishi, H. Yamada, H. Matsubara Kyoto-JAPAN
15.40USEFULNESS OF THE NUMBER NEEDED TO TREAT (OR TO HARM) IN CLINICAL TRIALS. REVIEW OF THE IMPACT OF ANTIHYPERTENSIVE TREATMENTS ON CORONARY OUTCOME AND MORTALITY REDUCTIONJ. Mourad (1), K. Kobalava (2)(1) Bobigny-FRANCE; (2) Moscow-RUSSIA 15.50HIGHER CARDIOVASCULAR (CV) RISK OF HYPERTENSIVE PATIENTS REQUIRING ADD-ON THERAPY IN THE FELODIPINE EVENT REDUCTION (FEVER) RANDOMIZED TRIALY.Q. Zhang (1) X.Z. Zhang (1) L.S. Liu (1) A. Zanchetti (2), on behalf of FEVER Study Group(1) Beijing-CHINA; (2) Milan-ITALY 16.00EFFECTS OF SINGLE OR MULTIPLE DRUG THERAPIES ON CARDIOVASCULAR OUTCOMES IN HYPERTENSION: ANALYSIS OF DATA FROM THE VALUE TRIALM. Weber (1), S. Julius (2), S. Kjeldsen (3), Y. Jia (4), H. Brunner (5), D. Zappe (4), T. Hua (4), G. McInnes (6), A. Schork (2), G. Mancia (7), A. Zanchetti (7)(1) Brooklyn, (2) Ann Arbor-USA; (3) Oslo-NORWAY; (4) East Hanover-USA; (5) Lausanne-SWITZERLAND; (6) Glasgow-UK; (7) Milan-ITALY
16.10NON PHARMACOLOGICAL INTERVENTION TO TREAT HYPERTENSION: INTENSIVE VERSUS REFERRED CAREL.A. Ferrara, D. Pacioni, B. Russo, L. Staiano, R. Gente, V. Di Fronzo, M.F. Di Rosa, L. MaioneNaples-ITALY 16.20REDUCED COMPLIANCE WITH CURRENT GUIDELINES FOR TREATING TOBACCO USE AMONG HYPERTENSIVESV. Katsi, G. Souretis, I. Vlasseros, D. Alexopoulos, D. Papoutsis, P. Theodoropoulos, M. Divani, P. Bounas, J. Orestis, D. Barlagiannis, C. Benekos, Ch. Stefanadis, I. KallikazarosAthens-GREECE 16.30FAILURE TO INTENSIFY THERAPY RELATED TO INADEQUATE CONTROL OF HYPERTENSION AND DYSLIPIDEMIA: A COMBINED STITCH AND STITCH2 ANALYSISS. Nelson, G. Dresser, J. Mahon, B. Feagan, M. Vandervoort, C. Wong, R. FeldmanLondon-CANADA
16.40LECTUREECONOMIC ASPECT OF ANTIHYPERTENSIVE THERAPY: MODELS, SIMULATION AND PUBLIC HEALTH POLICYF. Gueyffi erLyon-FRANCE
Sunday
19
354Sunday 19354 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011355
Sunday 1915.30 - 17.00 Orange Hall 3
Parallel Oral Session 6D
RENIN ANGIOTENSIN SYSTEM AND VASOACTIVE SUBSTANCES
Chairpersons: B. Jelakovic (Zagreb-CROATIA) A.H. van den Meiracker (Rotterdam-THE NETHERLANDS) 15.30COMPOUND 21 INDUCES VASORELAXATION VIA AN ENDOTHELIUM - AND ANGIOTENSIN II TYPE 2 RECEPTOR-INDEPENDENT MECHANISMJ. Van Esch (1), K. Verdonk (1), W. Batenburg (1), E. Moltzer (1), R. Van Veghel (1), T. Unger (2), U. Steckelings (2), A. Danser (1)(1) Rotterdam-THE NETHERLANDS; (2) Berlin-GERMANY 15.40CHANGES IN BAROREFLEX CONTROL OF HEART RATE PRODUCED BY CENTRAL INFUSION OF THE NOVEL NONPEPTIDE AT2 RECEPTOR AGONIST, COMPOUND 21D. Villela (1), M. Campagnole-Santos (2), T. Unger (1), U. Steckelings (1), R. Santos (2)(1) Berlin-GERMANY; (2) Belo Horizonte-BRAZIL
15.50IMPACT OF NALP3 INFLAMMASOME ON BLOOD PRESSURE, RENIN AND RENAL AND CARDIAC HYPERTROPHY IN 2K1C AND DOCA/SALT MICEQ. Wang (1), A. So (1), J. Nussberger (1), S. Schaefer (2), M. Burnier (1)(1) Lausanne, (2) Bern-SWITZERLAND 16.00(PRO)RENIN RECEPTOR BLOCKADE COUNTERACTS THE BENEFICIAL VASCULAR EFFECTS OF RENIN INHIBITION IN DIABETIC TRANSGENIC MREN2 RATS (TGR(MREN2)27)W.W. Batenburg, M. van den Heuvel, J.H.M. van Esch, R. van Veghel, A.H.J. DanserRotterdam-THE NETHERLANDS
16.10REAL LIFE ANALYSIS OF BLOOD PRESSURE REDUCTION IN OVER 5000 RESISTANT HYPERTENSIVE PATIENTS: RESULTS FROM THE 3A REGISTRYR. Dechend (1), R.E. Schmieder (2), E.A. Kaiser (3), E. Deeg (4), J. Senges (4), U. Zeymer (4)(1) Berlin, (2) Erlangen, (3) Nuernberg, (4) Ludwigshafen-GERMANY 16.20BLOOD PRESSURE CONTROL AND CARDIOVASCULAR OUTCOME IN CORONARY ARTERY DISEASE: EVIDENCE FROM THE ACTION TRIALP.A. Meredith, S. Lloyd, I. Ford, H.L. ElliottGlasgow-UK 16.30INTENSIFIED ANTIHYPERTENSIVE THERAPY AND BLOOD PRESSURE VARIABILITY IN OLDER THAN 70 OF CHINESE HYPERTENSIVE PATIENTSZ. Jin, S. Guoying, Z. Xiaowei, Z. Ye, F. Pingya, W. JiguangShanghai-CHINA 16.40CLINIC AND 24 H LONG-TERM BLOOD PRESSURE VARIABILITY IN NON BETA-BLOCKER AND BETA-BLOCKER-TREATED HYPERTENSIVE PATIENTS. DATA FROM ELSA TRIALG. Mancia, R. Facchetti, G. Parati, A. ZanchettiMilan-ITALY
16.50CHANGES IN VISIT-TO-VISIT BP VARIABILITY WITH BETABLOCKER, DIURETIC AND CALCIUM ANTAGONISTH. Charvat (1), T. Bejan-Angoulvant (1), V. Musini (2), F. Boutitie (1), M. Perez (2), J.A. Staessen (3), S.J. Pocock (4), J.M. Wright (2), F. Gueyffi er (1)(1) Bron-FRANCE; (2) Vancouver-CANADA; (3) Leuven-BELGIUM; (4) London-UK
Sunday
19
356Sunday 19356 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011357
Sunday 1916.00 - 17.00Yellow Hall
Minisymposium
Supported by an unrestricted educational grant by Servier
WHAT ARE THE TRUE DIFFERENCES BETWEEN RAS INHIBITORS
Chairpersons: P. Camici (London-UK) N.R. Poulter (London-UK)
IntroductionP. Camici (London-UK) Basic researcher’s point of viewB. Lévy (Paris-FRANCE) Clinical researcher’s point of viewS. Taddei (Pisa-ITALY) Clinical trialist’s point of viewA.S. Hall (Leeds-UK) DiscussionAll participants ConclusionN.R. Poulter (London-UK)
16.10QUANTITATIVE ANALYSIS OF (PRO)RENIN RECEPTOR IN THE MEDIUM OF HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS, HUVECK.B. Biswas (1), A.H.M.N. Nabi (1), Y. Arai (1), T. Nakagawa (1), A. Ebihara (1), A. Ichihara (2), T. Inagami (3), F. Suzuki (1)(1) Gifu, (2) Tokyo-JAPAN; (3) Nashville-USA
16.20URINARY RENIN, BUT NOT ANGIOTENSINOGEN, REFLECTS RENAL RENIN-ANGIOTENSIN SYSTEM (RAS) ACTIVITY AND THE EFFICACY OF RAS BLOCKADE IN THE KIDNEYM. van den Heuvel, W. Batenburg, S. Jainandunsing, I. Garrelds, J. van Gool, A. van den Meiracker, A. DanserRotterdam-THE NETHERLANDS 16.30EFFECT OF OLMESARTAN ON OXIDATIVE STRESS IN HYPERTENSIVE PATIENTS. MECHANISTIC SUPPORT TO CLINICAL TRIALS DERIVED EVIDENCEL. Calò, L. Dal Maso, P. Caielli, E. Pagnin, M. Pengo, A.C. PessinaPadua-ITALY
16.40VTP-27999: A NOVEL RENIN INHIBITOR WITH POTENTIAL FOR SUPERIOR NEPHROPROTECTIONR. Gregg (1), G. McGeehan (1), C. Bryson (1), A. Danser (2), D. Claremon (1), J. Balcarek (1)(1) Fort Washington-USA; (2) Rotterdam-THE NETHERLANDS 16.50CELL-SPECIFIC DELETION OF THE TYPE 1A (AT1A) ANGIOTENSIN RECEPTOR FROM COLLECTING DUCT EXAGGERATES ANGIOTENSIN II - DEPENDENT HYPERTENSIONJ. Stegbauer (1), S.B. Gurley (2), M.A. Sparks (2), L.C. Rump (1), T.M. Coffman (2)(1) Düsseldorf-GERMANY; (2) Durham-USA
Sunday
19
358Sunday 19358 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011359
Sunday 1918.30 - 20.30Blue Hall
Satellite Symposium
Sponsored By Omron Healthcare Europe
CARDIOVASCULAR RISK REDUCTION – FROM CURRENT CLINICAL PRACTICE TO NEW APPROACHES
Chairpersons: A.J. Manolis (Athens-GREECE) J. Redon (Valencia-SPAIN)
IntroductionA.J. Manolis (Athens-GREECE) Blood pressure measurement: what’s new?J. Redon (Valencia-SPAIN) Role of central blood pressureG. Schillaci (Perugia-ITALY) Hypertension and arrhythmiasA.J. Manolis (Athens-GREECE) The role of infl ammation in heart disease and strokeC. Tsioufi s (Athens-GREECE) Closing remarksJ. Redon (Valencia-SPAIN)
17.00 - 18.30Auditorium
Plenary Session
Chairpersons: E. Ambrosioni (Bologna-ITALY) K. Narkiewicz (Gdansk-POLAND) J. Redon (Valencia-SPAIN)
17.00-18.00Presentation of Awards Björn Folkow AwardP.M. de Leeuw (Maastricht-THE NETHERLANDS) Alberto Zanchetti Life Achievement AwardA.L. Mark (Iowa City, IA-USA) Lennart Hansson Memorial LectureL.M. Ruilope (Madrid-SPAIN) Peter Sleight AwardE. Agabiti Rosei (Brescia-ITALY) Peter A. van Zwieten AwardM. Azizi (Paris-FRANCE) ESH Honorary MembershipD.L. Clement (Gent-BELGIUM) Servier Grant ResearchK.E. Kotliar (Munich-GERMANY) Paul Milliez AwardP.F. Plouin (Paris-FRANCE) Jiri Widimsky Sr AwardZ. Somloova (Prague-CZECH REPUBLIC)A. Rojek (Gdansk-POLAND)P. Studinger (Budapest-HUNGARY) 18.00Björn Folkow Award LectureMechanisms in hypertension: Gödel, Escher, Bach revisitedP.M. de Leeuw (Maastricht-THE NETHERLANDS)
Monday
20
21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011361
Monday 2007.45 - 08.45 Orange Hall 1
Breakfast Workshop
RESISTANT HYPERTENSION: WHICH DRUGS ?
Chairperson: S. Erdine (Istanbul-TURKEY) IntroductionS. Erdine (Istanbul-TURKEY) How to manage resistant hypertension in primary careA. Coca (Barcelona-SPAIN) Renal nerve ablation and barorefl ex stimulationR.E. Schmieder (Erlangen-GERMANY) ConclusionsS. Erdine (Istanbul-TURKEY)
Monday
20
362Monday 20362 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011363
Monday 2007.45 - 08.45 Orange Hall 3
Breakfast Workshop
PROGRESS IN CARDIOVASCULAR IMAGING
Chairperson: E. Agabiti Rosei (Brescia-ITALY) HeartM.L. Muiesan (Brescia-ITALY) Atherosclerotic plaqueS. Vermeersch (Gent-BELGIUM)
07.45 - 08.45 Orange Hall 2
Breakfast Workshop
THE PICKERING SYNDROME - A PEBBLE IN THE MOSAIC OF CARDIO-RENAL SYNDROME
Chairpersons: F.H. Messerli (New York, NY-USA) P. Sleight (Oxford-UK) Historic aspects and defi nition of the Pickering syndromeF.H. Messerli (New York, NY-USA) Pathogenesis, clinical fi ndings - The Pickering syndromeS. Rimoldi (Bern-SWITZERLAND) The cardio-renal syndrome - Classifi cation and therapeutic considerationsM. Burnier (Lausanne-SWITZERLAND)
Monday
20
364Monday 20364 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011365
Monday 209.40LONG-TERM EFFICACY AND SAFETY OF COMBINATION OLMESARTAN MEDOXOMIL/AMLODIPINE BESYLATE + HYDROCHLOROTHIAZIDE BASED ON HYPERTENSION SEVERITY: THE TRINITY STUDYD. Kereiakes (1), S. Chrysant (2), J. Izzo (3), T. Littlejohn (4), S. Oparil (5), M. Melino (6), J. Lee (6), V. Fernandez (6), R. Heyrman (6)(1) Cincinnati, (2) Oklahoma City, (3) Buffalo, (4) Winston-Salem, (5) Birmingham, (6) Parsippany-USA 9.50LONG-TERM EFFICACY AND SAFETY OF COMBINATION OLMESARTAN MEDOXOMIL/AMLODIPINE BESYLATE + HYDROCHLOROTHIAZIDE STRATIFIED BY DIABETES STATUS AND BODY MASS INDEX: SUBGROUP ANALYSES OF THE TRINITY STUDYS. Oparil (1), J. Izzo (2), S. Chrysant (3), D. Kereiakes (4), T. Littlejohn (5), M. Melino (6), J. Lee (6), V. Fernandez (6), R. Heyrman (6)(1) Birmingham, (2) Buffalo, (3) Oklahoma City, (4) Cincinnati, (5) Winston-Salem, (6) Parsippany-USA 10.00LONG-TERM EFFICACY AND SAFETY OF COMBINATION OLMESARTAN MEDOXOMIL/AMLODIPINE BESYLATE + HYDROCHLOROTHIAZIDE STRATIFIED BY RACE: A TRINITY STUDY SUBGROUP ANALYSISS. Chrysant (1), D. Kereiakes (2), J. Izzo (3), T. Littlejohn (4), S. Oparil (5), M. Melino (6), J. Lee (6), V. Fernandez (6), R. Heyrman (6)(1) Oklahoma City, (2) Cincinnati, (3) Buffalo, (4) Winston-Salem, (5) Birmingham, (6) Parsippany-USA
10.10DISTRIBUTION OF SYSTOLIC BLOOD PRESSURE REDUCTIONS FROM THE TRINITY STUDY: EFFICACY OF COMBINATION OLMESARTAN MEDOXOMIL + AMLODIPINE BESYLATE + HYDROCHLOROTHIAZIDET. Littlejohn (1), D. Kereiakes (2), S. Chrysant (3), J. Izzo (4), S. Oparil (5), M. Melino (6), J. Lee (6), V. Fernandez (6), R. Heyrman (6)(1) Winston-Salem, (2) Cincinnati, (3) Oklahoma City, (4) Buffalo, (5) Birmingham, (6) Parsippany-USA
09.00 - 11.00 Auditorium
Parallel Oral Session 7A
THERAPEUTIC ASPECTS
Chairpersons: M. Doumas (Thessaloniki-GREECE) F. Pinto (Sant M. Feira-PORTUGAL) 9.00DOSE-RESPONSE RELATIONSHIP OF AMLODIPINE / LOSARTAN COMBINATION IN HYPERTENSIONC. Park (1), H. Youn (1), S. Chae (2), J. Yang (3), M. Kim (4), T. Hong (4), C. Kim (5), J. Kim (1), B. Hong (1), J. Jeong (6), S. Park (1), J. Kwan (7), Y. Choi (1), S. Cho (1)(1) Seoul, (2) Taegu, (3) Ilsan, (4) Pusan, (5) Bundang, (6) Iksan, (7) Incheon-SOUTH KOREA
9.10RELATIONSHIP BETWEEN BLOOD PRESSURE AND LIPID PROFILE IN EUROPE. THE EURIKA STUDYC. BorghiBologna-ITALY 9.20ALDOSTERONE-RECEPTOR ANTAGONISTS LEAD TO PROLONGED BLOOD PRESSURE REDUCTION IN UNCONTROLLED HYPERTENSION: A RETROSPECTIVE ANALYSISP.M. Jansen (1), K. Verdonk (1), B.P. Imholz (2), A.H.J. Danser (1), A.H. van den Meiracker (1)(1) Rotterdam, (2) Waalwijk-THE NETHERLANDS 9.30THERAPEUTIC INFLUENCE OF COMBINATION THERAPY ON LEFT VENTRICULAR MASS INDEX IN ESSENTIAL HYPERTENSIVE PATIENTS IS RELATED TO POLYMORPHISMS OF ACE, AGTR1, ENOS, PPAR-GAMMA2, AND ADRBETA1 GENESL. Sydorchuk (1), K. Amosova (2), A. Sydorchuk (1), R. Sydorchuk (1), J. Ursuliak (1), I. Sydorchuk (1)(1) Chernivtsi, (2) Kyiv-UKRAINE
Monday
20
366Monday 20366 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011367
Monday 2009.00 - 10.30 Red Hall
Topical Workshop
ADVANCES IN ADRENAL HYPERTENSION
Chairpersons: G. Opocher (Padua-ITALY) P.F. Plouin (Paris-FRANCE) Recent advances in primary aldosteronismG.P. Rossi (Padua-ITALY) Recent progress in the genetics of pheochromocytoma and paragangliomaN. Burnichon (Paris-FRANCE) Hypertension in patients with hypercortisolism and/or adrenal incidentalomasM. Terzolo (Turin-ITALY)
10.20SINGLE-PILL COMBINATION OF TELMISARTAN 80 MG/AMLODIPINE 10 MG PROVIDES SUPERIOR BLOOD PRESSURE REDUCTIONS TO AMLODIPINE IN ADDED RISK HYPERTENSIVE PATIENTS: TEAMSTA DIABETES STUDYA.M. Sharma (1), G. Bakris (2), T.W. Littlejohn (3), J.M. Neutel (4), M. Kobe (5), N. Ting (5), L. Ley (6)(1) Edmonton-CANADA; (2) Chicago, (3) Winston Salem, (4) Tustin, (5) Ridgefield-USA; (6) Ingelheim-GERMANY 10.30SUPERIOR PERIPHERAL AND CENTRAL BLOOD PRESSURE CONTROL AFTER SWITCHING TYPE 2 DIABETIC PATIENTS WITH UNCONTROLLED HYPERTENSION FROM RAMIPRIL/HYDROCHLOROTHIAZIDE TO PERINDOPRIL/INDAPAMIDET. Mengden (1), W. Sehnert (2)(1) Bad Nauheim, (2) Dortmund-GERMANY 10.40THE EFFECT OF A COMBINATION OF ANGIOTENSIN RECEPTOR BLOCKER AND DIURETIC ON LEFT VENTRICULAR DIASTOLIC FUNCTION IN HYPERTENSIVE PATIENTS: A MULTICENTER TRIALH. Kihara (1), H. Ito (2), K. Ishii (3), H. Watanabe (4), K. Shimada (5), J. Yoshikawa (6), on behalf of EDEN Investigators(1) Asahikawa, (2) Okayama, (3) Osaka, (4) Tokyo, (5) Osaka, (6) Nishinomiya-JAPAN 10.50BETA-BLOCKERS ARE RELATIVELY OVERUSED IN FINLAND. WHY ARE WE NOT FOLLOWING THE GUIDELINES? RESULTS FROM A LARGE NATIONAL DATABASE BETWEEN 2000 AND 2006T. Ahola (1), A. Jula (1), I. Kantola (1), P. Puukka (1), A. Reunanen (2)(1) Turku, (2) Helsinki-FINLAND
Monday
20
368Monday 20368 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011369
Monday 2009.00 - 10.30 Yellow Hall
Topical Workshop
SMALL VESSELS - LARGE PROBLEMS
Chairpersons: E. Agabiti Rosei (Brescia-ITALY) J. Gasowski (Cracow-POLAND) IntroductionJ. Gasowski (Cracow-POLAND) Pathophysiology of small vessels in hypertensionC. Aalkjaer (Aarhus-DENMARK) Alterations in small artery structure and function in diabetes and obesityD. Rizzoni (Brescia-ITALY) Role of perivascular fat tissue in health and diseaseA.M. Heagerty (Manchester-UK) Small vessels disease of the brain: from genes through hypertension to ageingA. Slowik (Cracow-POLAND) General Discussion Concluding remarksE. Agabiti Rosei (Brescia-ITALY)
09.00 - 10.30Blue Hall
Educational Session
Supported by an unrestricted educational grant by Novartis
VASCULAR AGING: SHIFTING THE PARADIGM OF RISK ASSESSMENT AND PREVENTION/REDUCTION IN HYPERTENSION
Chairpersons: J. Cockcroft (Cardiff-UK) G. Mancia (Milan-ITALY)
IntroductionJ. Cockcroft (Cardiff-UK) Defi ning vascular aging and CV riskS. Laurent (Paris-FRANCE) Impact of vascular aging on CVDP. Nilsson (Malmö-SWEDEN) Interventions to reduce central aortic pressure, arterial stiffness and morbidity mortalityB. Williams (Leicester-UK) Towards scoring of vascular aging and total CV predictionC. Vlachopoulos (Athens-GREECE) ConclusionsG. Mancia (Milan-ITALY)
Monday
20
370Monday 20370 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011371
Monday 209.40IMPAIRED RENAL FUNCTION IS ASSOCIATED WITH VASCULAR STIFFNESS AND INFLAMMATION IN PATIENTS WITH SEVERE CORONARY ARTERY DISEASES.H. Rossi (1), E.P. McQuarrie (1), R.M. Mackenzie (1), W.H. Miller (1), J.A. Dymott (1), M.U. Moreno (1), C. Taurino (1), A.M. Miller (1), U. Neisius (1), G.A. Berg (2), Z. Burneikaite (2), J. Hoyle (2), J.A. Hannay (1), A.F. Dominiczak (1), C. Delles (1)(1) Glasgow, (2) Clydebank-UK 9.50ARTERIAL STIFFNESS IS AN INDEPENDENT DETERMINANT OF COMPENSATORY HYPERFILTRATION AFTER KIDNEY DONATIONP. Fesler, J. Ribstein, G. du Cailar, G. Mourad, A. MimranMontpellier-FRANCE
10.00SHORT-TERM EFFECTS OF INTRARENAL EPROSARTAN INFUSION ON THE RENAL HANDLING OF ASYMMETRIC DIMETHYLARGININER. Ronden, A. Houben, C. Tazelaar, J. Bakker, J. Bierau, C. Stehouwer, P. de Leeuw, A. KroonMaastricht-THE NETHERLANDS 10.10RENAL DOPAMINERGIC ACTIVITY IS INCREASED IN THE RENALASE KNOCKOUT MOUSE MODELJ. Quelhas-Santos (1), P. Serrão (1), C. Fernandes-Cerqueira (1), L. Silva (1), I. Soares-Silva (1), D. Sizova (2), B. Sampaio-Maia (1), G. Desir (2), M. Pestana (1)(1) Porto-PORTUGAL; (2) New Haven-USA 10.20IN VIVO INTRARENAL EFFECTS OF ANGIOTENSIN II AT1- AND AT2-RECEPTOR BLOCKADE IN BOTH NORMAL AND DIABETIC RATSD. Patinha (1), A. Fasching (1), A. Albino-Teixeira (2), M. Morato (2), F. Palm (1)(1) Uppsala-SWEDEN; (2) Porto-PORTUGAL 10.30SUSTAINED REDUCTION OF CENTRAL SYMPATHETIC OUTFLOW AFTER RENAL DENERVATION IN END STAGE RENAL DISEASEM. Schlaich (1), G. Lambert (1), E. Lambert (1), H. Krum (1), T. Walton (1), P. Sobotka (2), M. Esler (1)(1) Melbourne-AUSTRALIA; (2) Mountain View-USA
10.40LECTUREHYPERTENSIVE NEPHROPATHY: CAUSE OR CONSEQUENCE?E. RitzHeidelberg-GERMANY
09.00 - 11.00 Orange Hall 1
Parallel Oral Session 7B
RENAL ASPECTS
Chairpersons: A.E. Birbari (Beirut-LEBANON) H. Ibsen (Holbaek-DENMARK) 9.00EVALUATION OF BLOOD PRESSURE BEFORE AND AFTER PERCUTANEOUS TRANSLUMINAL RENAL ANGIOPLASTY IN FIBROMUSCULAR DYSPLASIAJ. Smit (1), T. Wierema (2), P. de Leeuw (1)(1) Maastricht, (2) Tilburg-THE NETHERLANDS 9.10CYSTATIN C IS SUPERIOR TO CREATININE-BASED GFR ESTIMATES IN PREDICTION OF CARDIOVASCULAR EVENTS IN A MIDDLE-AGED CAUCASIAN POPULATIONP. Svensson-Färbom, M. Ohlson Andersson, B. Hedblad, G. Engström, A. Christensson, O. MelanderMalmö-SWEDEN
9.20PREVENTION OF MICROALBUMINURIA IN PATIENTS WITH TYPE 2 DIABETES AND HYPERTENSIONJ. Menne (1), J.L. Izzo (2), S. Ito (3), A. Januszewicz (4), S. Katayama (5), A. Mimran (6), T.J. Rabelink (7), E. Ritz (8), L.M. Ruilope (9), L.C. Rump (10), G.C. Viberti (11), H. Haller (1)(1) Hannover-GERMANY; (2) Buffalo-USA; (3) Sendai-JAPAN; (4) Warsaw-POLAND; (5) Iruma-JAPAN; (6) Montpellier-FRANCE; (7) Leiden-THE NETHERLANDS; (8) Heidelberg-GERMANY; (9) Madrid-SPAIN; (10) Düsseldorf-GERMANY; (11) London-UK 9.30LOW-GRADE RENAL ARTERY STENOSIS AND THE RENAL HANDLING OF THE NITRIC OXIDE SYNTHASE INHIBITOR ASYMMETRIC DIMETHYLARGININER. Ronden, A. Houben, J. Bakker, J. Bierau, C. Stehouwer, P. de Leeuw, A. KroonMaastricht-THE NETHERLANDS
Monday
20
372Monday 20372 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011373
Monday 209.50SODIUM AND POTASSIUM INTAKE OF THE ITALIAN ADULT POPULATION: PRELIMINARY RESULTS OF THE MINISAL-GIRCSI STUDYR. Ippolito (1), C. Donfrancesco (2), C. Lo Noce (2), O. Russo (1), L. Palmieri (2), D. Vanuzzo (3), F. Galletti (1), S. Giampaoli (2), P. Strazzullo (1)(1) Naples, (2) Rome, (3) Udine-ITALY 10.00OLIVETTI HEART STUDY: CIGARETTE SMOKING PREDICTS THE CHANGES IN BLOOD PRESSURE LEVELS AND THE RISK OF HYPERTENSIONL. D’Elia, D. De Palma, G. Rossi, R. Ippolito, P. Strazzullo, F. Galletti Naples-ITALY 10.10CAFFEINE INTAKE IS ASSOCIATED WITH REDUCED RISK OF HYPERTENSION IN NON-SMOKERSI. Guessous (1), M. Pruijm (1), F. Paccaud (1), V. Mooser (2), M. Burnier (1), G. Waeber (1), J.M. Gaspoz (3), P. Vollenweider (1), M. Bochud (1)(1) Lausanne-SWITZERLAND; (2) King of Prussia-USA; (3) Geneva-SWITZERLAND 10.20A POPULATION BASED ASSESSMENT OF CARDIOVASCULAR RISK FACTORS IN THE REGION OF MADRID (SPAIN)A. Sarria Santamera, M.A. Martin MartinezMadrid-SPAIN 10.30PREECLAMPTIC WOMEN DISPLAY SALT SENSITIVITY AND CARDIOVASCULAR DAMAGE BEFORE THEIR MENOPAUSEG. Martillotti, G. Wagner, J. Abdulcadir, M. Boulvain, O. Irion, P. Saudan, A. Pechere-BertschiGeneva-SWITZERLAND 10.40EFFECT OF SELF-ADMINISTERED RISK ASSESSMENT AND EDUCATIONAL INTERVENTION ON CARDIOVASCULAR RISK PROFILEJ. Tyszkiewicz, B. Symonides, J. Bugajska, Z. GaciongWarsaw-POLAND 10.50THE ROLE OF MATERNAL MALARIA IN THE RISE OF BLOOD PRESSURE IN NIGERIAN INFANTSOmolola Ayoola, I. Gemmell, P.E. Clayton, J.K. CruickshankManchester-UK
09.00 - 11.00 Orange Hall 2
Parallel Oral Session 7C
RISK FACTORS
Chairpersons: G. Leonetti (Milan-ITALY) L.S. Liu (Beijing-CHINA) 9.00MOST IMPORTANT CONSTITUENTS OF QUALITY OF LIFE OF ELDERLY PEOPLE WITH ARTERIAL HYPERTENSIONL. YankovskayaGrodno-BELARUS 9.10DAIRY CONSUMPTION AND INCIDENCE OF HYPERTENSION: DOSE-RESPONSE META-ANALYSIS OF PROSPECTIVE COHORT STUDIESL.D.M. Verberne (1), S.S. Soedamah-Muthu (1), E.L. Ding (2), F.B. Hu (2), J.M. Geleijnse (1)(1) Wageningen-THE NETHERLANDS, (2) Boston-USA 9.20HYPERTENSION MANAGEMENT IN A LOW-INCOME NEIGHBOURHOOD: A COMMUNITY-BASED CASE-CONTROL STUDY IN SINGAPOREL.E. Wee, G.C.H Koh, W.X. Yeo, B. Seow, R.T. ChinSingapore-SINGAPORE 9.30C-REACTIVE PROTEIN IS ASSOCIATED WITH DETERIORATED HEALTH RELATED QUALITY OF LIFE IN HYPERTENSIVE SUBJECTSV. Katsi, G. Souretis, K. Kontoangelos, S. Veioglanis, K. Koundi, I. Vlasseros, P. Sakkas, C.H. Stefanadis, G.N. Papadimitriou, I. KallikazarosAthens-GREECE
9.40ABO AND RHESUS BLOOD GROUPS AND CARDIOVASCULAR RISK IN ESSENTIAL HYPERTENSIVE PATIENTSS.M. Kyvelou, G. Vyssoulis, E. Karpanou, V. Tzamou, T. Gialernios, C. StefanadisAthens-GREECE
Monday
20
374Monday 20374 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011375
Monday 209.40PREVALENCE AND DETERMINANTS OF RESISTANT HYPERTENSION IN A HYPERTENSION UNITR.M. Bruno, I. Del Frate, V. Mazzi, E. Daghini, L. Ghiadoni, S. TaddeiPisa-ITALY 9.50EPIDEMIOLOGY OF ARTERIAL HYPERTENSION IN NORTH AFRICA: THE ETHNA STUDYC. Nejjari (1), M. Arharbi (2), M.T. Chentir (3), R. Boujnah (4), O. Kemmou (5), H. Megdiche (4), F. Boulahrouf (3), K. Messoussi (3), V. Bulatov (5)(1) Fès, (2) Rabat-MOROCCO; (3) Alger-ALGERIA; (4) Tunis-TUNISIA; (5) Casablanca-MOROCCO 10.00THE PROGNOSTIC SHIFT FROM DIASTOLIC TO SYSTOLIC BLOOD PRESSURE IN THE MORGAM PROJECTJ.K.K. Vishram (1), H. Ibsen (2), A. Borglykke (2), T. Jørgensen (2), A.H. Andreasen (2), G. Broda (3), L. Palmieri (4), S. Giampaoli (4), C. Donfranscesco (4), F. Kee (5), M.M. Ferrario (6), K. Kuulasmaa (7), O. Saarela (7), S. Sans (8), M.H Olsen (1)(1) Glostrup, (2) Holbæk-DENMARK; (3) Warsaw-POLAND; (4) Rome-ITALY; (5) Belfast-UK; (6) Varese-ITALY; (7) Helsinki-FINLAND; (8) Barcelona-SPAIN 10.10THE IMPACT OF FETAL SIZE AND MATERNAL FACTORS IN NEWBORN BLOOD PRESSUREC. Garcia-Vicent (1), I. Torro (2), F. Aguilar (1), J. Alvarez (1), F. Ponce (2),E. Lurbe (2)(1) Valencia, (2) Madrid-SPAIN 10.20CIRCADIAN RYTHM OF RENAL URATE HANDLING IN THE GENERAL POPULATIONM. Bochud, M. Maillard, T. Lyngdoh, P. Vollenweider, F. Paccaud, M. BurnierLausanne-SWITZERLAND 10.30CARDIOVASCULAR RISK FACTORS BY BLOOD PRESSURE CATEGORIES IN A CZECH POPULATION RANDOM SAMPLE. CROSS-SECTIONAL DATA AND LONGITUDINAL TRENDSR. Cifková, Z. Skodova, J. Bruthans, V. Lanska, M. Jozifova, P. Wohlfahrt, A. Krajcoviechova, V. Adamkova, M. Galovcova, R. Poledne, P. StavekPrague-CZECH REPUBLIC
09.00 - 11.00 Orange Hall 3
Parallel Oral Session 7D
EPIDEMIOLOGY
Chairpersons: D. Lovic (Nis-SERBIA) M.H. Olsen (Glostrup-DENMARK) 9.00EFFECTS OF PREHYPERTENSION AND HYPERTENSION SUBTYPE ON CORONARY HEART DISEASE IN THE ASIA-PACIFIC REGIONH. Arima, Y. Murakami, M. Woodward, on behalf of THE ASIA PACIFIC COHORT STUDIES COLLABORATIONSydney-AUSTRALIA 9.10RELATIONSHIP BETWEEN SALT INTAKE AND CENTRAL AORTIC HEMODYNAMICS IN A COHORT OF UNTREATED HYPERTENSIVE PATIENTSJ. Polonia, J.A. Silva, S. Bertoquini, L. BarbosaMatosinhos-PORTUGAL 9.20BLOOD PRESSURE CONTROL IN A SPANISH HYPERTENSIVE POPULATION AGED 80 YEARS OR OLDER ATTENDED IN PRIMARY CARE SETTINGS (THE PRESCAP 2010 STUDY)G.C. Rodríguez Roca (1), J.L. Llisterri Caro (2), F.J. Alonso Moreno (1), L.M. Artigao Rodenas (3), V. Barrios Alonso (4), J. Polo Garcia (5), C. Escobar Cervantes (4), J.A. Santos Rodriguez (6), J.M. Fernandez Toro (5), D. Asensio Torres (7), on behalf of the working group of arterial hypertension of the Spanish Society of Primary Care physicians (Group HTA / SEMERGEN) and the PRESCAP 2010 investigators(1) Toledo, (2) Valencia, (3) Albacete, (4) Madrid, (5) Cáceres, (6) Coruña, (7) Barcelona-SPAIN 9.30ADVERSE EFFECT OF VARIOUS CLINICAL AND GEOGRAPHICAL FACTORS ON BLOOD PRESSURE OUTCOMES IN PATIENTS WITH CORONARY HEART DISEASEV. Heazlewood (1), K. Kotseva (2), El. Turner (2), D. Wood (2)(1) Caboolture-AUSTRALIA; (2) London-UK
Monday
20
376Monday 20376 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011377
Monday 2009.00 - 11.00 Green Hall 1
Parallel Oral Session 7E
DIABETES
Chairpersons: J.J. Mourad (Bobigny-FRANCE) T. Rosenthal (Tel Aviv-ISRAEL) 9.00GENETIC VARIANTS IN THE SIRT1 GENE MAY AFFECT DIABETES RISK IN INTERACTION WITH PRENATAL EXPOSURE TO FAMINEI.P.G. Botden (1), M.C. Zilllikens (1), S.R. De Rooij (2), J.G. Langendonk (1), A.H.J. Danser (1), E.J.G. Sijbrands (1), T.J. Roseboom (2)(1) Rotterdam, (2) Amsterdam-THE NETHERLANDS 9.10SAFETY AND EFFICACY OF LOW BLOOD PRESSURE AMONG PATIENTS WITH DIABETES: SUB-GROUP ANALYSES FROM THE ONTARGET TRIALJ. Redon (1), G. Mancia (2), P. Sleight (3), H. Schumacher (4), P. Gao (5), J. Pogue (5), R. Fagard (6), P. Verdecchia (7), M. Weber (8), M. Böhm (9), B. Williams (10), K. Yusoff (11), K. Teo (5), S. Yusuf (5)(1) Valencia-SPAIN; (2) Milan-ITALY; (3) Oxford-UK; (4) Ingleheim-GERMANY; (5) Hamilton-CANADA; (6) Leuven-BELGIUM; (7) Perugia-ITALY; (8) Brooklyn-USA; (9) Homburg-GERMANY; (10) Leicester-UK; (11) Shah Alam-MALAYSIA 9.20RESTING HEART RATE AND THE RISK OF DEATH AND CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUSJ. Chalmers (1), M. Woodward (1), A. Rodgers (1), C. Chow (1), A. Patel (1), R. Webster (1), D. Batty (2), Q. Li (1), T. Ninomiya (3), S. Zoungas (1), G. Hillis (1)(1) Sydney-AUSTRALIA; (2) London-UK; (3) Fukuoka-JAPAN 9.30PRESERVED CAPILLARY DENSITY IN TREATED HYPERTENSIVE PATIENTS WITH OR WITHOUT TYPE 2 DIABETESF. Feihl, J. Aellen, A. Dabiri, A. Heim, L. Liaudet, M. Burnier, J. Ruiz, B. WaeberLausanne-SWITZERLAND
10.40INCOME FACTORS IN POPULATION BLOOD PRESSURE AND HYPERTENSION. RESULTS FROM THE COPENHAGEN CITY HEART STUDYU.O. Andersen, G.B. JensenCopenhagen-DENMARK
10.50PREVALENCE OF ABNORMAL URINARY ALBUMIN EXCRETION IN A GENERAL POPULATION SAMPLE IN SPAINF. J. Felix, D. Fernandez-Berges, J. Perez, M. Zaro, L. Lozano, P. Alvarez-Palacios, A. Garcia, V. Tejero, Y. Morcillo, A. Hidalgo, N.R. Robles, on behalf of HERMEX STUDY GROUPDon Benito-SPAIN
Monday
20
378Monday 20378 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011379
Monday 2010.30EVALUATING BENCHMARKING TO OPTIMIZE MANAGEMENT OF TYPE 2 DIABETIC PATIENTS: CONTROL OF HYPERTENSION IN THE EUROPEAN OPTIMISE STUDYC. Brotons (1), M. Elisaf (2), M. Hermans (3), G. Michel (4), E. Muls (5), A. Matthys (3)(1) Barcelona-SPAIN; (2) Ioannina-GREECE, (3) Brussels-BELGIUM; (4) Luxembourg-LUXEMBOURG; (5) Leuven-BELGIUM 10.40PREDICTIVE VALUE OF BLOOD BACTERIAL DNA ON THE ONSET OF TYPE 2 DIABETES FROM GENERAL POPULATIONJ. Amar (1), M. Serino (1), C. Lange (2), C. Chabot (1), O. Bouchez (3), J. Mariette (4), L. Perez (1), M. Courntey (1), M. Marre (5), P. Klopp (1), O. Lantieri (6), J. Dore (7), M.A. Charles (2), B. Balkau (2), R. Burcelin (1)(1) Toulouse, (2) Villejuif, (3) Auzeville, (4) Castanet Tolosan, (5) Paris, (6) La Riche, (7) Jouy en Josas-FRANCE 10.50NIGHTTIME SYSTOLIC BLOOD PRESSURE IN DIABETIC PATIENTS: DUBLIN OUTCOME STUDYL. Van Der Poel, E. Dolan, O. O’BrienDublin-IRELAND
9.40EFFECTS OF INTENSIVE BLOOD PRESSURE REDUCTION ON MYOCARDIAL INFARCTION AND STROKE IN DIABETES: A META-ANALYSIS IN 73,913 PATIENTSG. Reboldi (1), G. Gentile (1), F. Angeli (1), G. Ambrosio (1), G. Mancia (2), P. Verdecchia (3)(1) Perugia, (2) Milan, (3) Assisi-ITALY 9.50HIGH CENTRAL PULSE PRESSURE IS COMMON IN TYPE 2 DIABETES DESPITE CLINICAL NORMOTENSION, AND IS ASSOCIATED WITH MARKERS OF ATHEROSCLEROSISM. Wijkman, T. Länne, J. Engvall, T. Lindström, C.J. Östgren, F.H. NystromLinköping-SWEDEN 10.00MICROVASCULAR DYSFUNCTION INCREASES THE RISK OF TYPE 2 DIABETES MELLITUS. A META-ANALYSISD. Muris, A. Houben, M. Schram, C. StehouwerMaastricht-THE NETHERLANDS 10.10HIGHER HEART RATE IS ASSOCIATED WITH DECREASED INSULIN SENSITIVITY IN PATIENTS WITH TYPE 1 DIABETEST. Bulum, I. Prkacin, L. DuvnjakZagreb-CROATIA
10.20PREVENTION OF MICROALBUMINURIA: EFFECT OF BASELINE UACR AND CHANGES IN THE EGFR ON OUTCOME (ROADMAP TRIAL)H. Haller (1), S. Ito (2), J.L. Izzo Jr. (3), A. Januszewicz (4), S. Katayama (5),J. Menne (1), A. Mimran (6), T.J. Rabelink (7), E. Ritz (8), L.M. Ruilope (9), L.C. Rump (10), G.C. Viberti (11)(1) Hannover-GERMANY; (2) Sendai-JAPAN; (3) Buffalo-USA; (4) Warsaw-POLAND; (5) Iruma-JAPAN; (6) Montpellier-FRANCE; (7) Leiden-THE NETHERLANDS; (8) Heidelberg-GERMANY; (9) Madrid-SPAIN; (10) Düsseldorf-GERMANY; (11) London-UK
Monday
20
380Monday 20380 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011381
Monday 2012.00BLOOD PRESSURE REDUCTION FOLLOWING INTERVENTION ON PSYCHOSOCIAL WORK FACTORSX. Trudel (1), M. Gilbert-Ouimet (1), C. Brisson (1), A. Milot (1), M. Vezina (1), B. Masse (2)(1) Quebec-CANADA; (2) Seatle-USA
12.15HYPERTENSION PHENOTYPES DEFINED BY OFFICE AND AMBULATORY BLOOD PRESSURE IN 9,153 SUBJECTS REFERRED TO HYPERTENSION CLINICS IN FOUR CONTINENTS: THE ARTEMIS INTERNATIONAL REGISTRYG. Parati (1), S. Omboni (2), G. Stergiou (3), A. de la Sierra (4), E. Dolan (5), G. Head (6), T. Kahan (7), I. Kantola (8), K. Kawecka-Jaszcz (9), K. Narkiewicz (10), T. Ohkubo (11), J. Siegelovà (12), E. Silva (13) Y. Zhang (14), G. Mancia (1), on behalf of ARTEMIS (international Ambulatory blood pressure Registry: TeleMonitoring of hypertension and cardiovascular rIsk project) Investigators(1) Milan, (2) Varese-ITALY; (3) Athens-GREECE; (4) Terrassa-SPAIN; (5) Dublin-IRELAND; (6) Melbourne-AUSTRALIA; (7) Stockholm-SWEDEN; (8) Turku-FINLAND; (9) Krakow-POLAND; (10) Gdansk-POLAND; (11) Sendai-JAPAN; (12) Brno-CZECH REPUBLIC; (13) Maracaibo-VENEZUELA; (14) Beijing-CHINA
11.00 - 12.30Auditorium
Late-Breaker Session 3
Chairpersons: L.H. Lindholm (Umea-SWEDEN) A. Stella (Monza-ITALY)
11.00SYSTOLIC INTER-ARM BLOOD PRESSURE DIFFERENCE IS ASSOCIATED WITH INCREASED CARDIOVASCULAR AND ALL-CAUSE MORTALITY IN HYPERTENSION: META-ANALYSISC. Clark, R. Taylor, A. Shore, J. CampbellExeter-UK
11.15TREATING HYPERTENSION WITH FIRST-LINE THERAPIES IS CHEAPER THAN DOING NOTHINGR. Hughes (1), K. Lovibond (1), M. Caulfi eld (1), B. Williams (2)(1) London, (2) Leiscester-UK 11.30MEDICE CURA TE IPSUM: CARDIOVASCULAR RISK AND CONTROL AMONG PHYSICIANS IN SPAINE. Calvo-Bonacho (1), L.M. Ruilope-Urioste (1), M.A. Sánchez-Chaparro (2), C. Catalina-Romero (1), J.V. Monsonis-Artero (1), V. Navarro-Bisquert (1), E. Delgado-Palomar (1), I. Genis-Giner (1), A. Zanchetti (3)(1) Madrid, (2) Málaga-SPAIN; (3) Milan-ITALY 11.45AZILSARTAN MEDOXOMIL/CHLORTHALIDONE FIXED-DOSE COMBINATION LOWERS BP MORE THAN OLMESARTAN/HYDROCHLOROTHIAZIDE FIXED-DOSE COMBINATION IN STAGE 2 SYSTOLIC HYPERTENSIONW.C. Cushman (1), G. Bakris (2), W.B. White (3), M. Weber (4), D. Sica (5), A. Roberts (6), E. Lloyd (6), S. Kupfer (6)(1) Memphis, (2) Chicago, (3) Farmington, (4) New York, (5) Richmond, (6) Deerfield-USA
Monday
20
382Monday 20382 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011383
Monday 2011.00 - 12.30Blue Hall
Educational Session
Supported by an unrestricted educational grant by Boehringer Ingelheim
MANAGING COMPLEX HYPERTENSION: THE CHALLENGE OF TYPE 2 DIABETES
Chairpersons: A. Ceriello (Barcelona-SPAIN) P. Fioretto (Padua-ITALY)
Welcome and Introduction Why is the treatment of hypertension in type 2 diabetes so diffi cult?R.E. Schmieder (Erlangen-GERMANY) What should be the BP target in patients with diabetes?A.M. Heagerty (Manchester-UK) New alternatives in treating diabetesP. Fioretto (Padua-ITALY) Managing cardiovascular risk in patients with diabetes and hypertensionA. Ceriello (Barcelona-SPAIN)
11.00 - 12.30 Red Hall
Topical Workshop
TREATMENT OF HYPERTENSION IN ACUTE STROKE
Chairpersons: S.E. Kjeldsen (Oslo-NORWAY) A. Coca (Barcelona-SPAIN) The epidemiology of high blood pressure in acute strokeJ. Chalmers (Sydney-AUSTRALIA) The principal results of the SCAST studyE. Berge (Oslo-NORWAY) Ongoing research and future treatment of high blood pressure in acute strokeP. Bath (Nottingham-UK) Panel Discussion
Monday
20
384Monday 20384 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011385
Monday 2011.40BETTER COMPLIANCE TO ANTIHYPERTENSIVE MEDICATIONS REDUCES CARDIOVASCULAR RISKG. Mancia, A. Parodi, F. Nicotra, A. Zambon, L. Merlino, G. Cesana, G. CorraoMilan-ITALY 11.50ASSOCIATION OF MARINOBUFAGENIN-INDUCED NA/K-ATPASE INHIBITION WITH SALT-SENSITIVITY OF BLOOD PRESSURE IN RESISTANT HYPERTENSION AND EFFECTS OF ALDOSTERONE ANTAGONISTA. Kpnradi (1), I. Emelyanov (1), E. Frolova (1), O. Fedorov (2), A. Bagrov (2)(1) St. Petersburg-RUSSIA; (2) Baltimore-USA 12.00INDEXES OF PERCEIVED STRESS AND ANXIETY: AN OBSERVATIONAL STUDY IN NEWLY EVALUATED HYPERTENSIVE PATIENTSC. Del Seppia, L. Mezzasalma, S. Ghione, A. Gemignani, E. FommeiPisa-ITALY 12.10PREVALENCE AND CLINICAL CHARACTERISTICS OF PATIENTS ADMITTED TO AN EMERGENCY DEPARTMENT FOR HYPERTENSIVE EMERGENCIES AND URGENCIESA. Paini, M. Salvetti, S. Cobelli, L. Torazzi, C. Agabiti Rosei, C. Aggiusti, D. Zotti, A. Bazza, F. Bertacchini, F. Beschi, D. Stassaldi, C. Concoreggi, E. Agabiti Rosei, M.L. MuiesanBrescia-ITALY 12.20HYPERTENSIVE EMERGENCIES AND URGENCIES IN AN EMERGENCY DEPARTMENT. ASSOCIATION WITH SUBSEQUENT CARDIOVASCULAR EVENTS DURING 2 YEARS FOLLOW-UPM. Salvetti, A. Paini, L. Torazzi, S. Cobelli, C. Agabiti Rosei, C. Aggiusti, A. Bazza, D. Zotti, F. Bertacchini, D. Stassaldi, C. Concoreggi, E. Agabiti Rosei, M.L. MuiesanBrescia-ITALY
11.00 - 12.30Orange Hall 1
Parallel Oral Session 8A
CLINICAL ASPECTS
Chairpersons: J. Alsaid (Manama-BAHRAIN) A. Januszevicz (Warsaw-POLAND) 11.00CLINICAL SIGNIFICANCE OF BAROREFLEX SENSITIVITY IN HYPERTENSIVE PATIENTS AFTER ACUTE ISCHEMIC STROKED. Celovska (1), J. Stasko (2), J. Gonsorcik (3), A. Dukat (1)(1) Bratislava, (2) Presov, (3) Kosice-SLOVAK REPUBLIC 11.10QUANTIFICATION OF CLINICAL INERTIA DURING GENERAL PRACTITIONER’S MANAGEMENT OF UNCONTROLLED HYPERTENSIVE PATIENTS – CLEPSYDRE STUDYX. Girerd (1), B. Fiquet (2), S. Quere (2), A. Francillon (2)(1) Paris, (2) Rueil-Malmaison-FRANCE 11.20OPTIMAL CUT-OFF AMBULATORY BLOOD PRESSURE LEVEL FOR DIAGNOSIS OF TRUE RESISTANT HYPERTENSION AND EFFECT OF SPIRONOLACTONEJ.A. Garcia-Donaire, J. Segura, C. Cerezo, V. Moñivas, L. Fernandez, L. Guerrero, L.M. RuilopeMadrid-SPAIN 11.30TRENDS IN ALBUMINURIA UNDER RAS SUPPRESSION AND RELATIONSHIP WITH CARDIOVASCULAR DISEASEC. Cerezo (1), J. Segura (1), J.R. Banegas (1), J.J. De La Cruz (1), J.A. Garcia Donaire (1), T.J. Rabelink (2), L.M. Ruilope (1)(1) Madrid-SPAIN; (2) Leiden-THE NETHERLANDS
Monday
20
386Monday 20386 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011387
Monday 2011.40INSULIN, FATTY ACID SYNTHASE, HOMOCYSTEINE LEVELS AND MEASURE OF ARTERIAL PROPERTIES. THE ROTTERDAM STUDYG. Verwoert (1), F. Mattace-Raso (1), A. Hofman (1), B. Westerhof (2), W. Bos (3), E. Sijbrands (1), J. Witteman (1)(1) Rotterdam, (2) Amsterdam, (3) Nieuwegein-THE NETHERLANDS 11.50NORMAL VALUES FOR AORTIC PULSE WAVE VELOCITY IN A PEDIATRIC POPULATIOND. Kracht (1), A. Doyon (2), C. Jacobi (1), F. Schaefer (2), S. Sorrentino (1), B. Schmidt (1), E. Wuehl (2), A. Melk (1)(1) Hannover, (2) Heidelberg-GERMANY 12.00RELATIONSHIP BETWEEN CAROTID ARTERY PROPERTIES, MUSCLE SYMPATHETIC NERVE ACTIVITY AND CARDIOVASCULAR VARIABILITYD. Hering (1), R. Nowak (1), K. Czechowicz (1), W. Kucharska (1), P. Brands (2), P. Boutouyrie (3), S. Laurent (3), K. Narkiewicz (1)(1) Gdansk-POLAND; (2) Maastricht-THE NETHERLANDS; (3) Paris-FRANCE
12.10LECTUREMEASURING CENTRAL BP AND ARTERIAL STIFFNESS. VALUE AND DRAWBACKSR. AsmarParis-FRANCE
11.00 - 12.30Orange Hall 2
Parallel Oral Session 8B
LARGE ARTERIES
Chairpersons: B. Chamontin (Toulouse-FRANCE) M. Hausberg (Munster-GERMANY) 11.00CENTRAL BLOOD PRESSURE IS AN INDEPENDENT PREDICTOR OF WORSE OUTCOME IN YOUNG TO MIDDLE AGE SUBJECTS SCREENED FOR STAGE I HYPERTENSIONF. Saladini (1), E. Benetti (1), M. Santonastaso (2), L. Mos (3), N. Zanatta (2), G. Garavelli (4), A. Bortolazzi (5), P. Palatini (1)(1) Padua, (2) Vittorio Veneto, (3) San Daniele del Friuli, (4) Cremona, (5) Rovigo-ITALY 11.10AORTIC PULSE WAVE VELOCITY AND HEARTSCORE: IMPROVING CARDIOVASCULAR RISK STRATIFICATIONT. Pereira (1), J. Maldonado (1), J. Polónia (2), J.A. Silva (2), J. Morais (3), M. Marques (4)(1) Coimbra, (2) Matosinhos, (3) Leiria, (4) Lisboa-PORTUGAL
11.20COMPARISON OF TWO RADIO-FREQUENCY BASED ULTRASOUND SYSTEMS FOR ASSESSMENT OF CAROTID STIFFNESSC. Palombo (1), M. Kozakova (2), C. Morizzo (1), G. Bini (1), N. Guraschi (2), V. Di Bello (1), A. Balbarini (1)(1) Pisa, (2) Genoa-ITALY
11.30CENTRAL PRESSURES AND PRESSURE AMPLIFICATION AS PREDICTORS OF CARDIOVASCULAR DISEASE AND MORTALITY. THE ROTTERDAM STUDYF. Mattace-Raso (1), B. Westerhof (2), G. Verwoert (1), W.J. Bos (3), I. Guelen (2), A. Hofman (1), J.C.M. Witteman (1)(1) Rotterdam, (2) Amsterdam, (3) Nieuwegein-THE NETHERLANDS
Monday
20
388Monday 20388 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011389
Monday 2011.40THE PARADOX OF DIASTOLIC BLOOD PRESSURE IN HYPERTENSIVE PATIENTS WITH ACUTE MYOCARDIAL INFARCTION AND LONG TERM EVENT FREE SURVIVALG. Berton (1), R. Cordiano (2), R. Palmieri (2), G.L. Guarnieri (1), L. Collot (1), S. Pianca (1), P. Mormino (3), R. De Toni (3), P. Palatini (3)(1) Conegliano, (2) Adria, (3) Padua-ITALY
11.50CENTRAL HEMODYNAMICS AND ECHOCARDIOGRAPHIC ESTIMATES OF SYSTOLIC FUNCTION AND SUBCLNICAL CARDIAC ORGAN DAMAGE DO NOT SHOW ANY RELATIONSHIP IN A COHORT OF DIABETIC AND PREDIABETIC PATIENTSL. Sans Atxer, S. Vazquez, J. Pascual, A. OliverasBarcelona-SPAIN 12.00AORTIC ENLARGEMENT IS ASSOCIATED TO CENTRAL BLOOD PRESSURE IN ESSENTIAL HYPERTENSIONA. Milan, E. Puglisi, C. Magnino, E. Avenatti, A. Fabbri, D. Leone, A. Vairo, C. Di Stefano, V. Crudo, M. Covella, F. Tosello, M. Chiarlo, F. VeglioTurin-ITALY
12.10PREVALENCE OF SYSTOLIC DYSFUNCTION DESPITE NORMAL OR SUPERNORMAL EJECTION FRACTION IN AFRICAN-AMERICANS WITH HYPERTENSIVE KIDNEY DISEASE: THE AASK STUDYM. Chinali, G.P. Aurigemma, R.A. Phillips, G. Peterson, H. PokrelWorcester-USA
12.20METABOLIC SYNDROME RELATIONSHIP WITH LEFT VENTRICULAR HYPERTROPHY IN OVERWEIGHT/OBESE HYPERTENSIVES IS DEPENDENT ON BODY MASS INDEXF. Guerra, L. Mancinelli, L. Angelini, A. Buglioni, V. Pierini, P. Dessì-Fulgheri, R. SarzaniAncona-ITALY
11.00 - 12.30Orange Hall 3
Parallel Oral Session 8C
HEART
Chairpersons: A.C. Pessina (Padua-ITALY) M.K. Tsioufi s (Athens-GREECE) 11.00HERITABILITY OF LEFT VENTRICULAR STRUCTURE AND FUNCTION IN CAUCASIAN FAMILIESY. Jin (1), T. Kuznetsova (1), M. Bochud (2), T. Richart (3), L. Thijs (1), D. Cusi (4), R. Fagard (1), J. Staessen (1)(1) Leuven-BELGIUM; (2) Lausanne-SWITZERLAND; (3) Maastricht-THE NETHERLANDS; (4) Milan-ITALY 11.10BLOOD PRESSURE CONTROL AND ANTIHYPERTENSIVE MEDICATION POST MYOCARDIAL INFARCTION – THE FARIM REGISTRYJ. Spinar, J. Vitovec, L. SpinarovaBrno-CZECH REPUBLIC 11.20MICROVASCULAR BUT NOT MACROVASCULAR FEATURES SUPPORT DIAGNOSIS OF CORONARY ARTERY DISEASEU.N. Neisius, E. Olson, S. Rossi, H. Ibrahim, A. Dominiczak, C. DellesGlasgow-UK 11.30LEFT VENTRICULAR HYPERTROPHY IN HYPERTENSIVE PATIENTS WITH NORMAL ELECTROCARDIOGRAMA. Palermo, E. Nardi, G. Mule’, P. Cusimano, M. Costanzo, G. Bonanno, G. CerasolaPalermo-ITALY
Monday
20
390Monday 20390 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011391
Monday 2011.50CHANGES OF ENERGY METABOLISM IN PHEOCHROMOCYTOMAO. Petrák, T. Zelinka, D. Haluzíková, P. Kaválková, B. Štrauch, J. Rosa, R. Holaj,Z. Šomlóová, T. Indra, A. Vránková, D. Michalský, M. Haluzík, J. Widimský Jr.Prague-CZECH REPUBLIC 12.00THE ADRENAL VEIN SAMPLING INTERNATIONAL STUDY ON USE AND INTERPRETATION OF ADRENAL VEIN SAMPLING FOR DIFFERENTIATING THE MAJOR SUBTYPES OF PRIMARY ALDOSTERONISMG.P. Rossi (1), M. Barisa (1), B. Allolio (2), R. Auchus (3), G. Kline (4), A. Lacroix (5), J.W.M. Lenders (6), S.B. Magill (7), M. Naruse (8), T. Nishikawa (9), P.F. Plouin (10), M. Reincke (11), L.C. Rump (12), F. Satoh (13), M. Stowasser (14)(1) Padua-ITALY; (2) Wuerzburg-GERMANY; (3) Dallas, (4) Calgary-USA; (5) Montreal-CANADA; (6) Nijmegen-THE NETHERLANDS; (7) Menomonee Falls-USA; (8) Kyoto, (9) Yokohama City-JAPAN; (10) Paris-FRANCE; (11) Munich, (12) Duesseldorf-GERMANY; (13) Sendai-JAPAN; (14) Brisbane-AUSTRALIA
12.10UNDER- EXPRESSION OF THE TWIK-RELATED ACID-SENSITIVE K+ CHANNEL 2 (TASK-2) GENE IS A HALLMARK OF ALDOSTERONE PRODUCING ADENOMA CAUSING HUMAN PRIMARY ALDOSTERONISML. Lenzini (1), T.M. Seccia (1), B. Caroccia (1), G. Skander (1), C. Recarti (1), M.R. Pelizzo (1), A.C. Pessina (1), G. Ceolotto (1), A.S. Belloni (1), W.E. Rainey (2), G.P. Rossi (1)(1) Padua-ITALY; (2) Augusta-USA 12.20TARGETED CLINICAL FOLLOW-UP FOR PHEOCHROMOCYTOMA/PARAGANGLIOMA IN A POPULATION OF SUSCEPTIBLE SUBJECTS IDENTIFIED BY GENETIC ANALYSISM. Giacche’, L. Mori, M.C. Tacchetti, A. Panarotto, L. Daffi ni, C. Cappelli, E. Agabiti Rosei, M. CastellanoBrescia-ITALY
11.00 - 12.30Green Hall 1
Parallel Oral Session 8D
ENDOCRINE ASPECTS
Chairpersons: P. Stylianou (Nicosia-CYPRUS) J. Widimsky Jr. (Prague-CZECH REPUBLIC) 11.00SERUM ANDROGENS IN PRE-ECLAMPTIC AND NORMOTESIVE PREGNANT WOMENM. Kashanian, F. Sharifzadeh, F. Fatemi Tehran-IRAN
11.10BENEFITS OF MONITORING PATIENTS OPERATED ON FOR PHEOCHROMOCYTOMA OR FUNCTIONAL PARAGANGLIOMAJ.P. Baguet, C. Dalliet, N. Wion-Barbot, P. Chaffanjon, O. ChabreGrenoble-FRANCE 11.20PERIPHERAL ARTERIAL STIFFNESS IN PRIMARY ALDOSTERONISMJ. Rosa, O. Petrak, B. Strauch, Z. Somloova, T. Indra, T. Zelinka, R. Holaj, J. Widimsky Jr.Prague-CZECH REPUBLIC 11.30DIFFERENCES IN PULSE WAVE VELOCITY BETWEEN MAIN TYPES OF PRIMARY ALDOSTERONISMZ. Somloova, J. Rosa, T. Indra, O. Petrak, B. Strauch, T. Zelinka, R. Holaj, J. Widimsky Jr. Prague-CZECH REPUBLIC
11.40THE COMPARISON OF CLINICAL FEATURES BETWEEN HYPOKALEMIC AND NORMOKALEMIC PRIMARY ALDOSTERONISM PATIENTSL. Zhu, Y.C. Gong, S.X Chen, X.F Tang, B. Tao, X.H. Lu, B.X. Lin, W.Q. Niu, S.L Chu, P.J. Gao, D.L. ZhuShanghai-CHINA
Monday
20
392Monday 20392 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011393
Monday 2012.45 - 14.15Auditorium
Teaching Session
SESSION 3 - TREATMENT ISSUES
Chairpersons: J.L. Rodicio (Madrid-SPAIN) P.A. van Zwieten (Amsterdam-THE NETHERLANDS)
DementiaA. Coca (Barcelona-SPAIN) Atrial fi brillation and hypertensionA.J. Manolis (Athens-GREECE) Use of the 4th drug in the treatment of hypertension. The place of aldosterone antagonists and alpha-blockersJ. Redon (Valencia-SPAIN) The patient with pre-hypertensionS. Julius (Ann Arbor, MI-USA)
11.30 - 12.30Yellow Hall
How-To Session
Supported by an unrestricted educational grant by HemoSapiens Inc.
HEMODYNAMIC FACTORS AND APPROACHES IN HYPERTENSION
Chairpersons: S. Laurent (Paris-FRANCE) M. Viigimaa (Tallinn-ESTONIA)
Unmet needs in the therapeutic management of hypertensive patientsG. Parati (Milan-ITALY)
Management of antihypertensive treatment based on hemodynamic criteria.Examples by clinical casesK. Narkiewicz (Gdansk-POLAND)
Monday
20
394Monday 20394 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011395
Monday 2014.00 - 15.30Ground FloorATTENDED POSTER SESSIONS
Chairperson: G. Seravalle (Milan-ITALY)
PS 30. EPIDEMIOLOGY ROOM 1 / POSTERS FROM 1 TO 48
PS 31. BLOOD PRESSURE MEASUREMENT ROOM 2 / POSTERS FROM 49 TO 85
PS 36. HEART ROOM 7 / POSTERS FROM 200 TO 232
Chairperson: G.A. Head (Prahran-AUSTRALIA)
PS 32. HEALTH CARE STRATEGIES ROOM 3 / POSTERS FROM 86 TO 109
PS 33. BASIC PHARMACOLOGICAL ASPECTS ROOM 4 / POSTERS FROM
110 TO 131
PS 38. NEURAL MECHANISMS ROOM 9 / POSTERS FROM 257 TO 269
Chairperson: C. Delles (Glasgow-UK)
PS 34. GENETICS/MOLECULAR BIOLOGY ROOM 5 / POSTERS FROM 132 TO 159
PS 37. BRAIN ROOM 8 / POSTERS FROM 233 TO 256
Chairperson: G. Schillaci (Perugia-ITALY)
PS 35. LARGE ARTERIES ROOM 6 / POSTERS FROM 160 TO 199
PS 41. HAEMODYNAMICS ROOM 12 / POSTERS FROM 312 TO 326
Chairperson: L. Lonati (Milan-ITALY)
PS 39. ENDOCRINE ASPECTS ROOM 10 / POSTERS FROM 270 TO 294
PS 40. HEART FAILURE ROOM 11 / POSTERS FROM 295 TO 311
LATE-BREAKER POSTER SESSION 3 ROOM 17 / POSTERS FROM 441 TO 451
Chairperson: A. Oliveras (Barcelona-SPAIN)
PS 42. CLINICAL ASPECTS ROOM 13 / POSTERS FROM 327 TO 370
PS 43. CLINICAL TRIALS ROOM 14 / POSTERS FROM 371 TO 392
PS 44. THERAPEUTIC ASPECTS ROOMS 15-16 / POSTERS FROM 393 TO 440
Monday
20
396Monday 20396 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011397
Monday 20 1 6 / 14- YEARS INFLUENCE OF STRESS IN THE FAMILY ON THE RISK OF DEVELOPING OF ARTERIAL HYPERTENSION IN GENERAL POPULATION MEN 25-64 YEARS OLD IN RUSSIA (PROGRAM WHO MONICA-PSYCHOSOCIAL)V. Gafarov, E. Gromova, A. Gafarova, I. GagulinNovosibirsk-RUSSIA
1 7 / WHAT IS THE OPINION OF THE SPANISH PHYSICIANS ABOUT THE PREVENTION OF HYPERTENSION IN WOMENJ. Iturralde-Iriso, D. Ramirez-Puerta, A. De Santiago-Nocito, E. Redondo-Marguello, J.C. Aguirre-Rodriguez, J. Vazquez-Castro, J. Camarero-Palacios, M.C. Gomez-Gonzalez, F. Zubiri, N. Fernandez De Cano, A. Cano Espin, E. Garcia Viroste SPAIN
1 8 / HOW EFFECTIVE IS LIFESTYLE MODIFICATION ON DIABETES AND HYPERTENSION CONTROL AMONG OBESE?M. Gharipour, N. Sarrafzadegan, N. Toghianifar, A. Khosravi, S. ZarfeshaniIsfahan-IRAN
1 9 / HIGH LEVEL OF PLASMA REMNANT-LIKE PARTICLE CHOLESTEROL PREDICTS DEVELOPMENT OF HYPERTENSION IN NORMOTENSIVE SUBJECTSA. Kasahara, H. Adachi, Y. Hirai, M. Enomoto, A. Fukami, M. Otsuka, T. Miyamoto, Y. Nanjo, K. Yoshikawa, E. Kumagai, E. Esaki, K. Yokoi, K. Ogata, K. Murayama, T. ImaizumiKurume-JAPAN
1 10 / HIGH LEVEL OF PLASMA ENDOTHELIN-1 IS A PREDICTOR OF 10-YEAR MORTALITY IN A JAPANESE GENERAL POPULATIONK. Yokoi, H. Adachi, Y. Hirai, M. Enomoto, A. Fukami, M. Otsuka, T. Miyamoto, Y. Nanjo, K. Yoshikawa, E. Esaki, E Kumagai, A. Kasahara, E. Tsukagawa, K. Murayama, T. ImaizumiKurume-JAPAN
1 11 / PREVALENCE OF METABOLIC SYNDROME AND INSULIN RESISTANCE IN ATHEROTHROMBOTIC DISEASE IN TWO MODES OF ACUTE CLINICAL PRESENTATIONG. Barone-Rochette, G. Vanzetto, O. Detante, P.Y. Benhamou, M. Hommel, J.M. Mallion, J.P. BaguetGrenoble-FRANCE
14.00 - 15.30Ground Floor
Poster Session 30
EPIDEMIOLOGY
ROOM 1 / POSTERS FROM 1 TO 48
Chairperson: G. Seravalle (Milan-ITALY)
1 1 / CARDIOVASCULAR RISK EPIDEMIOLOGY IN GEORGIAN POPULATIONL. Sturua, B. Tsinamdzgvrishvili, D. Trapaidze, T. Abesadze, G. Abesadze,R. Tataradze, on behalf of NATIONAL CENTER FOR DISEASE CONTROL AND PUBLIC HEALTHTbilisi-GEORGIA
1 2 / A HALF OF STROKE PATIENTS COULD NOT HAVE A NORMAL LIFE EXPECTANCY; AKITA STROKE REGISTRYM. Izumi, K. KarioShimotuke City-JAPAN
1 3 / PREVALENCE OF HIGH BLOOD PRESSURE IN A HOSPITAL SURVEYC. Paulo, S. Pereira, E. Pinho, J. Mascarenhas, L. Silva, S. Ferreira, R. Santos, M. Silva, A. Flores, A. Vilas-Boas, V. Brás, M.J. LimaPorto-PORTUGAL
1 4 / REAL LIFE ANALYSIS AND BLOOD PRESSURE CONTROL IN HYPERTENSIVE PATIENTS CLASSIFIED BY THE SEVERITY OF BLOOD PRESSURE - RESULTS FROM THE 3A REGISTRYR. Dechend (1), R.E. Schmieder (2), E. Deeg (3), J. Senges (3), E.A. Kaiser (4), U. Zeymer (3)(1) Berlin, (2) Erlangen, (3) Ludwigshafen, (4) Nuernberg-GERMANY
1 5 / EPIDEMIOLOGICAL STUDY OF HYPERTENSION IN AHMEDABAD, INDIAH. NayakAhmedabad-INDIA
Monday
20
398Monday 20398 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011399
Monday 20 1 18 / ASSOCIATED FACTORS TO INADEQUATE CONTROL OF ARTERIAL BLOOD PRESSURE IN HYPERTENSIVE PATIENTS UNDER MEDICAL TREATMENT: CLINICAL PRACTICE BASED STUDY IN ARGENTINAG. Micali (1) D. Piskorz (2), on behalf of HTA NC study Investigators(1) Buenos Aires, (2) Rosario-ARGENTINA
1 19 / RESISTANT HYPERTENSION OR POOR THERAPEUTIC CONTROLB. Georgiev, N. Gotcheva, D. GotchevSofia-BULGARIA
1 20 / THE PREVALENCE OF HYPERTENSION AND METABOLIC DISORDERS IN YOUNG PEOPLEA. Osipov, E. Popova, L. Borisova, O. Antropova, V. Kondakov, I. OsipovaBarnaul-RUSSIA
1 21 / CIRCULATING ADIPOCYTOKINES LEVELS IN CHILDREN: THE ASSOCIATION WITH BIRTH WEIGHT, BLOOD PRESSURE AND METABOLIC FACTORSM. Franco, M. Rangel, R. Puccini, M.W. StrufaldiSão Paulo-BRAZIL
1 22 / COMPARISON OF AMBULATORY BLOOD PRESSURE MONITORING PROFILE IN AFRICAN BLACKS AND CAUCASIANS UNTREATED HYPERTENSIVE PATIENTS MATCHED FOR AGE AND GENDERJ. Polonia (1), C. Mavimbe (2), L. Barbosa (1), J.A. Silva (1), D. Diogo (2), T. Madede (2), A. Damasceno (2)(1) Matosinhos-PORTUGAL; (2) Maputo-MOZAMBIQUE
1 23 / METABOLIC SYNDROME AND THE RISK OF PERIPHERAL ARTERIAL DISEASE: DATA FROM THE EVALUATION OF ANKLE/BRACHIAL INDEX IN HUNGARIAN HYPERTENSIVES (ERV) SCREENING PROGRAMK. Farkas, Z. Járai, E. Kolossváry, A. Ludányi, I. KissBudapest-HUNGARY
1 24 / SURVEY OF MEDICATIONS USED IN THE MANAGEMENT OF HYPERTENSIVE PATIENTS WITH HYPER-CHOLESTEROLEMIA SEEN IN PRIMARY CARE CENTRES IN WEST ATTICA, GREECE (THE ELEFSIS I STUDY)S. Tsoutsos (1), M. Kiousi (1), A. Komantzia (1), G. Karahalios (2), G. Panoutsopoulos (2), Z. Alexiou (2), I. Kalpogiannakis (2), L. Hasbant (2), A. Korakidou (1)(1) Megara, (2) Elefsis-GREECE
1 12 / HYPERTENSION IN COMMUNITY DWELLING SUBJECTS AGED 85 YEARS: IS IT A MORTALITY RISK FACTOR?M. Bursztyn, E. Ein-Mor, J. StessmanJerusalem-ISRAEL
1 13 / ABDOMINAL OBESITY, BLOOD PRESSURE AND DIABETES MELLITUS IN BULGARIAN URBAN POPULATIONS.T. Naydenov, S.V. Torbova, F. Nikolov, S.V. Tsonev, N. NaydenovaSofia-BULGARIA
1 14 / CARDIOVASCULAR RISK IN WOMEN ATTENDED IN PRIMARY CARE. BASELINE DATA OF THE EVA STUDYM.A. Prieto Diaz (1), N. Suliman Jabary (2), F.J. Garcia Norro (3), F.J. Montero Luque (3), V. Garcia Vazquez (4), R. Sanchez Martinez (2), J. Florez Garcia (5), A. Gallardo Gonzalez (2), E. Fernandez Huelga (6), A. Diaz Villanueva (7), M.E. Martin Ceinos (2), R. Alonso Reguera (6), A. De La Vega Cuyas (5), B. Buznego Alvarez (8), F. Fernandez-Vega (6), on behalf of THE EVA STUDY INVESTIGATORS(1) Pruvia, (2) Valladolid, (3) Leon, (4) Cangas De Onis, (5) Aviles, (6) Oviedo, (7) Langreo, (8) Gijon-SPAIN
1 15 / EVALUATION OF DIFFERENCES IN BLOOD PRESSURE CONTROL AND ANTIHYPERTENSIVE STRATEGIES ACCORDING TO PATIENTS AGEC. Sierra, M. Doménech, A. Coca, G. Muñoz, B. Font, on behalf of the EXPRESION Study GroupBarcelona-SPAIN
1 16 / HYPERTENSION TREATMENT AS THE INITIATION OF COMPREHENSIVE GLOBAL RISK MANAGEMENTK. Kim, Y.S. Cho, T.J. Youn, G.Y. Cho, I.H. Chae, D.J. Choi, C.H. KimSeongnam-SOUTH KOREA
1 17 / THE INFLUENCE OF METABOLIC SYNDROME ON THE OCCURRENCE AND SEVERITY OF CAROTID ATHEROSCLEROSIS IN HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHYB. Lovic (1), D. Lovic (1), D. Djordjevic (1), M. Lovic (1), V. Stojanov (2), B. Jakovljevic (2), T. Lovic (1)(1) Niš, (2) Belgrade-SERBIA
Monday
20
400Monday 20400 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011401
Monday 20 1 33 / CHARACTERISTICS OF ADOLESCENT HYPERTENSION IN A CHINESE PATIENTS SERIESX. Yang, P. Gao, J. Wang, Y. Li Shanghai-CHINA
1 34 / CHARACTERISTICS OF HEALTH STATUS OF THE PATIENTS ATTACHED TO THE OUTPATIENT DEPARTMENTS OF TOMSK AND TOMSK REGIONA. Vasilyev, M. Komarova, T. PoponinaTomsk-RUSSIA
1 35 / THE INCREMENTAL EFFECT OF ALCOHOL CONSUMPTION ON REDUCED ARTERIAL ELASTICITY IN EASTERN EUROPEAN IMMIGRANTSV. Katsi, G. Souretis, C. Masoura, D. Barlagiannis, I. Vlasseros, M. Divani, A.N. Koumoulidis, D. Tsiachris, D. Papoutsis, N. Kalovidouris, D. Alexopoulos, C.H. Vlachopoulos, C.H. Stefanadis, I. KallikazarosAthens-GREECE
1 36 / IDENTIFICATION OF PATIENTS AT HIGH CARDIOVASCULAR RISK: A CLINICAL PRACTICE STUDY IN PRIMARY CARE SETTINGSF. Valls-Roca (1), V. Pallares-Carratala (2), V. Gil-Guillen (3), D. Orozco-Beltran (3), J.L. Llisterri-Caro (4), T. Fuster (5), J. Redon (4), A. Fernandez (3), J.C. Andres (3)(1) Beniganim, (2) Burriana, (3) San Juan, (4) Valencia, (5) Gandia-SPAIN
1 37 / CARDIOVASCULAR RISK FACTORS PREVALENCE IN GREEK HYPERTENSIVES STRATIFIED BY GENDER AND AGEC. Liakos, G. Vyssoulis, E. Karpanou, S.M. Kyvelou, V. Tzamou, C. StefanadisAthens-GREECE
1 38 / AGE- AND SEX- RELATED DIFFERENCES IN NUTRITION PATTERN IN SUBJECTS WITH HIGH NORMAL BLOOD PRESSUREO. Molchanova, A. BritovMoscow-RUSSIA
1 39 / PREVALENCE OF ANXIETY IN FEMALE POPULATION 25-64 YEARS IN RUSSIAD. Panov, V. Gafarov, I. Gagulin, E. GromovaNovosibirsk-RUSSIA
1 25 / COMPARISON OF CARDIOVASCULAR RISK PROFILE BETWEEN NON HYPERTENSIVE DIABETIC AND NON DIABETIC HYPERTENSIVE AFRICAN PATIENTSB. Alonge (1), A. Odili (2)(1) Kaduna, (2) Abuja-NIGERIA
1 26 / CARDIOVASCULAR RISK IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE. STUDY AMONG HOSPITALIZED PATIENTSM. Gonzalez-Benitez, I. Gallardo-Romero, A. Ruz-Zafra, M. Baron-Ramos, C. Luque-Amado, A. Muñoz-Claros, A. Perez-Rivera, M. Maiz-Jimenez, M. Godoy-Guerrero, A. Ruiz-CanteroRonda-SPAIN
1 27 / MICROALBUMINURIA IN RELATION TO THE METABOLIC SYNDROME AND ITS COMPONENTS IN A CHINESE POPULATIONC. Sheng, B. Hu, W. Fan, J. Zou, Y. Li, J. WangShanghai-CHINA
1 28 / HIGH BLOOD PRESSURE INCIDENCE AND PREDICTIVE FACTORS ACCORDING TO AGE IN THE IPC COHORTB. Pannier (1), G. London (2), F. Thomas (1), K. Bean (1), N. Danchin (1)(1) Paris, (2) Fleury-Merogis-FRANCE
1 29 / CARDIOVASCULAR RISK FACTOR(S) PREVALENCE IN GREEK HYPERTENSIVES. EFFECT OF GENDER AND AGEG. Vyssoulis, E. Karpanou, C. Liakos, S.M. Kyvelou, V. Tzamou, A. Michaelides, A. Triantafyllou, P. Spanos, C. StefanadisAthens-GREECE
1 30 / COMMON ACTIVITY OF PHYSICIAN, PHARMACIST AND PATIENT TO IMPROVE ADHERENCE TO MEDICATION IN HYPERTENSIONM. Leppée, J. Culig, J. BoskovicZagreb-CROATIA
1 31 / RISK FACTORS FOR PRIMARY PREVENTION OF HYPERTENSION IN THE POPULATION LIVING IN THE RADIONUCLIDE CONTAMINATED TERRITORYA. StchastlivenkoVitebsk-BELARUS
1 32 / EXPLORING CARDIOVASCULAR AND METABOLIC RISK IN HYPERTENSIVE PATIENTS IN GREECED. Richter, D. Georgiopoulos, G. Rombopoulos, G. LambrouAthens-GREECE
Monday
20
402Monday 20402 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011403
Monday 20 1 47 / ARE THERE DIFFERENCES IN CARDIOVASCULAR RISK STRATICATION BY COMPARING THREE WAY TO ASSESS SUBCLINICAL ORGAN DAMAGE?R.E. Peñuela Rodriguez, J. Lopez, I. Bastidas, R. Hernandez, M. Serrano, W. Zerpa, B. Roman, T. Peñuela, S. PereiraSan Cristobal-VENEZUELA
1 48 / CARDIOVASCULAR RISK STRATIFICATION IN KOREAN POPULATION: 3RD KOREAN NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY (KNHNES)S.H. Kim (1), J.K. Park (1), J.H. Shin (1), Y.H. Lim (1), J.H. Shin (1), J.U. Lee (2), K.S. Kim (1), S.K. Kim (2), J.H. Kim (1), H.K. Lim (1)(1) Seoul, (2) Kuri-SOUTH KOREA
1 40 / POORLY CONTROLLED HYPERTENSIVE PATIENT MONITORED IN GENERAL PRACTICE: CLINICAL PROFILE AND ADHERENCE TO TREATMENTJ.R. Banegas (1), F.J. Alonso Moreno (2), J.J. De La Cruz (1), C. Álvarez (1), P. Tarilonte (1)(1) Madrid, (2) Toledo-SPAIN
1 41 / PRESCRIPTION PATTERNS OF ANTIHYPERTENSIVE DRUGS AND THEIR CHANGES IN A GREEK HYPERTENSION CLINICA. Ptinopoulou, I. Tziolas, M. Pikilidou, P. Zebekakis, O. Giata, A. LasaridisThessaloniki-GREECE
1 42 / PREVALENCE AND RISK FACTORS FOR PREHYPERTENSION AND HYPERTENSION IN FIVE INDIAN CITIESJ. Fedacko (1), R.B. Singh (2), D. Pella (1), S. Ghosh (2), R. Begom (3), Z.A. Tumbi (4), A.K. De (5), M. Haque (6), S. Vajpeyee (7), T. Lopuchovsky (1), P. Fedackova (1), L. Jedlickova (1), L. Merkovska (1), B. Novakova (1), P. Jarcuska (1)(1) Kosice-SLOVAK REPUBLIC; (2) Moradabad, (3) Trivandrum, (4) Mumbai, (5) Kolkotta, (6) Nagpur, (7) Surat-INDIA
1 43 / RISK FACTORS FOR CARDIOVASCULAR DISEASE IN CHILDHOOD: THE ROLE OF BIRTH WEIGHT AND CURRENT OBESITYC. Ponzio, R. Sesso, M.W. Strufaldi, M. FrancoSão Paulo-BRAZIL
1 44 / PREVALENCE OF CARDIOVASCULAR RISK FACTORS AND LIPID DISORDERS IN ELDERLY WOMEN OF TALLINN, ESTONIA (2002-2004)J. Abina, M. Saava, M. Viigimaa, P. LaaneTallinn-ESTONIA
1 45 / SELF-EVALUATION OF CARDIOVASCULAR RISK IN EMPLOYEES USING INTERACTIVE COMPUTER-BASED AVATAR SYSTEMJ. Tyszkiewicz, B. Symonides, J. Bugajska, Z. GaciongWarsaw-POLAND
1 46 / ASSESSMENT OF THE PREVALENCE OF DYSFUNCTION ERECTILE IN PATIENTS WITH METABOLIC SYNDROME IN THE PROVINCE OF ALBACETEM.Á. Palomino Medina (1), P. J. Tarraga Lopez (2), J. Lucas Perez Romero (2), M. Lucas Perez Romero (2), P. Rodenas Romero (2), M.T. Tolosa Navalon (2), J.L. Castro Navarro (2), E. Arjona Laborda (2), J. Solera Albero (2), M.L. Marcos Navarro (2) (1) Almodovar Del Pinar, (2) Albacete-SPAIN
Monday
20
404Monday 20404 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011405
Monday 20 2 54 / GENDER-INDEPENDENT ELEVATION OF FASTING GLUCOSE WITH THE PROGRESSIVE DECREASE IN SLEEP-TIME RELATIVE BLOOD PRESSURE DECLINE: THE HYGIA PROJECTD.E. Ayala (1), J.J. Crespo (1), A. Moya (2), P.A. Callejas (1), P. Eiroa (1), A. Otero (3), A. Mojon (1), J.R. Fernandez (1), R.C. Hermida (1), on behalf of Hygia Project Investigators(1) Vigo, (2) Pontevedra, (3) Orense-SPAIN
2 55 / INFLUENCE OF DURATION OF AMBULATORY BLOOD PRESSURE MONITORING (48 VS 24 HOURS) ON CARDIOVASCULAR RISK ASSESSMENTR. Hermida, D.E. Ayala, M.J. Fontao, A. Mojon, J.R. FernandezVigo-SPAIN
2 56 / EFFECTS OF TIME OF HYPERTENSION TREATMENT ON THE CIRCADIAN BLOOD PRESSURE PATTERN OF SUBJECTS WITH RESISTANT HYPERTENSION: THE HYGIA PROJECTM.T. Rios (1), M. Dominguez-Sardiña (1), L. Pousa (1), J. Perez de Lis (1), A. Otero (2), M.J. Fontao (1), J.R. Fernandez (1), D.E. Ayala (1), R.C. Hermida (1), on behalf of Hygia Project Investigators(1) Vigo, (2) Orense-SPAIN
2 57 / THE ROLE OF HOME BLOOD PRESSURE MEASUREMENT IN THE CHRONOTHERAPY OF HYPERTENSIONV. Gorbunov, E. Fedorova, A. Deev, V. BelolipetskayaMoscow-RUSSIA
2 58 / BENCHMARKING AMBULATORY BLOOD PRESSURE VARIABILITY AGAINST TRADITIONAL AND ADVANCED BLOOD PRESSURE MEASUREMENTS REGARDING THEIR ASSOCIATION WITH SUBCLINICAL ORGAN DAMAGE: THE SABPA STUDYA.E. Schutte, R. Schutte, H.W. Huisman, J.M. Van Rooyen, C.M.T. Fourie, N.T. Malan, L. MalanPotchefstroom-SOUTH AFRICA
2 59 / INTER-ARM BLOOD PRESSURE DIFFERENCES: IMPORTANCE OF ITS RECOGNITION FOR CLINICAL DECISION IN 1057 HYPERTENSIVE PATIENTSJ. Maldonado (1), T. Pereira (1), P. Rodrigues (2), M. Carvalho (2)(1) Coimbra, (2) Aveleira-PORTUGAL
2 60 / PATIENTS’ PREFERENCE FOR OUT-OF-OFFICE BLOOD PRESSURE EVALUATION METHOD: AMBULATORY OR HOME MONITORING?E.G. Nasothimiou, N. Karpettas, A. Destounis, G. StergiouAthens-GREECE
14.00 - 15.30Ground Floor
Poster Session 31
BLOOD PRESSURE MEASUREMENT
ROOM 2 / POSTERS FROM 49 TO 85
Chairperson: G. Seravalle (Milan-ITALY)
2 49 / AMBULATORY BLOOD PRESSURE MONITORING AS PREDICTOR OF CAROTID INTIMA-MEDIA THICKNESS VALUES IN ADOLESCENTSG. Bermudez, E. Silva, J.J. Villasmil, L. Chacin, M. Bracho, C. Esis, G. Calmon,E. Clavell, A. GonzalezMaracaibo-VENEZUELA
2 50 / DIFFERENCES IN ORGAN DAMAGE FOR DIPPER AND NON-DIPPER PATTERNS IN 2 ETHNIC GROUPSY. Izumi (1), N. Takekoshi (1), T. Kanda (1), T. Mizuno (1), Y. Ozawa (2), Y. Kasamaki (2), M. Ohta (2), T. Nakayama (2), H. Kawamura (2), M. Maisumo (3), H. Dilxat (3)(1) Himi, (2) Tokyo-JAPAN; (3) Urumqi-CHINA
2 51 / RELATIONSHIP BETWEEN MORNING BLOOD PRESSURE SURGE AND EARLY ORGAN DAMAGE IN PREVIOUSLY UNTREATED HYPERTENSIVE PATIENTSA. Prejbisz, K. Jozwik-Plebanek, E. Florczak, M. Makowiecka-Ciesla, B. Pucilowska-Jankowska, K. Paschalis-Purtak, A. Klisiewicz, B. Kusmierczyk-Droszcz, B. Pregowska-Chwala, T. Zielinski, M. Kluk, G. Kowalewski, M. Kabat, P. Hoffman, A. JanuszewiczWarsaw-POLAND
2 52 / REPRODUCIBILITY OF 24-HOUR AMBULATORY BLOOD PRESSURE VARIABILITY INDICESG.S. Stergiou, A. Kollias, D. Tzamouranis, V. Rarra, L.G. RoussiasAthens-GREECE
2 53 / REFERENCE VALUES FOR OFFICE AND SELF-MEASURED BLOOD PRESSURE DURING PREGNANCYI. Fabry (1), T. Richart (2), L. Thijs (3), L. Van Bortel (1), J. Staessen (3)(1) Ghent-BELGIUM; (2) Maastricht-THE NETHERLANDS; (3) Leuven-BELGIUM
Monday
20
406Monday 20406 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011407
Monday 20 2 68 / CLINIC, HOME AND AMBULATORY BLOOD PRESSURE VARIABILITY AS INDEPENDENT PREDICTORS OF TARGET ORGAN DAMAGEE.G. Nasothimiou, N. Karpettas, A. Destounis, A. Protogerou, I. Moyssakis, G.S. StergiouAthens-GREECE
2 69 / BLOOD PRESSURE VARIABILITY ASSESSED BY CLINIC, HOME AND AMBULATORY MEASUREMENTSE.G. Nasothimiou, N. Karpettas, A. Destounis, I. Moyssakis, D. Tzamouranis, G.S. StergiouAthens-GREECE
2 70 / SYSTOLIC BLOOD PRESSURE AMPLIFICATION IS DECREASED DURING NIGHT HOURS IN HEALTHY SUBJECTSA. Bednarek, P. Jankowski, A. Olszanecka, A. Windak, D. Czarnecka, K. Kawecka-JaszczCracow-POLAND
2 71 / CHARACTERISTICS OF ABPM IN OCTOGENARIANSE. Podjarny (1), E. Golan (1), J. Bernheim (2)(1) Kfar Saba, (2) Tel-Aviv-ISRAEL
2 72 / BLOOD PRESSURE MEASUREMENT CERTIFICATE: A NEED FOR BETTER HYPERTENSION CAREB. Almustafa (1), A. Almobarak (1), E. Alsalman (2), N. Alfaraj (1), M. Hejlis (1), N. Aleid (1)(1) Qatif, (2) Khobar-SAUDI ARABIA
2 73 / COMPARING THE SYSTOLIC-DIASTOLIC VARIABILITY RATIO DETERMINED USING 24H AMBULATORY WITH GRAVITY GENERATED BLOOD PRESSURE VARIATIONS IN RESPONSE TO CHANGING ARM LEVELB. Gavish (1), M. Litvak (2), J. Mekler (2), M. Bursztyn (2)(1) Lod, (2) Jerusalem-ISRAEL
2 74 / INFLUENCE OF CIRCADIAN BLOOD PRESSURE PATTERNS ON HEART RATE AND PULSE PRESSURE LEVEL IN HEALTHY AND HYPERTENSIVE SUBJECTSA. Rekhviashvili, B. Tsinamdzgvrishvili, M. NadareishviliTbilisi-GEORGIA
2 75 / NOCTURNAL BLOOD PRESSURE DECLINE, IF NOT ADJUSTED FOR ASCERTAINED SLEEP TIME, OVERESTIMATES THE ASSOCIATION WITH THE VASCULAR DAMAGEP. Nazzaro, G. Schirosi, V. Vulpis, L. De Benedittis, G. Grandolfo, F. FedericoBari-ITALY
2 61 / NIGHTTIME PHYSIOLOGICAL MELATONIN LEVELS ARE INVERSELY ASSOCIATED WITH NOCTURNAL SYSTOLIC BLOOD PRESSURE AMONG THE ELDERLYK. Obayashi (1), K. Saeki (1), K. Tomioka (1), N. Okamoto (1), S. Nezu (1), J. Iwamoto (2), Y. Ikada (1), N. Kurumatani (1)(1) Nara, (2) Mie-JAPAN
2 62 / HOME VERSUS AMBULATORY MONITORING IN THE ASSESSMENT OF THE DIURNAL BLOOD PRESSURE PROFILE AND THE DETECTION OF NON-DIPPERSG.S. Stergiou, E.N. Nasothimiou, A. Destounis, I. Evagelou, D. Tzamouranis, L.G. RoussiasAthens-GREECE
2 63 / SEASONAL VARIATION OF CLINIC, HOME AND AMBULATORY BLOOD PRESSURE MEASUREMENTSG.S. Stergiou, A. Destounis, A. Kollias, P. KalogeropoulosAthens-GREECE
2 64 / NON-DIPPING PATTERN IS RELATED TO HYPOADIPONECTINEMIA AND INCREASED ARTERIAL STIFFNESS IN ESSENTIAL HYPERTENSIVE SUBJECTSI. Andrikou, C. Tsioufi s, I. Bafakis, K. Kintis, M. Almyroudi, D. Syrseloudis, A. Kordalis, D. Aragiannis, C. StefanadisAthens-GREECE
2 65 / PERSONALITY TRAITS IN MASKED HYPERTENSIOND. Sanchez Gelós, J. Altamirano, H. Gómez Llambí, S. AzzaraBuenos Aires-ARGENTINA
2 66 / KOROTKOV-BASED AUTOMATIC SPHYGMOMANOMETER USING THE ANALYSIS OF ARTERIAL WALL BEHAVIOUR DURING CUFF-DEFLATIONM. Takata, A. Shimakura, M. OharaToyama-JAPAN
2 67 / THE SIGNIFICANCE OF OFFICE AND HOME BLOOD PRESSURE MEASUREMENTS TO THE STRUCTURE AND FUNCTION OF THE LEFT VENTRICLE OF HYPERTENSIVE PATIENTSM.V. Papavasileiou, D. Mitas, A. Anastasopoulou, I. Tsiantis, G. Lambropoulou, I. Vasiliadis, C. Giannakopoulos, S. KarasAthens-GREECE
Monday
20
408Monday 20408 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011409
Monday 20 2 84 / BLOOD PRESSURE VARIABILITY ASSESSED BY ABPM: HOW SHOULD WE MEASURE IT?G. Ferraro, F. Colombo, G. Palmieri, A.M. AgratiMilan-ITALY
2 85 / ALARM REACTION RELATED TO WHITE-COAT EFFECT AND ITS DETERMINANTS IN SUCCESSIVE BLOOD PRESSURE MEASUREMENT IN A NATIONWIDE SURVEY IN SOUTH KOREAJ.H. Shin (1), J.K. Park (1), S.H Kim (2), Y.H. Lim (1), J.H. Shin (1), J.U. Lee (2), S.G. Kim (2), J.H. Kim (1), H.K. Lim (1)(1) Seoul, (2) Guri-SOUTH KOREA
2 76 / A NOVEL INDEX OF SODIUM-SENSITIVITY DERIVED FROM 24-HOUR AMBULATORY BLOOD PRESSURE RECORDINGS PERFORMED UNDER USUAL DIETP. Castiglioni (1), G. Parati (1), L. Brambilla (2), V. Brambilla (2), M. Gualerzi (2), M. Di Rienzo (1), P. Coruzzi (2)(1) Milan, (2) Parma-ITALY
2 77 / A COMPARISON OF OFFICE BLOOD PRESSURE, TELEMEDICAL HOME BLOOD PRESSURE AND AMBULATORY BLOOD PRESSURE MONITORINGN. Hoffmann-Petersen (1), T. Tambo (2), K. Bejder (2), E.B. Pedersen (1)(1) Holstebro, (2) Herning-DENMARK
2 78 / WHITE COAT HYPERTENSION AND DEMENTIA: ROLE OF AMBULATORY BLOOD PRESSURE MONITORING IN DIFFERENT SETTINGSM.C. Pieraccioli, N. Nesti, L. Lambertucci, S. Zanieri, E. Mossello, M. Belladonna, A.M. Mello, N. Marchionni, A. UngarFlorence-ITALY
2 79 / IMPROVED HOME BLOOD PRESSURE LOGBOOK FOR USE IN INDIRECT TELEMONITORINGJ. PeleskaPrague-CZECH REPUBLIC
2 80 / HYPERTENSION AND CARDIOVASCULAR RISK EVALUATION WITH A NEW CRITERIA IN AMBULATORY BLOOD PRESSURE MONITORINGG. MalgieriSant’Agata Dei Goti-ITALY
2 81 / COMPARATIVE EVALUATION OF AMBULATORY AND HOME ARTERIAL STIFFNESS INDICES IN TREATED HYPERTENSIVE MENOPAUSAL WOMENE. Platonova, M. Bystrova, V. Gorbunov, A. DeevMoscow-RUSSIA
2 82 / IMPORTANCE OF AMBULATORY BLOOD PRESSURE MONITORING IN PATIENTS WITH TINNITUSL. Gaspar, M. Makovnik, S. Hlinstakova, E. Gasparova, A. Dukat, M. FulleovaBratislava-SLOVAK REPUBLIC
2 83 / RELATIONSHIP BETWEEN BLOOD PRESSURE ELEVATION DURING EXERCISE TEST AND NIGHT-TO-DAY BLOOD PRESSURE VALUES IN AMBULATORY BLOOD PRESSURE MONITORING IN HYPERTENSIVE PATIENTSS. Filipova, D. Skultetyova, P. ChnupaBratislava-SLOVAK REPUBLIC
Monday
20
410Monday 20410 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011411
Monday 20 3 91 / EFFECT OF ENVIRONMENTAL TEMPERATURE INCREASE ON TREATED HYPERTENSIVESD. Gourlis (1), C. Grassos (2), A. Pittaras (2)(1) Nea Erythrea, (2) Athens-GREECE
3 92 / THERAPEUTIC INERTIA IN ARTERIAL HYPERTENSION TREATMENTA. Radziemski, A. Niklas, A. TykarskiPoznan-POLAND
3 93 / DYSLIPIDEMIC HYPERTENSIVES DO NOT ACHIEVE THE CHOLESTEROL GOALV. Katsi, G. Souretis, P. Theodoropoulos, I. Vlasseros, A.N. Koumoulidis, D. Barlagiannis, M. Divani, C. Benekos, J. Orestis, D. Alexopoulos, C.H. Stefanadis, I. KallikazarosAthens-GREECE
3 94 / REACHING TARGET LIPID LEVELS AND RESERVES IN HYPOLIPIDEMIC THERAPY IN PATIENTS AT VERY HIGH RISK OF CARDIOVASCULAR EVENTS – TWO CENTRES EXPERIENCEF. Malek (1), J.J. Frohlich (2), J.A. Klinke (2), V. Skalnikova (1), P. Neuzil (1)(1) Prague-CZECH REPUBLIC; (2) Vancouver-CANADA
3 95 / STRATIFICATION OF CARDIOVASCULAR RISK IN YOUNG HYPERTENSIVE MEN WITH GRADE I ARTERIAL HYPERTENSIONV. Podzolkov, T. SafronovaMoscow-RUSSIA
3 96 / COMPLIANCE TO TREATMENTS AMONG CORONARY HEART DISEASE PATIENTS IN THE BANJA LUKA REGION, REPUBLIC OF SRPSKA/BOSNIA AND HERZEGOVINAD. Vulic (1), S. Loncar (1), L.J. Sormaz (2), B. Vulic (1), J. Marinkovic (3), M. Ostojic (3)(1) Banja Luka, (2) Laktasi-BOSNIA HERZEGOVINA; (3) Belgrade-JUGOSLAVIJA
3 97 / WHY TARGET BLOOD PRESSURE IS NOT REACHED IN HYPERTENSIVE TYPE II DIABETES PATIENTS: ANALYSIS OF REAL PRACTICEM. Barabanschikova, L.S. Pak, E.A. Prokhorovich, A. MalykhinaMoscow-RUSSIA
3 98 / “SMS THERAPY”: A NEW APPROACH TO INCREASING COMPLIANCE TO ANTIHYPERTENSIVE TREATMENTM.M. Ciulla, R. Meazza, P. Giagnoni, C. Vecchiato, G. Acquistapace, C. Benfenati, P. Nicolini, G.L. Perrucci, F. MagriniMilan-ITALY
14.00 - 15.30Ground Floor
Poster Session 32
HEALTH CARE STRATEGIES
ROOM 3 / POSTERS FROM 86 TO 109
Chairperson: G.A. Head (Prahran-AUSTRALIA)
3 86 / MEETING TARGET LIPID LEVELS IN PATIENTS ADMITTED TO PERCUTANEOUS CORONARY ANGIOPLASTY IN EAST-TALLINN CENTRAL HOSPITAL (ESTONIA)E. Mäeots, K. Traumann, K. TuttTallinn-ESTONIA
3 87 / INFLUENCE OF DIABETIC PATIENTS ON ANTIHYPERTENSIVE DRUG AMONG HYPERTENSION ON HYPERTENSION PREVALENCE BEFORE AND AFTER HYPERTENSION GUIDELINES IN 2003, KOREAN NATIONAL HEALTH AND NUTRITIONAL SURVEY(K-NHANES) DATAJ. Shin (1), Y. Lim (1), S. Kim (1), Y. Kim (2), J. Lee (1)(1) Seoul, (2) Busan-SOUTH KOREA
3 88 / PHYSICIAN ATTITUDES TO BLOOD PRESSURE CONTROL IN ELDERLY HYPERTENSIVE PATIENTS (SHARE SURVEY)R. Kreutz (1), S. Erdine (2)(1) Berlin-GERMANY; (2) Istanbul-TURKEY
3 89 / INTERVENTION STUDY IN A HIGH RISK POPULATIONM. Iurciuc, L. Craciun, C. Avram, S. Ursoniu, A. Rusu, S. Iurciuc, D. GaitaTimisoara-ROMANIA
3 90 / HYPERTENSION GUIDELINES IMPLEMENTATION AND MULTIPLE CARDIOVASCULAR RISK FACTOR CONTROL IN GENERAL PRACTICE (HYGIA-GP STUDY)A. Symeonidis, A. Karotsis, V. Rarra, N. Karpettas, G.S. StergiouAthens-GREECE
Monday
20
412Monday 20412 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011413
Monday 20 3 107 / LIPIDS IN A HEALTH AREA OF THE BASQUE COUNTRY (SPAIN): CONTROL LEVEL AND ECONOMIC EXPENSEG. Mediavilla-Tris, J. Iturralde Iriso, A.A. Rodríguez-Fernández, J. Martínez-Gorostiaga, Mª L. Alarcia-Ceballos, I. LZ De Viñaspre-Muguerza, G. Arnaiz-Garcia, V. Espínola-Morel, L. Bastida-Eizaguirre, J.L. Hurtado-Mendoza, J. Garcia-LZ De Armentia, E. LZ De Uralde-PZ De Albeniz, A. LZ De Viñaspre-Muguerza, A. Ruiz De Loizaga-Arellano, J. Ocharan-CorcueraVitoria-SPAIN
3 108 / GAP BETWEEN GUIDELINE AND PRIMARY PRACTICE IN TREATMENT OF HYPERTENSIONC. Park, K. Lee, J. Na, C. Choi, H. Lim, E. Kim, S. Rha, H. Seo, D. OhSeoul-SOUTH KOREA
3 109 / TREATMENT OF HYPERTENSION IS BETTER AFTER HOSPITAL DISCHARGE THAN IN PRIMARY CAREN. Gotcheva, B. Georgiev, A. Alexandrov, D. GotchevSofia-BULGARIA
3 99 / EARLY BENEFIT OF AN EDUCATIONAL PROGRAM IN A POPULATION AT VERY HIGH CARDIOVASCULAR RISKP. Delsart, A. Noel, N. Vernet, P. Bocquet, L.M. Gore, G. Claisse, C. Craeymeersch, M. Goudji, P. Fayolle, C. Mounier-VehierLille-FRANCE
3 100 / THE EFFECTS OF A COMPREHENSIVE HEALTH EDUCATION PROGRAMME IN CHINESE PATIENTS AFTER PERCUTANEOUS CORONARY INTERVENTIONY. Gao, Y. Li, J. Zheng, R. Wang, H. MengTaiyuan-CHINA
3 101 / MEDITERRANEAN DIET AND CARDIOVASCULAR RISK IN MURCIA (SPAIN). PRELIMINARY RESULTSJ. Abellan, M.P. Zafrilla, M.C. Martinez, M.P. Zaragoza, P. Rosique, M. Leal, on behalf of Cooperative Group of food and cardiovascular risk COF MurciaMurcia-SPAIN
3 102 / ECONOMIC EFFICACY OF FIXED COMBINATION OF PERINDOPRIL/INDAPAMIDE IN TREATMENT OF ARTERIAL HYPERTENSION (MODELLING SURVEY IN RUSSIA)M. Leonova, A. Bykov, Y. ChurilinMoscow-RUSSIA
3 103 / PHARMACOECONOMIC EVALUATION OF DRUGS USED FOR THE TREATMENT OF HYPERTENSIONA. Kochar, P. MeghanaMohali-INDIA
3 104 / CLINICAL OUTCOMES OF TREATMENT WITH ANGIOTENSIN RECEPTOR BLOCKERSJ. Swindle (1), S. Panjabi (2), K. Ramaswamy (2), P. Buzinec (1), S. Iorga (1)(1) Eden Prarie, (2) Parsippany-USA
3 105 / TREATMENT APPROACH TO ARTERIAL HYPERTENSION IN DIFFERENT TYPES OF BULGARIAN CITIES: IS IT DIFFERENT?S. Tsonev, S. Torbova, S. Naydenov, N. NaydenovaSofia-BULGARIA
3 106 / CHANGES OF CLINICAL, MORPHOLOGICAL AND DOPPLER CHARACTERISTIC IN HYPERTENSIVE PATIENTS DUE TO TREATMENT WITHIN ONE YEAR FOLLOW UPI. Burazor (1), S. Stefanovic (2), M. Burazor (1), V. Stefanovic (2)(1) Nis-SERBIA; (2) Knjazevac-JUGOSLAVIJA
Monday
20
414Monday 20414 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011415
Monday 20 4 115 / EFFECT OF AGE AND GENDER ON BLOOD PRESSURE VALUES, DEVELOPMENT OF RENAL HYPERTENSION AND BLOOD NITRIC OXIDE LEVELS IN WHITE RATSV. Berdnikova, T. Anishchenko, O. Semyachkina-Glushkovskaya, I. Semyachkin-Glushkovsky, T. Sindyakova, S. Sindeev, O. Bibikova, A. SjestnovaSaratov-RUSSIA
4 116 / PHALARIS CANARIENSIS (BIRDSEED) REDUCES BLOOD PRESSURE IN SPONTANEOUSLY HYPERTENSIVE RATS: ROLE OF THE TRYPTOPHAN METABOLISMC. Dos Santos Passos, O. Ykuta, L.N. Carvalho, R.R. Campos Jr, M.A. BoimSão Paulo-BRAZIL
4 117 / AGE DEPENDENT CHANGES IN ANTI-AGE ANTIBODIES AND SOME MARKERS OF OXIDATIVE STRESS IN SPONTANEOUSLY HYPERTENSIVE RATSA. Dimitrova, S. Tisheva, M. Atanasova, M. Georgieva, A. RussevaPleven-BULGARIA
4 118 / ENDOTHELIN-CONVERTING ENZYME INHIBITOR PROMOTES RENOVASCULAR HYPERTENSION DEVELOPMENT IN RATS (ONE KIDNEY, ONE CLIP GOLDBLATT MODEL)M. Ilatovskaya, V.F. Pozdnev, N.A. MedvedevaMoscow-RUSSIA
4 119 / ENHANCED SUSCEPTIBILITY TO OXIDATIVE STRESS-INDUCED CELL DEATH IN HYPERTENSION IS LINKED TO REDUCED CATALASE ACTIVITY AND INCREASED JNK ACTIVATIONP. Gomes, S. Simão, J. Amaral, P. Soares-Da-SilvaPorto-PORTUGAL
4 120 / PHOSPHATIDYLCHOLINE-SPECIFIC PHOSPHOLIPASE C IS INVOLVED IN HYPOXIC PULMONARY VASOCONSTRICTIONI. Strielkov (1), A. Khromov (1), A. Soloviev (1), J. Ward (2)(1) Kyiv-UKRAINE; (2) London-UK
4 121 / VASCULAR RESPONSE TO ATRIAL NATRIURETIC PEPTIDE CHRONIC TREATMENT IN HYPERTENSIONM.A. Costa, M. Romero, G. Bouchet, L. Savignano, C. Caniffi , R. Elesgaray, M. Mac Laughlin, C. ArranzBuenos Aires-ARGENTINA
14.00 - 15.30Ground Floor
Poster Session 33
BASIC PHARMACOLOGICAL ASPECTS
ROOM 4 / POSTERS FROM 110 TO 131
Chairperson: G.A. Head (Prahran-AUSTRALIA)
4 110 / INHIBITORY EFFECT OF MG2+ ON PHOSPHATE-INDUCED VASCULAR CALCIFICATIONV. Jankowski (1), S. Salem (1), J. Passlick-Deetjen (2), M. Peter (2), W. Zidek (1), J. Jankowski (1)(1) Berlin, (2) Bad Homburg-GERMANY
4 111 / EFFECT OF CYCLOSPORINE A ADMINISTRATION IN PREGNANT RATS ON BLOOD PRESSURE IN THEIR OFFSPRINGN. Slabiak-Blaz (1), M. Adamczak (1), E. Ritz (2), A. Wiecek (1)(1) Katowice-POLAND; (2) Heidelberg-GERMANY
4 112 / DIURIDINE TETRAPHOSPHATE: A POTENT ENDOTHELIUM-DERIVED ANGIOGENIC FACTORV. Jankowski, M. Toelle, M. Van Der Giet, K. Lehmann, W. Zidek, J. JankowskiBerlin-GERMANY
4 113 / PARAMETER OF ARTERIES’ ELASTICITY FOR ELDERLY PATIENTS WITH ARTERIAL HYPERTENSIONA. Pristrom, T. Nechesova, E. GaishunMinsk-BELARUS
4 114 / ANTIHYPERTENSIVE AND CARDIOPROTECTIVE EFFECTS OF OLEA EUROPEA LEAF EXTRACT IN GENETICALLY HYPERTENSIVE RATSZ. Miloradovic, N. Mihailovic-Stanojevic, J. Grujic Milanovic, M. Ivanov, D. Dekanski, D.J. JovovicBelgrade-SERBIA
Monday
20
416Monday 20416 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011417
Monday 20 4 129 / EFFECTS OF PROXODOLOL AND CARVEDILOL ON BLOOD COENZYMES Q9 AND Q10 LEVELS IN ISCHEMIC RAT MODEL OF CONGESTIVE HEART FAILUREO. Medvedev, D. Shashurin, E. KalenikovaMoscow-RUSSIA
4 130 / MODULATION OF NITRIC OXIDE PRODUCTION AND OXIDATIVE STRESS BY A LOW DOSE OF L-NAME IN RATS WITH GENETIC PREDISPOSITION TO HYPERTENSIONI. Bernatova (1), A. Puzserova (1), J. Kopincova (2)(1) Bratislava, (2) Martin-SLOVAK REPUBLIC
4 131 / EVALUATION OF THE EFFECT OF SALT III AS NEW POSSIBLE ALLOSTERIC MODULATOR OF ANGIOTENSIN I CONVERTING ENZYMEA. Barrinha Fernandes (1), F. Aparecida Ronchi (1), R. Inacio Reis (1), P. Tambarussi Baraldi (2), L.G. Robello (2), D.E. Casarini (1)(1) Sao Paulo, (2) Hortolandia-BRAZIL
4 122 / LEFT VENTRICULAR DIASTOLIC DYSFUNCTION AND NITRIC OXIDE LEVELS.EXPERIMENTAL STUDY IN SPONTANEOUSLY HYPERTENSIVE RATSR. Cabrera Sole, L. Iñiguez, J. Cañas, M.J. Fernandez MartinezAlbacete-SPAIN
4 123 / THE CONTRIBUTION OF MECHANISMS DEPENDENT AND NOT-DEPENDENT ON SOLUBLE GUANYLATE CYCLASE TO THE DEVELOPMENT OF PULMONARY ARTERIAL HYPERTENSION IN A MODEL OF CONGENITAL HEART DISEASEA. Tsukanova, V. Babosha, M. DavydovaMoscow-RUSSIA
4 124 / SINGLE INTRAVENOUS ADMINISTRATION OF COENZYME Q10 FOLLOWING CHRONIC CORONARY OCCLUSION LIMITS POSTINFARCT MYOCARDIAL REMODELLING IN RATSE. Gorodetskaya, E. Kalenikova, A. Ivanov, O. MedvedevMoscow-RUSSIA
4 125 / MTOR INHIBITORS REDUCES THE IN VITRO MINERALIZATION OF VASCULAR SMOOTH MUSCLE CELLSJ. Prüfer (1), M. Schuchardt (1), M. Tölle (1), M. Höhne (2), W. Zidek (1), M. van der Giet (1)(1) Berlin, (2) Nürnberg-GERMANY
4 126 / AGE- AND SEX-RELATED DIFFERENCES OF ATORVASTATIN EFFICACY DEMONSTRATED IN THE SUPERIOR MESENTERIC ARTERY OF RATS SUFFERING FROM HYPERTRIGLYCERIDEMIA AND HYPERTENSIONR. Sotnikova, B. Bacova, J. Vlkovicova, J. Navarova, N. TribulovaBratislava-SLOVAK REPUBLIC
4 127 / EFFECTS OF ALISKIREN ON BLOOD PRESSURE AND VENOUS THROMBOSIS IN RENOVASCULAR HYPERTENSIVE RATSJ. Hermanowicz, A. Mogielnicki, K. Kramkowski, W. BuczkoBialystok-POLAND
4 128 / VASOPROTECTIVE EFFECTS OF PITAVASTATIN ON ENDOTHELIAL PROGENITOR CELLS IN ISCHEMIC HINDLIMBH. Takeshima, N. Kobayashi, W. Koguchi, M. Ishikawa, F. Sugiyama, T. IshimitsuTochigi-JAPAN
Monday
20
418Monday 20418 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011419
Monday 20 5 136 / THE RS10947803 SNP OF KCNK17 IS ASSOCIATED WITH CEREBRAL HEMORRHAGE BUT NOT ISCHEMIC STROKE IN A CHINESE POPULATIONY. Wang, Y. Shen, L. Wu, X. Liu, H. Zhang, L. Liu, X. WangBeijing-CHINA
5 137 / INFLUENCE OF OVERWEIGHT OR OBESITY ON THE GENETIC PREDICTION OF HYPERTENSIONG. Ceolotto (1), L. Mos (2), M. Santonastaso (3), F. Ragazzo (1), S. Cozzio (4), G. Zanata (5), A. Cattelan (1), P. Palatini (1)(1) Padua, (2) San Daniele del Friuli, (3) Vittorio Veneto, (4) Trento, (5) Sacile-ITALY
5 138 / THE AGT M235T AND THE GNB3 C825T POLYMORPHISMS AND INSULIN RESISTANCE IN PREHYPERTENSIONC. Maniotis, D. Papadogiannis, A. Miliou, C. Tsioufi s, K. Chantziara, G. Vaiopoulos, C. StefanadisAthens-GREECE
5 139 / -374 T/A POLYMORPHISM IN THE RECEPTOR OF ADVANCED GLYCATION END PRODUCT GENE IS ASSOCIATED WITH ONSET OF DIABETES MELLITUS, ATHEROSCLEROSIS, AND RENAL DYSFUNCTION IN JAPANESE HYPERTENSIVEST. Kawai, K. Kamide, N. Katoh, Y. Tatara, R. Oguro, K. Sugimoto, T. Katsuya, M. Ohishi, H. RakugiSuita-JAPAN
5 140 / DYNAMIC EXPRESSION OF PROTEINS ASSOCIATED WITH ADVENTITIAL REMODELING IN ADVENTITIAL FIBROBLASTS FROM SPONTANEOUSLY HYPERTENSIVE RATSS. Guo, P. Gao, D. ZhuShanghai-CHINA
5 141 / GENETIC VARIATIONS SCREENING OF TNNT2 AND MYH7 GENE IN A COHORT OF PATIENTS WITH HYPERTROPHIC AND DILATED CARDIOMYOPATHYM. Jachymova, A. Muravska, T. Palecek, P. Kuchynka, H. Rehakova, S. Magage, A. Kral, T. Zima, K. Horky, A. Linhart Prague-CZECH REPUBLIC
5 142 / PHARMACOGENETICS IN ANTIDYSLIPIDEMIC TREATMENT: A TOOL TO PREDICT CREATINE KINASE ELEVATION DURING STATIN TREATMENT?M. Ferrari, L. Guasti, F. Marino, M. Serratì, L. Castiglioni, V. Macchi, S. Contini, G. Interlandi, M. CosentinoVarese-ITALY
14.00 - 15.30Ground Floor
Poster Session 34
GENETICS/MOLECULAR BIOLOGY
ROOM 5 / POSTERS FROM 132 TO 159
Chairperson: C. Delles (Glasgow-UK)
5 132 / GENETIC POLYMORPHISM DETERMINES CORONARY ARTERY DISEASE AND ACUTE CORONARY SYNDROME IN HYPERTENSIVE PATIENTS: A DOUBLE-CENTRE STUDY OF TWO CANDIDATE GENES AND THEIR VARIANTSJ. Ursuliak, L. Sydorchuk, A. Sydorchuk, R. Sydorchuk, I. Sydorchuk Chernivtsi-UKRAINE
5 133 / PRAISE A FAIR DAY WITH TWINS: CENTRAL BLOOD PRESSURE, PULSE PRESSURE AND ARTERIAL STIFFNESSA.D. Tarnoki (1), D.L. Tarnoki (1), M.A. Stazi (2), E. Medda (2), F. Fanelli (2), C. Baracchini (3), G. Meneghetti (3), G. Schillaci (4), I. Preda (1), K. Karlinger (1), A. Lannert (1), A.A. Molnar (1), L. Littvay (1), Z. Garami (5), V. Berczi (1)(1) Budapest-HUNGARY; (2) Rome, (3) Padua, (4) Perugia-ITALY; (5) Houston-USA
5 134 / RELATIONSHIP BETWEEN A46G AND C79G POLYMORPHISMS IN THE β2-ADRENERGIC RECEPTOR GENE AND ESSENTIAL HYPERTENSION RISK AMONG THE HAN CHINESE POPULATION: A META-ANALYSISS. Wen (1), Y. Lou (1), Y. Liu (1), H. Wu (2), Z. Wang (1), K. Liu (1), Y. Li (2), Z. Li (1)(1) Beijing, (2) Shanghai-CHINA
5 135 / PERIPHERAL AND CENTRAL AUGMENTATION INDEXES IN RELATION TO THE CYP4F2 POLYMORPHISMS IN CHINESEB. HuShanghai-CHINA
Monday
20
420Monday 20420 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011421
Monday 20 5 150 / ASSOCIATION OF ALPHA-1-A ADRENERGIC RECEPTOR ARG347CYS POLYMORPHISM WITH BLOOD PRESSURE LEVELS IN A LATIN-AMERICAN POPULATIONJ.E. Ochoa (1), M.M. Correa (2), J.A. Gallo (2), J.G. McEwen (2), G. Bilo (1), D. Aristizabal (2), G. Parati (1)(1) Milan-ITALY; (2) Medellin-COLOMBIA
5 151 / AN ASSOCIATION BETWEEN THREE TAG SNPS WITHIN THE FTO GENE AND SMOKING BEHAVIOURV. Adamkova, J.A. Hubacek, D. Dlouha, V. LanskaPrague-CZECH REPUBLIC
5 152 / ROS-DEPENDENT MECHANISMS OF REGULATION OF CONTRACTILE ACTIVITY OF SMOOTH MUSCLE CELLSS. Gusakova, M. Baskakov, I. Kovalev, A. Zheludeva L. Smagly, K. Eremenko, S. Efremov, D. Nosov, T. Vtorushina Tomsk-RUSSIA
5 153 / ROLE OF CYTOSKELETON AND NITRIC OXIDE IN REGULATION PHENYLEPHRINE-INDUCED CONTRACTION OF VASCULAR SMOOTH MUSCLEA. Zheludeva, O. Melnik, K. Eremenko, S. GusakovaTomsk-RUSSIA
5 154 / IL-8 REDUCED VCAM-1 FROM SMOOTH MUSCLE CELLS BY INCREASING P-ERK WHEN 3-D CO-CULTURED WITH VASCULAR ENDOTHELIAL CELLSQ.Y. Dai, Z. ZhangShanghai-CHINA
5 155 / TELOMERE ATTRITION OVER FIFTEEN YEARS IS ASSOCIATED WITH CLINICAL MARKERS OF CARDIOVASCULAR AGEING IN MIDDLE-AGED SUBJECTS – THE MALMO DIET AND CANCER STUDY, SWEDENP.M. Nilsson (1), D. Dahlman (1), G. Roos (2), K. Nordfjäll (2), O. Melander (1)(1) Malmö, (2) Umeå-SWEDEN
5 156 / ASSOCIATION BETWEEN THE INSERTION-DELECTION POLYMORPHISM IN THE MONOCYTE CHEMOATTRACTANT PROTEIN 1 GENE AND ESSENTIAL HYPERTENSIONV. Belonogova, Y. Timasheva, O.L. Mustafi na, T. Nasibullin, I.L. TuktarovaUfa-RUSSIA
5 143 / HV1 REGION OF MTDNA IS A POSSIBLE MARKER OF PREDISPOSITION TO ESSENTIAL HYPERTENSION IN UZBEK HYPERTENSIVE PATIENTSG. Abdullaeva, A. Nagay, G. KhamidullaevaTashkent-UZBEKISTAN 5 144 / C825T POLYMORPHISM OF GNB3 GENE AND SALT SENSITIVITY IN PATIENTS WITH ESSENTIAL HYPERTENSIONA. Nagay, G. Khamidullaeva, G. AbdullaevaTashkent-UZBEKISTAN
5 145 / THE A640G POLYMORPHISM OF CYBA ASSOCIATES WITH PHAGOCYTIC NADPH OXIDASE AND SUBCLINICAL ATHEROSCLEROSIS IN TYPE 2 DIABETESM.U. Moreno, G. San José, A. Fortuño, J.L. Miguel-Carrasco, Ó. Beloqui, J. Díez, G. ZalbaPamplona-SPAIN
5 146 / PATTERN IDENTIFICATION/SYNDROME DIFFERENTIATION: GENETIC ASSOCIATION OF CODING REGION POLYMORPHISM OF PON1 AMONG KOREAN STROKE PATIENTSJ.H. Lim (1), M.H. Cha (1), M.M. Ko (1), B.K. Kang (1), H.Y. Ko (2), O.S. Bang (1)(1) Daejeon, (2) Chungju-SOUTH KOREA
5 147 / ASSOCIATION OF CHROMOSOMAL REGIONS 8P21.2 AND 2Q32.2 WITH URINARY ALBUMIN EXCRETION IN SPANISH GENERAL POPULATIONF. Martínez, M.L. Mansego, P. Rentero, E. Solaz, F.J. Chaves, J. RedónValencia-SPAIN
5 148 / A VARIANT UPSTREAM OF THE CDH13 ADIPONECTIN RECEPTOR GENE AND METABOLIC SYNDROME IN SWEDESC. FavaVerona-ITALY
5 149 / DAYTIME AND NIGHTTIME URINARY STEROIDS IN THE SWISS KIDNEY PROJECT ON GENES IN HYPERTENSIOND. Ackermann (1), G. Ehret (2), I. Guessous (2), B. Ponte (3), M. Pruijm (2), B. Dick (1), M. Burnier (2), F. Frey (1), P.Y. Martin (3), F. Paccaud (2), M. Bochud (2)(1) Bern, (2) Lausanne, (3) Geneva-SWITZERLAND
Monday
20
422Monday 20422 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011423
Monday 2014.00 - 15.30Ground Floor
Poster Session 35
LARGE ARTERIES
ROOM 6 / POSTERS FROM 160 TO 199
Chairperson: G. Schillaci (Perugia-ITALY)
6 160 / INTERRELATIONSHIPS OF URIC ACID WITH ASYMMETRIC DIMETHYLARGININE, L-ARGININE AND ARTERIAL STIFFNESS IN ESSENTIAL HYPERTENSIONK. Dimitriadis, C. Tsioufi s, L. Lioni, N. Alexopoulos, P. Pietri, A. Miliou, I. Bafakis, C. StefanadisAthens-GREECE
6 161 / DIFFERENTIAL EFFECTS OF CYCLOSPORINE AND TACROLIMUS ON ARTERIAL FUNCTIONF. Seibert, C. Behrendt, S. Schmidt, M. van der Giet, W. Zidek, T.H. Westhoff Berlin-GERMANY
6 162 / VALIDATION OF A NEW NON-INVASIVE TONOMETER FOR DETERMINING AORTIC PULSE WAVE VELOCITY IN RATSE. Tartagni (1), G. Simon (2), N. Sloboda (2), C. Labat (2), C. Borghi (1), L. Joly (2), P. Salvi (1), A. Benetos (2), P. Lacolley (2)(1) Bologna-ITALY; (2) Nancy-FRANCE
6 163 / AGE-RELATED EFFECTS OF POSTURAL CHANGES ON AORTIC PULSE WAVE VELOCITYK. Xu, M. Butlin, A. AvolioSydney-AUSTRALIA
6 164 / PRESSURE-INDEPENDENT ASSOCIATION BETWEEN AORTIC STIFFNESS AND LEFT VENTRICULAR CONCENTRIC GEOMETRYG. Schillaci, G. Pucci, L. Settimi, M. Pilati, A. Baroni, E. MannarinoPerugia-ITALY
5 157 / MYCOPHENOLIC ACID DIMINISHES MONOCYTE CHEMOATTRACTANT PROTEIN-1 PRODUCTION IN VASCULAR SMOOTH MUSCLE CELLS VIA ROS INHIBITIONM. Schuchardt (1), M. Tölle (1), J. Prüfer (1), S. Huber (1), T. Huang (1), M. Höhne (2), W. Zidek (1), M. van der Giet (1)(1) Berlin, (2) Nürnberg-GERMANY
5 158 / ASSOCIATION OF DISMETABOLIC DISORDERS IN HYPERTENSION WITH POLYMORPHISM OF PPAR-GAMMA2 (PRO12ALA) AND ACE (I/D) GENESA. Sokolenko, L. Sydorchuk, A. Sydorchuk, J. Ursuliak, R. SydorchukChernivtsi-UKRAINE
5 159 / MYOSPRYN K2960N GENE VARIANT AND DAMAGE OF HEART AND LARGE ARTERIES IN RUSSIAN PATIENTSE. Moguchaya, O. Rotar, A. Klyushina, N. Smolina, A. Kostareva, O. Dubrovskaya, N. Dzubenko, E. Malev, V. Ivanenko, V. Solntsev, A. Konradi, E. ShlyakhtoSt. Petersburg-RUSSIA
Monday
20
424Monday 20424 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011425
Monday 20 6 172 / OFFICE AND AMBULATORY HEART RATE AS MARKER OF ARTERIAL STIFFNESSL. Garcia-Ortiz, A. Garcia-Garcia, E. Rodriguez-Sanchez, J.I. Recio-Rodriguez, C. Agudo-Conde, A. De Cabo-Laso, B. Sanchez-Salgado, J. Prieto-Mateos, P. Delgado-Benito, M.A. Gomez-MarcosSalamanca-SPAIN
6 173 / RELATIONSHIP BETWEEN RETINAL VESSEL DIAMETERS AND ARTERIAL STIFFNESS IN HYPERTENSIVE PATIENTSJ.I. Recio-Rodriguez, M.A. Gomez-Marcos, L.J. Gonzalez-Elena, J. Parra-Sanchez, C. Agudo-Conde, M.C. Patino-Alonso, D. Pérez-Arechaederra, P. Delgado-Benito, J. Prieto-Mateos, L. Garcia-OrtizSalamanca-SPAIN
6 174 / CHANGES OF ARTERIAL STIFFNESS AND CENTRAL BLOOD PRESSURE DURING LONG-TERM ANTIHYPERTENSIVE THERAPYV. Ivanenko, O. Rotar, I. Emelyanov, A. KonradiSt. Petersburg-RUSSIA
6 175 / ELASTIC AND MUSCULAR ARTERIAL STIFFNESS IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROMES. Kushnir, Y. SirenkoKiev-UKRAINE
6 176 / ESTIMATION OF MEAN ARTERIAL PRESSURE AT BRACHIAL LEVEL IS NOT INFLUENCED BY REGIONAL ARTERIAL STIFFNESSS. Graf, D. Craiem, R. Armentano, H. Baglivo, R. SanchezBuenos Aires-ARGENTINA
6 177 / HIGHER FREQUENCY OF RENAL CYST AND HYPERTENSION IN PATIENTS WITH AORTIC ANEURYSMT. Hashizume (1), M. Arita (2), S. Shioji (1), T. Akasaka (2)(1) Tanabe, (2) Wakayama-JAPAN
6 178 / DETERMINATION OF THE BEST ANKLE BRACHIAL INDEX THRESHOLD VALUES FOR THE ROUTINE DETECTION OF A SIGNIFICANT LOWER LIMB ARTERIAL STENOSIS USING AN AUTOMATED DEVICED. Rosenbaum, S. Rodriguez-Carranza, P. Laroche, E. Bruckert, P. Giral, X. GirerdParis-FRANCE
6 165 / AORTIC STIFFNESS IN BLACK-AFRICAN PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS INFECTIOND. Lemogoum (1), W. Ngatchou (1), P. Ndobo (2), M. Leeman (1), L. Van Bortel (3), C. Kouanfack (2), J.P. Degaute (1), P.H. Van de Borne (1)(1) Brussels-BELGIUM; (2) Yaounde-CAMEROON; (3) Gent-BELGIUM
6 166 / PREDICTIVE PARAMETERS FOR PROGRESSION OF AORTIC DIAMETER AFTER SURGERY FOR TYPE A AORTIC DISSECTION OR HAEMATOMAJ.P. Baguet, L. Boggetto-Graham, M. Rodiere, O. Chavanon, F. Thony, J.L. Pepin, G. Barone-Rochette, E. VautrinGrenoble-FRANCE
6 167 / AORTIC STIFFNESS AFTER SURGERY FOR TYPE A AORTIC DISSECTION OR HAEMATOMAJ.P. Baguet, L. Boggetto-Graham, O. Chavanon, S. Bottari, G. Barone-Rochette, P. Faure, H. Pierre, O. Ormezzano, E. VautrinGrenoble-FRANCE
6 168 / PLASMA ENDOTHELIN-1 IS ASSOCIATED WITH AORTIC STIFFNESS IN ESSENTIAL HYPERTENSIONG. Mulè, S. Cottone, P. Cusimano, A. Palermo, A.C. Foraci, T. Viola, M. Costanzo, E. Nardi, G. CerasolaPalermo-ITALY
6 169 / ARTERIAL STIFFNESS IN HYPERTENSIVE PATIENTS IN NORMAL AND DECREASED GLOMERULAR FILTRATION RATEA. Troshina, Y. Kotovskaya, Z. KobalavaMoscow-RUSSIA
6 170 / ARTERIAL STIFFNESS INCREASE IN POSTMENOPAUSAL WOMEN WITH ARTERIAL HYPERTENSION AND SUBCLINICAL HYPOTHYROIDISMO. Ryabtseva, Z. Blankova, T. Chazova, F. Ageev, I. OrlovaMoscow-RUSSIA
6 171 / HYPERTENSION AND HIGHER LEFT VENTRICULAR END-DIASTOLIC PRESSURE INFLUENCE THE AORTIC DISTENSIBILITYM.S. Shin (1), B.R. Kim (2), K.H. Lee (1), W.J. Chung (1), W.C. Kang (1), T.H. Ahn (1), I.S. Choi (1), E.K. Shin (1)(1) Incheon, (2) Seoul-SOUTH KOREA
Monday
20
426Monday 20426 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011427
Monday 20 6 186 / DIFFERENCES BETWEEN THREE SINGLE CONSECUTIVE AND AVERAGED MEASUREMENTS OF PULSE WAVE VELOCITY IN TERMS OF THE EXTRAPOLATED CARDIOVASCULAR RISK AND THE CLASSIFICATION OF AORTIC STIFFNESST. Papaionnou, A. Protogerou, N. Skliros, E. Nasothymiou, D. Tzamouranis, A. Achimastos, D. Papadogiannis, C. StefanadisAthens-GREECE
6 187 / OMEGA 3 DIET SUPPLEMENTATION AND ARTERIAL STIFFNESS IN AN EXPERIMENTAL MODEL OF MENOPAUSEP. Losurdo, E. Panizon, M. Jevnikar, L. Macaluso, B. Fabris, B. Toffoli, M. Bardelli, G. Biolo, M. Zanetti, S. Mazzucco, G. Gortan Cappellari, R. CarrettaTrieste-ITALY
6 188 / PARAMETERS OF COMMON CAROTID ARTERY ELASTICITY ASSESSED BY ECHO-TRACKING TECHNOLOGY IN YOUNG MEN WITH ARTERIAL HYPERTENSION GRADE 1A. Zairova, A. Rogoza, E. OschepkovaMoscow-RUSSIA
6 189 / LIFETIME FIBRE INTAKE AND ITS MAJOR DIETARY SOURCES ARE FAVOURABLY ASSOCIATED WITH ARTERIAL STIFFNESS IN YOUNG ADULTHOOD: THE AMSTERDAM GROWTH AND HEALTH LONGITUDINAL STUDYR.J.J. Van De Laar (1), C.D.A. Stehouwer (1), B.C.T. Van Bussel (1), S.J. Te Velde (2), M.H. Prins (1), J.W.R. Twisk (2), I. Ferreira (1)(1) Maastricht, (2) Amsterdam-THE NETHERLANDS
6 190 / WEAK CARDIAC EJECTION PATTERNS RESULTS IN INCREASED CENTRAL TO PERIPHERAL PULSE PRESSURE AMPLIFICATIONB. Westerhof (1), B. van den Bogaard (1), B.J. van den Born (1), J.P. van den Wijngaard (1), F. Mattace-Raso (2)(1) Amsterdam, (2) Rotterdam-THE NETHERLANDS
6 191 / SYMPATHETIC ACTIVITY CONTRIBUTES TO ABDOMINAL AORTIC COMPLIANCE AND WALL DISTENSIBILITY IN RATSG. Lindesay, K. Viegas, M. Butlin, A. AvolioSydney-AUSTRALIA
6 192 / EFFECT OF HEART RATE ON AORTIC PULSE WAVE VELOCITY IS MODULATED BY WALL VISCOELASTICITY: A MODELLING STUDYK. Xu, M. Butlin, A. AvolioSydney-AUSTRALIA
6 179 / PARAMETERS OF PRESSURE WAVE REFLECTION ARE ASSOCIATED WITH ANKLE-BRACHIAL INDEX IN THE GENERAL POPULATIONJ. Seidlerová (1), J. Filipovský (1), R. Cífková (2), P. Wohlfahrt (2), A. Krajcoviechová (2)(1) Pilsen, (2) Prague-CZECH REPUBLIC
6 180 / AGE RELATED SHIFT OF THE REFLECTION POINT FROM PERIPHERAL TO CENTRAL ARTERIES IN HYPERTENSIVES: A MYTH OR A FACT?P. Forcada, S. Gonzalez, S. Obregon, J. Chiabaut, D. Olano, E. Cavanagh, F. Inserra, C. KotliarBuenos Aires-ARGENTINA
6 181 / SYMMETRIC DIMETHYL-L-ARGININE LEVEL IS POSITIVELY CORRELATED WITH CAROTID-FEMORAL PULSE WAVE VELOCITY IN HYPERTENSIVE SUBJECTSL. Klima (1), K. Stolarz-Skrzypek (1), J. Menne (2), A. Olszanecka (1), W. Wojciechowska (1), G. Bilo (3), K. Kawecka-Jaszcz (1)(1) Cracow-POLAND; (2) Hannover-GERMANY; (3) Milan-ITALY
6 182 / LEVELS OF METALLOPROTEINASES MMP-2 AND MMP-9 IN UNTREATED PATIENTS WITH ESSENTIAL HYPERTENSION AND RELATIONSHIP WITH INDICES OF ARTERIAL STIFFNESSE. Gkaliagkousi, S. Douma, M. Doumas, K. Vogiatzis, E. Gavriilaki, P. Anyfanti, A. Triantafyllou, K. Petidis, C. ZamboulisThessaloniki-GREECE
6 183 / DIFFERENT IMPACT OF AGE ON ARTERIAL STIFFNESS PARAMETERS IN HYPERTENSIVE PATIENTSE. Troitskaya, S. Villevalde, Y. Kotovskaya, Z. KobalavaMoscow-RUSSIA
6 184 / ASSOCIATION OF ARTERIAL STIFFNESS WITH INFLAMMATION BIOMARKERS IN A CHINESE GENERAL POPULATON:THE JINGNING STUDYF.H. Li, Y. Li, H.Q. Fan, C.S. Sheng, W.X. Fan, Y. Zhang, B.C. Hu, J.G. WangShanghai-CHINA
6 185 / ASSESSMENT OF CAROTID ELASTICITY DURING EXERCISE: A REPRODUCIBILITY STUDYF. Faita, E. Bianchini, R.M. Bruno, A.I. Corciu, V. Gemignani, L. Ghiadoni, E. Picano, R. SicariPisa-ITALY
Monday
20
428Monday 20428 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011429
Monday 2014.00 - 15.30Ground Floor
Poster Session 36
HEART
ROOM 7 / POSTERS FROM 200 TO 232
Chairperson: G. Seravalle (Milan-ITALY)
7 200 / PREVALENCE AND CORRELATES OF ECHOCARDIOGRAPHIC LEFT ATRIAL ENLARGEMENT IN HYPERTENSIVE OUTPATIENTS IN CLINICAL PRACTICEF. Negri, C. Cuspidi, L. Lonati, M.L. Muiesan, A. Capra, A. Milan, C. Sala, G.B. Danzi, M. Longo, A. Morganti, on behalf of Working Group on Heart and Hypertension of the Italian Society of HypertensionMilan-ITALY
7 201 / MITRAL DECELERATION INDEX IS ASSOCIATED TO AORTIC ROOT DILATATION AND NOT TO BIVENTRICULAR STRUCTURAL CHANGES IN ESSENTIAL HYPERTENSIONF. Negri, C. Cuspidi, C. Sala, G. ManciaMilan-ITALY
7 202 / ECHOCARDIOGRAPHIC ALTERATIONS IN MASKED HYPERTENSIONM. Camafort, J. Sobrino, M. Domenech, E. Vinyoles, A. Segarra, J.E. Lopez-Paz, J. Saban, J. Saban, L.M. Cuadrado, F. Gamazo, A. Vicente, M.J. Adrian, A. Felip, J. Vila, A. Coca, on behalf of the ESTHEN Study GroupSPAIN
7 203 / DETECTION OF SUBCLINICAL DIASTOLIC DYSFUNCTION IN HYPERTENSIVE PATIENTS USING DIASTOLIC STRESS ECHOCARDIOGRAPHYM. Deljanin Ilic, S. Ilic, V. Stoickov, V. IlicNis-SERBIA
7 204 / CAN THE SILENT MYOCARDIAL ISCHEMIA BE DETECTED IN ARTERIAL HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR REMODELING?S. Gurgenyan, S. Vatinyan, K. NikoghosyanYerevan-ARMENIA
6 193 / CAROTID-FEMORAL PULSE WAVE VELOCITY: AGE ADJUSTED DISTANCE ESTIMATIONS. Huybrechts, D. Devos, S. Vermeersch, D. Mahieu, E. Achten, T. De Backer, P. Segers, L. Van BortelGent-BELGIUM
6 194 / DETERMINANTS OF PULSE WAVE VELOCITY IN HYPERTENSIVESD. Terentes-Printzios, C. Vlachopoulos, G. Vyssoulis, K. Aznaouridis, N. Ioakeimidis, P. Pietri, P. Xaplanteris, N. Alexopoulos, E. Christoforatou, A. Samentzas, C. Stefanadis Athens-GREECE
6 195 / VALIDATION OF THE VICORDER DEVICE IN CHILDREN - A COMPARISON WITH THE SPHYGMOCORD. Kracht (1), S. Baig (1), A. Doyon (2), C. Jacobi (1), F. Schaefer (2), E. Wuehl (2), A. Melk (1), B. Schmidt (1)(1) Hannover, (2) Heidelberg-GERMANY
6 196 / ASSOCIATION BETWEEN CAROTID ARTERIES STRUCTURAL CHANGES AND SERUM URIC ACID IN ESSENTIAL HYPERTENSIVE PATIENTSO. GulkevychKyiv-UKRAINE
6 197 / NON-INVASIVE MEASUREMENT OF ARTERIAL STIFFNESS USING THE ANALYSIS OF OSCILLOMETRIC WAVEFORM DURING CUFF-INFLATIONM. Takata (1), A. Shimakura (1), T. Kusakabe (2), K. Ide (2)(1) Toyama, (2) Osaka-JAPAN
6 198 / CENTRAL BLOOD PRESSURE IN TYPE 2 DIABETIC AND PREDIABETIC PATIENTS: CORRELATION WITH PERIPHERAL BLOOD PRESSUREA. Oliveras (1), J. Segura (2), C. Suarez (2), M. Gomez-Marcos (3),L. Garcia-Ortiz (3), N. Martell-Claros (2), M. Abad (2), L. Vigil (4), D. Ferrero (4), L. Sans (1), J.J. De La Cruz (2), L.M. Ruilope (2), A. De La Sierra (5), on behalf of the PRESCEN Study, Spain(1) Barcelona, (2) Madrid, (3) Salamanca, (4) Móstoles, (5) Terrassa-SPAIN
6 199 / CENTRAL BLOOD PRESSURE AFTER MENTAL STRESS IN OBESE ADOLESCENTSM. Rovina, G. Tonini, E. Faleschini, B. Fabris, M. Bardelli, F. Fischetti, R. CarrettaTrieste-ITALY
Monday
20
430Monday 20430 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011431
Monday 20 7 211 / FACTORS ASSOCIATED WITH A PROLONGED QT INTERVAL IN HYPERTENSIVE PATIENTSI. Mozos, R. Patrascu, C. Serban, A. Pacurari, A. Tudor, L. SusanTimisoara-ROMANIA
7 212 / EFFECTIVENESS OF THERAPY USING BETA-BLOCKERS IN PATIENTS WITH ESSENTIAL HYPERTENSION AND STABLE EFFORT ANGINAS. Vatinian, S. Gurgenyan, K. NikoghosyanYerevan-ARMENIA
7 213 / ASSOCIATION OF INAPPROPRIATE LEFT VENTRICULAR MASS WITH CARDIOVASCULAR RISK FACTORS IN HYPERTENSIVE PATIENTSM. Vorobyeva, S. Villevalde, A. Safarova, Z. KobalavaMoscow-RUSSIA
7 214 / ASSOCIATION BETWEEN SERUM URIC ACID AND LEFT ATRIUM SIZE IN HYPERTENSIVES IS INDEPENDENT OF GLOMERULAR FILTRATION RATEC. Esis, M. Bracho, E. Silva, A. Gonzalez, S. Briceno, J. VillasmilMaracaibo-VENEZUELA
7 215 / NOVEL APPROACH FOR DIAGNOSTICS OF LEFT VENTRICULAR HYPERTROPHY BY ELECTROCARDIOGRAPHYV. Kuznetsov, E. Martynova, V. Solovyev, L. Evlampieva, V. Todosiychuk, D. Krinochkin, S. Vdovenko, E. Gorbatenko, E. Isaeva, A. NaimushinaTyumen-RUSSIA
7 216 / HYPERTENSION-RELATED LEFT VENTRICULAR HYPERTROPHY IS ASSOCIATED WITH RIGHT VENTRICULAR DYSFUNCTIONV. Katsi, C. Aggeli, I. Felekos, L. Raftopoulos, G. Souretis, I. Vlasseros, C.H. Stefanadis, I. KallikazarosAthens-GREECE
7 217 / CARDIAC AQUAPORIN 1 DURING OSMOTIC STRESS INDUCED BY WATER RESTRICTIONV. Netti, M. Vatrella, M. Chamorro, D. Vives, M.I. Rosón, A. Fellet, A.M. BalaszczukBuenos Aires-ARGENTINA
7 205 / PROGNOSTIC VALUE OF LEFT VENTRICULAR HYPERTROPHY AND BLOOD PRESSURE VARIABILITYS. Cinza Sanjurgo (1), A. Hermida Ameijeiras (2), J.E. López Paz (2), M. Pena Seijo (2), G. Calvo González (2), M.L. Romero Miguez (2), V. Martinez Durán (2), A. Pascual Montes (2), J.M. Paz Fernández (2), C. Calvo Gómez (2)(1) Malpica, (2) Santiago De Compostela-SPAIN
7 206 / ASSOCIATION BETWEEN EAS INDEX BY TISSUE DOPPLER IMAGING AND VENTRICULAR STIFFNESS INDEX OR VENTRICULOARTERIAL INTERACTIONH. Sako, S. Miura, K. SakuFukuoka-JAPAN
7 207 / TISSUE DOPPLER INDEXES OF LEFT VENTRICULAR SYSTOLIC FUNCTION IN RELATION TO THE PULSATILE AND STEADY COMPONENTS OF BLOOD PRESSURE IN A GENERAL POPULATIONT. Kuznetsova (1), W. Sakiewicz (2), M. Kloch-Badelek (3), J. Dhooge (1), A. Ryabikov (4), K. Kunicka (2), E. Swierblewska (2), L. Thijs (1), S. Malyutina (4), K. Stolarz-Skrzypek (3), K. Kawecka-Jaszcz (3), K. Narkiewicz (2), J.A. Staessen (1)(1) Leuven-BELGIUM; (2) Gdansk, (3) Cracow-POLAND; (4) Novosibirsk-RUSSIA
7 208 / TEN-YEAR DYNAMICS OF CARDIAC STRUCTURE AND LEFT VENTRICULAR DIASTOLIC FUNCTION IN HYPERTENSIVE PATIENTS WITH AND WITHOUT INITIAL LEFT VENTRICULAR HYPERTROPHYO. Matova, S. Pavlenko, O. Chervonopiskaya, L. MishchenkoKyiv-UKRAINE
7 209 / MORPHO-FUNCTIONAL HEART PECULIARITIES OF YOUNG SWIMMERS WITH SMALL ANOMALIES OF HEART EVOLUTIONA. Smolensky, O. Belichenko, A. MichailovaMoscow-RUSSIA
7 210 / LEFT VENTRICULAR HYPERTROPHY IN CHILDREN WITH CHRONIC KIDNEY DISEASED. Drozdz, Z. Kordon, P. Kwinta, K. Zachwieja, A. Rudzinski, J.A. Pietrzyk, M. DrozdzCracow-POLAND
Monday
20
432Monday 20432 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011433
Monday 20 7 225 / CIRCULATING STROMELYSIN-1 AS A POSSIBLE MARKER OF SEVERITY OF CARDIOVASCULAR REMODELING IN OBESITY PATIENTS AFTER MYOCARDIAL INFARCTIONA. Berezin, T. PanasenkoZaporozhye-UKRAINE
7 226 / ELECTROPHYSIOLOGY DATA IN HYPERTENSIVE PATIENTS WITH AND WITHOUT HYPERTROPHYE. Rebeko, A. Mrochek, D. Goncharik, V. Golenischa, O. Kovalenko, A. Chasnoyt Minsk-BELARUS
7 227 / RELATIONSHIP BETWEEN IMPAIRED LUNG FUNCTION AND CARDIAC FUNCTION IN OLDER INDIVIDUALSB.J. Mcdonnell (1), I. Munnery (1), M. Munnery (1), I. Wilkinson (2), C. Mc Eniery (2), J. Cockcroft (1), on behalf of the Anglo-Cardiff Collaborative Trial investigators(1) Cardiff, (2) Cambridge-UK
7 228 / GEOMETRICAL CHANGES OF LEFT VENTRICLE IN HYPERTENSIVE WOMEND. Lovic (1), V. Stojanov (2), B. Jakovljevic (2)(1) Nis, (2) Belgrade-SERBIA
7 229 / TISSUE DOPPLER IMAGING IN ASSESSMENT OF PATIENTS WITH PULMONARY HYPERTENSION AND HIGH BRAIN NATRIURETIC PEPTIDE LEVELS AS COMPARED WITH CONVENTIONAL ECHOCARDIOGRAPHYY.A. Andreeva, M.A. Saidova, T.V. Martynyuk, V.P. Masenko, A.V. Volkov, I.Ye. ChazovaMoscow-RUSSIA
7 230 / POSSIBILITIES OF TRADITIONAL DOPPLER AND TISSUE DOPPLER IMAGING IN DETECTION OF SYSTOLIC AND DIASTOLIC HEART FUNCTION IN VARIOUS FORMS OF PULMONARY HYPERTENSIONY.A. Andreeva, M.A. Saidova, T.V. Martynyuk, V.P. Masenko, K.A. Zikov, A.V. Volkov, I.Ye. ChazovaMoscow-RUSSIA
7 231 / ECHOCARDIOGRAPHIC ASSESSMENT OF THE THICKNESS OF LEFT PART OF INTERVENTRICULAR SEPTUM AND ITS ASSOCIATION WITH ARTERIAL HYPERTENSION SEVERITYV. Kuznetsov, D. Krinochkin, L. Gapon, A. Vershinina, N. ShurkevichTyumen-RUSSIA
7 218 / IN CHILDREN AND ADOLESCENTS WITH WHITE COAT HYPERTENSION: IS LEFT VENTRICULAR MASS INDEX ASSOCIATED WITH NEW-ONSET HYPERTENSION?M. Bracho, C. Esis, E. Silva, A. Gonzalez, J. Villasmil, S. Briceno, G. Bermudez, G. CalmonMaracaibo-VENEZUELA
7 219 / EFFECTIVENESS OF NUCLEAR SCAN STRATEGY IN CHEST PAIN PATIENTS PRESENTING WITH HYPERTENSIONM. Luzzi, A. Conti, C. Nanna, T. Focosi, Y. Mariannini, E. Canuti, G. Cerini, G. Viviani, S. Squarciotta, E. De Villa, S. Vicidomini, C. Gallini, E. CostanzoFlorence-ITALY
7 220 / NINE YEARS FOLLOW-UP OF PATIENTS WITH HYPERTENSIVE LEFT VENTRICULAR HYPERTROPHY AND PREDICTIVE VALUE OF NON-INVASIVE PARAMETERSD. Djordjevic (1), I. Tasic (1), B. Stamenkovic (1), M. Lovic (1), D. Lovic (2), B. Lovic (2)(1) Niska Banja, (2) Nis-SERBIA
7 221 / IMPACT OF DIABETES IN CARDIAC STRUCTURE AND FUNCTION IN HYPERTENSIVE PATIENTSA. Banushi, E. Zaimi, E. Petrela, A. Deljana, S. QirkoTirana-ALBANIA
7 222 / INTERRELATIONS OF PULSE ARTERIAL PRESSURE, MITRAL REGURGITATION AND LEFT HEART REMODELING IN PATIENTS WITH ARTERIAL HYPERTENSION AND ISCHEMIC HEART DISEASEL. Zhuravlyova, I. Ilchenko, A. YankevichKharkiv-UKRAINE
7 223 / PREDICTORS OF DEVELOPMENT FATAL CARDIOVASCULAR COMPLICATIONS IN HYPERTENSIVE PATIENTS WITH INITIALLY CONCENTRIC LEFT VENTRICULAR HYPERTROPHY (IN 20 YEARS)L. ZelenenkaKyiv-UKRAINE
7 224 / LEFT ATRIAL REMODELLING IN HYPERTENSIVE PATIENTSN. DovganychKyiv-UKRAINE
Monday
20
434Monday 20434 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011435
Monday 2014.00 - 15.30Ground Floor
Poster Session 37
BRAIN
ROOM 8 / POSTERS FROM 233 TO 256
Chairperson: C. Delles (Glasgow-UK)
8 233 / PROTECTIVE EFFECT OF VALSARTAN FOR STROKE IN JAPANESE SUBJECTS: AN ANALYSIS OF JIKEI HEART STUDYM. Shimizu (1), H. Yoshida (1), K. Ikewaki (2), I. Taniguchi (3), M. Yoshimura (3), G. Rosano (4), B. Dahlöf (5), S. Mochizuki (3)(1) Kashiwa-shi, (2) Tokorozawa, (3) Minato-ku-JAPAN; (4) Rome-ITALY; (5) Göteborg-SWEDEN
8 234 / RISK FACTORS ANALYSIS BY SUBTYPES IN ISCHEMIC AND HEMORRHAGIC STROKEK. Suzuki (1), K. Yoshimura (2)(1) Akita, (2) Tokyo-JAPAN
8 235 / EFFECT OF VERAPAMIL ON SUBCLINICAL BRAIN DAMAGE IN HYPERTENSIVE PATIENTSA.Yu. Falkovskaya, V.F. Mordovin, V.Yu. UssovTomsk-RUSSIA
8 236 / HEART RATE VARIABILITY IN HYPERTENSIVE PATIENTS WITH STRUCTURAL PATHOLOGY OF A BRAIN AND MILD COGNITIVE IMPAIRMENTN. Afanasyeva, V. Mordovin, G. SemkeTomsk-RUSSIA
8 237 / SIGNIFICANCE OF CEREBRAL HYPERTENSIVE CRISES IN DEVELOPMENT OF STRUCTURAL CHANGES OF A BRAIN IN HYPERTENSIVE PATIENTSG. Semke, V. Mordovin, N. Afanasyeva, S. PekarskyTomsk-RUSSIA
7 232 / REFERENCE VALUES FOR LEFT VENTRICULAR STRAIN BY TWO DIMENSIONAL STRAIN IMAGING IN NORMAL INDIVIDUALS: IMPACT OF TECHNICAL AND CLINICAL CONFOUNDERSM. Chinali (1), G.P. Aurigemma (1), N. Metha (1), Z. Zichittella (1), H. Pokrel (1), G. De Simone (2), J.H. Hill (1), D. Tighe (1)(1) Worcester-USA; (2) Naples-ITALY
Monday
20
436Monday 20436 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011437
Monday 20 8 244 / CORRELATION BETWEEN CAROTID WALL CHANGES AND COGNITIVE DECLINE IN HYPERTENSIVE PATIENTSC. Serban, S. Dragan, L. Susan, I. Mozos, A. Pacurari, R. Christodorescu, R. Susan, A. Caraba, A. Tudor, I. RomosanTimisoara-ROMANIA
8 245 / FACTORS ASSOCIATED WITH IMPAIRED COGNITIVE FUNCTION IN HYPERTENSIVE ELDERLY PATIENTSL. Susan, C. Serban, A. Pacurari, I. Mozos, R. Susan, A. Narita, M. Susan,I. RomosanTimisoara-ROMANIA
8 246 / TIME-DEPENDENT CHANGES IN CAROTID-FEMORAL PULSE WAVE VELOCITY IN PATIENTS AFTER ISCHEMIC STROKEM. Kwarciany (1), D. Gasecki (1), A. Rojek (1), R. Nowak (1), K. Kowalczyk (1), P. Boutouyrie (2), W. Nyka (1), S. Laurent (2), K. Narkiewicz (1)(1) Gdansk-POLAND; (2) Paris-FRANCE
8 247 / MULTINFARCTUAL ISCHEMIC CEREBRAL DISEASE IN THE “PATTI FOR STROKE” INTEGRATED ASSISTANCE MODELA. Grippa, F. D’AmicoMessina-ITALY
8 248 / RETINAL VASCULAR DETERIORATION IS ACCOMPANIED BY ADVERSE CARDIAC REMODELING IN ESSENTIAL HYPERTENSIONV. Katsi, G. Souretis, C. Vlachopoulos, N. Alexopoulos, K. Benekos, I. Vlasseros,D. Tousoulis, C. Stefanadis, I. KallikazarosAthens-GREECE
8 249 / TREATED AND NON-TREATED HYPERTENSION: COMPARISION OF LOBAR AND DEEP INTRACEREBRAL HAEMORRHAGET. Maisuradze, M. Janelidze, M. Beridze, S. Kapianidze, N. Kvirkvelia, N. Guldedava, I. Urushadze, N. Akiashvili, M. KapianidzeTbilisi-GEORGIA
8 250 / DISORDER OF BRAIN PERFUSION IN NON-COMPLICATED ARTERIAL HYPERTENSIVE PATIENTS IMPACTS NEGATIVELY ON RECOVERY OF MEMORY UNDER ANTIHYPERTENSIVE TREATMENTA. Kadykov, Y. Varakin, E. Oschepkova, G. Gornostayeva, M. Prokopovich, A. Fonyakin, N. LazarevaMoscow-RUSSIA
8 238 / DYNAMICS OF STRUCTURAL CHANGES OF A BRAIN IN PATIENTS WITH HYPERTENSIVE CRISES OVER THE PERIOD OF 5 YEARSG. Semke, V. Mordovin, N. Afanasyeva, S. PekarskyTomsk-RUSSIA
8 239 / RELATIONSHIP BETWEEN LEFT VENTRICULAR MASS INDEX, WHITE MATTER HYPERINTENSIVITY AND COGNITIVE PERFORMANCE IN HYPERTENSIVE STROKE PATIENTSS. Kapianidze, M. Janelidze, M. Beridze, N. Lobjanidze, N. Akiashvili, T. Maisuradze, M. Kapianidze, N. KvirkveliaTbilisi-GEORGIA
8 240 / LONG-TERM OUTCOMES WITH EARLY INITIATION OF ANTIHYPERTENSIVE TREATMENT IN ISCHEMIC STROKEL. Brescacin, C. Alonzo, M. Zurru, F. Ortega, S. Brienza, R. Martinez, M. Carretero, L. Camera, E. Cristiano, W. WaismanBuenos Aires-ARGENTINA
8 241 / MIGHT ANTIHYPERTENSIVE-DRUG CHOICE NEGATIVELY INFLUENCE LONG-TERM OUTCOMES IN STROKE PATIENTS UNDER STATIN THERAPY?L. Brescacin, C. Alonzo, M. Zurru, S. Brienza, F. Ortega, R. Martinez, J. Montecchia, L. Camera, E. Cristiano, G. WaismanBuenos Aires-ARGENTINA
8 242 / PROTEGE-ACV PROGRAM: A USEFUL TOOL TO ACHIEVE LONG-TERM ADHERENCE TO SECONDARY STROKE PREVENTION GOALSC. Alonzo, L. Brescacín, C. Zurrú, S. Brienza, R. Martínez, F. Ortega, D. Gil, L. Cámera, E. Cristiano, G. WaismanBuenos Aires-ARGENTINA
8 243 / PRIMARY CARE PHYSICIANS´ ERRORS IN HANDLING HYPERTENSION AND HYPERGLYCEMIA IN ACUTE STROKE. A PROSPECTIVE SURVEY IN A RURAL AREA OF SOUTHERN SPAINL. Castilla-Guerra (1), M.C. Fernandez-Moreno (2), L. Serrano-Rodriguez (2), L. Alpanseque-Hoogenstein (2), F. Villalba (2), C. Gonzalez (2), E. Carmona-Nimo (2), F. Pozuelo-Del Rosal (2), S. Vergara (2), J. Marin-Martin (2), A. Espino-Montoro (2), M.D. Jimenez-Hernandez (2), J.M. Lopez-Chozas (2)(1) Castilleja De Guzman, (2) Seville-SPAIN
Monday
20
438Monday 20438 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011439
Monday 2014.00 - 15.30Ground Floor
Poster Session 38
NEURAL MECHANISMS
ROOM 9 / POSTERS FROM 257 TO 269
Chairperson: G.A. Head (Prahran-AUSTRALIA)
9 257 / SIDESTREAM CIGARETTE SMOKE EFFECTS ON BAROCEPTOR REFLEXL.C. De Abreu (1), C. Ferreira (2), P.H.N. Saldiva (2), V.E. Valenti (2)(1) Santo André, (2) São Paulo-BRAZIL
9 258 / BAROREFLEX SENSITIVITY VARIABILITY IN JUVENILE SPONTANEOUSLY HYPERTENSIVE RATSL.C. De Abreu (1), C. Ferreira (2), P.H.N. Saldiva (2), V.E. Valenti (2)(1) Santo André, (2) São Paulo-BRAZIL
9 259 / THE ROLE OF THE CARDIAC AUTONOMIC BALANCE IN THE EARLY STAGES OF ESSENTIAL HYPERTENSIONS. González, C. Kotliar, P. Forcada, E. Cavanagh, J. Chiabaut Svane, F. Inserra, C. Castellaro, S. Obregon, D. Olano, A. HitaPilar-ARGENTINA
9 260 / DEFENSIVE ACTIVE COPING ASSOCIATED WITH LEFT VENTRICULAR DYSFUNCTION: THE SYMPATHETIC ACTIVITY AND AMBULATORY BLOOD PRESSURE IN AFRICAN (SABPA) STUDYL. Malan (1), N. Malan (1), H. Huisman (1), J. Van Rooyen (1), R .Schutte (1), A. Schutte (1), C. Fourie (1), J. Potgieter (1), B. Harvey (1), M. Hamer (2), E. De Geus (3), T. Ziemssen (4), M. Reimann (4), Y. Seedat (5)(1) Potchefstroom-SOUTH AFRICA; (2) London-UK; (3) Amsterdam-THE NETHERLANDS; (4) Dresden-GERMANY; (5) Durban-SOUTH AFRICA
9 261 / NEW APPROACHES TO CARDIOVASCULAR REACTIVITY EVALUATION DURING TILT TESTING OF PATIENTS WITH ARTERIAL HYPERTENSIONK. Protasov, S. Kuklin, A. Dzizinsky, V. Boronova, N. AntonenkoIrkutsk-RUSSIA
8 251 / EFFECT OF AMLODIPINE ON CAROTID STRUCTURE AND CEREBRAL BLOOD FLOW IN PATIENTS WITH ESSENTIAL HYPERTENSIONO. Gulkevych Kyiv-UKRAINE
8 252 / VASCULAR REACTIVITY OF BRAIN IN HYPERTENSIVE PATIENTS WITH OBSTRUCTIVE SLEEP APNEA BY HYPEROXIAT. Ripp, V. Mordovin, S. Zapodovnikov, E. RippTomsk-RUSSIA
8 253 / HISTORY OF HYPERTENSIVE CRISES IS ASSOCIATED WITH MORE SEVERE CLINICAL SYMPTOMS OF BRAIN INVOLVEMENT AND PROGRESSIVE IMPAIRMENT OF BIOELECTRICAL ACTIVITY OF A BRAIN IN ESSENTIAL HYPERTENSIVE PATIENTSG. Semke, V. MordovinTomsk-RUSSIA 8 254 / HYPERTENSION AND MULTIPLE BRAIN DAMAGE INTEGRITY IN LATE-LIFE DEPRESSIONN. Lobjanidze, M. Janelidze, M. Beridze, N. Kvirkvelia, N. Akiashvili, S. Kapianidze, I. Urushadze, T. Maisuradze, M. KapianidzeTbilisi-GEORGIA
8 255 / PHEOCHROMOCYTOMA AND STROKEG. Potapova, I. Chazova, N. Kuznetsov, V. Sitina, E. Popov, I. Gavrilov Moscow-RUSSIA
8 256 / COGNITIVE IMPAIRMENT IN UNSUFFICIENTLY CONTROLLED GRADE-1 HYPERTENSIVESP. Nazzaro, M.F. De Caro, C. Spinelli, G. Schirosi, G. Grandolfo, L. De Benedittis, F. FedericoBari-ITALY
Monday
20
440Monday 20440 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011441
Monday 2014.00 - 15.30Ground Floor
Poster Session 39
ENDOCRINE ASPECTS
ROOM 10 / POSTERS FROM 270 TO 294
Chairperson: L. Lonati (Milan-ITALY)
10 270 / AGING IN THYROID DYSFUNCTION: ARE CAVEOLINS PROTEINS INVOLVED IN THE CARDIOVASCULAR NITRIC OXIDE PRODUCTION?L.I. Sarati, C.R. Marinez, N. Artes, A.M. Balaszczuk, A.L FelletBuenos Aires-ARGENTINA
10 271 / ATHEROGENIC POTENTIAL OF SUBCLINICAL HYPOTHYROIDISM AND WAYS OF HIS CORRECTIONV. Romanov, I. Chulaievska, A. Iluischina, A. Logvinenko, L. Yakuschko, O. MitchenkoKyiv-UKRAINE
10 272 / SUBTLE HYPERPARATHYROIDISM: A NOVEL FEATURE OF PRIMARY ALDOSTERONISM THAT IS CORRECTED BY ADRENALECTOMYC. Maniero, A. Fassina, T.M. Seccia, G. Albertin, R. De Caro, L. Calo’, A.C. Pessina, G.P. RossiPadua-ITALY
10 273 / PRORENIN AND PRORENIN RECEPTOR ACTIVATION RESULTS IN ERK 1/2 PHOSPHORYLATION IN HUMAN ADRENOCORTICAL CARCINOMA CELL LINESC. Recarti, T.M. Seccia, L. Lenzini, G. Skander, B. Caroccia, G. Ceolotto, L. Petrelli, A.S. Belloni, A.C. Pessina, G.P. Rossi Padua-ITALY
10 274 / URINARY PROSTASIN, A SERIN- PROTEASE ACTIVATING ENAC, IS PHYSIOLOGICALLY MODULATED BY NATRIURESIS IN NORMOTENSIVE INDIVIDUALSL. Chiecchi (1), F. Pizzolo (1), K. Kitamura (2), R. Raffaelli (1), L. Consoli (1), M. Gunasekaran (1), A. Castagna (1), G. Salvagno (1), P. Guarini (1), O. Olivieri (1)(1) Verona-ITALY; (2) Kumamoto-JAPAN
9 262 / CAROTID ENDARTERECTOMY IMPROVES BARORECEPTOR SENSITIVITY IN MOLATERAL CAROTID STENOSISL.A. Dalla Vecchia, M. Pisacreta, T. Porretta, R. Gornati, R. FurlanMilan-ITALY
9 263 / AUTONOMIC NERVOUS SYSTEM AND HAEMODYNAMIC CHANGES INDUCED BY A HALF MARATHONL.A. Dalla Vecchia (1), E. Traversi (2), D. Lucini (1), M. Malacarne (1), M. Pagani (1)(1) Milan, (2) Montescano-ITALY
9 264 / CARDIAC AUTONOMIC REGULATION AFTER ACUTE LUNG EXPOSURE TO CARBON NANOTUBES: AN EXPERIMENTAL STUDY IN CONSCIOUS RATSJ.M. Legramante, S. Sacco, P. Crobeddu, A. Pietroiusti, A. Magrini, F. Valentini, G. Palleschi, G. GalanteRome-ITALY
9 265 / CHARACTERIZATION OF HEMODYNAMIC AND AUTONOMIC RESPONSE TO STRESS IN HYPERTENSIVE PATIENTS: A LATENT CLASS ANALYSIS APPROACHJ. Gallo (1), D. Aguirre-Acevedo (1), J.E. Ochoa (2), M. Correa (1), G. Bilo (2), D. Aristizabal (1), G. Parati (2)(1) Medellin-COLOMBIA; (2) Milan-ITALY
9 266 / IMPACT OF BARORECEPTOR SENSITIVITY ON PULSE WAVE VELOCITYF. Michas (1), E. Manios (1), K. Stamatelopoulos (1), E. Koroboki (1), V. Chouzouri (1), A. Dimitriou (1), R. Panerai (2), N. Zakopoulos (1)(1) Athens-GREECE, (2) Leicester-UK
9 267 / AN ARTERIAL BAROREFLEX INDEX DERIVED FROM AMBULATORY BLOOD PRESSURE IS ASSOCIATED WITH HYPERTENSION-RELATED SUBCLINICAL TARGET ORGAN DAMAGEH. Li, P.J. Gao, S.L. ChuShanghai-CHINA
9 268 / SYMPATHETIC NERVOUS SYSTEM ACTIVITY AND CIRCULATING SERUM CYTOKINES RELATED TO DIPPING STATUS IN HYPERTENSIVE PATIENTSV. Popov (1), V. Vizir (2), I. Voloshyna (2)(1) Moscow-RUSSIA; (2) Zaporozhye-UKRAINE
9 269 / EFFECTS ON BAROREFLEX SENSITIVITY AND RENAL RESISTIVE INDEX OF DAILY SESSIONS OF MUSIC GUIDED SLOW-BREATHINGC. Bazzini (1), A. Ferrari (1), M. Boddi (1), G. Costanzo (1), M.S. Romano (1), L. Massetti (1), G. Tartarisco (2), G. Pioggia (2), P.A. Modesti (1)(1) Florence, (2) Pisa-ITALY
Monday
20
442Monday 20442 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011443
Monday 20 10 282 / RELATIONSHIP BETWEEN TRIIODOTHYRONINE WITH BLOOD PRESSURE AND INSULIN RESISTANCE IN EUTHYROID TYPE 1 DIABETIC PATIENTST. Bulum, I. Prkacin, L. DuvnjakZagreb-CROATIA
10 283 / EFFECTS OF FEMALE SEX HORMONES AND CONTRACEPTIVE PILL ON THE 11BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2 ACTIVITY ESTIMATED BY URINARY METABOLITES RATIOF. Pizzolo, R. Raffaelli, L. Chiecchi, A. Memmo, L. Consoli, A.M. Stanzial, P. Guarini, G.C. Guidi, M. Franchi, O. Olivieri Verona-ITALY
10 284 / PLASMA ALDOSTERONE LEVELS ON NORMAL, LOW AND HIGH SODIUM INTAKE IN PATIENTS WITH ESSENTIAL HYPERTENSION WITH NORMAL AND LOW PLASMA RENIN ACTIVITYJ. Ciric, M. Zarkovic, B. Beleslin, M. StojkovicBelgrade-SERBIA
10 285 / EFFECT OF SURGICAL TREATMENT OF PHEOCHROMOCYTOMA ON BLOOD PRESSURE LEVEL AND VARIABILITYK. Michel-Rowicka, M. Peczkowska, H. Janaszek-Sitkowska, A. Prejbisz, E. Szwench, K. Jozwik-Plebanek, S. Kolodziejczyk-Kruk, M. Kabat, A. JanuszewiczWarsaw-POLAND
10 286 / HUMORAL AND CELL-MEDIATED AUTOIMMUNITY MECHANISMS IN THE PATHOGENESIS OF PRIMARY ALDOSTERONISMG. Rossitto (1), E. Rossi (2), L. Lenzini (1), A. Fassina (1), F. Marino (1), M. Facco (1), C. Agostini (1), A. Cabrelle (1), A. Teramo (1), T.M. Seccia (1), G.P. Rossi (1)(1) Padua, (2) Reggio Emilia-ITALY
10 287 / PRIMARY ALDOSTERONISM AND ESSENTIAL HYPERTENSION: ASSESSMENT OF THE GLOBAL CARDIOVASCULAR RISK AT DIAGNOSIS AND FOLLOW-UPV. Ronconi, F. Turchi, V. Di Tizio, G. Appolloni, M. Boscaro, G. GiacchettiAncona-ITALY
10 288 / HORMONAL AND METABOLIC CHARACTERISTICS OF ADRENAL INCIDENTALOMASA. Nikolic, J. Ciric, B. Beleslin, M. Stojkovic, M. ZarkovicBelgrade-SERBIA
10 275 / ACUTE D2 RECEPTOR DOPAMINERGIC BLOCKADE DOES NOT AFFECT ADRENAL CORTISOL AND CHROMOGRANIN A RELEASE: IMPLICATIONS FOR THE DIAGNOSIS OF PRIMARY ALDOSTERONISMT.M. Seccia, D. Miotto, R. De Toni, V. Gallina, A.C. Pessina, G.P. RossiPadua-ITALY
10 276 / MAGNETIC RESONANCE IMAGING IN PATIENTS WITH ADENOCARCINOMA OF ADRENAL GLAND AND ARTERIAL HYPERTENSIONO. Belichenko, A. Vorontsov, E. Averkieva, V. Vladimirova, A. Smolenskiy, A. MikhailovaMoscow-RUSSIA
10 277 / MAGNETIC RESONANCE IMAGING IN PATIENTS WITH MYELOLIPOMA OF ADRENAL GLAND AND ARTERIAL HYPERTENSIONO. Belichenko, A. Smolenskiy, A. Vorontsov, V. Vladimirova, E. Averkieva, A. MikhailovaMoscow-RUSSIA
10 278 / CONCURRENT PRIMARY ALDOSTERONISM AND SUBCLINICAL CORTISOL HYPERSECRETION. A PERSPECTIVE STUDYF. Fallo (1), C. Bertello (2), D. Tizzani (2), N. Sonino (1), A. Fassina (1), M.C. Zennaro (3), M. Covella (2), E. Berra (2), V. Crudo (2), J. Burrello (2), D. Leone (2), F. Veglio (2), P. Mulatero (2)(1) Padua, Turin-ITALY; (2) Paris-FRANCE
10 279 / PSYCHOLOGICAL ASSESSMENT OF PRIMARY ALDOSTERONISM. A CONTROLLED STUDYN. Sonino (1), E. Tomba (2), M.L. Genesia (3), C. Bertello (3), V. Crudo (3), J. Burrello (3), M. Covella (3), E. Berra (3), D. Leone (3), P. Mulatero (3), F. Veglio (3), G.A. Fava (2), F. Fallo (1)(1) Padua, (2) Bologna, (3) Turin-ITALY
10 280 / BLOOD PRESSURE PROFILE IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM BEFORE AND AFTER SURGICAL TREATMENTL. Petramala, M.C. Formicuccia, L. Zinnamosca, D. Cotesta, C. Marinelli, S. Sciomer, G. Cavallaro, G. De Toma, C. LetiziaRome-ITALY
10 281 / SENSITIVITY, SPECIFICITY AND REPRODUCIBILITY OF THE ALDOSTERONE-TO-RENIN-RATIO AS A SCREENING TEST FOR PRIMARY ALDOSTERONISMP.M. Jansen, A.H.J. Danser, A.H. van den Meiracker, on behalf of the Dutch ARRAT InvestigatorsRotterdam-THE NETHERLANDS
Monday
20
444Monday 20444 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011445
Monday 2014.00 - 15.30Ground Floor
Poster Session 40
HEART FAILURE
ROOM 11 / POSTERS FROM 295 TO 311
Chairperson: L. Lonati (Milan-ITALY)
11 295 / THE IMPORTANCE OF BLOOD PRESSURE FOR THE PROGNOSIS OF PATIENT HOSPITALISED WITH ACUTE HEART - ACUTE HEART DATABASE (AHEAD) REGISTRYJ. Spinar (1), J. Parenica (1), J. Vitovec (1), P. Widimsky (2), A. Linhart (2), F. Malek (2), L. Spinarova (1), R. Miklik (1), J. Jarkovsky (1), L. Dusek (1)(1) Brno, (2) Prague-CZECH REPUBLIC
11 296 / PREVALENCE OF DIASTOLIC LEFT VENTRICULAR DYSFUNCTION IN EUROPEAN POPULATIONS BASED ON CROSS-VALIDATED DIAGNOSTIC THRESHOLDSM. Kloch-Badelek (1), T. Kuznetsova (2), W. Sakiewicz (3), V. Tikhonoff (4), A. Ryabikov (5), A. González (6), L. Thijs (2), Y. Jin (2), S. Malyutina (5), K. Stolarz-Skrzypek (1), E. Casiglia (4), J. Díez (6), K. Narkiewicz (3), K. Kawecka-Jaszcz (1), J. Staessen (2), on behalf of the European Project On Genes in Hypertension (EPOGH) Investigators(1) Cracow-POLAND; (2) Leuven-BELGIUM; (3) Gdansk-POLAND; (4) Padua-ITALY, (5) Novosibirsk-RUSSIA; (6) Pamplona-SPAIN
11 297 / THE EFFECT OF CARVEDILOL VERSUS METOPROLOL ON PERIPHERAL AND CENTRAL HEMODYNAMICS IN HEART FAILURE PATIENTS WITH GENETIC VARIANTS OF THE BETA2-RECEPTORB. Van den Bogaard, O. De Peuter, J. Truijen, P. Kamphuisen, B.J. Van den BornAmsterdam-THE NETHERLANDS
11 298 / AMLODIPINE, CALCIUM CHANNEL ANTAGONIST COULD PREVENT STRESS INDUCED CARDIAC DYSFUNCTION LIKE α AND β BLOCKERY. Takano, F. Ishikura, M. Egawa, K. Komaru, S. ToyokawaSuita-JAPAN
10 289 / INCREASED PREVALENCE OF ARTERIAL HYPERTENSION AMONG PATIENTS WITH NON-FUNCTIONING ADRENAL ADENOMASV. Vasilev, J. Matrozova, S. ZacharievaSofia-BULGARIA
10 290 / ADRENALECTOMY IMPROVES COMMON CAROTID INTIMA-MEDIA THICKNESS IN PRIMARY ALDOSTERONISMR. Holaj, B. Štrauch, J. Rosa, T. Zelinka, O. Petrák, D. Michalský, K. Novák, J. Widimský Jr.Prague-CZECH REPUBLIC
10 291 / AN ABDOMINAL CT SCAN IN FIRST LINE IS AN EFFICIENT INVESTIGATION IN RESISTANT HYPERTENSIVES SUSPECTED TO HAVE AN ADRENAL CAUSED. Rosenbaum, F. Villeneuve, C.H. Gury, X. GirerdParis-FRANCE
10 292 / GENETICALLY NEGATIVE PARAGANGLIOMA OF THE BLADDER IN CHILDREN. REPORT ON 3 CASESJ. Antoniewicz, M. Baka-Ostrowska, P. Gastoł, L. Skobejko-Włodarska, A. Kosciesza, B. Dembowska-Baginska, A. Januszewicz, M. Peczkowska, R. GrendaWarsaw-POLAND
10 293 / MODULATION OF THE ALDOSTERONE/MINERALOCORTICOID RECEPTOR SYSTEM IN AGED WKY AND SHR: EFFECT OF LONG-TERM FOOD RESTRICTIONP. Gomes, V. Pinto, M.J. Pinho, S. Simão, E. Silva, M.P. Serrão, P. Soares-Da-SilvaPorto-PORTUGAL
10 294 / BLOOD PRESSURE, GONADOTROPINES AND ESTRADIOL VARIATIONS IN WOMEN WITH MILD AND SEVERE HOT FLUSHESM. Stojanovic (1), V. Stojanov (1), M. Ivovic (1), M. Tancic (1), D. Lovic (2), L.J. Marina (1), M. Marinkovic (1), M. Matic (1), B. Subotic (1), J. Ciric (1), M. Zarkovic (1), S. Vujovic (1)(1) Belgrade, (2) Nis-SERBIA
Monday
20
446Monday 20446 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011447
Monday 20 11 307 / EFFECTS OF TESTOSTERONE ON CARDIAC FUNCTION IN PHYSICALLY ACTIVE RATSJ. Klimas, P. Krenek, G. Doka, J. KyselovicBratislava-SLOVAK REPUBLIC
11 308 / HEART FAILURE AND LEFT VENTRICULAR SYSTOLIC FUNCTION AFTER ACUTE Q-MYOCARDIAL INFARCTION WITH ANTECEDENT HYPERTENSIONE. Amosova, A. Bezrodnyi, I. Prudkiy, N. Netyazhenko, Y. Sychenko, O. GerulaKyiv-UKRAINE
11 309 / HYPERTENSION CONTROL AND POSTURAL BLOOD PRESSURE CHANGES IN HEART FAILURE PATIENTSB. Wizner (1), M. Fedyk-Łukasik (1), W. Musiał (2), J. Górski (3), T. Rywik (4), T. Grodzicki (1)(1) Cracow, (2) Bialystok, (3) Gdynia, (4) Warsaw-POLAND
11 310 / STATE OF AUTONOMIC REGULATION OF CARDIOVASCULAR SYSTEM IN PATIENTS WITH CHRONIC HEART FAILUREG. Dadashova, A BakhshaliyevBaku-AZERBAIJAN
11 311 / CHANGES OF PARAMETERS OF COAGULATION IN PATIENTS WITH HEART FAILURE TREATED WITH FILTRATION PLASMAPHERESISL. Simonyan, Lu. Simonyan, L. KhachatryanYerevan-ARMENIA
11 299 / THE EVALUATION OF CARDIOPULMONARY EXERCISE TEST IN PATIENTS WITH CHRONIC HEART FAILURE IN RELATION TO GENERATED BLOOD PRESSUREK. Malaczynska-Rajpold, I. Niskiewicz, M. Laskowski, E. Straburzynska-MigajPoznan-POLAND
11 300 / EFFECT OF HYPERTENSION ON CHRONIC HEART FAILURE PATIENTS PROGNOSISE. Mezhonov, S. ShalaevTyumen-RUSSIA
11 301 / PARAMETERS OF CENTRAL AORTIC PRESSURE AND ARTERIAL STIFFNESS IN HYPERTENSIVE PATIENTS WITH CHRONIC HEART FAILUREV. IvanenkoSt. Petersburg-RUSSIA
11 302 / PEAK OXYGEN PULSE IN MILD CHRONIC HEART FAILURE PATIENTS - THE EFFECTS OF BETA-BLOCKERSS. Dimopoulos, A. Ntalianis, A. Tasoulis, C. Kapelios, C. Manetos, S. Koutroumpi, V. Agapitou, G. Tzanis, S. Sventzouri, J. Terrovitis, S. NanasAthens-GREECE
11 303 / NEUROTICISM PERSONALITY TRAIT, ANXIETY STATE AND SEVERITY OF DISEASE, INDEPENDENTLY PREDICT QUALITY OF LIFE IN PATIENTS WITH CHRONIC HEART FAILUREL. Samartzis, S. Dimopoulos, E. Kaldara, C. Manetos, A. Ntalianis, V. Agapitou, S. Vakrou, S. Gyftopoulos, J. Terrovitis, S. NanasAthens-GREECE
11 304 / ECHOCARDIOGRAPHIC PARAMETERS IN PATIENTS WITH ARTERIAL HYPERTENSION AND DIASTOLIC HEART FAILUREM. Tsverava, D. TsveravaTbilisi-GEORGIA
11 305 / THE CONTROL OF BLOOD PRESSURE BY ABPM CAN REDUCE CONGESTIVE HEART FAILURE HOSPITAL READMISSION?E. Badila, S.A. Frunza, S. Ghiorghe, C. Tirziu, D. Bartos, M. DorobantuBucharest-ROMANIA
11 306 / EFFECTS OF BETA-BLOCKERS ON PEROXIDE OXIDATION IN ISCHEMIC MODEL OF CONGESTIVE HEART FAILURE IN RATSD. Shashurin, A. Piryazev, O. Azizova, O. MedvedevMoscow-RUSSIA
Monday
20
448Monday 20448 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011449
Monday 20 12 317 / INCREASE STROKE VOLUME DETERMINES A HYPERDYNAMIC PATTERN IN PREDOMINANTLY DIASTOLIC HYPERTENSIONC. Romero (1), R. Chamale (1), P. Jimenez (1), J. Alfi e (2), G. Waisman (2), A. Tabares (1), M. Orias (1)(1) Cordoba, (2) Buenos Aires-ARGENTINA
12 318 / TRANSTHORACIC DOPPLER ECHOCARDIOGRAPHY AND RIGHT HEART CATHETERIZATION IN THE ASSESSMENT OF SYSTOLIC PULMONARY ARTERY PRESSURE IN PATIENTS WITH IDIOPATHIC PULMONARY ARTERIAL HYPERTENSIONE. Kobal, N. Danilov, T. Martynyuk, O. Arkhipova, M. Saidova, I. ChazovaMoscow-RUSSIA
12 319 / THE CORRELATION BETWEEN ARTERIAL STIFFNESS AND THE CHANGE OF BLOOD PRESSURE AND PULSE WAVE VELOCITY BY ACUTE BLOOD PRESSURE REDUCTION: A STUDY USING BRACHIAL-ANKLE PULSE WAVE VELOCITY AND SUBLINGUAL ADMINISTRATION OF NITROGLYCERINJ.K. Park (1), J.H. Shin (1), S.H. Kim (2), Y.H. Lim (1), J.H. Shin (1), J.U. Lee (2), K.S. Kim (1), S.K. Kim (2), J.H. Kim (1), H.K. Lim (1)(1) Seoul, (2) Guri-SOUTH KOREA
12 320 / PARAMETERS OF CENTRAL HEMODYNAMICS AND ARTERIAL STIFFNESS IN YOUNG PATIENTS WITH ESSENTIAL HYPERTENSIONI. Chernova, S. Serdyuk, M. Loukianov, S. BoytsovMoscow-RUSSIA
12 321 / SHORT-TIME BLOOD PRESSURE FALLS IN PATIENTS WITH ARTERIAL HYPERTENSIONK. Protasov, V. Boronova, A. Dzizinsky, D. SinkevichIrkutsk-RUSSIA
12 322 / SYNCHRONISATION OF 0.1 HZ RHYTHMS IN CARDIOVASCULAR SYSTEM – PREDICTOR OF FATAL EVENTS IN FIVE-YEAR PERIODA. Kiselev, O. Posnenkova, V. Gridnev, V. Shwartz, M. Prokhorov, A. Karavaev, V. Ponomarenko, V. Bezruchko, P. DovgalevskySaratov-RUSSIA
12 323 / NON-UNIFORM EFFECT OF VERAPAMIL ON BAROREFLEX-MEDIATED VASOMOTION IN FOREARM MUSCLES OF HYPERTENSIVESI. Kukulis, V. Dzerve, D. Matisone, R. ErtsRiga-LATVIA
14.00 - 15.30Ground Floor
Poster Session 41
HAEMODYNAMICS
ROOM 12 / POSTERS FROM 312 TO 326
Chairperson: G. Schillaci (Perugia-ITALY)
12 312 / INTENSIFIED ANTIHYPERTENSIVE TREATMENT FOR 6 MONTHS DOES NOT IMPROVE EJECTION FRACTION OR VENTRICULO-VASCULAR COUPLING IN PATIENTS WITH TYPE-II-DIABETES AND HYPERTENSIONT.K. Sonder, J. Lambrechtsen, J. Hangaard, K. EgstrupSvendborg-DENMARK
12 313 / DIFFERENCES IN POSTPRANDIAL HEMODYNAMIC RESPONSE ON A HIGH PROTEIN VERSUS A HIGH CARBOHYDRATE DIETJ. Dopheide (1), J.M. Geleijnse (2), S.J.L. Bakker (3), E.J. Brink (4), M.A. van Baak (1), on behalf of Top Institute Food and Nutrition, Wageningen(1) Maastricht, (2) Wageningen, (3) Groningen, (4) Zeist-THE NETHERLANDS
12 314 / AN INVASIVE BUT SIMPLE AND ACCURATE METHOD FOR ASCENDING AORTA-FEMORAL ARTERY PULSE WAVE VELOCITY MEASUREMENTH. Kilic, S. Orcun, R. Akdemir, O. Karakurt, E. Yeter, M. Dogan, S. Acikel, G. Cagirci, U. ArslantasAnkara-TURKEY
12 315 / DIFFERENTIAL PROGNOSTIC IMPACT OF LEFT VENTRICLE PEAK WALL STRESS IN HYPERTENSIVE PATIENTS WITH A MYOCARDIAL INFARCTIONS. Barra, P. Gomes, L. Paiva, F. Caetano, C. Faustino, R. Providência, A. Leitão MarquesVila Nova De Gaia-PORTUGAL
12 316 / THE DIASTOLIC PART OF THE CENTRAL AORTIC PRESSURE WAVEFORM SHOULD NOT BE NEGLECTED IN PULSE WAVE ANALYSISA. Heim, L. Liaudet, B. Waeber, F. FeihlLausanne-SWITZERLAND
Monday
20
450Monday 20450 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011451
Monday 2014.00 - 15.30Ground Floor
Poster Session 42
CLINICAL ASPECTS
ROOM 13 / POSTERS FROM 327 TO 370
Chairperson: A. Oliveras (Barcelona-SPAIN)
13 327 / HYPERTENSIVE WOMEN ARE CHARACTERIZED BY POOR QUALITY OF LIFE COMPARED TO HYPERTENSIVE MENV. Katsi, G. Souretis, J. Orestis, J. Vlasseros, C. Benekos, M. Divani, D. Barlagiannis, N. Alexopoulos, C. VlachopoulosAthens-GREECE
13 328 / SECONDARY HYPERTENSION ASSOCIATED WITH RENAL ARTERY STENOSIS: STUDY POST-ANGIOPLASTYM.I. Poveda-García, M.A. Esteban-Moreno, F.J. González-Martínez, M.D. Del Pino Y PinoAlmería-SPAIN
13 329 / IS MICROALBUMINURIA RELATED TO CAROTID ABNORMALITIES IN ELDERLY SUBJECTS?M. Otero-Losada, J.H. Altamirano, D. Sanchez Gelos, J. MileiBuenos Aires-ARGENTINA
13 330 / HEMORHEOLOGY, SUBCLINICAL INFLAMMATION AND CIRCADIAN RHYTHM OF BLOOD PRESSURE IN THE ESSENTIAL HYPERTENSIVE PATIENTSV. Dmitriev, E. Oschepkova, N. Ageeva, A. Rogoza, V. TitovMoscow-RUSSIA
13 331 / SYSTEMATIC REVIEW: NEUTROPHILS AND CLINICAL OUTCOMES IN PATIENTS WITH ACUTE CORONARY SYNDROMES AND/OR CARDIAC REVASCULARIZATIONL. Guasti, F. Dentali, L. Castiglioni, L. Maroni, F. Marino, A. Squizzato, W. Ageno, G. Gaudio, A.M. Grandi, M. Cosentino, S. Contini, V. Macchi, M. Serratì, G. Interlandi, A. VencoVarese-ITALY
12 324 / CENTRAL HEMODYNAMICS, MYOCARDIAL FUNCTION AND LEFT HEART CHAMBERS REMODELING IN THE PATIENTS WITH POSTINFARCTION CARDIOSCLEROSIS AND NON-ALCOHOLIC FATTY LIVER DISEASEM. Dolzhenko (1), A. Bazylevich (2), S. Potashev (1)(1) Kiev, (2) Lviv-UKRAINE
12 325 / THE EFFECT OF COLD PRESSOR TEST UPON ARTERIAL STIFFNESS IN HYPERTENSIVE PATIENTS WITH OR WITHOUT OTHER CARDIOVASCULAR RISK FACTORSK. Keramida, E. Karpanou, G. VyssoulisAthens-GREECE
12 326 / CENTRAL AORTIC PRESSURE ESTIMATED BY RADIAL APPLANATION TONOMETRY IN HYPERTENSIVE PULMONARY OEDEMAO. Istratoaie, R. MustafaCraiova-ROMANIA
Monday
20
452Monday 20452 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011453
Monday 20 13 340 / COMPARISON OF INTERFERENCE OF HYPERTENSION AND SLEEP DISORDERS AMONG NORMAL ADULT POPULATION AND REFUGEESL. Chinchaladze, M. Janelidze, M. Beridze, M. Jibladze, N. Lobjanidze, T. Maisuradze, N. Akiashvili, S. Kapianidze, M. KapianidzeTbilisi-GEORGIA
13 341 / THE ASSOCIATIONS BETWEEN METABOLIC DISORDERS, 24-H AMBULATORY BLOOD PRESSURE MONITORING AND ADIPONECTIN LEVEL IN PATIENTS WITH ESSENTIAL HYPERTENSIONA. Brzeska, J. Porzezinska-Furtak, K. Widecka, T. MiazgowskiSzczecin-POLAND
13 342 / PREVENTION OF RADIAL ARTERY GRAFT VASOSPASM DURING CABG IN PATIENTS WITH ARTERIAL HYPERTENSION COMBINED WITH ISCHEMIC HEART DISEASE: CLINICAL ASPECTSM. Dyakova, Y. Vechersky, V. Zatolokin, K. EremenkoTomsk-RUSSIA
13 343 / USEFULNESS OF A SIMPLE ANTICIPATORY PRESCRIPTION TOOL TO FIGHT AGAINST THERAPEUTIC INERTIA IN ARTERIAL HYPERTENSIONJ.J. Mourad, S. Le Jeune, M. Lopez-Sublet, on behalf of THE CASSANDRE STUDY INVESTIGATORSBobigny-FRANCE
13 344 / BLOOD PRESSURE CONTROL IN ELDERLY PATIENTSP.J. Labrador, P.M. Gonzalez CastilloPlasencia-SPAIN
13 345 / HIGH SODIUM CONSUMPTION: A SIMPLE RULE TO IDENTIFY INDIVIDUALS AT RISKL. Luzardo Domenichelli, J. Boggia, M. Sottolano, I. Lujambio, A. Barindelli, O. NoboaMontevideo-URUGUAY
13 346 / THE ROLE OF PSYCHOLOGICAL ASPECTS IN HYPERTENSIVE PATIENTSM.L. Genesia, E. Testa, E. Berra, M. Covella, S. Totaro, D. Leone, F. Rabbia, F. VeglioTurin-ITALY
13 332 / PREVALENCE OF LEFT VENTRICULAR HYPERTROPHY IN GENERAL POPULATION BY SEVENTEEN DIFFERENT ELECTROCARDIOGRAPHIC CRITERIA. THE HERMEX STUDYF. Felix-Redondo (1), D. Fernandez-Berges (1), A. Calderon (2), L. Consuegra (3), V. Barrios (2), P. Alvarez-Palacios (1), A. Hidalgo (1), V. Tejero (1), Y. Morcillo (1)(1) Villanueva De La Serena, (2) Madrid, (3) Cartagena-SPAIN
13 333 / MAGNESIUM THERAPY IN BORDERLINE HYPERTENSIONK. Kisters (1), F. Tokmak (2), M.Q. Nguyen (2), B. Gremmler (1), C. Funke (1), M. Hausberg (3)(1) Herne, (2) Bochum, (3) Karlsruhe-GERMANY
13 334 / FACTORS ASSOCIATED WITH CONTROL OF HYPERTENSION IN OUR AREAM.Á. Barón Ramos, A. Ruz Zafra, M.I. Maiz Jiménez, A. Perez Rivera, I. Gallardo Romero, A. Ruiz CanteroRonda-SPAIN
13 335 / ERECTILE DYSFUNCTION AND CORONARY ARTERY DISEASE IN HYPERTENSIVE MEN: A DIFFERENT REALITY?F. Caetano, I. Almeida, J. Silva, L. Paiva, P. Mota, A. Botelho, A. Leitão-MarquesCoimbra-PORTUGAL
13 336 / CLINICAL CHARACTERISTICS OF ELDERLY PATIENTS WITH NEWLY-DIAGNOSED HYPERTENSIONS. Seki, I. Taniguchi, M. YoshimuraTokyo-JAPAN
13 337 / ASSESSMENT OF MICROALBUMINURIA IMPROVES THE DEFINITION OF CARDIOVASCULAR RISK PROFILE IN HYPERTENSIVE PATIENTSA. Meccariello (1), F. Buono (1), F. Basile (2), V. Falco (2), E. Fedele (2), F. Romeo (3), C. Morisco (1)(1) Naples, (2) Nola, (3) Rome-ITALY
13 338 / ARTERIAL HYPERTENSION IN LONG-LIVERS: PREVALENCE, CLINICAL CHARACTERISTICSV. Sushynsky, M. PristromMinsk-BELARUS
13 339 / ELECTRIC HEART INSTABILITY IN MEN OF STRESS PROFESSIONS WITH ARTERIAL HYPERTENSIONK. Shakhmatova, A. Zalzman, O. Antropova, I. Osipova, N. LobanovaBarnaul-RUSSIA
Monday
20
454Monday 20454 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011455
Monday 20 13 354 / DIAGNOSTIC APPROACH AND TREATMENT OF HYPERTENSION AMONG HEALTH CARE WORKERS POPULATIONC. Konin, M. Adoh, E. Kramoh, J.B. Anzouan-Kacou, R. N’guetta, A. Yaye, J.J. N’djessan, A. Essam N’looAbidjan-IVORY COAST
13 355 / LATE FOLLOW UP OF THE LEFT VENTRICULAR GEOMETRY IN HYPERTENSIVE PATIENTS WITHOUT REMODELINGD. Piskorz, A. TommasiRosario-ARGENTINA
13 356 / IMPACT OF BLOOD PRESSURE IN DAMAGE SUBCLINICAL TARGET ORGAN IN HYPERTENSIVE PATIENTSR.E. Peñuela Rodriguez, J. Lopez, I. Bastidas, R. Hernandez, M. Serrano, W. Zerpa, B. Roman, T. Peñuela, S. PereiraSan Cristobal-VENEZUELA
13 357 / LEFT VENTRICULAR HYPERTROPHY: INFLUENCE OF ECHOCARDIOGRAPHIC METHOD USED ON THE PROGNOSISS. Cinza Sanjurgo (1), J.E. López Paz (2), A. Hermida Ameijeiras (2), G. Calvo González (2), M.L. Romero Míguez (2), V. Martinez Durán (2), A. Pascual Montes (2), J.M. Paz Fernández (2), G. Calvo Gómez (2)(1) Malpica, (2) Santiago De Compostela-SPAIN
13 358 / RELATIONSHIP BETWEEN WAVE INTENSITY ANALYSIS AND CAROTID STIFFNESS IN DETECTION OF VENTRICULAR ARTERIAL STIFFENINGD. Skultetyova, S. Filipova, P. Chnupa, J. SkultetyBratislava-SLOVAK REPUBLIC
13 359 / PREVALENCE OF ORGANIC DAMAGE AND SUBCLINICAL LESIONS IN REFRACTORY HYPERTENSIOND. Abellan Rivero, N. Ortega Lopez, P. Gomez Jara, S. Balanza Galindo, G. Ortega Gonzalez, J. Rodriguez Romero, J.L. Abellan Atenza, J. Abellan AlemanMurcia-SPAIN
13 360 / HOW TO DETERMINE THE ANKLE BRACHIAL INDEX IN THE INTERNAL MEDICINE OFFICES OF TWO SPANISH HOSPITALSJ.J. Tamarit-García, B. Roig-Espert, C. Sala-Sáinz, F. García-Tolosa, L. Sánchez-Suárez, A. Sáez-Segura, J.M. Giner-Morales, I. Carbonell-Casañ, V. Navarro-IbánezValencia-SPAIN
13 347 / EFFECT OF ANTIHYPERTENSIVE TREATMENT WITH QUINAPRIL ON BLOOD PRESSURE VARIABILITY AND HEART RATE VARIABILITY PARAMETERS IN ESSENTIAL HYPERTENSIVE PATIENTS ACCORDING TO TIME OF DRUG ADMINISTRATIONA. Niklas, K. Niklas, A. Radziemski, A. TykarskiPoznan-POLAND
13 348 / MENOPAUSE AND BLOOD PRESSURE CONTROLJ. Zilberman, A. Vicario, G. Cerezo, M. Del SueldoCordoba-ARGENTINA
13 349 / THE RESPONSIVENESS OF THE BRACHIAL-ANKLE PULSE WAVE VELOCITY RELATIVE TO ACUTE BLOOD PRESSURE REDUCTION AND ITS CLINICAL DETERMINANTSJ.K. Park (1), J.H. Shin (1), S.H. Kim (2), Y.H. Lim (1), J.H. Shin (1), J.U. Lee (2), K.S. Kim (1), S.K. Kim (2), J.H. Kim (1), H.K. Lim (1)(1) Seoul, (2) Guri-SOUTH KOREA
13 350 / EVALUATION OF BODY FLUID DISTRIBUTION AND HORMONAL SYSTEMS IN HYPERTENSIONC. Catena, G.L. Colussi, C. Petri, F. Pezzutto, L.A. SechiUdine-ITALY
13 351 / HEADACHE: PREVALENCE OF A NEW CARDIOVASCULAR RISK FACTOR IN PATIENTS WITH ARTERIAL HYPERTENSIONS. Leoni, B. Stagni, S. Flori, I. Serio, L. Bolondi Bologna-ITALY
13 352 / LEFT VENTRICULAR HYPERTROPHY IN HYPERTENSIVE PATIENTS - THE IMPORTANCE OF BLOOD PRESSURE CONTROL AND CARDIOVASCULAR RISKM. Santos, J. Silva, T. Rodrigues, L. SíopaSantarém-PORTUGAL
13 353 / EVALUATION OF PATIENTS ADMITTED TO A DEPARTMENT OF SUB-ACUTE CARE WITH A DIAGNOSIS OF INJURY AFTER AN ACCIDENTAL FALL: PREVALENCE OF TRUE SYNCOPEL.M. Beltrami, L. Bagnara, V. De Grazia, A. Fontanella, R. Ghidini, A. Lucini, V. Mansi, F. Zilli, L.C. Zingale, L.A. Dalla VecchiaMilan-ITALY
Monday
20
456Monday 20456 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011457
Monday 20 13 368 /FREQUENCY AND RISK FACTORS ASSOCIATED WITH HELLP SYNDROMEP. Stanciu, M. Craina, E. Bernad, C. Serban, R. NituTimisoara-ROMANIA
13 369 / PREVALENCE AND PREDICTIVE VALUE OF MASKED HYPERTENSION IN PREGNANCYO. Papazachou, C. Thomopoulos, M. Daskalaki, N. Rodolakis, D. Papadopoulos, A. Komnou, M. Papavassiliou, T. MakrisAthens-GREECE
13 370 / MATERNAL AND FETAL OUTCOME IN PATIENTS WITH HELLP SYNDROME AS A SEVERE HYPERTENSIVE DISORDER IN PREGNANCYM.L. Miranda Guisado, A.J. Vallejo Vaz, P. Stiefel García-Junco, V. Alfaro Lara, L.M. Beltrán Romero, L. Gómez Morales, S. Rodríguez Suarez, A. González, J. Villar OrtizSevilla-SPAIN
13 361 / THE PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN RUSSIAN FEDERATION IN NATIONAL-WIDE DIREG STUDYO. Drapkina, V. IvashkinMoscow-RUSSIA
13 362 / RESISTANT HYPERTENSION IN A GENERAL POPULATION IN NORTHERN ITALY: PREVALENCE, ASSOCIATED CARDIOVASCULAR RISK FACTORS AND TARGET ORGAN DAMAGEM. Salvetti, M.L. Muiesan, A. Paini, C. Agabiti Rosei, C. Aggiusti, F. Bertacchini, D. Stassaldi, F. Beschi, S. Cobelli, G. Rubagotti, C. Monteduro, M. Castellano, E. Agabiti RoseiBrescia-ITALY
13 363 / PREVALENCE OF HYPERTENSION AND EFFECTIVENESS OF ITS TREATMENT IN CORONARY HEART DISEASE PATIENTS OF NORTH CAUCASUSR. Didigova (1), Z. Ugurchieva (1), M. Imagozeva (2), A. Inarokova (2), A. Kontsevaya (3), M. Mamedov (3)(1) Magas, (2) Nalchik, (3) Moscow-RUSSIA
13 364 / DEFINITION OF HYPERTENSION IN AFRICAP. Ghataorhe (1), N. Heeney (2), M. Rehan (2), R. Sahibzada (2), N. Heeney (2), M. Ahmad (1), I. Jawad (1), K. Nijjer (1)(1) Gillingham, (2) London-UK
13 365 / PROGNOSTIC VALUE OF WHITE-COAT DIAGNOSED BY AMBULATORY MONITORING IN INITIALLY UNTREATED SUBJECTSC. dos Santos Moreira, P. Alcântara, C. Alcântara, V. Ramalhinho, C. Bastos, J. Braz NogueiraLisbon-PORTUGAL
13 366 / ASSOCIATION OF EARLY SYSTOLIC BLOOD PRESSURE RESPONSE TO EXERCISE WITH FUTURE CARDIOVASCULAR EVENTS IN UNCOMPLICATED MILD TO MODERATE HYPERTENSIVE PATIENTM.S. Cho, C.H. Lee, J.Y. Lee, C. ParkSeoul-SOUTH KOREA
13 367 / INCREASING OF HIGHLY SENSITIVE C-REACTIVE PROTEIN AND FIBRINOGEN LEVELS IN WOMEN WITH PREECLAMPSIAM. Craina, P. Stanciu, E. Bernad, C. Serban, R. NituTimisoara-ROMANIA
Monday
20
458Monday 20458 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011459
Monday 20 14 376 / EFFICACY OF TREATMENT BASED ON LORISTA HD – LOSARTAN 100 MG + HYDROCHLORTHIAZIDE 25 MG IN COMPARISON WITH COMBINATION BISOPROLOL 10 MG + HYDROCHLORTHIAZIDE 25 MG IN PATIENTS WITH MODERATE AND SEVERE ARTERIAL HYPERTENSION: ELIZA TRIALG. Radchenko, X. Micheeva, Yu. Sirenko, S. Kushnir, G. PonomarevaKiev-UKRAINE
14 377 / ADDITION OF SPIRONOLACTONE IN PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION (ASPIRANT): A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIALJ. Václavík (1), R. Sedlák (2), M. Plachý (3), K. Navrátil (1), J. Plášek (4), J. Jarkovský (3), T. Václavík (5), R. Husár (6), E. Kociánová (1), M. Táborský (1)(1) Olomouc, (2) Proste˛jov, (3) Brno, (4) Ostrava, (5) Prague, (6) Hranice n. Mor.-CZECH REPUBLIC
14 378 / DECREASING SLEEP-TIME BLOOD PRESSURE DETERMINED BY AMBULATORY MONITORING REDUCES CARDIOVASCULAR RISK IN RESISTANT HYPERTENSIONR. Hermida (1), D.E. Ayala (1), A. Mojon (1), L. Chayan (2), M.J. Dominguez (2), M.J. Fontao (1), I. Alonso (1), J.R. Fernandez (1)(1) Vigo, (2) Santiago de Compostela-SPAIN
14 379 / NO DIFFERENCE IN PULSE WAVE VELOCITY BETWEEN PRIMARY HYPERALDOSTERONISM AND ESSENTIAL HYPERTENSIONI. Kantola, V. Väliaho, J. VarisTurku-FINLAND
14 380 / IMPACT OF INDAPAMIDE SR, AMLODIPINE, AND CANDESARTAN ON BLOOD PRESSURE VARIABILITY: THE X-CELLENT TRIALY. Zhang (1), D. Agnoletti (2), M.E. Safar (2), J. Blacher (2)(1) Shanghai-CHINA; (2) Paris-FRANCE
14 381 / BLOOD PRESSURE REDUCTION IN CARDIO-RENAL HYPERTENSIVE PATIENTS: RESULTS FROM THE 3A REGISTRYM. Lehmann (1), R. Dechend (2), E. Kaiser (3), E. Deeg (4), J. Senges (4), U. Zeymer (4), R.E. Schmieder (1)(1) Erlangen, (2) Berlin, (3) Nuernberg, (4) Ludwigshafen-GERMANY
14 382 / AMLODIPINE/VALSARTAN SINGLE PILL COMBINATION REAL LIFE SAFETY AND EFFECTIVENESS IN THE TREATMENT OF HYPERTENSIONI. Chazova (1), N. Dongre (2), A. Vigdorchik (1)(1) Moscow-RUSSIA; (2) Basel-SWITZERLAND
14.00 - 15.30Ground Floor
Poster Session 43
CLINICAL TRIALS
ROOM 14 / POSTERS FROM 371 TO 392
Chairperson: A. Oliveras (Barcelona-SPAIN)
14 371 / ADMINISTRATION-TIME DIFFERENTIAL BENEFIT ON CARDIOVASCULAR RISK REDUCTION OF THE VARIOUS CLASSES OF HYPERTENSION MEDICATIONSR.C. Hermida, D.E. Ayala, A. Mojon, J.R. FernandezVigo-SPAIN
14 372 / CHARACTERISTICS OF CONTROLLED VS RESISTANT ESSENTIAL HYPERTENSIVE PATIENTS AFTER A STANDARDIZED 4-WEEK THREE DRUG-REGIMENG. Bobrie, M. Frank, M. Azizi, S. Peyrard, P. Boutouyrie, G. Chatellier, S. Laurent, J. Menard, P.F. PlouinParis-FRANCE
14 373 / CHIEF: CHINESE HYPERTENSION INTERVENTION EFFICACY STUDYW. Wang, L.Y. Ma, M.B. Liu, Q. Deng, Y.Q. Zhang, L.S. LiuBeijing-CHINA
14 374 / ADMINISTRATION-TIME DEPENDENT EFFECTS ON AMBULATORY BLOOD PRESSURE OF HYDROCHLOROTHIAZIDE AS ADDED THERAPY IN HYPERTENSIVE SUBJECTS UNCONTROLLED WITH VALSARTAND.E. Ayala, R.C. Hermida, A. Mojon, J.R. FernandezVigo-SPAIN
14 375 / INFLUENCE OF NUMBER OF HYPERTENSION MEDICATIONS AND CIRCADIAN TIME OF TREATMENT ON CARDIOVASCULAR MORBIDITY AND MORTALITYR. Hermida, D.E. Ayala, A. Mojon, J.R. FernandezVigo-SPAIN
Monday
20
460Monday 20460 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011461
Monday 20 14 390 / DIFFERENTIAL EFFECTS OF ANTIHYPERTENSIVE TREATMENT ON OXIDATIVE STRESS AND INFLAMMATIONM. Serg (1), P. Kampus (1), J. Kals (1), M. Zagura (1), J. Eha (1), K. Zilmer (1), T. Kullisaar (1), C.M. Mceniery (2), I.B. Wilkinson (2), M. Zilmer (1)(1) Tartu-ESTONIA; (2) Cambridge-UK
14 391 / THE INFLUENCE OF AGE AND INITIAL BLOOD PRESSURE LEVELS ON BLOOD PRESSURE CONTROL AND TOLERABILITY IN HYPERTENSIVE PATIENTS UNDER SINGLE PILL FIXED-DOSE COMBINATION OF ANGIOTENSIN RECEPTOR BLOCKER AND CALCIUM CHANNEL BLOCKERB. Boyaci (1), P. Kizilirmak (2), M. Berktas (2)(1) Ankara, (2) Istanbul-TURKEY
14 392 / ALISKIREN/AMLODIPINE COMBINATION THERAPY LOWERS BLOOD PRESSURE MORE EFFECTIVELY THAN AMLODIPINE ALONE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS OR METABOLIC SYNDROMER.C. Braun-Dullaeus (1), D. Zappe (2), C. Cherif Papst (3), J. Zhang (2)(1) Magdeburg-GERMANY; (2) East Hanover-USA; (3) Basel-SWITZERLAND
14 383 / CHANGES IN WITHIN- AND BETWEEN-INDIVIDUAL BP VARIABILITY WITH BETA-BLOCKER, DIURETIC AND CALCIUM ANTAGONISTT. Bejan-Angoulvant (1), H. Charvat (1), V. Musini (2), F. Boutitie (1), M. Perez (2), J.A. Staessen (3), S.J. Pocock (4), J.M. Wright (2), F. Gueyffi er (1)(1) Bron Cedex-FRANCE; (2) Vancouver-CANADA; (3) Leuven-BELGIUM; (4) London-UK
14 384 / COMPARATIVE STUDY OF A LONG-TERM CONTINUOUS THERAPY BY ANTAGONISTS OF CALCIUM IN PATIENTS WITH ARTERIAL HYPERTENSIONF.Z. Gasimova, R.N. Mammadova, F.N. GasimovaBaku-AZERBAIJAN
14 385 / HAEMODYNAMIC IN PENILE ARTERIES AND DYNAMIC OF SEXUAL HORMONES IN MEN WITH ESSENTIAL HYPERTENSION IN SHORT-TERM MONOTHERAPY BY BISOPROLOL, NEBIVOLOL, CARVEDILOLG. Nur-Mammadova, I. MustafayevBaku-AZERBAIJAN
14 386 / ALISKIREN-BASED ANTIHYPERTENSIVE TREATMENT REGIMEN PROVIDES EFFECTIVE BLOOD PRESSURE CONTROL IN PATIENTS WITH DIABETESD. Richter (1), C. Mickel (2), S. Acharya (3), C. Militaru (4), P. Brunel (5)(1) Jarny-FRANCE; (2) East Hanover-USA; (3) Hyderabad-INDIA; (4) Craiova-ROMANIA; (5) Basel-SWITZERLAND
14 387 / ADDITION OF HYDROCHLOROTHIAZIDE INCREASES ANTIHYPERTENSIVE EFFICACY IN PATIENTS WITH MODERATE-TO-SEVERE HYPERTENSION WHOSE BLOOD PRESSURE IS INADEQUATELY CONTROLLED BY DUAL COMBINATION THERAPY WITH OLMESARTAN MEDOXOMIL PLUS AMLODIPINEJ. Scholze (1), D. Magometschnigg (2)(1) Berlin-GERMANY; (2) Wien-AUSTRIA
14 388 / EFFECTS OF OLMESARTAN MEDOXOMIL/AMLODIPINE COMBINATION THERAPY ON AMBULATORY BLOOD PRESSURE GOAL ACHIEVEMENT IN PATIENTS WITH MODERATE-TO-SEVERE HYPERTENSIONG. Bilo (1), G. Parati (1), W. Koch (2)(1) Milan-ITALY; (2) Schriesheim-GERMANY
14 389 / DOSE-DEPENDENT EFFICACY OF PERINDOPRIL ARGININE IN PATIENTS WITH ARTERIAL HYPERTENSION IN THE PREMIA NATIONAL PROGRAMI. Chazova, V. Mychka, M. Kirilova, U. ProkhorovaMoscow-RUSSIA
Monday
20
462Monday 20462 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011463
Monday 20 15-16 398 / CHRONOTHERAPEUTIC ADMINISTRATION OF ALOPURINOL AT PREHYPERTENSIONA. Hermida Ameijeiras, J.E. López Paz, M. Pena Seijo, G. Calvo Gonzalez, M.L. Romero Míguez, A. Pascual Montes, V. Martinez Durán, A. Pose Reino, I. Rodríguez López, C. Calvo GómezSantiago De Compostela-SPAIN
15-16 399 / ARE HYPERTENSIVE PATIENTS WITH A MYOCARDIAL INFARCTION APPROPRIATELY TREATED?S. Barra, L. Paiva, R. Providência, P. Gomes, C. Faustino, F. Caetano, A. Leitão MarqueVila Nova De Gaia-PORTUGAL
15-16 400 / INFLUENCE OF THE LONG-TERM THERAPY BY RAMIPRIL AND LOSARTAN ON THE PLATELET AGGREGATION IN PATIENTS WITH ARTERIAL HYPERTENSIOND. Shorikova, E. ShorikovChernivtsy-UKRAINE
15-16 401 / EPROSARTAN-BASED HYPERTENSION THERAPY, SYSTOLIC ARTERIAL BLOOD PRESSURE AND COGNITIVE FUNCTION: ANALYSIS OF MIDDLE EAST DATA FROM THE OSCAR STUDYG.A. Radaideh (1), P. Choueiry (2), E. Eid (2), A. Ismail (2), J-P. Berrou (3),A. Sedefdjian (4), F. Sévenier (4), A. Pathak (5), on behalf of the OSCAR Publication Group(1) Dubai-UNITED ARAB EMIRATES; (2) Beirut-LEBANON; (3) Allschwil-SWITZERLAND; (4) Rueil-Malmaison, (5) Toulouse-FRANCE
15-16 402 / BLOOD PRESSURE RESPONSES TO EPROSARTAN-BASED THERAPY AND TRENDS IN COGNITIVE FUNCTION IN PATIENTS WITH INITIAL RESISTANT HYPERTENSION: SUB-ANALYSIS OF THE OSCAR STUDYR.J. Petrella (1), E. Shlyakhto (2), A.O. Conrady (2), J-P. Berrou (3), A. Sedefjian (4), A. Pathak (5), on behalf of the OSCAR Publication Group(1) London-CANADA; (2) St. Petersburg-RUSSIA; (3) Allschwil-SWITZERLAND; (4) Rueil-Malmaison, (5) Toulouse-FRANCE
15-16 403 / ALISKIREN CHRONOTHERAPEUTIC REGIMEN IN NO-DIPPER HYPERTENSIVE SUBJECTSJ.E. López Paz, A. Hermida Ameijeiras, M. Pena Seijo, G. Calvo Gonzalez, M.L. Romero Míguez, F. Lado Lado, I. Rodríguez López, A. Pose Reino, C. Calvo GómezSantiago De Compostela-SPAIN
14.00 - 15.30Ground Floor
Poster Session 44
THERAPEUTIC ASPECTS
ROOMS 15-16 / POSTERS FROM 393 TO 440
Chairperson: A. Oliveras (Barcelona-SPAIN)
15-16 393 / ADVANCED FORM OF PERINDOPRIL ARGININE IN THE TREATMENT OF HYPERTENSIVE MENOPAUSAL AND NON-MENOPAUSAL WOMEN IN THE NATIONAL PROGRAM «PREMIA»M. Kirillova, V. Mychka, J. Prokhorova, S. Olimpieva, V. Kilikovsky, I. ChazovaMoscow-RUSSIA
15-16 394 / EFFECTS OF ALISKIREN-BASED THERAPY ON AMBULATORY BLOOD PRESSURE PROFILE AND CENTRAL AORTIC PRESSURE IN UNTREATED PATIENTS WITH MILD-TO-MODERATE ESSENTIAL HYPERTENSIONT. Kanaoka, K. Tamura, H. Wakui, M. Osawa, M. Yanagi, S. Haku, A. Maeda, T. Dejima, K. Azushima, K. Azuma, Y. Toya, S. UmemuraYokohama-JAPAN
15-16 395 / THE ANTIHYPERTENSIVE AND RENOPROTECTIVE EFFICACY OF ALISKIREN: RESULTS OF EVERY OTHER DAY ADMINISTRATIONG. Spanos, R. Kalaitzidis, K. Pappas, D. Karasavvidou, E. Evangelou, K. SiamopoulosIoannina-GREECE
15-16 396 / EFFECTS OF ALISKIREN VERSUS TELMISARTAN ON CENTRAL AORTIC SYSTOLIC PRESSURE DURING ACTIVE TREATMENT AND FOLLOWING TREATMENT WITHDRAWALR. Düsing (1), B. Williams (2), F. Baschiera (3), I-Y. Baek (3), P. Brunel (3)(1) Bonn-GERMANY; (2) Leicester-UK; (3) Basel-SWITZERLAND
15-16 397 / IRBESARTAN/AMLODIPINE FIXED COMBINATION IN PATIENTS UNCONTROLLED ON AMLODIPINE 5 MG (I-COMBINE STUDY)G. Bobrie, on behalf of the I-COMBINE investigatorsParis-FRANCE
Monday
20
464Monday 20464 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011465
Monday 20 15-16 412 / RENAL SYMPATHETIC NERVE DENERVATION FOR THE TREATMENT OF RESISTANT HYPERTENSION: FIRST RESULTS IN ROTTERDAM, THE NETHERLANDSN. Van der Linde, T. Leertouwer, P. Pattynama, A. Van den MeirackerRotterdam-THE NETHERLANDS
15-16 413 / CHANGES OF MARKERS FOR SUDDEN CARDIAC DEATH IN PATIENTS WITH ARTERIAL HYPERTENSION AND CORONARY ARTERY DISEASE DURING IVABRADINE THERAPYN. Koziolova, M. Surovtseva, M. Eltsova, A. ChernyavinaPerm-RUSSIA
15-16 414 / IMPACT OF COMPUTER SYSTEM USING TEXT MESSAGES FOR PATIENT FEEDBACK ON BLOOD PRESSURE CONTROL IN PATIENTS WITH ARTERIAL HYPERTENSIONO. Posnenkova, A. Kiselev, V. Gridnev, V. Schwarz, P. DovgalevskySaratov-RUSSIA
15-16 415 / THE EFFECT OF DIFFERENT NITRATES FORMS ON 24-HOUR BLOOD PRESSURE IN PATIENTS WITH ANGINA PECTORIS AND HYPERTENSIONN. Pozdnyakova, V. Gorbunov, E. KokurinaMoscow-RUSSIA
15-16 416 / THE IMPACT OF A COMMUNITY TRIAL ON PHARMACOLOGICAL TREATMENT IN INDIVIDUALS WITH METABOLIC SYNDROME 2000-2007: FINDINGS FROM THE ISFAHAN HEALTHY HEART PROGRAMM. GharipourIsfahan-IRAN
15-16 417 / EFFECTIVENESS OF HIGH DOSE OF PERINDOPRIL/INDAPAMIDE FIXED COMBINATION ON AMBULATORY BLOOD PRESSURE ADDED TO CURRENT ANTIHYPERTENSIVE THERAPY IN UNCONTROLLED HYPERTENSIVE PATIENTSD. Raev, T. YanevSofia-BULGARIA
15-16 418 / INFLUENCE COMBINATION LERCANIDIPINE WITH DILTIAZEM ON BLOOD PRESSURE AND CENTRAL BLOOD PRESSURE IN PATIENTS WITH MILD TO MODERATE ARTERIAL HYPERTENSIONO. Rekovets, Yu. Sirenko, A. Dobrokhod, G. Primak, A. Vaschilko, K. Mikheeva, S. Kushnir, E. Pavlyuk, V. GranichKiev-UKRAINE
15-16 404 / MAGNESIUM SUPPLEMENTATION ON BLOOD PRESSURE, INTRACELLULAR IONS LEVEL AND INSULIN RESISTANCE IN HYPERTENSIVE PATIENTS USING DIURETICSV. Maluly, M. Rodrigues, D. Valença, M. Torres, S. Argolo, J. Nogueira Neto, A. SanjulianiRio de Janeiro-BRAZIL
15-16 405 / PECULIARITIES OF BETA BLOCKERS EFFECT ON HEART RATE VARIABILITY IN HYPERTENSIVE PATIENTS WITH DIFFERENT SYMPATHO-VAGAL BALANCET. OvdiienkoKiev-UKRAINE
15-16 406 / INAPPROPRIATE ANTIPLATELET THERAPY IN HYPERTENSIONV. Gil-Guillen (1), V. Pallares-Carratala (2), M.J. Matinez (1), Z. Perseguer (1), D. Orozco (1), M. Mayor (1), F. Valls-Roca (3)(1) San Juan, (2) Burriana, (3) Beniganim-SPAIN
15-16 407 / ARTERIAL BLOOD PRESSURE CONTROL AND AGE: THE EXPERIENCE OF A SINGLE CENTRES. Flori, S. Leoni, B. Stagni, I. Serio, L. BolondiBologna-ITALY
15-16 408 / LERCANIDIPINE EFFECTS IN HYPERTENSIVE NEPHROPATHY PATIENTSL. Bezrodna, L. Mishchenko, V. Bezrodnyy, O. Kupchinska, M. MospanKiev-UKRAINE
15-16 409 / POPULATION PHARMACOKINETIC-PHARMACODYNAMIC ANALYSIS OF THE ANTIHYPERTENSIVE EFFECT OF EPROSARTANP.C. Van Rijn-Bikker (1), O. Ackaert (2), R. van Hest (3), N. Snelder (2), B. Ploeger (2), G. van Montfrans (1), R. Koopmans (4), R. Mathot (1)(1) Amsterdam, (2) Leiden, (3) The Hague, (4) Maastricht-THE NETHERLANDS
15-16 410 / PHYSICIAN’S EXPECTATIONS ABOUT NEW DRUGS FOR THE CONTROL OF HYPERTENSION: THE HYPERTENSION 2020 PROJECTA. Coca (1), E. Lopez De Sa (2), P. Aranda (3), P. Conthe (2), J.L. Llisterri (4), J. Ampudia (4)(1) Barcelona, (2) Madrid, (3) Malaga, (4) Valencia-SPAIN
15-16 411 / ANTIHYPERTENSIVE AND VASOPROTECTIVE EFFICACY OF COMBINED THERAPY WITH LERCANIDIPINE AND PERINDOPRIL IN HYPERTENSIVE PATIENTSL. Hafi sova, G. Khamidullaeva, B. Karimova, F. ZakirovaTashkent-UZBEKISTAN
Monday
20
466Monday 20466 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011467
Monday 20 15-16 425 / COMPARATIVE TRIAL OF ANGIOTENSIN RECEPTOR BLOCKER (ARB)–DIURETIC VERSUS ARB–CALCIUM CHANNEL BLOCKER COMBINATION THERAPY FOR HYPERTENSION UNCONTROLLED BY ARB MONOTHERAPY: THE KANAGAWA COMBINATION ANTIHYPERTENSIVE THERAPY (K-CAT) STUDYJ. Oshikawa (1), Y. Toya (1), J. Okabayashi (2), S. Kobayashi (3), T. Mikawa (4), M. Miyakawa (1), K. Shimizu (5), G. Yasuda (1), K. Kimura (4), S. Umemura (1)(1) Yokohama, (2) Yamato, (3) Kamakura, (4) Kawasaki, (5) Sagamihara-JAPAN
15-16 426 / CLINICAL AND VASOPROTECTIVE EFFICIENCY OF COMBINED THERAPY WITH LERCANIDIPINE WITH PERINDOPRIL AND EPROSARTAN IN HYPERTENSIVE PATIENTSL. Khafi zova, F. Zakirova, B. Karimova, G. KhamidullaevaTashkent-UZBEKISTAN
15-16 427 / EFFECT OF COMBINED THERAPY WITH LERCANIDIPINE AND RAMIPRIL ON LEFT VENTRICULAR HYPERTROPHY IN ELDERLY PATIENTS WITH ISOLATED SYSTOLIC HYPERTENSIONE. Ter-Stepanyants, A. Ordyan, L. Aleksanyan, A. Naghdalyan Yerevan-ARMENIA
15-16 428 /COMPARISON OF MONOTHERAPY VS COMBINATION THERAPY ON BLOOD PRESSURE CONTROLE. Arslan (1), S. Erdine (1), M. Senocak (1), A.M. Erdem (1), A. Kaya (2)(1) Istanbul, (2) Konya-TURKEY
15-16 429 / LEFT VENTRICULAR DIASTOLIC DYSFUNCTION, PULSE PRESSURE AND CENTRAL PRESSURE IN HYPERTENSIVE PATIENTS SUBMITTED TO COMBINED OR MONOTHERAPY TREATMENTR. Cabrera Sole, S. Garcia Ruiz, S.J. Martinez Gonzalez, C. Turpin Lucas,M. Aguilera Saldaña, M.J. Fernandez MartinezAlbacete-SPAIN
15-16 430 / COMPARATIVE EFFECTIVENESS OF RENIN ANGIOTENSIN SYSTEM BLOCKADES PLUS CCB OR DIURETIC FOR ESSENTIAL HYPERTENSION: A SYSTEMATIC REVIEWR. Ma, X. Zhang, L. Yang, F. Bai, J. YuLanzhou-CHINA
15-16 419 / DIFFERENTIAL EFFECTS BETWEEN ALISKIREN AND BENAZEPRIL WHEN USED IN COMBINATION WITH ANGIOTENSIN II RECEPTOR BLOCKER ON ALBUMINURIA AND CARDIAC HYPERTROPHY IN CHRONIC KIDNEY DISEASE PATIENTS WITH HYPERTENSIONM. Ohsawa, K. Tamura, K. Azushima, S. Haku, T. Kanaoka, A. Maeda, T. Dejima, H. Wakui, K. Azuma, Y. Toya, S. UmemuraYokohama-JAPAN
15-16 420 / FIXED COMBINATION OF VALSARTAN AND AMLODIPINE: DECREASE OF CARDIOVASCULAR RISKS IN PATIENTS WITH HYPERTENSION ACCOMPANIED BY METABOLIC SYNDROMEN. Maksimchuk, E. Tarlovskaya, S. Malchicova, I. SapozhnikovaKirov-RUSSIA
15-16 421 / AMLODIPINE AND VALSARTAN SINGLE PILL COMBINATION EFFICACY AND SAFETY IN TREATMENT OF ARTERIAL HYPERTENSION IN REAL LIFE PRACTICE IN RUSSIAI. Chazova, Y. Karpov, A. Vigdorchik, A. ZazulinaMoscow-RUSSIA
15-16 422 / LONG-TERM EFFICACY AND SAFETY OF COMBINATION OLMESARTAN MEDOXOMIL/AMLODIPINE BESYLATE+HYDROCHLOROTHIAZIDE STRATIFIED BY AGE: A TRINITY STUDY SUBGROUP ANALYSISS. Chrysant (1), D. Kereiakes (2), S. Oparil (3), J. Izzo (4), T. Littlejohn (5), M. Melino (6), J. Lee (6), V. Fernandez (6), R. Heyrman (6)(1) Oklahoma City, (2) Cincinnati, (3) Birmingham, (4) Buffalo, (5) Winston-Salem, (6) Parsippany-USA
15-16 423 / EFFECTIVENESS OF COMBINATION OF THE DIRECT RENIN INHIBITOR ALISKIREN AND HYDROCHLOROTHIAZIDE IN HYPERTENSIVE PATIENTSL. Samerkhanova, M. Loukyanov, S. BoizovMoscow-RUSSIA
15-16 424 / BLOOD PRESSURE REDUCTION WITH FIXED-COMBINATION PERINDOPRIL ARGININE/AMLODIPINE IN THE IMPRESS NATIONAL PROGRAMR. Accetto, P. DolencLjubljana-SLOVENIA
Monday
20
468Monday 20468 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011469
Monday 20 15-16 438 / THE POSSIBILITY OF RECEIVING ALISKIREN IN OBESE PATIENTS WITH ARTERIAL HYPERTENSIONE. Velizhanina, T. Zhupanova, A. RudakovTyumen-RUSSIA
15-16 439 / EFFICIENCY OF EPLERENONE AS FIRST CHOICE ADDITION DRUG TO THE TREATMENT OF RESISTANT HYPERTENSIOND. Agapakis (1), M. Baltatzi (2), Ch. Savopoulos (2), E. Massa (2), A. Myrou (2), E. Satsoglou (1), A. Hatzitolios (2)(1) Goumenissa, (2) Thessaloniki-GREECE
15-16 440 / THE EFFECT OF ANTIHYPERTENSIVE DRUGS ON SYSTOLIC BLOOD PRESSURE OF HYPERTENSIVE PATIENTS OVER THE COURSE OF THEIR TREATMENTA. Ptinopoulou (1), I. Tziolas (1), M. Pikilidou (1), B.H. Stricker (2), P. Zebekakis (1), O. Giata (1), A. Lasaridis (1)(1) Thessaloniki-GREECE; (2) Rotterdam-THE NETHERLANDS
15-16 431 / EFFICACY AND SAFETY OF LOSARTAN AND COMBINATION OF LOSARTAN AND AMLODIPINE IN THE TREATMENT OF HYPERTENSIONE. Bazaeva, E. Mordvinova, A. Rogoza, M. Loukyanov, S. BoytsovMoscow-RUSSIA
15-16 432 / EFFICACY OF THE SINGLE-PILL COMBINATION OF ALISKIREN 300/AMLODIPINE 10MG (+/- HCT 12.5) IN HYPERTENSIVE PATIENTS NOT CONTROLLED BY THE COMBINATION OF OLMESARTAN 40/AMLODIPINE 10MG INCLUDING A SUBANALYSIS OF THE NON ELDERLY VS ELDERLYC. Axthelm (1), C. Sieder (2), E. Kaiser (2)(1) Pirna, (2) Nuernberg-GERMANY
15-16 433 / EFFICACY OF THE SINGLE-PILL COMBINATION OF ALISKIREN 300/AMLODIPINE 10MG IN HYPERTENSIVE PATIENTS NOT CONTROLLED BY THE COMBINATION OF OLMESARTAN 40/AMLODIPINE 10MG - A SUBANALYIS IN OVERWEIGHT, OBESE AND METABOLIC RISK PATIENTSA. Axthelm (1), C. Sieder (2), E. Kaiser (2)(1) Pirna, (2) Nuernberg-GERMANY
15-16 434 / EFFECT OF COMBINATION THERAPY WITH PERINDOPRIL AND AMLODIPINE ON ARTERIAL HYPERTENSION AND HEART RATE VARIABILITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASEM. Drambyan, N. Fljyan, A. Ter-Margaryan, Y. MakaryanYerevan-ARMENIA
15-16 435 / COMPARATIVE EVALUATION OF THE IMPACT OF DIFFERENT COMBINATION IN ANTIHYPERTENSIVE THERAPY IN HYPERTENSIVE PATIENTSK. Nikoghosyan, S. Gurgenyan, S. VatinianYerevan-ARMENIA
15-16 436 / INFLUENCE OF THE LEFT VENTRICULAR HYPERTROPHY AND ELEVATED ARTERIAL STIFFNESS ON CORONARY EVENTS IN PATIENTS WITH ARTERIAL HYPERTENSION AND EFFICACY OF LONG-TERM TREATMENTS. Gurgenyan, S. Vatinyan, K. NikoghosyanYerevan-ARMENIA
15-16 437 / EFFICACY OF ROSUVASTATIN ON GLUCOSE, LIPID METABOLISM AND BLOOD PRESSURE VALUES IN HYPERTENSIVE ELDERLY PATIENTSL. Susan, C. Serban, A. Pacurari, I. Mozos, R. Susan, A. Narita, S. Gotia, M. Susan, I. RomosanTimisoara-ROMANIA
Monday
20
470Monday 20470 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011471
Monday 20 17 447 / ANTI-INFLAMMATORY EFFECTS OF ESTROGEN AND RALOXIFEN: A MATTER OF TIMINGS. Novella (1), M. Heras (2), C. Hermenegildo (1), A.P. Dantas (2)(1) Valencia, (2) Barcelona-SPAIN
17 448 / EVIDENCE THAT CAT1 OVER EXPRESSION CAN PREVENT OXIDATIVE STRESS INDUCED HYPERTENSIONG. Konstantinidis, G. Head, R. Evans, T. Nguyen-Huu, D. Kaye, N. RajapakseMelbourne-AUSTRALIA
17 449 / BIOCHEMICAL AND CLINICAL CHARACTERISTICS OF HYPOURICEMICS PATIENTS WITH RESPECT TO THOSE WITH NORMAL OR HIGH URIC ACID LEVELSA.Y. Sanchez (1), S. Suria (1), M. Riaño (1), N. Esparza (1), C. Garcia-Canton (1), F. Batista (1), I. Auyanet (1), V. Garcia-Nieto (2), M.D. Checa (1)(1) Las Palmas, (2) Santa Cruz De Tenerife-SPAIN
17 450 / NOMOGRAM OF CIRCULATING SOLUBLE FMS-LIKE TYROSINE KINASE-1 AND PLACENTAL GROWTH FACTOR IN NORMOTENSIVE THAI PREGNANT WOMENT. Wataganara, B. Pratumvinit, J. Leetheerakul, S. Pongprasobchai, P. Lahfahroengron, J. PooliamBangkok-THAILAND
17 451 / MATURATION OF THE POSTJUNCTIONAL RESPONSES TO ANGIOTENSIN II IN THE RABBIT AORTAE. César, L. Graça, L. Coutinho, M. Moreira-Rodrigues, D. Moura, on behalf of Neuropharmacology, IBMC, PortoPorto-PORTUGAL
14.00 - 15.30Ground Floor
LATE-BREAKER POSTER SESSION 3
ROOM 17 / POSTERS FROM 441 TO 451
Chairperson: L. Lonati (Milan-ITALY)
17 441 / DEPRIVATION AND BLOOD PRESSURE IN PEOPLE ATTENDING PRIVATE MEDICAL SCREENING: A RETROSPECTIVE ANALYSISL. Guo (1), A. Ogunleye (2), G. Sandercock (2), D. Brodie(1) Uxbridge, (2) Colchester-UK
17 442 / USE OF ALISKIREN IN THE CLINICAL PRACTICE: DATA FROM A LARGE ITALIAN COHORT OF HYPERTENSIVE PATIENTS INCLUDED IN THE NATIONAL AIFA WEB-BASED DRUG MONITORING SYSTEMM. Volpe (1), G. Tocci (1), F. Bianchini (2), M. De Rosa (3), E. Fedozzi (3), A. Covezzoli (3), A.P. Maggioni (2) (1) Rome, (2) Florence, (3) Casalecchio di Reno- ITALY
17 443 / RELATIONSHIP BETWEEN RENAL FUNCTION, LEFT VENTRICULAR DIASTOLIC FUNCTION AND PLASMA NT-PROBNP IN ESSENTIAL HYPERTENSIVE PATIENTSY. Yang, Y. Wang, P.J. GaoShanghai-CHINA
17 444 / ROLE OF (PRO)RENIN RECEPTOR BLOCKADE IN PREVENTING OBESITY AND OBESITY-RELATED DISEASEB. Ahmed, S. Bisotto, C. Michel, T. Nguyen, P.W. Schiller, J.L. LavoieMontréal-CANADA
17 445 / MYOCARDIAL REMODELING IN HYPERTENSIVE PATIENTS WITH IMPAIRED GLUCOSE TOLERANCEO. Kochubei, O. Kovalyova, G. DemydenkoKharkiv-UKRAINE
17 446 / CARBOHYDRATE AND LIPID METABOLISM DISORDERS IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITYO. Pionova, O. KovalyovaKharkiv-UKRAINE
Monday
20
472Monday 20472 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011473
Monday 2014.30 - 15.30Blue Hall
Meet-The-Expert Session
WHEN TO USE RENAL ANGIOPLASTY
Chairperson: A. Morganti (Milan-ITALY)
14.30 - 15.30Red Hall
Clinical Case
HYPERTENSION AND DYSLIPOPROTEINEMIA
Chairperson: J.M. Mallion (Grenoble-FRANCE)
Monday
20
474Monday 20474 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011475
Monday 2015.30 - 17.00 Red Hall
Workshop on Current Topics
SESSION III
Chairpersons: J. Chalmers (Sydney-AUSTRALIA) H. Wang (Beijing-CHINA)
Hypertension and neglected co-morbiditiesC. Borghi (Bologna-ITALY) Immunosystem and hypertensionD.N. Müller (Berlin-GERMANY) Isolated diastolic hypertensionJ. Sundström (Uppsala-SWEDEN) High salt intake: a catastrophy?R.E. Schmieder (Erlangen-GERMANY) General Discussion
14.30 - 15.30Yellow Hall
How-To Session
HOW TO ASSESS AND INTERPRET RETINAL CHANGES
Chairperson: C. Cuspidi (Monza-ITALY)
Traditional assessment of retinal vascular changes in arterial hypertension: value and limitationsC. Cuspidi (Monza-ITALY) Recent approaches in retinal vascular imagingD. Rizzoni (Brescia-ITALY)
Monday
20
476Monday 20476 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011477
Monday 2015.30 - 17.00Yellow Hall
Topical Workshop
JOINT SYMPOSIUM EUROPEAN SOCIETY OF HYPERTENSION (ESH) AND LATINAMERICAN SOCIETY OF HYPERTENSION (LASH)
Chairpersons: A. Coca (Barcelona-SPAIN) R. Sánchez (Buenos Aires-ARGENTINA) Epidemiology of cardiovascular risk in Latinamerican countriesD. Piskorz (Buenos Aires-ARGENTINA) Evaluation of silent damage in low resource countriesJ. Redon (Valencia-SPAIN) Evaluation of biological markers of heart damage in hypertensionJ. Diez (Pamplona-SPAIN) European Guidelines vs JNC Guidelines in Latinamerican countriesM. Díaz (Montevideo-URUGUAY)
15.30 - 17.00Blue Hall
Topical Workshop
OBSTRUCTIVE SLEEP APNOEA (OSA): AN UNRECOGNIZED CARDIOVASCULAR RISK FACTOR
Chairpersons: G. Parati (Milan-ITALY) J. Hedner (Gotenburg-SWEDEN) How to identify OSAJ. Hedner (Gotenburg-SWEDEN) OSA, resistant hypertension and strokeK. Narkiewicz (Gdansk-POLAND) OSA and arrhythmiasJ.L. Pépin (Grenoble-FRANCE) Treatment of OSA and of OSA-related hypertensionR. Tkacova (Kosice-SLOVAK REPUBLIC)
Monday
20
478Monday 20478 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011479
Monday 2016.10BLOOD PRESSURE REDUCTION IN 7000 ELDERLY HYPERTENSIVE PATIENTS: RESULTS FROM THE 3A REGISTRYR.E. Schmieder (1), M. Lehmann (1), R. Dechend (2), E. Kaiser (3), E. Deeg (4), J. Senges (4), U. Zeymer (4)(1) Erlangen, (2) Berlin, (3) Nuernberg, (4) Ludwigshafen-GERMANY 16.20BLOOD PRESSURE LOWERING DRUGS DO NOT DECREASE THE RISK OF SUDDEN DEATHY. Mimouni (1), A. Le Digarcher (1), M. Armanet (1), R. Quarta Colosso (1), T. Bejan Angoulvant (1), P. Chevalier (1), J.M. Wright (2), F. Gueyffi er (1)(1) Bron-FRANCE, (2) Vancouver-CANADA 16.30THE EFFECT OF CARVEDILOL, NEBIVOLOL AND METOPROLOL ON CENTRAL ARTERIAL PRESSURE AND ITS DETERMINANTS: A RANDOMIZED CLINICAL TRIALP. Studinger (1), P. Torzsa (1), B. Fekete (1), J. Kapocsi (1), Z. Jarai (1), J. Nemcsik (1), A. Tabak (1), T. Othmane (1), P. Salvi (2), A. Tisler (1)(1) Budapest-HUNGARY; (2) Nancy-FRANCE
16.40BLOOD PRESSURE TARGETS RECOMMENDED BY GUIDELINES AND INCIDENCE OF CARDIOVASCULAR AND RENAL EVENTS IN THE ONTARGET TRIALG. Mancia (1), H. Schumacher (2), J. Redon (3), P. Verdecchia (4), R. Schmieder (5), G. Jennings (6), K. Yusoff (7), L. Ryden (8), G.-L. Liu (9), R. Fagard (10), K. Teo (11), P. Sleight (12), S. Yusuf (11)(1) Milan-ITALY; (2) Ingelheim-GERMANY; (3) Valencia-SPAIN; (4) Assisi-ITALY; (5) Erlangen-GERMANY; (6) Melbourne-AUSTRALIA; (7) Selangor-MALAYSIA; (8) Stockholm-SWEDEN; (9) Beijing-CHINA; (10) Leuven-BELGIUM; (11) Hamilton-CANADA; (12) Oxford-UK
16.50BENEFITS AND PSYCHOLOGICAL RISKS OF M-HEALTH REMOTE PATIENT MONITORING OF HYPERTENSION IN DIABETES: A 1-YEAR RANDOMIZED CONTROLLED TRIALA. Tisler (1), J. Irvine (2), W. McIsaac (2), D. Feig (2), J. Cafazzo (2), A. Logan (2)(1) Budapest-HUNGARY; (2) Toronto-CANADA
15.30 - 17.00Orange Hall 1
Parallel Oral Session 9A
CLINICAL TRIALS
Chairpersons: R. Accetto (LJublJana-SLOVENIA) J.K. Cruickshank (Manchester-UK) 15.30EFFECTS OF VALSARTAN FOR HIGH-RISK HYPERTENSIVE PATIENTS WITH NEW-ONSET DIABETES: NEW FINDING FROM KYOTO HEART STUDYT. Sawada, S. Kimura, J. Shiraishi, H. Yamada, H. MatsubaraKyoto-JAPAN 15.40EFFECT OF ATORVASTATIN TREATMENT ON ARTERIAL STIFFNESS AND CENTRAL AORTIC BLOOD PRESSURE IN PATIENTS WITH MILD HYPERTENSION AND HYPERCHOLESTEROLEMIA. A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDYA. Kanaki, P. Georgianos, P. Sarafi dis, I. Tziolas, E. Zairi, L. Hadjistavri, V. Liakopoulos, S. Iliadis, V. Tyradelli, A. LasaridisThessaloniki-GREECE 15.50BLOOD PRESSURE VARIABILITY IN RELATION TO AUTONOMIC NERVOUS DYSREGULATION: THE X-CELLENT TRIALY. Zhang (1), D. Agnoletti (2), J. Blacher (2), M.E. Safar (2)(1) Shanghai-CHINA; (2) Paris-FRANCE 16.00PREDICTIVE FACTORS OF BLOOD PRESSURE CONTROL IN RESISTANT HYPERTENSION TREATED BY SEQUENTIAL NEPHRON BLOCKADE VS SEQUENTIAL RENIN ANGIOTENSIN SYSTEM BLOCKADEG. Bobrie, M. Franck, M. Azizi, S. Peyrard, P. Boutouyrie, G. Chatellier, S. Laurent, J. Menard, P-F. PlouinParis-FRANCE
Monday
20
480Monday 20480 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011481
Monday 2016.10THE SHORT TERM EFFECT OF BARIATRIC SURGERY ON HAEMODYNAMICSB. Van Den Bogaard, B.A. De Weijer, M.J. Serlie, B.J. Van Den BornAmsterdam-THE NETHERLANDS
16.20PULSE WAVE VELOCITY IN YOUNG PEOPLE: ROLE OF BIRTH WEIGHT, POSTNATAL GROWTH, LIFESTYLE, ANTHROPOMETRIC AND HEMODYNAMIC PARAMETERSP. Salvi (1), M. Temmar (2), L. Joly (3), M. Iaia (4), C. Borghi (1), A. Benetos (3)(1) Bologna-ITALY; (2) Ghardaia-ALGERIA; (3) Nancy-FRANCE; (4) Cesena-ITALY 16.30DIFFERENT CALIBRATION METHODS FOR ESTIMATION OF CENTRAL BLOOD PRESSURE PROVIDES CLINICALLY DIFFERENT RESULTST.K. Sonder, J. Lambrechtsen, J. Hangaard, K. EgstrupSvendborg-DENMARK
16.40LECTURE EXERCISE AS THERAPY IN HYPERTENSION: PHYSIOPATHOLOGICAL BACKGROUNDM. PaganiMilan-ITALY
15.30 - 17.00Orange Hall 2
Parallel Oral Session 9B
HAEMODYNAMICS
Chairpersons: E. Gerdts (Bergen-NORWAY) C. Grassos (Athens-GREECE) 15.30AORTIC ROOT DILATATION IN HYPERTENSIVE PATIENTS: A MULTICENTER SURVEY IN ECHOCARDIOGRAPHIC PRACTICEC. Cuspidi, F. Negri, M. Salvetti, L. Lonati, C. Sala, A. Capra, A. Milan, G.B. Danzi, A. Morganti, on behalf of Working Group on Heart and Hypertension of the Italian Society of HypertensionMilan-ITALY
15.40RENAL FLOW RESERVE IS ASSOCIATED WITH ADMA LEVELS IN HYPERTENSION. AN INVASIVE APPROACH OF RENAL MICROCIRCULATIONC. Tsioufi s, D. Tsiachris, G. Latsios, K. Dimitriadis, I. Tatsis, D. Syrseloudis, D. Rousos, C. StefanadisAthens-GREECE
15.50THE ISOLATED AND ASSOCIATED EFFECTS OF AEROBIC EXERCISE AND LOW-DOSE ESTROGEN THERAPY ON BLOOD PRESSURE, SYMPATHETIC NERVE ACTIVITY AND FOREARM BLOOD FLOW IN HEALTHY POSTMENOPAUSAL WOMENB. Oneda, T. Araújo, J. Gusmão, F. Bernardo, C. Forjaz, S. Abrahão, E. Labes,A. Fonseca, D. Mion Jr, T. Tinucci São Paulo-BRAZIL
16.00PULSE PROPAGATION AND WAVE REFLECTION IN ARTERIES: NEW INSIGHTS USING ADVANCED MODELING METHODSL. Taelman, J. Degroote, A. Swillens, J. Vierendeels, P. SegersGent-BELGIUM
Monday
20
482Monday 20482 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011483
Monday 2016.30LONGITUDINAL TRACKING OF MUSCLE SYMPATHETIC NERVE ACTIVITY AND ITS RELATIONSHIP WITH BLOOD PRESSURE IN NORMOTENSIVE SUBJECTSD. Hering, K. Czechowicz, R. Nowak, W. Kucharska, K. NarkiewiczGdansk-POLAND 16.40IMPACT OF ELEVATED PERIPHERAL CHEMOSENSITIVITY ON SPONTANEOUS BAROREFLEX FUNCTION IN CHRONIC HEART FAILURE PATIENTS WITH CARDIORENAL ANAEMIA SYNDROMEN. Franchitto, F. Despas, M Labrunee, M. Galinier, J.M. Senard, A. PathakToulouse-FRANCE 16.50ASSOCIATION OF BETA-1 ADRENERGIC RECEPTOR SER49GLY POLYMORPHISM WITH BEAT-TO-BEAT CARDIAC DYNAMICS IN LATINSJ.E. Ochoa (1), M.M. Correa (2), J.A. Gallo (2), J.G. McEwen (2), G. Bilo (1), D. Aristizabal (2), G. Parati (1)(1) Milan-ITALY; (2) Medellin-COLOMBIA
15.30 - 17.00Orange Hall 3
Parallel Oral Session 9C
NEURAL MECHANISMS
Chairpersons: J.L. Reid (Glasgow-UK) C. Rump (Dusseldorf-GERMANY) 15.30LECTURESLEEP, DEATH AND THE HEARTV.K. SomersRochester, MN-USA 15.50SUSTAINED VOLTAGE-DEPENDENT RESPONSE OF BLOOD PRESSURE WITH CAROTID BAROREFLEX ACTIVATION IN RESISTANT HYPERTENSIONT. Alnima, I. Scheffers, P.W. De Leeuw, B. Winkens, H.A. Jongen-Vancraybex,A.A. KroonMaastricht-THE NETHERLANDS 16.00MUSCLE SYMPATHETIC NERVE ACTIVITY IS NOT INFLUENCED BY LONG-TERM SLOW BREATHING TRAINING IN HYPERTENSIOND. Hering (1), W. Kucharska (1), T. Kara (2), V.K. Somers (2), G. Parati (3), K. Narkiewicz (1)(1) Gdansk-POLAND; (2) Rochester-USA; (3) Milan-ITALY 16.10NEUROADRENERGIC PROFILE IN PATIENTS WITH RESISTANT HYPERTENSIONG.L. Seravalle (1), M. Volpe (2), F. Ganz (2), L. Magni (2), G. Brambilla (2), R. Dell’oro (2), M. Bombelli (2), G. Mancia (2), G. Grassi (2)(1) Milan, (2) Monza-ITALY 16.20CHANGES IN SYMPATHETIC TONE CORRELATE WITH REGIONAL CHANGES IN BRAIN ACTIVATIONJ. Coulson, K. Murphy, A. Harris, M. Fjodorova, J. Cockcroft, R. WiseCardiff-UK
Monday
20
484Monday 20484 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011485
Monday 2016.10TISSUE-SPECIFIC REGULATION OF KIBRA GENE EXPRESSION IN NEUROBLASTOMA AND KIDNEY CELLSK. Guske, M. Herrmann, M. Schelleckes, B. Schmitz, K. Duning,J. Kremerskothen, S.M. Brand, E. BrandMunster-GERMANY 16.20MOLECULAR MECHANISM FOR ANGIOTENSIN II INDUCED PROTEINURIAE. Koenigshausen, M. Ruetze, U. Zierhut, S.A. Potthoff, M. Woznowski, J. Stegbauer, I. Quack, L.C. Rump, L. SellinDusseldorf-GERMANY
16.30SMOKING AND OBESITY ASSOCIATED BDNF GENE VARIANCE PREDICTS TOTAL AND CARDIOVASCULAR MORTALITY IN SMOKERS (THE CARENORTH CONSORTIUM)S. Halldén (1), M. Sjögren (1), B. Hedblad (1), G. Engström (1), K. Narkiewicz (2), M. Hoffmann (2), B. Wahlstrand (3), T. Hedner (3), O. Melander (1)(1) Malmö-SWEDEN; (2) Gdansk-POLAND; (3) Göteborg-SWEDEN
16.40PROTEIN KINASE, CGMP-DEPENDENT, TYPE I GENE (PRKG1) AFFECTS SALT-SENSITIVE HYPERTENSION MEDIATING SMOOTH MUSCLE CELL RELAXATION AND VASODILATIONL. Citterio, S. Delli Carpini, M. Simonini, C. Lanzani, L. Zagato, E. Brioni, C. Barlassina, E. Salvi, D. Cusi, P. ManuntaMilan-ITALY 16.50ISOLATION OF A QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 18 INFLUENCING VARIABILITY OF BP AND PULSE INTERVAL IN SODIUM LOADED SPONTANEOUSLY HYPERTENSIVE RATSG. Parati (1), T. Kurtz (2), M. Pravenec (3), M. Di Rienzo (1), G. Mancia (1), P. Castiglioni (1)(1) Milan-ITALY; (2) Ann Arbor-USA; (3) Prague-CZECH REPUBLIC
15.30 - 17.00Green Hall 1
Parallel Oral Session 9D
GENETICS/MOLECULAR BIOLOGY
Chairpersons: J. Hoyer (Marburg-GERMANY) A.V. Stanton (Dublin-IRELAND) 15.30LONGITUDINAL CHANGE IN BLOOD PRESSURE IN RELATION TO 5 CANDIDATE GENES AND URINARY SODIUM EXCRETION IN 1405 SUBJECTS FROM 5 EUROPEAN POPULATIONSK. Stolarz-Skrzypek (1), T. Kuznetsova (2), L. Thijs (2), W. Wojciechowska (1), V. Tikhonoff (3), J. Seidlerova (4), E. Brand (5), G. Bianchi (6), S. Malyutina (7), E. Casiglia (3), J. Filipovsky (4), K. Kawecka-Jaszcz (1), Y. Nikitin (7), J. Staessen (2), on behalf of the European Project on Genes in Hypertension (EPOGH) Investigators(1) Krakow-POLAND; (2) Leuven-BELGIUM; (3) Padua-ITALY; (4) Pilsen-CZECH REPUBLIC; (5) Munster-GERMANY; (6) Milan-ITALY; (7) Novosibirsk-RUSSIA 15.40INVESTIGATION OF THE 9P21 LOCUS AS A SUSCEPTIBLE LOCUS FOR RENAL ARTERIAL FIBROMUSCULAR DYSPLASIAX. Jeunemaitre, E. Grand, D. Vernerey, D. Kahila, T. Ong, L. Golmard, B. Fiquet,J. Julien, A.P. Gimenez-Roqueplo, P. Meneton, P. Boutouyrie, M. Azizi, P.F PlouinParis-FRANCE 15.50TRANSCRIPTIONAL REGULATION OF SOLUBLE ADENYLYL CYCLASE AND SAC BINDING TO CAMP RESPONSE ELEMENT BINDING SITESM. Herrmann, K. Guske, B. Schmitz, A. Salomon, S.M. Brand, E. BrandMunster-GERMANY
16.00ANALYSIS OF 5´-FLANKING REGULATORY ELEMENTS OF THE HUMAN IMMUNODEFICIENCY VIRUS TYPE I ENHANCER BINDING PROTEIN 1 (HIVEP1)A. Salomon (1), B. Schmitz (1), A. Rötrige (1), E. Brand (1), P.E. Morange (2), F. Cambien (3), L. Tiret (3), D. Tregouet (3), S.M. Brand (1)(1) Munster-GERMANY; (2) Marseille, (3) Paris-FRANCE
Monday
20
486Monday 20486 21st European Meeting on Hypertension and Cardiovascular Prevention
Milan 17-20, 2011487
Monday 2018.30 - 20.30Orange Hall 1
Special Workshop from Balcan Countries
Chairpersons: A.J. Manolis (Athens-GREECE) V. Stojanov (Belgrade-SERBIA) Cardiovascular risk assessment: are we understanding?S. Erdine (Istanbul-TURKEY) Hypertension and target organ damage: experiences from SerbiaD. Lovic (Nis-SERBIA) Are we ready for an epidemiological study in Balkan countries?A. Pittaras (Athens-GREECE) EUROASPIRE III - Coaching primary care modelD. Gaita (Timisoara-ROMANIA)
17.00 - 18.30Auditorium
Plenary Session
Chairpersons: S.B. Harrap (Melbourne-AUSTRALIA) J.L. Rodicio (Madrid-SPAIN)
17.00 - 17.20Lennart Hansson Memorial LectureCross-talk between the kidney and the cardiovascular systemL.M. Ruilope (Madrid-SPAIN) 17.20 - 17.55DebateHeart rate reduction in hypertension: benefi cial or detrimental? Detrimental: F.H. Messerli (New York, NY-USA)Benefi cial: S. Julius (Ann Arbor, MI-USA) 17.55 - 18.30DebateMeta-analysis: fi rst-rank evidence or second-hand information? First-rank: J. Staessen (Leuven-BELGIUM)Second-hand: A. Zanchetti (Milan-ITALY)
Monday
20
488Monday 20488
18.30 - 20.30 Orange Hall 2
ESH Working Group ON HYPERTENSION AND THE KIDNEY
THE PREHYPERTENSIVE KIDNEY
Chairperson: P.W. de Leeuw (Maastricht-THE NETHERLANDS)
Early markers of renal dysfunction in prehypertensionA. Rosenkranz (Graz-AUSTRIA) Tubulo-interstitial changes in early hypertensionH. Haller (Hannover-GERMANY) Renal dysfunction and chronic abnormalities in prehypertensionL.M. Ruilope (Madrid-SPAIN) Pathophysiological renal characteristics of prehypertensionP.W. de Leeuw (Maastricht-THE NETHERLANDS) Fibromuscular dysplasia in prehypertension: the French approachA. Persu (Brussels-BELGIUM)